Hospitals, private hospital assessment and Medicaid funding program sunset clause removed.
1st Chamber
2nd Chamber
Executive
check_circle_outline
check_circle_outline
check_circle_outline
check_circle_outline
Introduced
January 14, 2026
Passed (Senate)
March 11, 2026
Passed (House)
April 01, 2026
Enacted
April 09, 2026
Enacted • 2026 Regular Session • Introduced: January 14, 2026
Sponsors: Greg Albritton (R)
Summary
AI Overview
FULL SUMMARY
The bill makes Alabama’s “hospital provider privilege tax” regime for privately operated hospitals permanent for the state fiscal years 2026, 2027, and 2028 by continuing and extending the existing hospital assessment and Medicaid financing/payment structure in the Code of Alabama. It does so by revising multiple sections governing the assessment base (net patient revenue), creation and use of the Hospital Assessment Account, hospital payment methodologies (inpatient and outpatient base and access payments), conditions for assessment/tax takeoff and refunds, and the treatment of federal participation.
Key changes include: (1) the assessment imposed on each privately operated hospital remains 6.00% of net patient revenue for state fiscal years 2026–2028, using Medicare cost report data for fiscal year ending 2023/2024/2025 as applicable (with annual review/update) and a mechanism for the Medicaid Agency to report adverse Medicaid reimbursement impacts that would prompt proposed legislative changes; (2) refinements to net patient revenue determination logistics, including use of CMS Healthcare Cost Report Information System data and a requirement that hospitals submit a copy to the department if CMS data is not available, or if a hospital commenced operations after the applicable Medicare cost-report due date; and (3) continuing the “Hospital Assessment Account” structure within the Health Care Trust Fund, specifying allowable sources and uses of funds, separation from the State General Fund, restrictions against supplanting Medicaid general revenues, exemptions from certain budget cuts, and limits on carrying over balances through fiscal year 2028, after which remaining funds are refunded proportionally if there is no new assessment beginning October 1, 2028.
For Medicaid hospital payments, the bill preserves/continues the payment framework for fiscal years 2026–2028: the agency must pay inpatient and outpatient “base” amounts calculated from per diem (or a specified 2019 inpatient payments-to-patient-days methodology) and outpatient fee schedules (with potential updates subject to Hospital Services and Reimbursement Panel approval). It also keeps “access payments” tied to the upper payment limit (UPL) structure: all eligible hospitals receive access payments so that total payments (including base payments) aggregate to the UPL for each category (public/state-owned vs. privately operated) until the Hospital Assessment Account is exhausted; inpatient and outpatient access payments are required on a quarterly basis; and hospital access payments cannot be used to offset other Medicaid hospital payments. The bill also maintains provisions that: assessment take effect/continuation can cease with triggers such as reduced hospital reimbursement performance, CMS-approved rate changes, loss of federal matching eligibility for the financing mechanisms, or certain alternative-care-provider contracting arrangements; and the entire article becomes ineffective if federal financial participation under Title XIX is not available at the approved FMAP for 2026–2028.
The bill also repeals Section 40-26B-88 (the existing statutory termination provision for the Hospital Provider Privilege Tax), and it sets an effective date of October 1, 2026.
bill
Regulation • 🇺🇸 United States • Alabama • Proposed Notice
The regulation amends Alabama Medicaid Agency Rule 560-X-6-.01 (Physician Program-General) to clarify Medicaid payment rules for services provided by certified physician assistants (PAs) and certified registered nurse practitioners (CRNPs).
Key provisions retained but clarified in the PA/CRNP payment framework specify that Medicaid payment may be made for professional services of PA and CRNP employed practitioners when they are (1) legally authorized to furnish services and (2) render services under the supervision of an employing physician. Payment is made to the employing physician’s billing group, not directly to the PA or CRNP, and the employing physician must be an Alabama Medicaid provider in active status. The PA or CRNP must enroll with Alabama Medicaid, obtain an Alabama Medicaid provider number, and be listed with the employing physician as the payee.
The rule also describes operational and billing constraints tied to PA/CRNP services, including: covered services must be billed under the PA/CRNP’s name and NPI; PA/CRNP-approved services include certain injectable drugs, CLIA-certified laboratory services, and select CPT codes listed in specified appendices; PA/CRNP office visits count against the recipient’s yearly benefit limitation; the PA/CRNP must submit a copy of the prescriptive authority granted by the licensing board to the Medicaid fiscal agent; PA/CRNPs cannot make physician-required hospital/institutional visits solely to qualify as physician visits; and PA/CRNPs cannot sign or place the initial prescription/order for home health services or certain medical supplies/equipment/appliances (only the ordering physician may do so). Additionally, the employing physician is responsible for the PA/CRNP’s professional activities, medically necessary and appropriate care, and there is no independent unsupervised practice by PAs or CRNPs.
An “intended action” notice establishes the amendment process and solicitation of public input: written or oral comments are accepted at the Alabama Medicaid Agency address during business hours, with a final comment date of Friday, March 6, 2026. The notice provides no stated economic impact and frames the amendment’s purpose as clarifying PA/CRNP payment language.
Alaska
2
bill
Regulation • 🇺🇸 United States • Alaska • Regulatory Notice
The document provides notice that Alaska’s Department of Health intends to seek CMS approval for a Medicaid State Plan Amendment (SPA) with a July 1, 2026 effective date. The SPA’s stated purpose is to update the effective dates of rates shown on the frontispiece (page 1) of Attachment 4.19-B to the most current fiscal year rate. It also makes targeted edits to rate description language to remove redundant wording and to point to the frontispiece effective date.
For services with inflationary adjustments, the notice states that the frontispiece rates include preplanned annual percentage increases for specified service categories: ambulatory surgical clinical services (3.1%), licensed behavior analysts & substance use rehabilitation services combined with mental health clinic (3.2%), personal care services (3.2%), personal care services for the Community First Choice option (3.2%), and chore services for the Community First Choice option (3.2%), along with LTSS Targeted Case Management (3.2%). It also states that in-home peritoneal service reflects a rebasing adjustment and that physician services reflect updated Medicare rates plus a revised conversion factor of 46.513. The notice includes estimated cost increases for federal/state funds for SFY 2027 (and one item for SFY 2026) tied to these adjustments.
The notice further specifies language/reference clarification updates to reduce redundancy in several rate descriptions by changing the operative effective-date phrasing. Examples include (1) revising ambulatory surgical clinic services language to state rates are effective for services “on or after the date listed on Attachment 4.19-B, page 1,” (2) revising Community First Choice personal care services and chore services descriptions to change the effective-date language to provider reimbursement language tied to the Attachment 4.19-B frontispiece date, (3) updating Justice Involved Youth (JIY) – Targeted Case Management to replace fee-schedule/effective-date wording with an Attachment 4.19-B-based effective date, and (4) correcting other redundant references where the description also states rates are effective on or after the Attachment 4.19-B frontispiece date.
The notice states the proposed amendments will not affect how Alaska Medicaid provides or reimburses EPSDT services. A public comment period is announced through 5:00 PM on Thursday, July 30, 2026; comments may be submitted by email to christal.hays@alaska.gov with subject “2026 Fee Schedule Updates” and must include the sender’s full name and email address. Accommodation requests for people with disabilities must be submitted no later than Wednesday, July 15, 2026. Comments that cannot be emailed must be mailed/submitted to the DOH Commissioner’s Office (c/o Christal Hays, 3601 C Street, Suite 902, Anchorage, AK 99503).
The bill establishes minimum standards for health insurance provider networks and directs the Alaska Director of Insurance to account for certain “limited network” requirements when setting or approving covered-person benefits or related contractual requirements.
For provider networks, a health care insurer must include (1) every in-state hospital, skilled nursing facility, and licensed mental health or substance abuse facility, and (2) in-state physicians, physician assistants, or advanced practice registered nurses employed or contracted by those facilities, plus analogous requirements for facilities and clinicians operated/employed/contracted by Alaska tribal health organizations. The insurer must also include a sufficient number of in-region clinicians in each contracting region (and only clinicians meeting specified licensing/credentialing and principal-practice-location conditions may be counted under defined circumstances), with all included clinicians shown as in-network in the insurer directory.
The bill divides Alaska into six contracting regions and imposes percentage minimums for inclusion of actively practicing physicians/PA/APRNs by specialty and provider groups, using Centers for Medicare and Medicaid Services Medicare Advantage “network adequacy” specialty/provider-group categories. The required percentages vary by region: 70% for Anchorage; 75% for the Matanuska-Susitna Borough and the Fairbanks North Star Borough/Southeast Fairbanks Census Area; and 80% for the Kenai Peninsula Borough, the Juneau/Ketchikan Gateway/Sitka region, and the remainder of the state. The Director may grant exceptions from the minimum network standards for limited periods (not exceeding 36 months), subject to procedures/regulatory standards, and insurers must annually attest compliance and, if they do not meet a specific standard, submit a corrective-action plan; the Director may also adopt additional higher standards by region.
Separately, the bill creates standards for settlement of health insurance claims in the absence of a contract setting allowable charges. The Director must set regulations requiring insurers to use a statistically credible methodology to establish “allowable charges” for in-state services/supplies, based on the most current 12-month provider-charged data, uniformly applied statewide, and at least 345% of the applicable federal CMS physician fee schedule for the state in effect at delivery. The Director must periodically audit/validate insurer methodology. Insurers must review/update allowable charges no more often than every three years and at least every five years unless otherwise directed. The bill also requires uniform and equal reimbursement-rate application for a given service/supply type and authorizes definitions for “allowable charge,” “health care insurer,” and “health care provider.” A transition rule requires allowable charges for calendar year 2027 to use the most current data based on 12-month periods beginning in 2024 or earlier, and takes effect January 1, 2027; it also repeals AS 21.07.020(3).
The bill establishes an “Emergency Medicine Study Committee” tasked with reviewing Arizona’s emergency medical services system and the state of emergency medicine, focusing on delivery challenges, capacity and rural/urban adequacy, uncompensated care’s effects on financial viability, and factors affecting the stability of emergency medicine providers.
The committee’s membership includes three House members (appointed by the Speaker; one designated chair), three Senate members (appointed by the President), the director of the Arizona Department of Health Services (or designee), two emergency department operators split by county population (under vs. at least 500,000), three emergency medicine physicians split by county population plus a medical director of an emergency medical services agency, one emergency-medicine registered nurse or nurse practitioner, and two pre-arrival EMS providers split by the same county population thresholds; appointment authority is divided between the Speaker and Senate President for the listed public members.
The committee must (1) review EMS system delivery and obstacles to sustainability, (2) analyze emergency medicine capacity including factors affecting adequacy in rural and urban areas, (3) review the financial impact of uncompensated care on the practice of emergency medicine, (4) identify factors impacting provider entity stability, and (5) solicit stakeholder and patient input on both service delivery and emergency medicine financial viability. It may hold public hearings, conduct fact-finding tours, request data from the Department of Health Services, and take testimony; the legislature and the Department of Health Services must provide staffing and support. Members receive no compensation, but are eligible for expense reimbursement under Arizona law.
The bill requires an initial report by December 31, 2026 and annual reports thereafter to the Governor, President of the Senate, and Speaker of the House, with a copy provided to the Secretary of State. The committee is set to be repealed effective after June 30, 2029 (i.e., on or after that date the study committee no longer exists).
bill
Regulation • 🇺🇸 United States • Arizona • Proposed Notice
The proposed amendments revise AHCCCS Administration rules governing the AHCCCS Differential Adjusted Payment (DAP) initiatives for hospitals and hospital-based freestanding emergency departments (FSEDs). The changes focus on clarifying eligibility and the operational requirements needed to qualify for increased reimbursement for specified contract years, including DAP requirements tied to participation in value-based care programs and performance/quality measures.
Key changes occur in rules R9-22-712.35, R9-22-712.61, R9-22-712.71, and R9-22-712.90. For the outpatient and inpatient DAP payment framework, the amendments extend/adjust the eligibility criteria and milestone obligations for hospital subtypes across contract years (e.g., CYE 2025/2026/2027), including continuing/maintaining connections to designated HIE platforms, submitting required agreements/SOWs, completing integration and testing milestones, and meeting data-quality profile/improvement requirements. The HIE-related requirements include specific timelines and obligations to submit patient identifiable information elements (e.g., ADT, lab/radiology, medications, immunizations, discharge summaries) and to complete required data-quality profiles and improvement plans tied to specified percentage thresholds, with exceptions when data-quality results exceed 90% for each measure.
The amendments also add/clarify qualification and implementation requirements for additional DAP program components. These include: (1) DAP activities tied to the Maternal Syphilis Program, requiring timely submission of Letters of Intent (LOIs), development/submission of facility policies meeting ADHS standards, initiation of testing, and submission of baseline and subsequent metrics (including testing counts, positive/negative results, treatment initiation, pregnancy status, and opt-out data), plus a narrative reporting requirement for the following year’s outcomes (public sharing). (2) DAP activities tied to the Medications for Opioid Use Disorder (MOUD) Enhancement Program, requiring LOIs, attested participation in a statewide clinical opioid workgroup, development of facility MOUD program policies, completion of designated project types (e.g., recognition/diagnosis, medical coding/documentation, MOUD utilization rate, EHR buildout/clinical decision support, expanding prescribers, or bridge/connector programs), and defined stakeholder engagement. (3) DAP activities tied to Naloxone Distribution Program (NDP) for hospital emergency department–related settings, requiring LOIs, facility policy development ensuring naloxone is purchased through standard routine pharmacy ordering, initiation of distribution by specified dates, and submission of program attestation; also includes different eligibility timing for facilities that did vs. did not participate in prior contract-year NDP DAP.
Procedurally, the notice establishes the public comment and hearing schedule: written comments accepted in person or via email; mailed comments postmarked within 30 days of publication; and an oral proceeding scheduled for August 11, 2026, 2:00 p.m. (virtual), with the comment period and close of record both ending August 11, 2026 at 5:00 p.m. The agency estimates about $55 million in additional payments for the contract year October 1, 2026 through September 30, 2027 to 116 hospitals under the DAP-related initiative framework.
Arkansas
1
bill
Regulation • 🇺🇸 United States • Arkansas • Final Notice
The document establishes updated Arkansas Medicaid State Plan payment-rate provisions (Attachment 4.19-B, “Methods and Standards for Establishing Payment Rates—Other Types of Care”) by revising the “Physician Services” section to adjust several specific reimbursement components, with an Effective Date of June 1, 2026 and approval on June 9, 2026 (TN: 26-0006, superseding TN 25-0003).
For dates of service beginning January 1, 2021, it sets a 3% increase to the maximum reimbursement rates for evaluation and management (E/M) codes, calculated as 3% of the July 1, 2020 fee-for-service rate for each E/M code; it further reiterates that state-developed fee schedule rates apply equally to governmental and private providers and that the fee schedule rate was set as of January 1, 2021.
For dates of service beginning July 1, 2025, it increases reimbursement rates for obstetrical care (including prenatal care, delivery, and postpartum care) by 70%, with the increase based on an analysis of private-pay rates from state fiscal years 2023 and 2024 (Arkansas Blue Cross Blue Shield and Centene), while again stating state-developed rates are the same for governmental and private providers.
It also specifies immunization-related administration fee rules: for dates of service on or after July 1, 2020, the influenza immunization administration fee is set using the 2020 Medicare flu vaccine administration fee, and other immunization administration fees are based on the Medicare 2020 physician fee schedule for Arkansas; and for dates of service on or after June 1, 2026, the administration fee for RSV (immunization or monoclonal antibody) for infants and toddlers is $19.54 (equal to 100% of the maximum Arkansas VFC regional administration fee published in the Federal Register).
California
8
bill
Legislation • 🇺🇸 United States • California • Bill
The bill establishes two new requirements/authorizations in California’s Medi-Cal system and creates a new state workgroup. First, it adds Section 14197.85 to the Welfare and Institutions Code to govern situations where a Medi-Cal managed care plan enrollee also has other health care coverage and Medi-Cal is the payer of last resort.
Under Section 14197.85, when an enrollee in a Medi-Cal managed care plan also has other health care coverage (excluding Medicare in the fee-for-service provider contracting rule), the department must ensure that a non-contracted provider that bills the Medi-Cal managed care plan for Medi-Cal allowable costs not paid by the other coverage does not face administrative requirements significantly more burdensome than those for billing the same costs to Medi-Cal fee-for-service. In the same payer-of-last-resort scenario (excluding Medicare), a Medi-Cal fee-for-service participating provider is not required to contract as an in-network provider with the Medi-Cal managed care plan in order to bill the plan for Medi-Cal allowable costs for covered services. The bill allows, in specified circumstances, a Medi-Cal managed care plan to require a letter of agreement (or similar agreement) with a non-contracted provider: (1) where the service needs prior authorization or where the other coverage does not cover the service but the plan covers it, and the letter is tied to that service; and (2) where continuity of care/completion of covered services applies under existing continuity-of-care provisions, permitting an agreement for the applicable services. The bill further specifies that, absent the letter/agreement in circumstance (1), providers may be responsible for billed amounts exceeding the Medi-Cal fee-for-service allowable rate (or applicable service limits), and it reiterates that providers may not bill the Medi-Cal managed care enrollee for excess amounts not paid by the Medi-Cal managed care plan.
Section 14197.85 also requires the department to take actions it deems necessary to clarify billing conditions for providers rendering services to Medi-Cal managed care enrollees with other coverage, with examples that may include regulatory updates, revised guidance, increased reporting, and enforcement. It states legislative intent that the department offer educational resources to enrollees needing assistance coordinating Medi-Cal and other coverage when requested. It requires annual reporting to the Assembly and Senate health committees from 2027 through 2030 on effectiveness of implementation, and authorizes implementation through all-county letters, plan letters, bulletins, information notices, or similar instructions without additional regulatory action. Implementation is conditioned on obtaining necessary federal approvals and having federal financial participation available and not jeopardized.
Second, the bill adds Division 110.5 (Section 130350) to the Health and Safety Code, requiring the California Health and Human Services Agency to convene a workgroup to explore the use and effectiveness of functional, hormonal, integrative, and metabolic health and medicine. The workgroup must meet at least four times per year and report findings to the Senate Health and Human Services Committee and the Assembly Health Committee.
bill
Legislation • 🇺🇸 United States • California • Bill
AB 125 establishes a replacement Medi-Cal managed care organization (MCO) provider tax regime to generate nonfederal funding for Medi-Cal and to meet federal permissibility requirements. It creates the Medi-Cal Stability Fund in the State Treasury, continuously appropriates deposited tax revenues (and retained interest/dividends) to the Department of Health Care Services (DHCS), and prioritizes uses including: DHCS administrative costs (capped at $4 million annually), the nonfederal share of increased Medi-Cal managed care capitation payments driven by the tax, the nonfederal share of certain specified Medi-Cal payments, and at least $2 billion annually of the nonfederal share of specified Medi-Cal managed care rates for children/adults/seniors/people with disabilities and dually eligible individuals.
AB 125 amends Section 14105.201 by changing how reimbursements and directed payments for specified services (primary care, obstetric care and doula services, and certain outpatient mental health services) are funded and administered during the relevant period. It continues a methodology that sets reimbursement rates based on a Medicare “lowest maximum allowance” standard and related adjustments, requires DHCS to annually review/revise rates (or develop methodology where no Medicare maximum exists), and requires DHCS to seek federal approvals so the provisions operate only when approvals are obtained and federal financial participation is available and not jeopardized. It also removes an existing inoperative community health worker eligibility provision from the reimbursement rate framework by deleting the inoperative reference described in the bill.
The bill adds Article 7.2 (Sections 14199.90–14199.97) to the Welfare and Institutions Code to impose an MCO provider tax for calendar years 2027–2029 (subject to federal approval conditions). The tax is assessed per “countable enrollee” at $8.85 per enrollee per month unless DHCS determines an alternative tax amount is needed to meet the funding goal (with caps on how far alternative amounts can deviate from the base amount). DHCS computes and collects the tax in quarterly installments; it may not collect until either (1) DHCS certifies the tax meets federal broad-based/uniformity and hold-harmless requirements, or (2) DHCS receives written CMS approval. The bill sets procedures for notice to plans, payment timing requirements (including that the first payment cannot be due earlier than 20 calendar days after notice and that installment payments are at least one month apart), interest/penalties for late payment (10% per annum interest; penalties after 60 days overdue), and potential waiver of interest/penalties upon a showing of undue financial hardship or significant difficulty providing services (conditioned on an alternative payment schedule). It also allocates tax responsibility in mergers/acquisitions/establishment transactions.
Operationally, Article 7.2 becomes operative on July 1, 2026 (or chaptering date, whichever is later), is intended to take effect for tax purposes no earlier than January 1, 2027 (or later if federal approval is necessary and obtained), and generally becomes inoperative on January 1, 2031 with repeal on January 1, 2032 (except that Section 14199.92 continues to function to the extent not in conflict with federal law). It includes mechanisms to cease operability and refund amounts if federal approvals are rejected, the tax cannot be implemented, or final judicial/federal administrative determinations require ending the tax, while keeping accrued taxes/interest/penalties due and payable until fully satisfied. The bill also declares legislative intent to ensure the new tax is not subject to an earlier initiative-based MCO provider tax structure (Protect Access to Health Care Act of 2024), and it includes requirements for DHCS to request any necessary CMS waivers (e.g., broad-based/uniformity).
bill
Legislation • 🇺🇸 United States • California • Bill
The California Health Care Quality and Affordability Act establishes a framework for analyzing health care costs and setting statewide cost targets for various health care entities, including providers, integrated delivery systems, and pharmaceutical companies. The legislation aims to address the rising costs of health care by implementing measures that promote affordability and quality.
Key provisions of the act include the adjustment of cost targets based on projected increases in prescription drug costs and organized labor costs for nonsupervisory employees. This approach is designed to ensure that health care entities can manage their expenditures while adhering to the established targets, which will be informed by historical cost data, economic indicators, and demographic changes.
The act emphasizes the importance of collaboration among health care entities to minimize fragmentation within the system. By establishing specific targets for different health care sectors, the legislation encourages cooperation and transparency in cost management.
Overall, the act seeks to create a more sustainable health care system in California by promoting accountability and informed decision-making regarding health care spending. Through comprehensive data analysis and stakeholder engagement, the legislation aims to enhance the quality and affordability of health care for all Californians.
bill
Legislation • 🇺🇸 United States • California • Bill
The bill establishes a revised state process for setting and negotiating Medi-Cal Program of All-Inclusive Care for the Elderly (PACE) capitation rates under Welfare and Institutions Code Section 14301.1.
It changes the PACE capitation rate methodology requirements in Section 14301.1(n): the department must negotiate capitation rates with each contracting PACE organization (consistent with federal requirements) and make a good-faith effort to reach agreement, rather than engaging in the prior consultation requirement in developing the rate methodology. Before submitting negotiated rates to the federal Centers for Medicare and Medicaid Services (CMS) for approval, the department must notify the contracting PACE organization of the proposed rates at least 60 days in advance. The department may set a reasonable deadline for the PACE organization to submit written questions or feedback, and must respond in writing to those questions or feedback no later than 30 days before submitting the rates to CMS; upon request, the department must provide rationales for assumptions or calculations used in the proposed rates (including the underlying data/methodologies, the experience-based rate range, and the capitation rate for the PACE organization).
The bill also retains/continues the existing federal-law-aligned requirements that capitation rates be actuarially certified and that the department calculate an upper payment limit for PACE payments, with corrections to applicable data and consideration of nursing home placement risk for comparable populations. Implementation of the PACE rate provisions is limited to receipt of necessary federal approvals and availability of federal financial participation, and applies only for rates implemented no earlier than January 1, 2017.
All other aspects of Section 14301.1 shown in the bill text (including additional Medi-Cal managed care rate-setting subsections and CalAIM-related provisions) are carried as context rather than being substantively changed in the portions reproduced.
bill
Legislation • 🇺🇸 United States • California • Bill
The bill requires Medi-Cal copayments for “newly eligible beneficiaries” with income above 100% and up to 138% of the federal poverty level (with the specified 5% disregard). It sets a $0.01 copayment for defined nonemergency services in an emergency department/emergency room when those services do not result in treatment of an emergency medical condition or inpatient admission, limits where copayments apply by excluding a broad list of service categories (including emergency services, family planning, certain inpatient/hospice/age/pregnancy populations, COVID-19 testing, specified vaccines, Indian Health Service/referrals, primary care, and mental health/substance use disorder and several clinic types), prohibits providers from denying care solely for nonpayment, exempts visits/services/devices/items when Medi-Cal payment is $10 or less, and caps total family cost-sharing/deductions (aggregate) at 5% of monthly family income.
The bill also modifies Medi-Cal retroactive eligibility procedures. It provides that, upon request, assistance is made available for care and services during the three months immediately before the month of application if the individual was (or would have been) eligible for medical assistance, and makes conforming changes specifying that these three months may be federally funded or state funded with federal reimbursement sought to the maximum extent allowable. In addition, it amends county Medi-Cal redetermination-related provisions (including eligibility during the redetermination process, notice and information-gathering requirements, timelines for obtaining information, and processes for termination or continuation when sufficient information cannot be obtained) and includes provisions related to redeterminations involving MAGI-based methods and non-MAGI situations.
For Medi-Cal eligibility systems and the broader insurance affordability programs (including the Exchange/CHIP context), the bill strengthens requirements around eligibility application usability, verification, and system integrity. It requires a single standardized application to be user-tested for accuracy/readability in Medi-Cal threshold languages and operational by the date required by the federal Secretary (including ahead of certain federal change effective dates). It also expands rules on self-attestation and limits what information the application/supplemental forms may request, allows/structures use of the application to determine compliance with federal work/community engagement requirements (including exemptions) without seeking additional information, requires accessible/plain-language forms, and requires that eligibility system stakeholder processes address functionality/accuracy/legal appropriateness of electronic eligibility systems and public websites, including regular (at least quarterly) user-testing and user-centered design, tracking defects/enhancements, and monitoring screening/evaluation.
Finally, it provides implementation conditions for the Medi-Cal copayment provision (only with federal approvals and federal financial participation, and no sooner than October 1, 2028), and includes a mechanism for state-mandate cost reimbursement if the Commission on State Mandates determines the bill imposes reimbursable costs on local agencies/school districts.
bill
Legislation • 🇺🇸 United States • California • Bill
The bill establishes a new “Facility Fees” article in California’s Health and Safety Code (Chapter 2.5, Division 107) that limits when facility fees may be charged for outpatient services and requires patient-facing notice and reporting. Beginning January 1, 2028, it prohibits specified facility fees in several circumstances (off-campus hospital-based CPT/assessment-and-management outpatient locations; telehealth; and preventive services), while clarifying that these prohibitions do not bar billing professional fees.
For health care providers, hospitals, and health systems, the bill requires notice at scheduling and at check-in when a facility fee may be charged, including: (1) an express statement that a facility fee may be charged; (2) a good-faith estimate of the facility fee amount; (3) an explanation distinguishing professional fees from facility fees; and (4) whether the facility fee for the scheduled service is prohibited under the article. It also requires providers/hospitals to (a) post on their internet websites a list of services for which a facility fee may be charged (if permitted), and (b) separately itemize any allowed facility fee on patient bills. It then creates substantive prohibitions: no facility fee for outpatient CPT E/M or A/M services furnished at physician practices/clinics/outpatient locations that are hospital facilities located offsite from a hospital campus (regardless of Medicare provider-based designation, place-of-service code, ownership/affiliation, or fee terminology); no facility fee for any health care services furnished via telehealth; and no facility fee for preventive services identified by cross-references to specific preventive-service mandates.
The bill adds an enforcement and remedy scheme in the new Health and Safety Code article: the Director of the Department of Health Care Access and Information must impose an administrative penalty for each noncompliance, with multiple violations found during the same investigation treated as a single violation for penalty purposes. It also requires reimbursement to patients of any amount actually paid for a prohibited facility fee, tied to an existing reimbursement process reference. It authorizes the department to adopt (including emergency) regulations and makes the article operative January 1, 2028. It separately requires hospitals and health systems (under the new facility-fee definitions) to file facility-fee reports with DHCAI containing facility-level and service-level fee and revenue information, with authorization to incorporate reporting into an existing requirement to minimize costs; the reporting requirement is also operative January 1, 2028.
Finally, the bill adds parallel restrictions in the Insurance Code (operative January 1, 2028) enforced by the Insurance Commissioner: health plans/insurers may not reimburse, pay, or otherwise provide coverage for prohibited facility fees; may not include in contracts/provider agreements terms permitting payment of prohibited facility fees; must deny payment of claims that include prohibited facility fees; and may not pass through or shift prohibited facility fees to insureds. It also includes a state-mandate reimbursement carveout (no reimbursement required) because the act is connected to changes affecting local agency/school district costs via creation/elimination/changing of crimes or infractions/penalties or crime definitions under referenced constitutional provisions.
bill
Legislation • 🇺🇸 United States • California • Bill
The bill (1) revises Medi-Cal reimbursement methodology for certain primary care, obstetric/doula, and outpatient mental health services funded through directed payments, and (2) creates a new, federally conditional Managed Care Organization (MCO) provider tax structure for calendar years 2027–2029, with revenues deposited to a new Medi-Cal Stability Fund and continuously appropriated for specified Medi-Cal purposes. It also establishes intent that the new tax be designed to avoid conflict with the Protect Access to Health Care Act of 2024 and to meet federal requirements for permissible health care-related taxes.
For Section 14105.201, the bill updates the statute governing reimbursement rates and managed care directed payments for: (A) primary care; (B) obstetric and doula services; and (C) specified outpatient mental health services. It keeps the existing “greater of” reimbursement framework tied to Medicare lowest maximum allowance (with inclusions for exemption from Medi-Cal payment reductions and specified Proposition 56-funded supplemental payments/rate increases in effect as of Dec. 31, 2023), and requires annual departmental review/revisions. It also clarifies that the directed payment structure must be supported by revenues from the new MCO provider tax (Article 7.2) or other appropriated state funds, and includes a transition that discontinues other fee-for-service supplemental payments and managed care directed payments for the identified services once the payments under subdivisions (a) and (b) are effective.
The bill adds Article 7.2 (Sections 14199.90–14199.97) establishing the continuation framework and operational mechanics of the new MCO provider tax. It defines key terms (including countable enrollees and base-year/data sources), creates the Medi-Cal Stability Fund in the State Treasury, and continuously appropriates tax revenues (net of refunds) to the Department of Health Care Services in a priority order: up to $4 million annually for administrative costs; the nonfederal share of increased capitation payments; the nonfederal share of payments described in Section 14105.201; and at least $2 billion annually in the nonfederal share of Medi-Cal managed care rates for specified populations/services. It then imposes a $8.85 per countable enrollee per month tax for 2027, 2028, and 2029, with Department discretion to adjust via alternative amounts/tax tiers (bounded by specified percentage limits for alternative tax amounts) and to modify parameters to secure or maintain federal approval and financial participation, while constraining changes that would significantly increase projected aggregate collections.
Collection and operability are conditioned on federal permissibility: the Department cannot collect until the Director certifies federal compliance (including broad-based/uniformity and hold-harmless requirements) or until CMS approves in writing, after which the Department issues notice to health plans with tax due dates. The bill sets interest (10% per annum) and penalties for late payment (with additional monthly penalties after 60 days overdue), allows the Director to waive interest/penalties upon a finding of likely undue financial hardship or significant difficulty in providing Medi-Cal services, and addresses transactions transferring tax responsibility in mergers/acquisitions/establishment events. The tax becomes effective and operative on January 1, 2027 (or later upon certified federal approval if approval is necessary), ceases to be operative if federal approvals are denied/conditions fail or under specified final judicial or federal administrative determinations (with refunds of tax for affected periods, subject to continued payment obligations until fully paid). Provisions in the article generally become inoperative January 1, 2031 and are repealed January 1, 2032, except that the Medi-Cal Stability Fund provisions (Section 14199.92) persist to the extent not conflicting with federal law. The bill takes effect immediately.
bill
Legislation • 🇺🇸 United States • California • Bill
The document outlines significant changes to the Medi-Cal program concerning reimbursement rates for clinical laboratory services, particularly those related to the diagnosis and treatment of sexually transmitted infections. These changes primarily impact clinical laboratory service providers and healthcare services in this area.
Under the new provisions, Medi-Cal reimbursement for clinical laboratory services will be capped at the lowest of four specified metrics, including the amount billed and the charge to the general public. Importantly, the previous requirement for a 10% payment reduction for these services has been eliminated.
The new reimbursement rates for clinical laboratory services associated with sexually transmitted infections will take effect for services rendered on or after July 1, 2027, or when funding is appropriated, whichever occurs first. Additionally, data reporting exemptions for these services will apply for dates of service on or after January 1, 2027, or when funding is appropriated.
The department is tasked with publishing updated reimbursement rates and related datasets in conjunction with these changes. Overall, the bill aims to align Medi-Cal reimbursement rates with those of other payers while ensuring compliance with state and federal laws.
The bill changes Colorado’s out-of-network health-care dispute-related provisions in CRS 10-16-704 to modify how the state division enforces carrier payment requirements and how carriers provide payment and related transparency information to providers.
The bill updates CRS 10-16-704(13) by directing the General Assembly’s stated intent for subsection (13): (1) streamline out-of-network dispute resolution by granting the Division additional enforcement authority within the out-of-network complaint process, including requiring prompt payment by carriers when underpayment is identified; (2) require “jurisdictional transparency” by mandating that carriers clearly state on a remittance advice when a patient’s health benefit plan is governed by state law; and (3) empower data-driven enforcement by requiring carriers to disclose specific methodologies used to determine out-of-network reimbursement and by granting the Commissioner authority to order corrective payments and impose fines for noncompliance.
Operationally, when a carrier makes a payment pursuant to specified provisions of the section, providers may request—and the Commissioner must collect—data from the carrier to evaluate compliance in paying the highest rate required, including the methodology used to determine the carrier’s median in-network rate and corresponding reimbursement for each service in the same geographic area. The data submitted are characterized as proprietary/traet secret/confidential under the referenced confidentiality statute. In addition, beginning January 1, 2027, when making such payments, the carrier must provide a remittance advice identifying when the health benefit plan is regulated by state law and that the payment was made pursuant to the specified subsections. The bill also requires that each remittance advice include the carrier’s median in-network reimbursement rate for out-of-network claims.
The act becomes effective after the statutory referendum-petition period, specifically at 12:01 a.m. on the day following expiration of the 90-day period after final adjournment (August 12, 2026 if adjournment sine die is May 13, 2026), unless a referendum petition is filed and the act is approved by voters in November 2026; if approved, it takes effect upon official declaration of the vote by the governor. It applies to payments owed by health insurance carriers on or after the applicable effective date.
bill
Regulation • 🇺🇸 United States • Colorado • Final Notice
The rule establishes Colorado Medicaid and Children’s Basic Health Plan (CHP+) eligibility requirements tied to federal financial participation (FFP) eligibility for “qualified non-citizens,” effective October 1, 2026, by aligning state citizenship/immigration categories and related verification and exception processes with federal requirements under OBBBA provision 71109 and related federal Medicaid/CHIP rules.
It revises 10 CCR 2505-10 Sections 8.100.3.G and 8.100.4.G to update the definition and eligibility categories of lawfully residing non-citizens and to conform the state’s verification workflow. The rule requires that for Medicaid eligibility determinations, legal immigration status must be verified using the Verify Lawful Presence (VLP) interface connected to the federal Systematic Alien Verification for Entitlements (SAVE). If electronic verification is unsuccessful, a “Reasonable Opportunity Period” is triggered: the applicant receives a Notice of Action and has 90 days to submit required documentation; benefits must not be delayed, denied, reduced, or terminated during the Reasonable Opportunity Period if the applicant is otherwise eligible. The Reasonable Opportunity Period applies to MAGI, Adult, and Buy-In programs, with the rule listing the applicable program categories.
The rule also makes specific changes to the Reasonable Opportunity Period-related policy alignment language (Section 8.100.3.G.3) to better track federal regulatory text (42 CFR 435.956(a)(5)) regarding how a Reasonable Opportunity Period is handled when an applicant or member declares new or updated satisfactory immigration status that the department cannot verify electronically. In addition, it revises the “Legal Immigrant Prenatal” (LIP) policy in Section 8.100.4.G.6 to add additional exception reasons for maintaining eligibility beyond the guaranteed eligibility period; the rule states this will not change current LIP logic in the eligibility system (CBMS), but clarifies when exception requests/applications may be made.
Operationally, the department must implement system and process updates (including CBMS updates, verification procedures, and increased use of manual SAVE queries) to ensure benefits are provided only when immigration status qualifies for FFP and to avoid noncompliant eligibility decisions. The filing indicates no temporary/emergency rule is required (emergency adoption is not justified as imperatively necessary in the submission), and the rule is set to take effect October 1, 2026.
bill
Regulation • 🇺🇸 United States • Colorado • Proposed Notice
The document establishes Colorado’s Workers’ Compensation “Rule 18 Fee Schedule” for services rendered on or after January 1, 2027, setting maximum reimbursement amounts, reimbursement rules, and numerous billing/documentation requirements across professional services, facilities, and ancillary services. It limits reimbursement to the fee schedule unless the Director approves an exception to exceed maximum allowances, and it is intended to be read together with Rule 16 (Utilization Standards) and Rule 17 (Medical Treatment Guidelines). It also incorporates by reference multiple CMS/AMA/other pricing and coding manuals (with specified edition dates) and adopts specific code systems and hierarchy rules (Division-created codes supersede standard codes; certain status codes require prior authorization or are non-payable).
The fee schedule sets the core payment methodology for professional services: maximum allowances are calculated from RBRVS RVUs multiplied by conversion factors that vary by CPT section (e.g., E/M, anesthesia, SRPM, PM&R). It specifies provider-level reimbursement (generally 100% for most providers; APPs generally paid at 85% unless specified conditions apply, including rural-area definitions and certain accreditation/credential scenarios), and it defines RBRVS status codes/payment designations that determine whether services are separately payable, bundled, priced by report, non-payable, or payable only under specified conditions (including multiple specific HCPCS/CPT ranges and dentistry rules).
For professional services, the document contains detailed policies and limits for evaluation & management (including documentation standards, what constitutes new vs. established patient within workers’ comp claims, visit frequency limits, telephone/online treating physician billing documentation, and consult/transfer/IME billing rules), anesthesia (eligible provider types, medical direction requirements, required modifiers, time reporting, physical-status add-on units, qualifying circumstance add-on RVUs, and non-time-based billing modifier use), surgery payment adjustments (global surgical package inclusions/exclusions, assistant surgeon and co-surgeon/team surgery modifiers and payment apportionment, multiple/bilateral/reduced-discontinued procedure rules), radiology accreditation and interpretation rules (technical component accreditation requirement and limits on multiple interpretations), pathology/lab (CLIA waiver vs compliance rules, lab reimbursement percentages and component splitting), medicine (e.g., biofeedback qualifications/requirements; EMG classification references; manipulation prior authorization and therapy limits), physical medicine & rehab (PT/OT/AT evaluation rules, PM&R plan-of-care functional objectives, modality/procedure time and unit caps, special tests and prior-authorization thresholds, and therapy billing modifiers), and telemedicine (covered services only with prior authorization unless otherwise specified, required modifier 95 for synchronous services, originating site and HIPAA security requirements, and originating-site fee criteria). The rule also establishes extensive ancillary-service payment frameworks including DMEPOS rental/purchase caps and invoice/servicing rules, drug reimbursement methodology (AWP-based with DAW and prior authorization triggers, compounding/topical/OTC/injectable rules, and repackaged drug billing rules), home care service limits and hourly/per-15-minute caps, app-based interventions payment limits, and ambulance and facility reimbursement methodologies.
In addition to the overall fee schedule, it establishes multiple “division-established” fee items and reimbursement structures for meetings, reports (including WC164 initial/progress/closing forms with distribution timing and countersignature requirements when completed by NP/PA), independent medical examinations (RIME/CIME/DIME definitions, report service timing, audio recording obligations, and cancellation/rescheduling payment treatment), permanent impairment ratings (Level II accreditation requirements, limits on number of whole-person ratings per claim with specified circumstances for additional ratings), missed appointments, interpreter services (certification/qualification requirements and billing/cancellation treatment), guardian ad litem/conservator services (authorization and reasonableness factors), and deposition/testimony preparation/payment rules (including ALJ authority for certain reimbursement above the fee schedule). It also includes quality initiatives payment provisions (opioid management review codes, definitions of acute/subacute/chronic opioid use, drug testing/PDMP expectations for coverage, QPOP provider qualifications, required tools/documentation, and billing frequency constraints) and provides exhibits: E/M decision-making tables (with time-based coding instructions and scoring definitions), hospital base rates and cost-to-charge ratios used for MS-DRG facility payments, and a comprehensive dental fee schedule. The fee schedule is effective January 1, 2027 (and applies to services rendered on/after that date); where applicable, it specifies additional effective/coverage constraints within specific subsections.
Connecticut
8
bill
Regulation • 🇺🇸 United States • Connecticut • Proposed Notice
SPA 26-0025 would be submitted to CMS to update Connecticut’s Medicaid payment methodologies in Attachments 4.19-A (inpatient hospital supplemental payments) and 4.19-B (outpatient hospital supplemental payments and practitioner supplemental payments), effective on or after July 1, 2026 (SFY 2027). The stated purpose is to implement reimbursement changes added to Connecticut General Statutes section 17b-239e by Public Act 26-68, and to maintain sufficient access to inpatient and outpatient hospital services and specified physician and mid-level practitioner services for Medicaid members.
It revises inpatient hospital supplemental payment pools for non-governmental short-term general hospitals not receiving DSH payments (and related tiering criteria) by setting SFY 2027–SFY 2031 pool amounts and eligibility/distribution rules using hospital characteristics as of January 1, 2025 and Medicaid revenue/other measures based on FFY 2024 or specified OHS-reported data. Key pool categories and SFY 2027–2031 total pool amounts include: a general inpatient supplemental pool ($202,823,819; $220,864,276; $239,696,267; $258,122,646; $277,597,027); a small hospital inpatient pool (tiers by Medicaid revenue with $3,425,000/$9,675,000 for SFY 2027, growing through SFY 2031); a midsized hospital inpatient pool (tiers by Medicaid revenue with totals $9,250,000/$19,000,000 for SFY 2027, increasing through SFY 2031); a midsized inpatient independent hospital pool (tiers by Medicaid revenue with $2,225,000/$6,700,000 for SFY 2027, increasing through SFY 2031); and a large inpatient hospital supplemental pool (tiers by Medicaid revenue with $63,000,000/$117,000,000 for SFY 2027, increasing through SFY 2031). The SPA also provides additional DSH changes for certain private acute care hospitals meeting specified uncompensated care/DSH criteria, including municipality/population and Medicaid-charge-percentage thresholds, with annual DSH pool amounts for SFY 2027–SFY 2031 (e.g., $45,792,235; $45,648,705; $45,516,217; $45,395,510; $45,282,754 for one category, and $7,706,981; $8,541,956; $9,393,031; $10,260,616; $11,146,556 for another). DSH payments remain subject to hospital-specific DSH limits calculated under federal requirements.
It revises outpatient hospital supplemental payment pools similarly for nongovernmental hospitals not receiving DSH payments, establishing SFY 2027–SFY 2031 pool amounts and tiered criteria based on Medicaid outpatient revenue/FFY 2024 OHS reporting and emergency-department visit thresholds for midsized/independent groups. The general outpatient pool totals are $194,995,425 (SFY 2027) through $305,623,328 (SFY 2031). The midsized outpatient supplemental pool totals are $65,425,000 (SFY 2027) through $80,025,000 (SFY 2031), and include tiering by Medicaid revenue (less than $30 million vs. $30 million or more). There is also an “independent” midsized outpatient supplemental pool with smaller tiered amounts ($2,225,000/$6,700,000 for SFY 2027, increasing to $2,875,000/$8,400,000 for SFY 2031).
For practitioner supplemental payments, the SPA creates/expands hospital-based and hospital-affiliated-group supplemental pools effective July 1, 2026, funded annually at $72,750,000 (gross) for eligible hospital-affiliated medical groups and their physician/APRN/PA services, and $32,250,000 (gross) annually for eligible faculty practice plans; eligibility and distribution use a “funding gap” methodology comparing Medicaid payments for physician/APRN/PA services during the Medicaid period (SFY 2025) to what would have been paid under the calendar-year 2026 Medicare physician fee schedule. It also updates existing UConn and children’s hospital-related practitioner supplemental provisions: (1) the UConn physician group/advanced practice nurse group supplemental methodology is effective for dates on or after July 1, 2026 and uses an ACR-based “Medicare equivalent” calculation to pay the difference between Medicaid payments and ACR-to-Medicare-adjusted amounts; (2) Connecticut Children’s Medical Center’s physician group supplemental provision is likewise updated so that it applies to physician/APRN/PA employed by or under contract to CCMC (or its affiliated physician group) with the “difference vs. Medicare” approach effective July 1, 2026; and (3) mid-level practitioners affiliated with children’s hospitals are explicitly included in the existing federally approved practitioner supplemental authorization for medical groups affiliated with children’s hospitals, and UConn’s practitioner pool scope is expanded to include additional service categories (APRNs/PAs and certain provider types) as specified.
Public comment must be received no later than July 30, 2026 (submission via email or mail is provided). The SPA’s financial impact estimates include increased annual gross expenditures of approximately $359.1 million in SFY 2027 and $427.2 million in SFY 2028, including category increases for inpatient supplemental payments, DSH, outpatient supplemental payments, and practitioner supplemental payments.
bill
Legislation • 🇺🇸 United States • Connecticut • Bill
The bill appropriates General Fund money to the Connecticut Department of Social Services to increase Medicaid reimbursement rates for private providers. It specifies that an appropriation amount is to be set in the bill (currently blank) for the fiscal year ending June 30, 2027.
The use of the funds is tied to “phase one of the Medicaid rate study,” directing that the increase in reimbursement rates occur in accordance with that phase of the study. No other program changes, eligibility requirements, or regulatory amendments are specified in the text provided.
The document’s operative content consists solely of this targeted appropriation and its purpose statement indicating the goal of funding Medicaid rate increases consistent with the Medicaid rate study.
bill
Legislation • 🇺🇸 United States • Connecticut • Bill
AN ACT CONCERNING PEER SUPPORT SERVICES UNDER THE MEDICAID PROGRAM.
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
March 05, 2026
Failed (House)
April 07, 2026
Failed Sine Die • 2026 Regular Session • Introduced: March 05, 2026
Sponsors: Joint Human Services Committee
Co-sponsors: Lucy Dathan (D), Eleni Kavros DeGraw (D), Sarah Keitt (D), Anne M. Hughes (D), Gary A. Turco (D), Nick Gauthier (D), Savet Constantine (D), Mary M. Mushinsky (D), Nick Menapace (D), Renee LaMark Muir (D), Joshua Elliott (D), Amy Morrin Bello (D), Kenneth Gucker (D), William Heffernan (D), John Santanella (D), Bob Godfrey (D), Julie Kushner (D), Saud Anwar (D), MJ Shannon (D), John-Michael Parker (D), Kerry Szeps Wood (D)
The bill establishes Medicaid “peer support services” in the Connecticut Medical Assistance Program. It defines peer support services as recovery-focused behavioral health services that help an individual learn to manage their recovery with help from a “peer support specialist.” It defines a peer support specialist as a person with lived experience recovering from mental illness or a substance use disorder who is certified to provide peer recovery support under a Department of Mental Health and Addiction Services-administered program.
Beginning July 1, 2026, the Commissioner of Social Services must amend the Medicaid state plan to integrate peer support services into care teams funded under the medical assistance program and must provide Medicaid reimbursement to peer support specialists for providing those services.
By no later than August 1, 2027, the Commissioner of Social Services must report to the General Assembly’s joint standing committees with cognizance over human services and public health, in accordance with Conn. Gen. Stat. § 11-4a, including: (1) the number of peer support specialists who received Medicaid reimbursement; (2) the number of Medicaid enrollees served by those specialists; and (3) any outcome data on treatment provided to those enrollees. (See Section 1(c), pages 2–3.)
bill
Legislation • 🇺🇸 United States • Connecticut • Bill
The bill requires the Commissioner of Social Services to amend Connecticut’s Medicaid state plan to increase reimbursement rates for pediatric care services by at least 5% compared to the rates in effect on June 30, 2026.
The bill also requires the Commissioner to file a report evaluating the impact of these pediatric rate increases on (1) provider participation in the Medicaid program, (2) access to care, and (3) the state budget.
bill
Legislation • 🇺🇸 United States • Connecticut • Bill
The bill establishes a new statutory definition of “emergency medical condition” for purposes of Medicaid and directs the Commissioner of Social Services to expand “emergency Medicaid coverage” consistent with federal law for treatment of qualifying emergency conditions. It requires emergency Medicaid coverage to include emergency labor and delivery and defines emergency medical conditions as those manifesting acute symptoms severe enough that the absence of immediate medical attention could reasonably be expected to place the person’s health in serious jeopardy, seriously impair bodily functions, or cause serious dysfunction of any bodily organ or part.
It further requires the emergency Medicaid expansion to include (to the extent allowed by federal law) specified condition categories, including: high-risk pregnancy; type 1 diabetes in persons under age 21; diabetic emergencies (including diabetic ketoacidosis); renal failure requiring ongoing dialysis; certain skull/arm/neck/leg/spine/pelvis fractures occurring in the two months before a request; hypertensive emergencies with end-organ damage and specified blood pressure thresholds (SBP ≥180 or DBP ≥120); unstable seizure disorder with specified seizure duration/frequency and impaired consciousness; active cancer treatment; ventilator dependency; labor and delivery; and acute inpatient or outpatient psychiatric treatment.
By no later than July 1, 2027, the bill establishes an administrative process requiring the commissioner to provide a system allowing individuals to apply in advance for emergency Medicaid coverage when the emergency medical condition can be treated in outpatient settings rather than hospital emergency departments. It requires the Department of Social Services to publish a prominent link to the advance-application and a list of covered emergency medical conditions on its website, and to include information about advance applications and the covered-condition list in department forms and policy manuals.
The act takes effect July 1, 2026 (Section 1), with a requirement that the advance-application administrative system be established by July 1, 2027; a fiscal note indicates administrative costs to DSS of at least $250,000 in FY27 associated with implementing the advance-application registration system and anticipates at least $125,000 in federal reimbursement/grants revenue, while the cost impact of expanding the emergency-medical-condition definition is stated as not determinable at the time.
bill
Legislation • 🇺🇸 United States • Connecticut • Bill
Failed Sine Die • 2026 Regular Session • Introduced: February 26, 2026
Sponsors: Joint Insurance and Real Estate Committee
Co-sponsors: Martin M. Looney (D), Saud Anwar (D), Martha E. Marx (D), Amy Morrin Bello (D), Nick Gauthier (D), MD Rahman (D), Joshua Elliott (D), Joan V. Hartley (D), Patricia Billie Miller (D), Julie Kushner (D)
The bill establishes new requirements for contracts between health insurers (and similar entities) and health care providers entered into, renewed, or amended on or after July 1, 2026 for covered outpatient benefits. Contracts must require reimbursement for covered outpatient benefits billed using certain CPT E/M codes, CPT A/M codes, telehealth codes, or drug infusion codes in an amount that does not vary based on the facility where the provider furnishes the benefit, and must use equal reimbursement rates for all contracting providers in the same geographic region as determined by the Insurance Commissioner, regardless of employer or affiliation, for each covered outpatient benefit when reimbursement is fee-for-service or standardized bundled payment. Contracts must also include a conspicuous statement of compliance, and the Insurance Commissioner must adopt regulations to implement these provisions.
The bill updates the definition of “anti-steering clause” in Conn. Gen. Stat. § 38a-477i(a)(2) effective October 1, 2026 by clarifying that it includes provisions (including utilization management provisions) restricting a health carrier or plan administrator from encouraging enrollees to obtain services from competitors of a hospital or health system, including incentives to use specific providers (e.g., centers of excellence) or other pay-for-performance programs. It also requires the Insurance Commissioner, effective from passage, to conduct a study on revisions to insurance statutes, including excess insurance, the Health Care Cabinet, and outpatient health care services provided at off-site hospital facilities (not later than January 1, 2027, via a report to the relevant joint standing committee).
The bill adds new protections against “downcoding” for claims. Effective October 1, 2026, it defines “downcode” and prohibits health carriers from using software tools (including artificial intelligence or algorithms) to automatically downcode or deny a health insurance claim submitted by a provider without review by a clinical peer. It also removes a limitation on contract continuation during disputes: effective October 1, 2026, it repeals and replaces a notice-related provision in Conn. Gen. Stat. § 38a-472f(g)(1)(C), changing the circumstances under which reimbursement terms continue after termination or nonrenewal (the replacement removes the prior “sixty days”/timing framework and instead ties continuation to when the dispute is resolved or the policyholder’s renewal date).
Effective January 1, 2027, the bill strengthens utilization review and adverse determination processes for services ordered by providers in the highest tier of a tiered network by creating rebuttable presumptions of medical necessity for such services and shifting the burden of proof to the health carrier. It requires utilization-review and adverse-determination reviews to be conducted with clinical peer independence and impartiality, specifies that clinical peers cannot have been involved in the initial adverse determination, requires consideration of all relevant documents and information submitted by the covered person regardless of whether previously considered, and requires providing any new/additional documents, evidence, and scientific or clinical rationale free of charge before the carrier issues a decision. Finally, effective October 1, 2026, the bill revises both individual and group prescription drug step therapy prohibitions (Conn. Gen. Stat. §§ 38a-510(a) and 38a-544(a)) by removing a specific exception tied to stage IV metastatic cancer, and otherwise retains the general restrictions while keeping the provider’s ability to deem step therapy clinically ineffective and obtain an override/authorization for the prescribed drug. The bill’s effective dates are set by section across July 1, 2026 through October 1, 2026 and January 1, 2027, with the study requirement taking effect from passage.
bill
Legislation • 🇺🇸 United States • Connecticut • Bill
The bill establishes a voluntary hospital financial assistance program effective October 1, 2026. Participating hospitals must provide inpatient and outpatient care for eligible patients by: (1) providing care at no cost to uninsured patients with income up to 200% of the federal poverty level (FPL); (2) providing subsidized care for uninsured patients with income above 200% but not exceeding 300% FPL; (3) providing subsidized care for patients with income up to 400% FPL who are enrolled in SNAP or WIC; and (4) for patients with household income under 200% FPL who are deemed ineligible for hospital financial assistance, billing on a payment schedule capped at no more than 2% of annual household income. After 36 cumulative months of payments under this capped schedule, participating hospitals must consider the patient’s hospital bill paid in full and permanently cease any collection activity on any remaining unpaid balance.
Participation triggers several eligibility/documentation limits. Participating hospitals may not count patient assets to determine eligibility and may not require proof that applications for specified public or other coverage (state medical assistance/Medicaid, Emergency Medicaid, Medicare, or Connecticut Health Insurance Exchange coverage) were denied. Hospitals must use software meeting industry standards for electronic income verification and may accept specified documents to verify income (recent tax return; W-2 and 1099s; two most recent pay stubs; or employer written verification for cash-paid patients). Hospitals must exempt patients experiencing homelessness or imminently at risk from providing documentation, while allowing self-attested information for screening and application. The bill also requires participating hospitals to make information about the program available in the top non-English languages spoken by at least 5% of the population in the hospital’s geographic service area, included in discharge paperwork and on the hospital website, with Office of the Health Care Advocate contact information and ADA-compliant effective communications.
The bill authorizes reimbursement of participating hospitals through Medicaid’s disproportionate share hospital payments (DSH). The Commissioner of Social Services must amend the Medicaid state plan to use DSH payments to compensate hospitals that participate in the hospital financial assistance program, and must establish criteria for participating hospitals to document financial assistance and receive timely payment. A hospital aggrieved by a final commissioner decision on the validity of the hospital’s bills for hospital financial assistance may pursue a rehearing and then appeal using the referenced existing process.
In addition to creating the hospital program and DSH reimbursement framework, the bill changes the rehearing/appeal procedure in the DSS payment/rate context by repealing and substituting a revised subsection 17b-238(b) (effective October 1, 2026) and further making a technical update to that subsection effective January 1, 2027. The bill sets an effective date of October 1, 2026 for the new sections (with the hospital rehearing provision taking effect January 1, 2027).
bill
Legislation • 🇺🇸 United States • Connecticut • Bill
The bill establishes requirements for Medicaid provider rate increases and ongoing oversight beginning July 1, 2026. It defines “Medicaid rate study” as the study commissioned by the Department of Social Services (DSS) under section 1 of Public Act 23-186, and uses a “five-state rate benchmark” (the average of rates for the same health care services in Maine, Massachusetts, New Jersey, New York, and Oregon) and the “Medicare Economic Index” (MEI) as calculated by CMS for physician practice costs and wage levels.
Within available appropriations, the DSS Commissioner must phase in Medicaid provider rate increases starting July 1, 2026, so that by June 30, 2029 all provider rates are at least (1) 75% of the most recent Medicare rates for the same health care services, or (2) for services with no corresponding Medicare rates, a percentage of the five-state rate benchmark that produces an equivalent rate increase. On and after June 30, 2029, the Commissioner must adjust rates annually to maintain at least 75% of the most recent Medicare rates (or an equivalent percentage of the five-state benchmark for services without Medicare counterparts), or alternatively by increasing rates by the percentage change in MEI. Any review or rebasing of Medicaid rates must include (a) rates required to be studied under the Medicaid rate study and (b) rates with no corresponding Medicare rate or benchmark rate in that study; if any of the five benchmark states has a corresponding rate for the same or substantially similar service, that state’s rate must be used for comparison. The Commissioner is also required to streamline and consolidate Medicaid fee schedules so that every provider is reimbursed using the same fee schedule, incorporating the most recent Medicare fee schedule for services covered by Medicare to the extent applicable.
The bill also establishes an ongoing systemic review process for Medicaid provider reimbursement rates by the Council on Medical Assistance Program Oversight (MAPOC). MAPOC must develop and implement the review to ensure Medicaid provider rates are adequate to sustain a sufficient provider pool for high-quality care access, and must file annual reports to relevant General Assembly committees beginning no later than January 15, 2027. The report must include MAPOC’s recommendations for necessary appropriations to compensate Medicaid providers for services in accordance with the bill’s rate-setting requirements.
According to the fiscal and bill analysis materials included with the bill (pages 4–5 and 6–7), the rate phase-in is expected to create significant costs for DSS due to increases through June 30, 2029, and an example provided shows phase-in costs of $50.0 million per year across three years (total $150.0 million annualized by FY29), depending on provider groups and funding needed to meet the benchmarks and rate-update mechanisms.
Sponsors: Bryan Townsend (D), Raymond Seigfried (D), Nnamdi O. Chukwuocha (D), Melissa Minor-Brown (D)
Co-sponsors: Eric L. Buckson (R), Sarah Elizabeth Lockman (D), David P. Sokola (D), Laura Viviana Sturgeon (D), Krista Griffith (D), Kerri Evelyn Harris (D), Edward S. Osienski (D), Madinah Wilson-Anton (D)
The bill establishes and refines Delaware’s primary-care value-based delivery framework administered through the Health Care Commission (Title 16) and the Office of Value-Based Health Care Delivery (OVBHCD). It requires coordinated monitoring of provider uptake and compliance with value-based care delivery models (in coordination with the Primary Care Reform Collaborative), and it directs the OVBHCD/Commissioner to collect specified reporting and develop regulations that standardize primary-care performance measurement and program design elements.
The bill also changes insurer rate and coverage requirements by (1) creating/clarifying a set of “Medicare Reference-Based Pricing (RBP) Targets” used to limit costs per inpatient hospital service, outpatient service, and emergency department service for commercial and group coverage for plan years beginning in 2028 (with special treatment for Free-Standing Children’s Hospitals), including defined exemptions (e.g., Medicare-Dependent Rural Hospitals, Urban Medicaid DSH Hospitals, and participation in approved multi-payer global budget models); and (2) extending primary-care “spend-at-least” requirements—starting in 2026—for both commercial and state group insurance markets. Specifically, carriers must spend at least 11.5% of total cost of medical care on primary care, with at least 5% via prospective primary care management payments; carriers must offer value-based care programs meeting Department program design elements and may not deny participation to contracted providers willing to accept program terms on the same basis as other providers.
On enforcement and accountability, the bill modifies administrative penalty authority for violations tied to the primary-care and value-based care framework (Title 18 §329), including changing penalty treatment for specified violations to be equivalent to the monetary value associated with the violation, and establishing a Primary Care Fund. Penalty-related funds are directed for use by the Statewide Benefits Office and the Division of Medicaid and Medical Assistance for functions supporting implementation of Medicaid and related primary-care requirements under Title 29/31, subject to annual appropriations and a cap on the unencumbered carryover (with excess transferred to the OPEB Fund). The bill also extends the Commission’s ability to request insurer reports (removing a time limitation referenced in Title 16).
The bill applies parallel public-plan requirements: it amends primary-care spending and reporting obligations for the state’s group insurance for public officers/employees (Title 29 §5224) and creates a new primary-care coverage spending/reporting provision for entities providing health insurance under state public assistance (Title 31 §539). It also removes a sunset/expiration clause that would have repealed the specified insurer rate/primary-care sections effective January 1, 2027. Finally, the Department of Insurance must promulgate implementing regulations within 18 months of enactment, and must, on or before January 1, 2027, establish a methodology for annual inflationary/other adjustments to a hospital’s “Full Medicare Rate” not otherwise captured in the annual Medicare rate update.
District Of Columbia
3
bill
Regulation • 🇺🇸 United States • District of Columbia • Final Notice
The regulation establishes a new Medicaid beneficiary reimbursement framework in Chapter 9 (Title 29) of the District of Columbia Municipal Regulations by adding Section 933, “Beneficiary Reimbursement for Medicaid Covered Services.” It specifies when reimbursement may be requested, which types of out-of-pocket expenses are reimbursable (including “other services covered under the Medicaid State Plan” and other listed categories), circumstances under which reimbursement is available due to improper denial of coverage, and submission requirements for reimbursement requests, including a deadline. It also sets agency and Medicaid Managed Care Plan (MCP) responsibilities and timelines for processing claims and issuing final written determinations, including due-process appeal rights for beneficiaries.
Section 933.1 allows reimbursement to occur if a Medicaid covered expense was incurred and paid (on a date consistent with 29 DCMR 95) and the reimbursement requirements in § 933.2 are met. Section 933.2 lists reimbursable out-of-pocket expenses and adds a catch-all category for “Other services covered under the Medicaid State Plan” (covering services available to children through EPSDT, without naming EPSDT separately). It also defines additional reimbursement triggers where beneficiaries are improperly denied coverage, including when DHCF incorrectly determined ineligibility at renewal/recertification, when a provider seeks payment because the beneficiary was incorrectly identified as ineligible, for beneficiaries under age 21 required to pay for EPSDT services, and for dual eligibles where a third-party insurer does not cover the Medicaid covered portion. Section 933.3 extends the general reimbursement request window to 12 months from the date the expense was incurred or 12 months from the date of Medicaid eligibility determination, whichever is later.
Section 933.4 requires submission of a Medicaid Reimbursement Form (link provided) or equivalent information to the Department or to the beneficiary’s MCP based on enrollment status at the date of service. Each submission must include beneficiary and provider identifiers, service date, amounts paid/owed, amounts paid by other insurers (including Medicare), the amount the beneficiary seeks Medicaid to reimburse, and either a receipt showing payment to the provider or a signed statement explaining why a receipt cannot be presented. The “reasonable inability” standard for missing receipts includes specified provider-related circumstances and allows a Department case-by-case determination.
Sections 933.5 through 933.12 set claim routing and decision/processing timelines: DHCF identifies whether the beneficiary was enrolled in Medicaid fee-for-service (FFS) or an MCP on the service date; if MCP-enrolled, DHCF must within 30 calendar days provide written notice of MCP processing and the right to appeal/request a fair hearing (and forward the claim and notice). MCPs must issue final written determinations within 60 calendar days of receiving a claim from DHCF or the beneficiary. Final determinations must include full payment, partial payment with explanation, or denial with explanation and due process appeal rights; if MCPs miss the 60-day deadline, they must pay the full claim within 5 business days after the deadline. Additional safeguards provide for DHCF payment when DHCF fails to submit a claim to an MCP within 30 calendar days (resulting in longer downstream delay), and for DHCF payment when it fails to issue a determination within 90 calendar days for FFS claims. Section 933.11 allows appeals by both FFS and MCP enrollees pursuant to applicable appeal processes; Section 933.12 limits MCP appeals when a beneficiary prevails at fair hearing challenging an MCP denial.
The Director of DHCF took final action to adopt the rulemaking on April 1, 2026, and the rules become effective upon publication of the notice in the District of Columbia Register.
bill
Legislation • 🇺🇸 United States • District of Columbia • Bill
The document outlines a comprehensive series of legislative amendments and provisions aimed at enhancing various sectors in the District of Columbia, with a strong focus on economic development, community support, education, public safety, and healthcare. Key initiatives include funding flexibility for Advisory Neighborhood Commissions, support for small businesses through delayed sales tax increases, and the establishment of programs like Baby Bonds to assist families financially. Significant allocations for public safety and education are highlighted, including funding for immigrant legal services and adjustments to public school funding formulas.
In the realm of community development, the document emphasizes the transfer of jurisdiction over the Rock Creek Tennis Center to the District government and the establishment of a program to preserve historic burial grounds for African Americans. Community land trusts will benefit from tax exemptions, and business licensing regulations are updated to encourage compliance. Additionally, funding for educational programs, particularly for special education and early childhood initiatives, is set to increase, ensuring better support for at-risk students.
Healthcare provisions include changes to the medical cannabis industry and expanded criminal background checks for child services providers. The document also addresses environmental health by transferring responsibilities related to lead poisoning prevention to the Department of Health. Furthermore, amendments aim to improve youth services through grant programs focused on employment and recidivism reduction, while reforming child support systems to better support families in need.
Public benefits are enhanced through the expansion of the Health Care Ombudsman Program, and new regulations for body art establishments are introduced to ensure safety. Significant financial allocations are made for stormwater management and energy initiatives, including the establishment of a Sustainable Energy Trust Fund. Additionally, new regulations are introduced to enhance road safety and update vehicle for hire regulations.
Overall, these legislative changes reflect a systematic approach to fund management and reallocation, aiming to enhance service delivery and support critical programs in healthcare, housing, education, and public safety. The amendments are designed to ensure that surplus revenues are effectively utilized to address community needs and promote sustainable development, ultimately fostering economic growth and improving public services in the District of Columbia.
bill
Regulation • 🇺🇸 United States • District of Columbia • Proposed Notice
The regulation sets out proposed District of Columbia Medicaid changes to the eligibility and reimbursement framework for Private Duty Nursing (PDN) under 29 DCMR Chapter 9, Section 947. It would require PDN reimbursement to apply only when a beneficiary needs “complex and continuous medical intervention,” defined in the rule as either (1) individualized and continuous medically necessary care enabling the beneficiary to remain at home instead of a hospital or nursing facility, or (2) dependence on ventilator equipment/other technology where discontinuation is likely to cause immediate deterioration of vital signs. It also clarifies reimbursable PDN service requirements, including who may order PDN and how the plan-of-care must be developed, reviewed, signed, updated, and documented.
Key ordering, face-to-face, documentation, and plan-of-care changes include: PDN orders must include physician certification of medical necessity under Section 947.7 and must be submitted with documentation demonstrating medical necessity. Medicaid reimbursable PDN requires an R.N.-developed plan of care (signed by the R.N.) and a physician review/approval process: the physician must review and (if needed) amend and sign the initial plan within 30 days, and the physician must review/update and sign the plan every 60 calendar days. The ordering physician must also document that a relevant face-to-face encounter occurred within 30 days before the start of services and within 30 days before the order, conducted by the ordering physician, or an NP in collaboration with the ordering physician, or a physician assistant under the ordering physician’s supervision. The plan-of-care must be developed collaboratively (R.N., ordering physician, Home Care Agency, beneficiary, and caregiver) and “optimized” for effective home delivery.
The rule would update PDN reimbursement administration by: establishing prior authorization requirements for all PDN requests, with specific criteria DHCF (or its designee) must use (including eligibility under the complex/continuous standard; plan-of-care compliance; ability to meet needs safely in the home; cost-effective delivery; and documentation and clinical appropriateness standards). It would maintain a baseline Medicaid reimbursement limit of up to 12 hours per day, while allowing additional hours only if DHCF determines they are medically necessary under the complex/continuous criteria. It would add additional operational provisions: DHCF audit authority and provider recordkeeping/access for audits (records retained for 10 years or longer if audits are ongoing); expanded detail on PDN duties and progress-note expectations; service limitations excluding PDN billing for duties that are assessments/reassessments/supervisory components in computing the daily hour limit; rules preventing double billing when ADLs occur during assessments/supervisory/PDN visits; and restrictions on concurrent delivery with personal care aide services (only reimbursable if DHCF determines concurrency is necessary for health and safety). It also would bar concurrent PDN reimbursement where the beneficiary concurrently receives skilled nursing services under the State Plan.
The proposal would add definitions for “Continuous care,” “Home setting,” and “Complex health care” within Section 947.99. Public comments must be submitted in writing within 30 days after publication in the District of Columbia Register (submission via email, online at dcregs.dc.gov, or by mail to DHCF). The rule is tied to a State Plan amendment approved by CMS effective October 1, 2025, and the notice states DHCF projects no fiscal impact in FY 2026.
Florida
15
bill
Regulation • 🇺🇸 United States • Florida • Final Notice
The document establishes eligibility criteria for employers/facilities, physicians, and employment contracts under Florida’s Conrad 30 program (rule 64W-1.003). It requires all sponsoring facilities/employers and practice site locations in Florida to accept and actively bill Florida Medicaid (whether fee-for-service or as a managed care provider), and it limits physician eligibility at the practice site to specific categories (e.g., free clinics as defined in statute, physicians funded 100% by government funds without charging patients, or physicians who accept Medicaid, with the condition that the applicant cannot be the only Medicaid-accepting physician at the site).
It further sets physician eligibility requirements for applicants, including that applicants (i) currently reside in the United States, (ii) have an active U.S. Department of State case number at the time of application, (iv) hold an unrestricted, active Florida license as an allopathic or osteopathic physician that is effective on or before October 31 (excluding residents, graduate assistants, interns, fellows, and house physicians), (v) agree to reside in Florida and treat only patients in Florida during the entire approved Conrad 30 employment period, and (vi) be ineligible if they are eligible to apply through the HHS Exchange Visitor Program.
For employment contracts to qualify, the rule specifies mandatory contract content and prohibits certain terms. Contracts must include signed physician and employer signatures with signature dates; must clearly list all practice locations and prohibit language that permits changing/adding locations without prior Department notification under Rule 64W-1.008; must state the physician will provide direct patient care for at least 40 hours per week, disallowing administrative duties, telemedicine, or being merely “available” to provide direct patient care as part of those 40 hours (and requiring an explanation if shift work is mentioned); must provide a minimum 3-year full-time term with stated start and end dates; must state that full-time employment starts within 90 days after USCIS approves the waiver (and disallow caveats to that statement); must require written notice to the Department Primary Care Office at least 60 days before termination by either party (or immediately for immediate termination); must contain no non-compete clauses; and must limit termination provisions to “for cause.” The rule also requires that legally binding provisions in an Offer of Employment letter be included in the contract (not used as a separate cover letter), and that any addendum/attachment altering contract terms be signed and dated by both parties.
The rule concludes with statutory authority/implementation citations (Rulemaking Authority 381.4018(3) FS; Law Implemented 381.4018 FS) and indicates its history (new in 8-12-21, amended 10-24-22, and amended 8-23-26).
The bill makes multiple changes to Florida’s Medicaid program, with an emphasis on (1) creating mandatory work/community engagement conditions for certain able-bodied adult Medicaid recipients, and (2) expanding and tightening Medicaid drug-policy, managed-care accountability, and program integrity processes. It also establishes new statutory sections and revises several existing Medicaid statutes related to drug pricing/rebates, managed care encounter data, integrity and overpayment determinations, and managed care plan governance.
Key Medicaid eligibility change: it creates a new requirement under new sections 409.9041/409.9041 (and related cross-references) requiring the Agency for Health Care Administration (AHCA), coordinated with the Department of Children and Families, to implement mandatory work and community engagement requirements for able-bodied adults as a condition of obtaining and maintaining Medicaid coverage. AHCA must seek federal approval to implement these requirements for specified populations. The bill specifies which Medicaid recipients ages 18–64 are subject (with listed exemptions including, among others, certain caregiving roles, medically frail/disabled categories, some SNAP-compliant individuals, participants in residential substance use disorder treatment, inmates of public institutions, and certain pregnancy/postpartum categories) and identifies the specific activities that can satisfy the requirement (e.g., paid employment, training, certain education and high-school-equivalency activities, and other designated work activities). Parents with children ages 6–18 must participate only during standard school hours. Medicaid recipients must demonstrate compliance at specified times to maintain coverage; the bill directs AHCA to develop compliance processes and to require the department to verify compliance at redetermination (or more often as determined). AHCA must conduct outreach, and if noncompliance is found, AHCA must notify the recipient and specify eligibility impacts. The notice must include a 30-day grace period to come into compliance or request an exemption, continued coverage during the grace period, and consequences thereafter (including denial and service termination timing) plus the right to request a fair hearing.
Drug policy and pharmacy reimbursement changes: the bill authorizes AHCA retrospective reviews/audits for certain emergency Medicaid claims (revising s. 409.904(4)). It also changes Florida’s Medicaid Pharmaceutical and Therapeutics framework by revising the committee’s purpose and revising Medicaid preferred drug list structure: it creates a set of preferred lists including a “preferred physician-administered drug list,” a “preferred product list,” and a “high-cost drug list,” and requires AHCA adoption upon committee recommendations, with review frequency requirements. Reimbursement for drugs not on the preferred lists (except antiretrovirals) becomes subject to prior authorization. AHCA must publish and disseminate the lists, including on the agency website, without needing chapter 120 rulemaking procedures for posted updates. Additional drug cost-control mechanisms are required/authorized within s. 409.912’s spending-control program (including prior authorization processes such as step-therapy and step-edit definitions, dispensing supply limits, return/reuse program parameters, 340B fiscal impact study requirements, and new or revised supplemental rebate negotiation provisions and preferred-list-linked rebate floors/limitations). The bill also establishes an alternative reimbursement methodology for long-acting injectables administered in a hospital setting for severe mental illness, and expands prescription drug management system authority.
Managed care governance, encounter data, integrity, and dental pilot program: the bill adjusts multiple statutes governing managed care plan accountability. It amends provisions on mandatory hospital inpatient service coverage purchasing practices and adds an expanded home- and community-based behavioral health program for adults with serious mental illness (subject to federal approval). It revises managed care plan requirements including (a) encounter data reporting/validation and uniform cost accounting, and (b) additional analysis and public reporting using encounter data (including an annual “Analysis of Potentially Preventable Health Care Events” report with defined inclusions and timing). Program integrity statutes are amended to clarify “overpayment” and to allow/require retrospective reviews, investigations, analyses, and audits, with random audit minimums and specific fraud-detection tracking/medical necessity methods. Managed care plan procurement/accountability provisions are strengthened by requiring a longer initial contract term structure and by imposing additional contract requirements on third-party administrative entities, including physician compensation benchmarks, electronic prior authorization acceptance, provider network standards with online searchable databases and feedback capability, enhanced quality improvement obligations (including HEDIS/core set behavioral measures stratified by demographics and disability determinations), accreditation timing and consequences, program integrity functions, grievance processes, and penalties/fines for encounter data noncompliance and for plan departures/noncompliance. The bill also creates a new statute defining “control” for affiliated entities and requires managed care plans to report affiliations and related party/controlled interests by specified dates, plus an AHCA public assessment by December 31, 2026 of affiliated entity payment transactions and deviations for medical and administrative costs. Finally, it creates an Integrated Managed Care Pilot Program for combined medical and state-plan dental services in designated regions (subject to federal approval), including contract amendments, timing, continuity-of-care requirements, minimum dental “medical loss ratio” standards, evaluation measures, and reports to the Governor/Legislature beginning December 1, 2028.
Effective date: the bill takes effect July 1, 2026.
The regulation establishes new standards for provider access and information transparency. It requires that at least 50% of primary care providers offer appointments outside of regular business hours, specifically outside of Monday through Friday 5 p.m. to 8 a.m., and on all day Saturday and Sunday. Additionally, plans must maintain an online, complete, and searchable provider database. These requirements are effective starting July 1, 2026.
Failed • Regular Session 2026 • Introduced: November 24, 2025
Sponsors: Chase Tramont (R-FL), Debra Tendrich (D-FL), House Health Care Facilities & Systems Subcommittee
Co-sponsors: Robin Bartleman (D-FL), Kimberly Daniels (D-FL), Jennifer Harris (D-FL), Christine Hunschofsky (D-FL), Johanna López (D-FL), James Vernon Mooney (R-FL), Angela Nixon (D-FL), Susan L. Valdes (R-FL)
The bill requires the Agency for Health Care Administration (AHCA) to establish network adequacy standards specifically for prepaid dental plans, including time and distance travel standards for each provider type and covered specialty service. It also requires sedation dentistry network standards to ensure sufficient capacity so that enrollees who require sedation dentistry can access at least two preventive or treatment appointments per year, with sedation dentistry travel standards no more than those for general dentistry.
The bill expands Medicaid managed care plan provider network database requirements by requiring contract/provider databases to identify whether providers are accepting additional Medicaid patients. For prepaid dental plans, it further requires online provider database fields that clearly identify sedation dentistry providers, list specialty providers separately from general dentists, and specify the specialty services offered by each provider; the database must also be available online to both AHCA and the public, allow comparison to network adequacy standards, and accept and display feedback from patients.
It requires AHCA to conduct, or contract for, systematic and continuous testing of plan-maintained provider network databases to confirm database accuracy, confirm behavioral health providers are accepting enrollees, and confirm enrollees have access to behavioral health services. The bill also adds/clarifies several managed care operational requirements: managed care plans must accept prior authorization requests electronically (including by their fiscal agents/intermediaries), and plans serving children in the custody of the Department of Children and Families must maintain complete medical, dental, and behavioral health encounter information and participate in making it available for coordinated case management, with an interagency agreement governing confidentiality, recipient, scope, format, and submission deadlines.
The document introduces several significant changes to Florida's healthcare statutes and regulations. It repeals statutes related to the prohibition of using state funds for travel to other states for abortion services, sex-reassignment procedures, and protections for healthcare providers' conscience rights. It establishes new requirements for covered entities to adopt policies, submit lists of refused services, notify the Department of Health of changes, and include such lists in grant or contract applications, with a deadline of October 1, 2026. The Department is tasked with publishing current refused service lists, developing public education programs, and maintaining an online list of covered entities and their refused services by January 1, 2027.
The bill mandates that health care facilities disclose refused services to patients and the Department, with penalties for non-compliance up to $5,000 per day. It also clarifies that the section does not alter existing legal liabilities or rights related to health care service denials. Additionally, it requires the development of public education and awareness programs about service denials and their impacts.
A new requirement is added that pregnancy and parenting support services must constitute at least 85% of contract funds, replacing the previous 90% threshold. The bill also prohibits telehealth abortions and the mailing or couriering of medications for medical abortions, mandating in-person performance of pregnancy termination procedures by licensed physicians.
Legal definitions are introduced or clarified for sex-reassignment prescriptions or procedures, with specific exceptions for treatments related to genetic disorders, injuries, or illnesses posing imminent danger. Emergency jurisdiction is expanded to include cases where minors are subjected to or threatened with sex-reassignment procedures, allowing courts to issue custody warrants if serious harm is likely. Reimbursement policies for Medicaid are revised to allow retroactive recalculations based on updated cost reports, with full payment at the new rate, and provisions are included for adjusting reimbursement rates, fees, and service parameters to align with available funds and legislative intent. The bill also emphasizes increased reporting and transparency in Medicaid fraud prevention, including detailed fiscal analyses, performance standards, and educational materials for recipients, along with provisions for emergency license suspension of practitioners arrested for certain offenses, including sex-reassignment procedures for minors.
The bill makes multiple changes to Florida Department of Health-related programs and several health-professional statutes, including creating a new grant program for neurofibromatosis research, expanding/adjusting newborn metabolic screening requirements, revising dental shortage-area and loan-repayment eligibility definitions, and updating several medical marijuana and health care regulatory provisions.
Key changes include: (1) Dental Student Loan Repayment Program statutory definitions are revised by defining “Low-income” and removing reliance on “medically underserved area,” and eligibility requirements are adjusted by changing the program’s qualifying geographic/population criteria (Section 1, s. 381.4019). (2) Medical marijuana law is revised by updating the definition of “Low-THC cannabis” and revising requirements tied to department approval of qualified physicians and medical directors (s. 381.986), including deletion of obsolete language. The bill also extends an exemption related to marijuana rulemaking and adjusts provisions about the timeframe for certain medical marijuana rules (Sections 16–17 and related text changes). (3) A new “Neurofibromatosis Disease Grant Program” is created within the Department of Health (s. 381.994), requiring competitive, peer-reviewed grantmaking for scientific and clinical research, with specific application eligibility, peer review panel process and conflict-of-interest restrictions, and authorization for carryforward of obligated but undisbursed general revenue appropriations for up to five years (Sections 3 and related carryforward provision).
In addition, newborn screening is expanded: the Department of Health must require newborn screening for infantile Krabbe disease beginning January 1, 2027 (subject to legislative appropriation), and the bill adds Duchenne muscular dystrophy screening beginning January 1, 2027 (also subject to appropriation) (Section 4 amending s. 383.14). The bill also requires the Department to create and distribute an evidence-based educational pamphlet for parents/guardians of preterm infants treated in neonatal intensive care units, including specified nutritional-content topics, with electronic availability by January 1, 2027 to hospitals providing neonatal intensive care services (Section 4).
Other program and regulatory changes include: revisions to the Early Steps Program and Early Steps Extended Option related to statewide uniform transition protocols to education settings and local notice/conference procedures around a child’s move to age 3 (Sections 5–6, amending s. 391.308 and s. 391.3081); redesignation/expansion of pediatric trauma center designation authority to require level assignment based on American College of Surgeons verification (Section 7, amending s. 395.4025); emergency suspension of certain health care practitioners’ licenses for arrests involving murder (Section 8, amending s. 456.074); authorization under controlled-substance delegation rules for certain administration by home health aides for medically fragile children in an emergency seizure context (Section 9, amending s. 464.0156); new scope permissions for dental hygienists to use a dental diode laser under direct supervision with defined training, continuing education, documentation, and evidence requirements (Sections 10, adding to s. 466.023); exemptions for licensed cosmetologists performing specified aesthetic body contouring services, including defining “aesthetic body contouring services” (Section 11, amending s. 480.034); and a statutory change prohibiting certain incestuous marriages entered after July 1, 2026 (Section 13, amending s. 741.21). The bill also expands “health care provider/provider” definition for a governmental contractor relationship to include certain students in accredited programs preparing for licensure under specified professional categories (Section 14, amending s. 766.1115), updates University of Florida Center for Autism and Neurodevelopment micro-credential requirements (Section 15, amending s. 1004.551(1)(f)), and sets the bill’s effective date as July 1, 2026 (Section 19).
The bill changes Florida’s inmate welfare trust fund requirements for contractor-operated correctional facilities. It amends s. 945.215(3)(b), Florida Statutes, to require that “maintenance and repair deduction fees” collected from contractor-operated correctional facilities be deposited into the Contractor-Operated Institutions Inmate Welfare Trust Fund (in addition to other specified sources already directed to that fund). It also specifies how money in the fund may be used: funds must be used exclusively to provide or operate programs to aid inmates’ reintegration into society and to support environmental health upgrades to facilities, including fixed capital outlay for repairs and maintenance that improve environmental conditions.
The bill further requires that expenditures from the Contractor-Operated Institutions Inmate Welfare Trust Fund be made only pursuant to a legislative appropriation. To conform cross-references after the s. 945.215 change, it reenacts s. 944.72(1), Florida Statutes, so that the trust fund’s purpose (inmate benefit and welfare in contractor-operated facilities) and the statement that deposits and expenditures are handled as provided in s. 945.215 remains accurate.
The document introduces new requirements for managed care plans and providers, including the obligation to negotiate mutually acceptable rates, methods, and terms of payment, with plans specifically required to pay dentists at rates equal to or higher than the agency's set rates. Managed care plans must accept electronic prior authorization requests and share complete medical, dental, and behavioral health encounter data for children in the care of the Department of Children and Families, establishing interagency data-sharing agreements. Additionally, statutes are amended to specify Medicaid provider agreement procedures for school districts, including certification of school-based services (excluding family planning, immunizations, and prenatal care) and the participation of lab schools in Medicaid programs. Procurement procedures for transportation services are revised to require negotiations with the transportation commission before contracting.
Furthermore, the bill mandates that managed care plans include essential Medicaid providers, including specific categories of statewide essential providers, and negotiate payment rates for non-contracted essential providers, with plans authorized to exclude certain providers after 12 months based on quality or performance, provided notice is given. It also establishes criteria for selecting plans in a pilot program for individuals with developmental disabilities, emphasizing experience, community partnerships, benefits, provider development, and person-centered planning, with a preference for plans meeting specific service standards. An effective date of July 1, 2026, is specified for these provisions.
The bill makes multiple changes to Florida’s Medicaid and food assistance programs, primarily by (1) creating a mandatory Medicaid work/community engagement framework (with federal approval and legislative-plan approval prerequisites), (2) strengthening Medicaid program integrity and oversight rules affecting overpayment determinations, audits, and notices, and (3) expanding Medicaid drug cost-control and preferred-drug-list administration through new/modified lists, prior authorization processes, and additional program requirements.
A new section (s. 409.9041) establishes Medicaid work and community engagement requirements for able-bodied adults ages 19–64 as a condition of obtaining and maintaining Medicaid coverage. The Agency for Health Care Administration (AHCA) must seek federal approval (via a Medicaid waiver) and may not implement the requirements until AHCA’s business plan is specifically approved by the Legislature. The business plan must include ongoing eligibility/exemption determination methods, an analysis of enrollment and expenditure effects, and an income-earning transition method modeled on temporary cash-assistance Medicaid continuity. The bill specifies which Medicaid recipients are subject to the requirements, the exemptions/exclusions (including a defined “family caregiver”), acceptable activities (80 hours/month), a school-hours-only rule for certain parents, and procedures for demonstrating compliance at enrollment/redetermination and at least every 6 months. It also requires agency outreach, a compliance process aligned to SNAP processes where possible, Department of Children and Families verification at set intervals, and notice procedures for noncompliance—including a 30-day grace period, consequences after the grace period (denial and service termination timing), fair-hearing rights, and reapplication instructions.
The bill amends Medicaid service and drug-related statutes. It allows AHCA, for a specified emergency Medicaid eligibility category, to conduct retrospective reviews/audits to validate the existence/duration of the emergency medical condition and necessity of services, regardless of whether prior authorization was obtained (s. 409.904(4)). It also removes a requirement that AHCA discontinue its hospital retrospective review program and clarifies that AHCA may still conduct retrospective reviews under the Medicaid integrity statute even after implementing hospital inpatient prior authorization. For optional Medicaid services, it adds a requirement for AHCA to seek federal approval to expand home- and community-based behavioral health services for adults 18+ with serious mental illness who are high utilizers in institutional settings, with a coordination requirement and a requirement that program cost estimates be appropriated before implementation.
The bill substantially revises Medicaid pharmaceutical governance. It changes the Medicaid Pharmaceutical and Therapeutics Committee’s purpose and directs AHCA, upon committee recommendations, to adopt (and publish) a Medicaid preferred physician-administered drug list, a preferred product list, and a high-cost drug list, reviewed on a 6–12 month cadence. It provides that reimbursement for drugs not on those lists (with an antiretroviral exception) is subject to prior authorization and adds detailed prior-authorization/step-edit process requirements, including timing/availability rules and limits on dispensing supply. It requires AHCA to establish and manage a broader drug spending-control program (including preferred lists, prior authorization and step-therapy processes for non-preferred drugs, and a return-and-reuse program for drugs dispensed to institutional recipients). It also requires (1) a detailed fiscal impact study of the federal 340B Drug Pricing Program, including data submission by specified entities and sanctions for noncompliance, and submission of results to the Governor and Legislature by June 30, 2027; and (2) further drug therapy management processes for recipients with high prescription utilization, including an agency program that may include comprehensive reviews and case evaluations. Separately, it modifies Medicaid integrity law (s. 409.913) to allow overpayment determinations to be based on retrospective reviews/investigations/analyses/audits and clarifies that “overpayment” includes certain amounts paid as a result of utilization review/prior authorization processes; it also updates confidentiality cross-references for supplemental rebate negotiation materials. The bill also adds new food assistance provisions: it limits eligibility to specified resident categories, requires documentation of shelter/utility expenses (and prohibits relying solely on self-attestation), creates a food assistance payment accuracy improvement plan with a target error-rate reduction and specified plan/reporting requirements (with repeal on Oct. 1, 2028), requires photographic identification on front of newly issued/reissued EBT cards to the maximum extent permitted by federal law, and revises SNAP employment/training participation criteria and related work requirement compliance rules (effective July 1, 2026).
The bill creates a Joint Legislative Committee on Medicaid Oversight and sets requirements for its membership, leadership (including alternating chair/vice chair appointments), subcommittees, meeting frequency, and staffing. It assigns the committee duties to evaluate Medicaid program financing, quality of care/health outcomes, administrative and operational functions; identify and recommend policies to limit Medicaid spending growth while improving outcomes; review Medicaid managed care plan data (including provider credentialing/payment timeliness, claim denial rates, prior authorizations, consumer complaints, and encounter data); review health outcomes (including HEDIS/National Committee for Quality Assurance and Medicaid managed care organization quality goals); and develop a plan of action for the Medicaid program’s future. The committee may issue periodic reports to the Legislature and is authorized to access records and compel testimony/evidence using specified subpoena-like procedures and powers consistent with joint legislative committee rules.
To support the committee, the bill requires the Auditor General and the Agency for Health Care Administration (AHCA) to enter and maintain a data sharing agreement by July 1, 2026, to ensure full access to data needed by the committee, and requires AHCA to notify the committee before implementing changes to Medicaid managed care capitation rates, including appearing with specified capitation-rate and cost/expense trend reporting. It also requires AHCA to provide the committee copies of other required legislative reports related to the Medicaid program. It further expands Medicaid managed care accountability in multiple areas: it revises Medicaid encounter data requirements by specifying plan submission of encounter data including denied and capitated reimbursed encounters, requiring AHCA validation and ongoing analysis (adjusting for plan enrollee characteristics) to detect overspending, above-market payments, underutilization/denials, inappropriate utilization, and potential fraud/waste/abuse; requiring use of this analysis in capitation rate setting; requiring quarterly reporting of provider assignment counts by plans and systematic continuous testing of network databases to confirm accuracy and behavioral health access; and requiring annual reporting by AHCA of potentially preventable health care events, due October 1 each year.
The bill strengthens managed care contract and pricing oversight. It updates contract procurement and contract/accountability provisions by requiring a 6-year contract structure for managed care plans (beginning with specified procurement activity) and revising numerous contract standards, including network access/provider database requirements, electronic prior authorization requirements, continuous improvement requirements (including quality measurement and accreditation timelines), grievance processes with quarterly reporting, program integrity functions and minimum fraud/abuse controls, and additional penalties and termination procedures tied to noncompliance (including encounter data reporting fines and notice/termination triggers). It tightens achieved savings rebate calculations by revising prohibited items and—effective January 1, 2027—changing the income-sharing ratios used to compute achieved savings rebates (shifting retention/refund percentages across income thresholds). It also revises the medical loss ratio (MLR) framework by requiring calculation as applicable and changing reporting timing and classification rules; it requires AHCA to report MLRs quarterly and annually for each contracted managed care plan within a set timeframe. Finally, it adds affiliated entities and related-party oversight by creating new reporting and transparency requirements: managed care plans must report controlled/affiliated persons and certain investment/ownership or common-control relationships by March 31, 2027 and annually thereafter, report changes within 60 days, and AHCA must calculate/analyze and publicly report on affiliated entity payment transactions and related administrative costs beginning by December 31, 2026 and annually thereafter.
The bill also modifies pharmacy benefit manager (PBM) and related insurer statutes. It amends PBM transparency/accountability provisions by defining “affiliated manufacturer,” revising the definition of “pharmacy benefits plan or program,” expanding required contract terms between PBMs and participating pharmacies (including prohibitions on certain financial clawbacks/reconciliations/offsets and specified exceptions), adding/clarifying an administrative appeal process for maximum allowable cost pricing (including electronic spreadsheet submission options, minimum filing time after updates/adjudications, PBM response deadlines, and required outcomes if upheld), and requiring periodic quarterly reporting by PBMs starting August 15, 2026 for denied appeals by drug. It amends PBM prohibited practices to add specific restrictions (including limits on recoupment and affiliate-related reimbursement practices). It also updates a cross-reference in the prior authorization law definition of “health insurer.” The act takes effect July 1, 2026 except for provisions with specified earlier effective timing (including those tied to enactment, and one provision effective January 1, 2027).
The document clarifies the definition of "outside of regular business hours" for the purpose of establishing provider access standards in Medicaid managed care plans. Specifically, it defines these hours as Monday through Friday from 5 p.m. to 8 a.m. local time, and all day Saturday and Sunday. This new definition aims to ensure consistent application of provider access standards during non-standard hours and on state holidays. The operative change is a replacement of the previous or undefined term with this specific, detailed time frame, effective July 1, 2026.
The document repeals sections 286.31, 286.311, and 381.00321, which previously restricted the use of state funds for travel related to abortion services, sex-reassignment procedures, and protected healthcare providers' conscience rights. It establishes new requirements for healthcare entities to provide written notices of refused services, submit lists of such services to the Department of Health, and maintain publicly accessible information on refused services, with policies to be adopted by October 1, 2026, and enforcement mechanisms including fines up to $5,000 per day. The department is tasked with developing rules, publishing lists of refused services, and overseeing compliance.
Additionally, the bill mandates that providers promote childbirth exclusively, ensure informational materials are current and cite sources, and deliver services that are noncoercive and free of religious content. It introduces detailed reporting obligations on service provision and expenditures, and restricts third-trimester abortions to specific conditions such as physician certification, emergencies, fetal abnormalities, or cases involving rape, incest, or trafficking, with documentation requirements. In-person physician performance of abortions is required, while telehealth and mailing of medications for medical abortions are prohibited. The bill grants the agency authority to regulate abortion clinics, including licensing, inspections, and record-keeping, and repeals section 395.3027.
The definition of "sex" is clarified to be based on reproductive anatomy, chromosomes, and hormones present at birth, and "sex-reassignment procedures" are clarified to exclude treatments for genetic or physical disorders, infections, injuries, or illnesses that could be caused or worsened by such procedures. Telehealth providers are prohibited from performing abortions via telehealth, including medical abortions. Statutes related to emergency jurisdiction and child custody enforcement are amended to include protections concerning sex-reassignment procedures. Medicaid reimbursement policies are modified to include protections for gender-affirming care, with specific provisions for hospital services and local government funding.
Finally, the bill enhances oversight of Medicaid fraud and abuse by establishing detailed reporting requirements, including annual reports to the Legislature, policy recommendations with fiscal analyses, and performance standards. It also updates provisions related to Medicaid recipient communication, the licensing deadline for Medicaid mental health service providers (set for December 31, 1998), and authorizes Medicaid payments for gender-affirming care.
bill
Regulation • 🇺🇸 United States • Florida • Regulatory Notice
The document issues a notice of changes to a previously proposed Florida Medicaid rule establishing the drug reimbursement methodology in Rule 59G-4.251 (Prescribed Drugs Reimbursement Methodology). It specifies that certain subsections of the proposed rule remain unchanged while revising particular reimbursement details, including the 340B reimbursement provision and the reimbursement basis for practitioner-administered drugs in an office setting.
In subsection (6), Florida Medicaid reimbursement for drugs purchased under the 340B program is clarified/adjusted to be the actual purchased drug price, not to exceed the 340B ceiling price, plus a $10.24 dispensing fee. The provision applies only to covered entities, Indian Health Services, tribal organizations, urban Indian pharmacies, and federally qualified health centers that dispense drugs at prices authorized under section 340B of the Public Health Services Act.
In subsection (8), Florida Medicaid reimbursement for prescribed drugs administered by a licensed practitioner in an office setting is set at 106% of ASP as provided by CMS in quarterly drug pricing files (with specific CMS pricing file locations listed). If no ASP rate is available, reimbursement is at WAC.
In subsection (11), Florida Medicaid reimbursement for DRG and EAPG exempt high-cost drugs is specified as reimbursement at AAC.
bill
Regulation • 🇺🇸 United States • Florida • Proposed Notice
The document contains a notice of development of rulemaking for Florida Medicaid’s provider reimbursement and billing codes in Rule 59G-4.002, Florida Administrative Code. It announces an update intended to revise the fee schedules and billing codes incorporated by reference so that the rule uses reference materials effective January 1, 2026, while also listing additional fee schedule reference materials effective July 1, 2025; July 8, 2025; and October 1, 2025. It also lays out a rule development workshop and public comment/participation deadlines for that proposed update (workshop April 10, 2026; workshop requests by April 8, 2026; official comments due April 13, 2026).
Operative content changes are confined to the “preliminary text of the proposed rule development,” which updates the incorporated-by-reference fee schedule and billing code links for their effective dates. Specifically, it provides a revised set of “Florida Medicaid Fee Schedules Effective January 1, 2026” reference links (covering multiple categories such as assistive care, behavior analysis, behavioral health overlay, birth center, community-based substance abuse county match, dental general, DME/medical supplies, and many others). It also lists fee schedule reference links for later effective dates (July 1, 2025; July 8, 2025; and October 1, 2025).
In addition, the proposed preliminary text updates “Florida Medicaid Billing Codes Effective January 1, 2026,” replacing/setting new incorporated-by-reference billing code reference links for multiple provider/service groups (including county health department, federally qualified health center, hospice, hospital outpatient services, intermediate care facility for individuals with intellectual disabilities, nursing facility services, prescribed drugs physician administered, rural health clinic, statewide inpatient psychiatric program services, and additional specified categories). It also states an “Effective July 1, 2025” billing codes reference link for prescribed drugs physician administered billing codes.
The notice does not specify effective or compliance dates for the rule change itself within the text provided; rather, it identifies the incorporated reference schedules/codes that will be effective on specific calendar dates (January 1, 2026; July 1, 2025; July 8, 2025; October 1, 2025). The document identifies Medicaid’s rulemaking authority and law implemented (409.919 FS; and implemented provisions including 409.902, 409.905, 409.906, 409.907, 409.908, 409.912, 409.913 FS).
bill
Regulation • 🇺🇸 United States • Florida • Final Notice
The regulation sets the Florida Medicaid fee schedules and Medicaid billing code sets that are incorporated by reference and made available on the Agency for Health Care Administration (AHCA) website, specifying the effective dates for each schedule/code group.
It establishes fee schedules effective January 1, 2025 (including assistive care, behavior analysis, behavioral health overlay services, birth center, several community match/behavioral health services, county health department match, dental general, durable medical equipment and medical supplies for all Medicaid recipients, early intervention, family home health aide, hearing, home health visits, licensed midwife, Medicaid certified school match, medical foster care, occupational therapy, personal care, physical therapy, physician pediatric surgery, prescribed drugs immunization, and private duty nursing), and it also lists additional fee schedules effective July 1, 2025 (independent laboratory, practitioner, practitioner laboratory, and prescribed pediatric extended care services) and July 8, 2025 (specialized therapeutic services). It further specifies fee schedules effective October 1, 2025 (independent laboratory, practitioner, practitioner laboratory, and targeted case management services).
It establishes billing code sets incorporated by reference with effective dates: January 1, 2025 billing codes for multiple provider categories (county health department, federally qualified health center, hospice, hospital outpatient, intermediate care facility for individuals with intellectual disabilities, and nursing facility services); July 1, 2025 billing codes for additional provider categories and service groups (including rural health clinic and statewide inpatient psychiatric program services, plus a separate set for prescribed drugs physician administered billing codes). The document also reflects later-extending coverage on page 2 by listing other July 1, 2025 billing code categories (rural health clinic and statewide inpatient psychiatric program services).
Operatively, the document is structured as a single rule (59G-4.002) with incorporated-by-reference links to the AHCA/Rulemaking Gateway reference documents. No public comment, hearing, or delayed compliance dates are stated in the provided text; the key effective dates are January 1, 2025, July 1, 2025, July 8, 2025, and October 1, 2025. Rulemaking authority and law implemented are listed for references to Florida Statutes 409.919 and 409.902–409.913, and the rule’s history indicates it was newly created in 2005 and amended multiple times through 2026.
The bill establishes the “Georgia Medicare for All Program” as a universal single-payer healthcare system for all Georgia residents, to be administered by a newly created Georgia Medicare for All Board and funded through a newly created “Georgia Medicare for All Trust Fund.” The program is required to be established and implemented by no later than July 1, 2029, and the bill authorizes the Board to organize, administer, market, and contract for program services, while also seeking federal waivers/approvals and submitting state plan amendments to secure federal funding and federal program integration.
The bill creates an eligibility and enrollment structure under which every Georgia resident is automatically enrolled as a program member (unless disenrolled/disqualified). It prohibits members from paying enrollment fees and disallows member cost-sharing (premiums, copayments, coinsurance, deductibles, or other cost-sharing) for covered benefits. Covered benefits are broadly defined to include a wide range of medical services, ancillary services, care coordination, prescription drugs, and—explicitly—reproductive healthcare and gender-affirming care, as well as benefits that the bill requires to be covered regardless of the prior source (including Medicaid/PeachCare/Medicare and certain other state-covered services) and essential health benefits mandated as of January 1, 2026 under the federal Affordable Care Act. The bill requires participation rules for licensed healthcare providers and introduces an out-of-state service concept for medically necessary care furnished while a member is temporarily out of state.
A key program design feature is mandatory care coordination: the bill requires each member to enroll with a care coordinator before receiving services that the program pays for, and it defines care coordination to include administrative tracking and medical recordkeeping subject to state and federal privacy and record-retention requirements. The bill also authorizes and regulates “healthcare organizations” (nonprofit/governmental entities approved by the Board) that can provide program care coordination and ancillary services, and it establishes standards for care coordinators and healthcare organizations, including approval, renewal, and potential limitation/suspension/revocation for specified grounds.
The bill further creates data transparency requirements (including inpatient, emergency/ambulatory surgery, and detailed hospital financial data) and restricts law enforcement from using program money/property or program information to investigate/enforce certain violations. It also includes payment and reimbursement rules, including: payment rates must be reasonable and related to the cost of efficiently providing services; healthcare services (other than care coordination) default to fee-for-service unless/ until the Board establishes other methodologies; integrated delivery systems/essential community providers/group practices may choose specified budget-based reimbursement; participating providers may not charge amounts above the program’s payment rates or solicit/accept extra payment from members/third parties (subject to federal-program exceptions); and payments are “considered payment in full.” It also adds a collective negotiation framework allowing healthcare providers to negotiate terms for contracts through an authorized providers’ representative, with limits on concerted actions outside the representative framework.
Separately from the single-payer program, the bill repeals and replaces Georgia abortion-related statutes by creating a “Reproductive Freedom Act” in Title 31 (including explicit state protections for the right to choose abortion and refuse contraception/sterilization), establishes prohibitions on state/local law enforcement interference with abortion rights when performed in accordance with the new chapter, and sets limits on disclosure of reproductive-health information by covered entities without consent. It repeals related earlier gender-dysphoria/minors provisions in multiple titles (Title 31 for minors’ treatment rules; Title 42 for certain prohibited inmate treatment categories as revised; Title 43 for certain gender-dysphoria-related professional restrictions) and repeals a Medicaid expansion prohibition provision by amending prior Medicaid-related statutes. Finally, it makes numerous conforming statutory changes across Titles 1, 15, 16, 19, 31, 33, 43, 45, 48, and 49, including revising definitions to include “unborn child” as a “natural person,” revising juvenile court reporting provisions related to abortion without disclosure under open-records rules, and adding a Medicaid payment requirement for abortion/abortion-related services for medical assistance recipients.
The bill includes a contingent effective date for Part II (the Medicare for All program) that applies only upon the effective date of a specific appropriation item in the state’s General Appropriations Act referencing the bill, while Parts III–VI become effective upon approval by the Governor or upon becoming law without such approval.
The bill adds a new statutory section to Georgia’s pharmacy benefits manager (PBM) regulation chapter requiring PBMs to ensure final reimbursements to certain “eligible pharmacies” for prescription drugs follow specified minimum pricing formulas tied to drug acquisition costs plus a professional dispensing fee.
The new section defines “affiliate pharmacy” (based on ownership/investment ties to a licensed PBM), “eligible pharmacy” (a pharmacy not owned by an entity/natural person with ownership interests in more than 10 pharmacies), “rural area” (counties with population under 50,000 per the 2020 decennial census or any future such census), and “rural pharmacy” (eligible pharmacies located in rural areas). It then requires that, after accounting for all fees/charges/adjustments/reductions (including direct/indirect renumeration fees, administrative/performance-based/network access fees, and similar constructs), the final reimbursement equals the national average drug acquisition cost at dispensing plus a professional dispensing fee equal to the current Georgia Medicaid professional dispensing fee determined by the Department of Community Health. If the national average drug acquisition cost is unavailable, the PBM must reimburse at the wholesale acquisition cost (as defined in 42 U.S.C. §1395w-3a(c)(6)(B)) as of January 1, 2026, plus the same Medicaid-determined professional dispensing fee, and must exclude reimbursements made under the new subsection from any “effective rate guarantees” (defined as contract provisions that permit adjusting reimbursement rates so overall reimbursement averages out to a predetermined rate).
The section includes applicability limits: it does not apply to a “state health plan” (as defined in O.C.G.A. §45-18-22) and does not apply to Medicaid under Chapter 4 of Title 49, including Medicaid managed care programs administered through care management organizations. It also clarifies that PBMs are not prohibited from reimbursing a rural pharmacy above the required national average acquisition cost plus the Medicaid dispensing fee; however, that rural-upcharge exception does not apply to affiliate pharmacies, mail-order pharmacies, and specialty pharmacies. The bill sets an effective date of July 1, 2027, and repeals conflicting laws.
The bill establishes a restructuring of Hawaii’s Medicaid delivery and administration away from risk-based managed care and toward a managed fee-for-service model with separate funding for care coordination. Beginning July 1, 2026, the Department of Human Services (DHS) is prohibited from initiating, renewing, or extending any contract with a “financial risk-bearing entity” to administer Medicaid services for all DHS Medicaid programs, including Med-QUEST and successors; existing managed care organization contracts must terminate no later than December 31, 2026.
To operationalize the new model, DHS must contract with one or more “administrative services organizations” to perform non-risk administrative functions for Medicaid administration. These functions include prior authorization review (used judiciously and only for demonstrated risk of unnecessary use), provider credentialing/recruitment (with DHS retaining participation-status authority and permitting exclusion for specified misconduct), customer service and grievance resolution, data analytics and utilization monitoring, claims processing, and administrative support for care coordination programs. DHS retains primary responsibility and oversight; administrative services organizations may not create separate provider networks and must operate within a unified statewide, publicly managed network. Contracts must include transparency and data-sharing obligations, and DHS must ensure public reporting of performance metrics, audit results, and stakeholder feedback.
The bill requires DHS to create a Medicaid care coordination program that contracts with community-based interdisciplinary teams to provide culturally responsive patient navigation, transportation, care planning, chronic disease management, specialist consultations to primary care, specialized programs (including for serious mental illness and substance use disorders), geriatric needs programming, behavioral health integration, and culturally competent outreach. DHS must provide fixed, predetermined care coordination payments to primary care practices designated by enrollees as their coordinated-care source, and care coordination program funding must come from program budgets (not capitation) to avoid shifting insurance risk to providers. DHS must also develop and publish performance metrics. DHS must establish regional health hubs in each county (with quarterly meetings and specified community representation) to monitor community needs, disparities, and service gaps, recommend best practices, and support care coordination strategies; hubs receive operational funding and must submit annual reports to DHS and the legislature. The bill further requires transparency and data ownership: DHS contracts for administrative functions must comply with Hawaii’s Uniform Information Practices Act and related public-record laws, the State must retain exclusive ownership of Medicaid-related data, and DHS must maintain a quarterly public data dashboard (de-identified data) plus an annual data report.
Public health functions (vaccination programs, disease surveillance, emergency response coordination, and health education) must remain under the direct administration of DHS’s Department of Health and cannot be delegated to administrative services organizations or other contractors; DHS must integrate public health operations with Medicaid where appropriate using its own staffing, infrastructure, and funding without reliance on privatized intermediaries. DHS must convene a Medicaid stakeholder advisory group during the transition. DHS is directed to seek any necessary amendments to the state Medicaid plan or Medicaid waivers from CMS to implement the above operational changes. The bill appropriates general funds for FY 2026–2027 for transition and administrative systems, care coordination fund activities, regional health hubs, and provider recruitment/training/retention, and sets the effective date as July 1, 2026, except that Sections 2–7 take effect only upon CMS approval of the Hawaii Medicaid state plan. It also includes a standard severability clause and provides definitions for key terms including administrative services organization, financial risk-bearing entity, managed fee-for-service, care coordination, and regional health hub.
The bill establishes a shift in Hawaii’s Medicaid delivery and administration model away from risk-based managed care toward (1) fee-for-service payment for clinical services directly by the State and (2) separately funded, non-risk care coordination and administrative functions. It creates requirements for contracting with administrative services organizations that do not assume financial risk, sets up a statewide Medicaid care coordination program, requires direct provider payment, and establishes county-based regional health hubs and a statewide Medicaid stakeholder advisory group to guide and monitor implementation.
Beginning July 1, 2026, the Department of Human Services may not initiate, renew, or extend contracts for Medicaid administration with “financial risk-bearing entities,” and all existing managed care organization contracts must terminate no later than December 31, 2026. The bill also prohibits a fiscal intermediary from receiving capitated payments or assuming financial risk for Medicaid enrollees; Medicaid health care services must be paid directly from the State to providers on a fee-for-service basis, with care coordination funded separately (except that capitation is not used for direct care other than a fixed, predetermined monthly care coordination fee paid to a provider/practice designated by the beneficiary as the coordinator of care).
The bill requires the Department to contract with one or more administrative services organizations to perform defined non-risk administrative functions, including judicious prior authorization review (focused on services with demonstrated risk of non-medically necessary use), provider credentialing and recruitment (with the State retaining authority over participation status, subject to disqualification for material professional misconduct), customer service and grievance resolution, data analytics and utilization monitoring, claims processing, and administrative support for care coordination program operations. Administrative services organizations must not maintain separate provider networks; each enrollee must access care through a unified statewide publicly managed provider network inclusive of safety-net and culturally competent providers, and contracts must require compliance with Hawaii’s Uniform Information Practices Act and other public-record/data transparency laws, with the State retaining exclusive ownership of Medicaid-related data.
The bill establishes the Medicaid care coordination program through community-based interdisciplinary teams providing patient navigation, transportation, interdisciplinary care planning, chronic disease management, specialist consultations to primary care, specialized programs for serious mental illness and substance use disorders, geriatric-focused care, behavioral health integration, and culturally competent outreach. It sets direct compensation terms: physicians and independent practitioners are paid directly by the State on a fee-for-service basis at least 100% of applicable Medicare rates (adjusted for geographic and practice-specific factors), and eligible providers receive a fixed, predetermined care coordination fee drawn from the care coordination program. Hospitals and institutional providers must also be reimbursed directly via fee-for-service methodologies designed to promote stability and access. Regional health hubs must be established in each county, convene at least quarterly, include specified stakeholder representation, and submit annual reports; public health functions (vaccination, surveillance, emergency response coordination, and health education) must remain under the Department of Health and cannot be delegated to non-risk administrative contractors. The Department must apply to CMS for Medicaid plan amendments or waivers needed to implement sections 2 through 7, publish a quarterly publicly accessible de-identified data dashboard and an annual data report, and provide legislative reporting: an annual report due at least 40 days before each regular session beginning with 2027, plus a detailed budget and implementation timeline due by December 1 (year not fully displayed in the text). The bill appropriates general funds for fiscal year 2026–2027 for transition and infrastructure, the care coordination fund, regional health hubs, and provider recruitment/training/retention, and it takes effect July 1, 2026 with sections 2–7 effective upon CMS approval of the state Medicaid plan.
The bill directs the Hawaii Department of Human Services (DHS) to adopt rules under Hawaii’s administrative procedures (chapter 91, Hawaii Revised Statutes) to expand eligibility for the State’s Medicaid programs to all children statewide from birth through age five years, with no income requirement.
The bill appropriates general funds for fiscal year 2026–2027 to support the Medicaid eligibility expansion, to be expended by DHS for the purposes of the Act.
The bill establishes a new Medicaid operating model for Hawaii based on non-risk administration and separate funding for clinical services versus care coordination. It prohibits the Department of Human Services (DHS) from initiating, renewing, or extending contracts with financial risk-bearing entities for Medicaid administration and requires that existing managed care organization contracts end by December 31, 2026, with DHS support for a smooth transition. It also bars a fiscal intermediary from receiving capitated payments or assuming financial risk for Medicaid enrollees; Medicaid clinical payments must be made directly from the State to providers on a fee-for-service basis, while care coordination is funded through a separate mechanism.
DHS is required to contract with one or more “administrative services organizations” (ASOs) to perform non-risk administrative functions, including judicious prior authorization (only where non-medically necessary use is demonstrated risk), provider credentialing and recruitment, customer service and grievance resolution, data analytics/utilization monitoring, and claims processing. ASOs must not establish separate provider networks; care must be accessed through a unified statewide provider network that DHS manages and that includes safety-net, culturally competent, and geographically distributed providers. DHS must retain primary responsibility for Medicaid administration, provider payment, and oversight of ASOs, and DHS must impose transparency and data-sharing requirements, including public reporting of performance metrics, audit results, and stakeholder feedback. The bill also requires DHS to establish a Medicaid care coordination program that contracts with community-based interdisciplinary programs to provide patient navigation, transportation for health care, interdisciplinary care planning, chronic disease management, specialist consultations to primary care, programs for serious mental illness and substance use disorders, geriatric care needs, behavioral health integration, and culturally competent outreach.
The bill requires direct provider payment: physicians and other independent practitioners must be paid fee-for-service by the State Medicaid agency at not less than 100% of applicable Medicare rates for the same services, adjusted for geographic and practice-specific factors set by DHS. Hospitals and other institutional providers must be reimbursed directly through fee-for-service payments using methodologies intended to promote financial stability, access, and alignment with the bill’s goals. Separately, DHS must provide a fixed, predetermined care coordination fee to primary care practices formally designated by a Medicaid enrollee as their source of coordinated care; care coordination is funded through care coordination program budgets (not capitation) and DHS must develop and publish performance metrics covering patient satisfaction, reductions in avoidable hospitalizations, improved chronic disease management, and culturally appropriate service delivery.
The bill creates county-based “regional health hubs” as localized oversight bodies that monitor community health needs and disparities, identify service gaps, recommend culturally responsive best practices, facilitate continuous provider/patient feedback, and provide quarterly meetings with specified stakeholder representation. It mandates transparency and data ownership: contracts with ASOs must comply with Hawaii’s Uniform Information Practices Act and other open-records laws; the State retains exclusive ownership of Medicaid-related data; and DHS must maintain a publicly accessible, de-identified data dashboard updated quarterly plus an annual data report. It also keeps public health functions under the direct control of the Department of Health and prohibits delegation of vaccination, disease surveillance, emergency response coordination, and health education to ASOs or other third parties. Additionally, DHS must convene a Medicaid stakeholder advisory group to monitor implementation during the transition. DHS must submit legislative reports (beginning 40 days before the 2027 regular session) with detailed financial, provider participation/quality metrics, challenges, and recommendations, and must also submit a detailed budget and implementation timeline by December 1 (with a fill-in in the text). DHS must apply to CMS for any Medicaid plan amendments or waiver authority necessary to implement sections 2 through 7. The bill appropriates general funds for FY 2026–2027 for transition infrastructure/system shifts, care coordination funding, regional health hubs, and provider recruitment/training/retention, and it takes effect July 1, 2026, except that sections 2 through 7 take effect upon CMS approval of the Hawaii Medicaid state plan.
The bill establishes a new Idaho “Prior Authorization Reform Act” within Title 41 (new Chapter 35) creating requirements governing how health insurance issuers and contracted utilization review organizations administer prior authorization for health benefit plans and stand-alone dental benefit plans.
Key changes and requirements include: (1) defining “prior authorization,” “complete prior authorization request,” “adverse determination,” and “expedited prior authorization request,” and setting chapter purposes (reduce unreasonable interference, prevent disruption of medical judgment, and require transparency); (2) requiring issuers to maintain and publicly post complete, current prior authorization service lists and access to clinical review criteria (including Idaho-specific effective/termination dates and, when applicable, access to standardized electronic submission processes); (3) requiring clinical review criteria to meet evidence- and standards-based consistency, accreditation alignment, and annual physician-directed updates; (4) establishing notice and timing rules for new or amended prior authorization requirements (generally 60 days advance notice to impacted enrollees and providers, with limited exceptions such as fraud/abuse findings, scarcity, FDA-authorized clinical trials, legal changes in <60 days, or removal of requirements); and (5) requiring issuers to report prior authorization approval/denial and appeal statistics to the Department of Insurance.
Operational process requirements include: (1) an electronic prior authorization API by January 1, 2027, conforming to CMS interoperability standards and supporting electronic request/response exchange; (2) rules for what makes a prior authorization request “complete,” including that minor clerical/technical errors not materially affecting adjudication cannot prevent “complete” status and that completeness is presumed unless additional specific information is requested within one business day; (3) standard prior authorization decisions within 7 calendar days after receipt of a complete request (with only reasonably necessary additional information and limit on requests for additional information to once per request absent materially new clinical information); (4) expedited decisions for urgent health care services within 72 hours after receipt of a complete expedited request (and requiring trained, appropriately licensed physician consultation mechanisms); and (5) adverse determination notices that must include reasons/evidence-based criteria and appeal rights, plus instructions for filing appeals, documentation needed for appeal, and the right to independent external review under Idaho law.
The bill also establishes appeal personnel and insurer and continuity rules: appeals must be peer reviewed by appropriately licensed and specialty-qualified professionals not directly involved in the adverse determination; insurers must periodically review prior authorization requirements and consider removal; issuers are limited in revoking or further restricting valid prior authorization approvals except for defined circumstances (fraud/abuse, unavailability/need for alternative service, FDA safety alerts or public health emergencies, changes required by accepted standards, legal changes within 60 days, or documented material clinical change); approvals have set validity periods (generally 6 months, with potential extension by agreement); recurring chronic-condition approvals must remain valid for the lesser of 12 months or the treatment length determined by the treating professional; and the bill requires continuity of prior approvals for at least the initial 90 days after an enrollee moves to a new health plan upon receipt of documentation, while allowing issuer review during that continuity window. Enforcement and administration are assigned primarily to the Idaho Department of Insurance, including cease-and-desist authority, plans of correction, and administrative fines up to $10,000 per violation for specified failures; there is no private right of action. The bill includes mandatory annual issuer reports (first due by June 1, 2027, and each June 1 thereafter) and creates penalties for knowing false prior authorization requests by routing findings to relevant licensing oversight and prosecuting authority. Finally, it creates a de minimis exemption allowing issuers with prior authorization use on fewer than 1% of claims to elect exemption via annual Department attestation, subject to Department verification and potential revocation. The act becomes effective January 1, 2027.
The bill amends Idaho Code § 56-265 (Provider Payment) and nullifies specified Idaho Administrative Procedure Act (IDAPA) rules effective on and after July 1, 2026. It also contains an emergency clause making the act effective upon passage and approval.
The substantive statutory change is in § 56-265(2): for Medicaid home and community-based services (HCBS) without a Medicare-equivalent rate, the department must cost-survey annually and ensure at least 15% of responses are audited, using the cost survey and other sources to evaluate rate adequacy. The bill further requires payment rates to include allocations for direct care worker wages, employee-related expenses, program-related expenses, and general and administrative costs, with providers required each year to expend at least the allocated amounts for wages and employee-related expenses. Failure to meet that expenditure requirement can trigger department-approved corrective action plans, closure of intake, or termination of the provider agreement. The department must also summarize the audited cost-survey work by provider type and service in a publicly available report no later than December 31 each calendar year.
The bill also removes/overrules the continued effect of certain administrative Medicaid Plan Benefits rules identified as IDAPA 16.03.26, specifically Section 051 and Section 052. Those rules are declared null, void, and of no force and effect on and after July 1, 2026.
Finally, the bill includes an emergency declaration, so it takes effect on and after passage and approval, despite parts of the administrative-rule nullification being effective later (July 1, 2026).
The bill establishes a new “Emergency Care Affordability Act” within Title 41, creating insurance requirements to protect covered persons from high-cost billing for emergency services provided by out-of-network freestanding emergency rooms and out-of-network providers.
It defines key terms including “allowed amount,” “emergency medical condition,” “emergency services,” and—critically—“freestanding emergency room” (a 24-hour, physically separate facility that principally provides unscheduled emergency services and participates in the federal independent dispute resolution process; exclusions include critical access hospitals and certain hospital- and physician-owned facilities). It also defines “out-of-network provider/facility,” including affiliates and billing entities that submit or attempt to submit claims on their behalf.
For covered emergency services, an out-of-network freestanding emergency room must accept the health benefit plan’s “allowed amount” for the same specialty/type in-network service in the same geographic area as payment in full, and may not bill the covered person for amounts above that allowed amount (regardless of billing entity, coding modifiers, or use of affiliated third parties). The covered person’s cost-sharing must be calculated using the plan’s in-network benefit design; the plan must pay the provider directly (minus covered-person cost sharing) without regard to beneficiary assignment or similar agreements. Any contract or consent allowing excess billing/balance billing for covered emergency services is void and unenforceable.
The bill further requires specified disclosure when an out-of-network freestanding emergency room furnishing emergency services is not enrolled in Medicare, Medicaid, or TRICARE: a plain-language notice (given as soon as practicable after the medical screening exam, only when the patient is conscious/oriented/capable and without interfering with stabilization) stating the facility’s nonparticipation and that the covered person may be personally responsible for some/all charges. Failure to provide the required disclosure creates a rebuttable presumption the covered person was not informed and, absent contemporaneous compliance documentation, bars the facility from billing/collecting/seeking reimbursement for emergency-services charges, rendering violative bills/invoices/collection attempts void. It adds rules for self-funded plans: the chapter applies to self-funded health plans only if they elect to participate by annual notice to the Idaho Department of Insurance and the election applies for the plan year; the director must publish an annual list of participating self-funded plans. Enforcement includes attorney’s fees and costs for covered persons or plans to challenge violations, voiding any violative billing by out-of-network facilities and affiliated billing entities, authorizing the director (upon written request) to inquire with the patient’s health benefit plan to verify payment consistency, and treating each attempt to bill/collect in violation as a separate violation. The act takes effect July 1, 2026, and an emergency clause makes it effective that date.
Illinois
10
bill
Regulation • 🇺🇸 United States • Illinois • Proposed Notice
The rulemaking proposes changes to 89 Ill. Adm. Code Part 148 (Hospital Services) by targeting two existing reimbursement provisions: Section 148.423 (Hospital Outpatient Adjustment) and Section 148.425 (Directed Payment Classifications).
For Section 148.423, the proposal lowers the Hospital Outpatient Adjustment Payment rates effective January 1, 2024. Specifically, for High Medicaid General Acute Care Hospitals, the rate would drop from $375 (through December 31, 2023) to $136 (effective on and after January 1, 2024). For Other General Acute Care Hospitals, the rate would drop from $325 (through December 31, 2023) to $118 (effective on and after January 1, 2024). The annual payment methodology (hospital’s 2019 outpatient claims multiplied by the applicable group rate) remains the same, with the qualifying criteria unchanged in the text provided.
For Section 148.425, the proposal adds a directed-payment classification election for certain hospitals. Beginning January 1, 2026, hospitals that were assigned to the High Medicaid Hospital class in the prior year and newly qualify as safety-net hospitals would be permitted to elect to remain in the High Medicaid Hospital class for directed-payment purposes for certain services. If a hospital makes this election, it must remain in the High Medicaid Hospital class for the entire calendar year. The rulemaking states that if the amendment cannot be adopted on January 1, 2026, the Department will reconsider emergency rulemaking at that time.
The notice requests written comments within 45 days after publication of the notice and indicates the Department will consider comments received during the first notice period as required by the Illinois Administrative Procedure Act. It also provides that there is no automatic repeal date and no incorporations by reference. The proposed changes are authorized under the Illinois Public Aid Code (305 ILCS 5), and the notice identifies public act authority including SPA IL-23-0032 (for the outpatient adjustment rate changes) and Public Act 104-0007 (for the safety-net election related to directed payments).
bill
Regulation • 🇺🇸 United States • Illinois • Final Notice
The rule establishes a new hospital reimbursement provision in 89 Ill. Adm. Code 148.200 to provide quarterly supplemental “Critical Access Hospital OB and Other Treatment Services Payment (CAHOOTS)” to publicly owned critical access hospitals in Illinois for perinatal and obstetrical or gynecological services and other specialty services. Payments are financed through an annual amount of $3,500,000 and are implemented under criteria tied to hospital location, eligibility as a Critical Access Hospital, and whether the hospital is owned or operated by an Illinois government body or municipality. The rule became effective May 20, 2026 and does not include an automatic repeal date or incorporations by reference.
The provision sets qualification requirements: (1) the hospital must be located in Illinois; and (2) it must meet the definition of a Critical Access Hospital in Section 148.25(g). For qualifying government/municipality-owned or -operated hospitals, the quarterly payment equals $875,000 multiplied by the lower of (a) a market-share quotient based on the hospital’s “adjusted outpatient claims” for the data quarter divided by the total “adjusted outpatient claims” for all qualifying hospitals in the same quarter, or (b) 10%. For qualifying hospitals not owned or operated by an Illinois government body or municipality, the quarterly payment equals $2,500,000 multiplied by the same “lower of” formula using adjusted outpatient claims, subject to the same 10% cap.
The rule also establishes a redistribution mechanism for any remaining funds after quarterly payments under the capped formula for the government-owned/municipality-owned group and the non-government group. Remaining funds are distributed in the payment quarter to qualifying hospitals that have not reached the 10% limitation, calculated as the product of (1) all remaining funds and (2) a quotient of the hospital’s total adjusted outpatient claims in the data quarter divided by the total adjusted outpatient claims for only those qualifying hospitals that have not reached the 10% limitation.
Definitions are included for key terms used in the payment methodology. “Data Quarter” is the quarter of the calendar year that begins six months and ends three months prior to the payment period; “Payment Quarter” is the quarter of the calendar year when payments will be made. “Adjusted Outpatient Claims” are defined as the number of paid MCO encounter outpatient claims for services covered under Title XIX of the Social Security Act, excluding days for individuals eligible for Medicare under Title XVIII (with additional definitional detail continuing in the section text). The rule’s adopted-action notice states that it was added by public act authority and that prior CMS-directed payment policy changes delayed implementation until after January 1, 2025; a provider notice issued June 16, 2025 set the methodology for the first two quarters of calendar year 2025.
Co-sponsors: Natalie A. Manley (D- IL ), Nicolle S Grasse (D-IL), Theresa Mah (D- IL ), Justin Cochran (D-IL), Maurice A. West (D-IL), Will Guzzardi (D-IL ), Nabeela Syed (D-IL ), Michael Crawford (D-IL), Lisa Davis (D-IL), Yolonda Morris (D- IL ), Anna C. Moeller (D- IL ), Sue Scherer (D- IL ), Suzanne M. Ness (D-IL ), Maura Hirschauer (D- IL ), Barbara Hernandez (D- IL ), Kelly M. Cassidy (D- IL ), Kevin John Olickal (D- IL ), Mary Beth Canty (D- IL ), Curtis J. Tarver (D- IL ), Lawrence M. Walsh (D-IL ), Sonya Marie Harper (D-IL ), Sharon Chung (D-IL ), Edgar Gonzalez (D-IL ), Jaime M. Andrade (D-IL ), Janet Yang Rohr (D-IL ), Rita Mayfield (D- IL ), Norma Hernandez (D-IL ), La Shawn K. Ford (D-IL ), Katie Stuart (D-IL), Margaret A. DeLaRosa (D-IL), William Davis (D-IL ), Jawaharial Omar Williams (D-IL ), Daniel Didech (D- IL ), Amy Briel (D- IL), Anne Stava (D- IL )
HB4701 establishes the “Limitations on Facility Fees Act,” creating new limits on when health care providers may charge, bill, or collect “facility fees” for certain outpatient services and emergency-center settings.
Under the Act, a health care provider generally may not charge a facility fee except in three site-specific circumstances: (1) services provided on a hospital’s campus; (2) services provided at a facility that includes a licensed hospital emergency department; or (3) emergency services provided at a freestanding emergency center. In addition, the Act imposes service-specific limits: notwithstanding the site rules, no facility fee may be charged for outpatient evaluation and management services, or for other outpatient diagnostic or imaging services that the Department of Public Health identifies through its annual process.
The Department must annually identify which outpatient diagnostic or imaging services may reliably be provided safely and effectively in settings other than hospitals; the identified services are those for which facility-fee limitations do not apply under the Act’s service-specific restrictions. The Act also requires annual reporting by each hospital, health system, and freestanding emergency center to the Department about facility fees charged or billed during the preceding calendar year, including facility locations, patient-visit counts, Medicare/Medicaid/private insurance amounts and ranges, hospital-based facility and provider/system-wide revenue totals from facility fees, and detailed “top 10” procedures/services (by both fee gross revenue and patient volume) using CPT category I code groupings, plus other information the Department may require. Providers must also make relevant books, documents, records, or data available to the Department (or its designee) for audit purposes until four years after furnishing services for which a facility fee was charged, billed, or collected.
The Department may adopt rules to implement the Act, including reporting formats/content and penalties for noncompliance. Enforcement treats violations as unlawful practices under the Consumer Fraud and Deceptive Business Practices Act, and authorizes administrative penalties up to $1,000 per occurrence. The bill also: (1) amends the Fair Patient Billing Act’s Section 12 to align with the new facility-fee limits while retaining the requirement that hospitals develop patient-notification policies when charging facility fees separate and distinct from professional fees; and (2) adds a new provision to the Consumer Fraud and Deceptive Business Practices Act stating that any person who violates the Limitations on Facility Fees Act commits an unlawful practice.
bill
Legislation • 🇺🇸 United States • Illinois • Resolution
The document contains a house resolution urging action by the Illinois Department of Healthcare and Family Services (HFS) regarding Medicaid managed care pharmacy reimbursement.
It resolves that HFS should ensure pharmacies participating in Medicaid managed care networks are reimbursed for covered outpatient prescription drugs at a rate no less than what pharmacies would receive under the Illinois Medicaid fee-for-service (FFS) pharmacy program, including both the ingredient cost methodology and the professional dispensing fee.
It further urges HFS to implement this reimbursement “parity” through Medicaid managed care organization (MCO) contracts and pharmacy benefit manager (PBM) agreements to promote consistent, transparent, and fair pharmacy reimbursement across the Medicaid program. The resolution also urges HFS to monitor and report to the General Assembly on the impact of reimbursement parity on pharmacy network participation, patient access to medications, and pharmacy closures in Illinois, and to evaluate how parity affects pharmacy deserts, rural health access, and Medicaid beneficiary access to pharmacist-provided patient care services (including medication counseling, chronic disease management support, HIV PrEP/PEP, contraception assessment, and preventive health services).
Finally, it directs delivery of a copy of the resolution to the Director of HFS.
Enacted • 2025-2026 Regular Session • Introduced: February 02, 2026
Sponsors: David Koehler (D-IL), Julie A. Morrison (D-IL), Cristina Castro (D-IL), Robert James Peters (D-IL), Sharon Chung (D-IL ), William E. Hauter (R-IL ), Jeffrey Keicher (R-IL ), Katie Stuart (D-IL), Jawaharial Omar Williams (D-IL )
Co-sponsors: Laura Fine (D-IL), Andrew S. Chesney (R-IL), Christopher Belt (D-IL), Graciela Guzman (D-IL), Paul Faraci (D-IL), Suzanne Glowiak Hilton (D-IL), Linda Holmes (D-IL), Ramachandra Villivalam (D-IL), Michael A. Porfirio (D-IL), Meg Loughran Cappel (D-IL), Doris Turner (D-IL), Sally J. Turner (R-IL), Sue Rezin (R-IL), Napoleon B. Harris (D-IL), Rachel F. Ventura (D-IL), Elgie R. Sims (D-IL), Lakesia Collins (D-IL), Michael W. Halpin (D-IL), Michael Simmons (D-IL), Chris Balkema (R-IL), Emil Jones (D-IL), Nicolle S Grasse (D-IL), Dagmara Lopez Avelar (D-IL ), Ryan Spain (R-IL ), David A. Vella (D- IL ), Rick Ryan (D-IL), Justin Cochran (D-IL), Anthony J. DeLuca (D-IL ), Joyce Mason (D-IL ), Mary Gill (D-IL ), Michael J. Kelly (D- IL ), Natalie A. Manley (D- IL ), Matt Hanson (D- IL ), Martha Deuter (D-IL), Tracy Katz Muhl (D-IL), Harry Benton (D), Gregg Johnson (D-IL ), William Davis (D-IL ), Jennifer Gong-Gershowitz (D- IL ), Kelly M. Cassidy (D- IL ), Michelle Mussman (D- IL ), Maurice A. West (D-IL), Mary Beth Canty (D- IL ), Bob Morgan (D- IL ), Stephanie A. Kifowit (D- IL ), Amy Briel (D- IL), Sue Scherer (D- IL ), Lisa Davis (D-IL), Rita Mayfield (D- IL ), Michael Crawford (D-IL), Lawrence M. Walsh (D-IL )
The bill establishes the “Transparency in Downcoding Act” to regulate how Illinois health care payors (including group health plan sponsors, health insurance issuers, and Medicaid managed care organizations) adjust or reduce (“downcode”) submitted claim codes. It defines key terms (including CARCs and RARCs; “downcoding” and an exclusion for grouping/bundling required by integrity rules) and applies to specified health insurance policies/contracts and certain publicly issued coverage arrangements issued, amended, delivered, or renewed on or after the act’s effective date.
Beginning January 1, 2028, the bill prohibits (1) automatic downcoding that bypasses evaluation of billing provider information and requires downcoding determinations to be made or reviewed by a qualified natural person consistent with CPT coding guidance; and (2) downcoding solely based on reported diagnosis codes. When downcoding occurs, payors must notify billing health care professionals using appropriate CARCs/RARCs and must include the specific clinical/coding justification, the original and revised service codes and payment amounts, and the process to dispute the decision.
The bill requires a dispute process for downcoded claims, including clear written/electronic instructions, dispute contact information, and submission timelines no less than 90 days. It also requires that all downcoding disputes be reviewed by a natural person who is knowledgeable about the services under dispute, was not directly involved in the original decision, performs a documented review of supporting clinical information (including pertinent medical records and any medical literature provided by the billing professional), and follows CPT coding guidelines in effect at the time of service. The bill further requires that downcoding not be targeted or discriminatory against providers who routinely treat patients with complex or chronic conditions, and clarifies that the existence of the dispute process does not limit other available appeals under applicable state or federal utilization review law.
For enforcement, the Department of Insurance enforces payors’ compliance (including restrictions on automated downcoding and pattern/practice violations), while the Department of Healthcare and Family Services enforces Medicaid managed care organizations’ compliance subject to federal requirements. The bill adds a new provision to the Illinois Public Aid Code requiring all managed care organizations to comply with the act, includes severability, and sets the effective date as January 1, 2028.
The bill adds a new Section 368k to the Illinois Insurance Code establishing minimum reimbursement requirements for physicians in specified Illinois counties. It defines relevant terms (including “County” as Cook, DuPage, Lake, and Will; “covered health care service” as services for which a Medicare rate has been established at the time provided; “Medicare rate” as the applicable Medicare Physician Fee Schedule CPT rate in effect when services are rendered; and “physician” to include licensed physicians/osteopaths and advanced practice providers practicing under physician supervision).
Under the new Section 368k(b), a health insurance company must reimburse a physician for covered health care services provided in any of the covered counties at no less than 160% of the applicable Medicare rate for the same service. If Medicare establishes multiple payment rates for a service, subsection (c) requires calculating the reimbursement floor using the rate that most closely corresponds to the setting and type of service.
The bill makes lower-than-minimum reimbursement provisions void and unenforceable to the extent they conflict with the minimum reimbursement requirements. It also prohibits a physician from waiving the protections of the Section as a condition of participation in a health benefit plan or for any other reason. The Department of Insurance is directed to enforce the Section and may adopt rules to implement it.
Violations by a health insurance company subject the company to civil penalties up to $15,000 per individual violation, payment of restitution to the affected physician, and any additional remedies authorized by the Department.
bill
Regulation • 🇺🇸 United States • Illinois • Proposed Notice
The Department of Healthcare and Family Services proposes changes to 89 Ill. Adm. Code 140.71 governing C-13 invoice voucher advance payments and expedited claims payments. The proposal is tied to Public Act 104-0470 and adds/clarifies the Department’s authority and procedures to recoup unpaid advance balances when a provider fails to comply with advance payment agreement terms, including the methods and processes for recovery, notice, timing, and continued recoupment until the liability is satisfied.
The proposal establishes more detailed advance approval and repayment requirements for C-13 advance payments: C-13 advances remain an exception to the regular reimbursement process, limited to qualified providers under extraordinary circumstances. Eligibility criteria include enrollment with the Department, a defined emergency (severe and irreparable harm from withholding), and meeting “significant number of clients” thresholds by provider type; providers must also sign an agreement specifying reasons, amount, when recoupment begins, and recoupment method (e.g., percentage of payable amounts, fixed monthly amounts, warrant intercept, or combinations). For requests, the Department may require additional supporting financial documentation at its discretion, including lists of real/personal property and related liens/encumbrances, with provider certification and updates, and may also demand similar documentation upon default/breach/non-compliance and related renegotiation.
The proposal adds/clarifies recoupment terms and enforcement mechanics. For advance repayment agreements, the rule limits the recoupment period to a maximum of 36 months for properly certified/licensed/qualified providers, while stating recoupment should not exceed six months from the month payment is authorized; for providers not in good standing, recoupment proceeds from the next available payments and/or the designated recoupment methods. If the provider fails to comply, the remaining balance is subject to immediate recovery as specified in the recoupment provisions. It also maintains that prior agreements survive adoption/amendment of the section’s terms notwithstanding the new section.
Critically, the proposal establishes Department recoupment procedures upon default/breach/non-compliance: (1) notice requirements (a default/non-payment/breach notice, then an additional notice if non-compliance persists for 30 days); (2) a 30-day compliance window after which recovery actions begin, while clarifying that delay by the Department in initiating recoupment does not reduce provider liability or bar later action; (3) monthly recoupment of an agreed percentage (or Department-determined percentage if not listed), with an explicit option for the Department to immediately recoup the full remaining balance at any time after non-compliance; (4) recoupment sources in a specified order/availability approach (MCAPs/state-directed payments; FFS supplemental/GME supplementals; FFS Medicaid claims; MCO Medicaid claims; and other amounts payable by any State agency, including grants); (5) use of the Illinois Office of the Comptroller’s Offset System when applicable, and pursuit of other collection methods if no funds are available; (6) continued recoupment until the balance is satisfied with discretionary suspension/pausing if compliance is restored, and a limitation that after two recoupment initiations in a fiscal year the Department may terminate the agreement and collect the full remaining balance immediately; and (7) authorization to use any other collection remedies available under state or federal law.
The proposal also adds a limited-time renegotiation authorization for nursing facilities for advance repayment agreements involving nursing homes in effect prior to June 16, 2026: nursing facilities may enter renegotiated agreements only until August 15, 2026. If they do not renegotiate by that deadline, renegotiation is not reached, or the nursing facility fails to comply, the Department may immediately collect unpaid advance debts using the PA 104-0470 and other specified recoupment methods. Renegotiated agreements must provide repayment of the total amount owed over a 12-month period in equal increments, with payments beginning within 30 days of the signed agreement. Finally, expedited claims payments are retained as an acceleration mechanism under extraordinary circumstances with similar emergency and “significant number of clients” criteria, periodic Department review of continued need, and a written application requirement.
A public comment period is requested for 45 days after publication of the notice. (The notice text does not state an effective date or compliance deadline; it specifies only the comment submission deadline and review period.)
bill
Regulation • 🇺🇸 United States • Illinois • Proposed Notice
The rulemaking establishes four new Medicaid provider reimbursement sections within 89 Ill. Adm. Code 140, Subpart G (Maternal and Child Health Program): Section 140.925 (Doula Services), Section 140.926 (Lactation Consultation Services), Section 140.927 (Home Visiting Services), and Section 140.928 (Licensed Certified Professional Midwife (LCPM) Services). It also includes a new provider enrollment/payments framework for each service type and, for lactation and LCPM, replaces language from previously repealed sections.
Doula Services (140.925) requires doulas seeking enrollment to be certified by the Illinois Medicaid-Certified Doula Program administered by Southern Illinois University. Payment is made only when services are rendered by a certified and enrolled doula, recommended either by a physician/LPHA within scope per 42 CFR 440.130(c) or via the Illinois Department of Public Health standing recommendation, and provided to pregnant and birthing persons throughout the perinatal period (including labor and delivery) and up to 12 months postpartum regardless of how the pregnancy ends. Reimbursable doula services are limited to specified categories (e.g., perinatal counseling/education/support, labor support and birth attendance with birth plan development, coordination with community services, accompanying clients to clinician visits, emotional/physical support, and visits for basic infant care), and reimbursement is capped at the lesser of provider charges or the maximum fee schedule rate published by the Department.
Lactation Consultation Services (140.926) defines provider and credential requirements for Medicaid enrollment: lactation consultants must be certified and remain in good standing with one of several certifying pathways (IBCLCs, CLCs, or CLSs, as specified). Covered services must be performed within the scope appropriate to the credential and include comprehensive assessments and management of lactation-related conditions; evidence-based counseling on infant feeding decisions (including information about medications, alcohol/tobacco/addictive drugs, and herbs/supplements and impacts on milk production and child safety); development/implementation of personalized feeding plans; support to meet breastfeeding goals; and coordination to access other clinical and non-clinical supports (including WIC, primary care, and pediatric care and related services). Reimbursement is provided for the lesser of provider charges or the maximum fee schedule rate. The section also includes compliance and audit authority, with potential consequences for non-compliance (e.g., suspension/termination of provider status, recoupment of overpayments, and legal penalties) and an appeal right requiring submission within 30 days of Department decisions.
Home Visiting Services (140.927) establishes that “home visiting services” are prenatal, postpartum, and child home visits provided by a Home Visiting Organization to deliver informational support, facilitate screening, and provide care coordination for healthy outcomes. To enroll, organizations must demonstrate full accreditation or compliance with national standards for home visiting delivered under a state-approved evidence-based or research-informed model, as detailed in the Department-issued provider handbook. Payment is made when services follow the state-approved model standards, are delivered within the home visitor’s scope/credentialing, and are recommended by an LPHA within scope under 42 CFR 440.130(c) or using the Illinois Department of Public Health standing recommendation. Reimbursement is capped at the lesser of provider charges or the maximum fee schedule rate for the specific home visiting model. Licensed Certified Professional Midwife (LCPM) Services (140.928) establishes enrollment/credentialing: LCPMs must be licensed by Illinois (or equivalent out-of-state licensing body) and certified by the North American Registry of Midwives (NARM). Payment requires services to be delivered by the enrolled LCPM (or an assistant under direct supervision) and recommended by a licensed physician/PA/APRN under 42 CFR 440.130(c), with services provided to pregnant and birthing persons throughout pregnancy, birth, and postpartum. LCPM-covered services include comprehensive assessment/diagnosis/treatment across pregnancy through newborn care, physical exams, medication/device administration, ordering/interpreting allowable labs/diagnostic tests, and consultation/referral/linkage to other healthcare professionals; reimbursement is again limited to the lesser of provider charges or the maximum fee schedule rate.
Comment deadline and dates: the Department requests written comments within 45 days after publication of the notice; the notice itself does not specify an effective/compliance date for the proposed changes (it contains placeholders in the source sections). The rulemaking is stated to not replace an emergency rule and not include an automatic repeal date.
bill
Regulation • 🇺🇸 United States • Illinois • Proposed Notice
This notice sets proposed changes to Illinois’ Medical Payment rules for mental health services in 89 Ill. Adm. Code 140, specifically requesting amendments to Sections 140.424 and 140.453 and listing additional proposed new sections (140.925–140.928) elsewhere in the Part. The proposal is made pursuant to Public Act 102-0043 and Section 12-13 of the Illinois Public Aid Code, and it would broaden or clarify behavioral health provider eligibility and service definitions/qualifications for reimbursement under the Medical Assistance Program.
The proposed changes to Section 140.424 (Subpart D) revise the “Other Licensed Behavioral Health Practitioner” provider category to cover licensed clinical professional counselors (LCPC) and licensed marriage and family therapists (LMFT), not only licensed clinical social workers (LCSW). It defines “Other Licensed Behavioral Health Practitioner” to include LCSWs, LCPCs, and LMFTs, and specifies reimbursable services within each practitioner’s scope and clinical training: (1) developmental and behavioral health screening, (2) diagnostic evaluation, and (3) therapeutic services delivered in office, home, or community settings, including individual psychotherapy and family or group psychotherapy (with group psychotherapy required to meet referenced clinic guidelines in Section 140.462). Reimbursement is set at the lesser of provider charges or the maximum fee schedule rate published by the Department, and the section includes a provision that payment is not made for services identified in Section 140.6. It also reflects an effective dates concept for LCSWs (services effective for dates of service January 1, 2017 and after), while the notice text indicates the overall amended framework would incorporate the broader “Other Licensed Behavioral Health Practitioner” concept.
The proposed changes to Section 140.453 update community-based mental health service definitions and professional qualifications. The revised text reiterates that qualified professionals may provide only the services listed in the section within their scope of practice and includes expanded professional definitions relevant to reimbursement. Key qualification updates include explicit inclusion of licensed clinical professional counselors and marriage and family therapists within the “Licensed Practitioner of the Healing Arts (LPHA)” definition, and expansion of “Mental Health Professional (MHP)” to include additional credentialed roles, including (as listed) recovery support and family partnership professionals certified by the Illinois Alcohol and Other Drug Abuse Professional Certification Association, and a “veteran support specialist” who is certified by and in good standing with that Association. The “Peer Support Worker (PSW)” definition is also expressly retained/embedded with eligibility criteria (age 21, lived experience/caregiver experience, agency/teamwork and supervision participation, and completion of a Department-approved training/certification).
For timelines and process, interested parties may submit written comments within 45 days after publication of the notice; comments are considered during the first notice period as required by Section 5-40 of the Illinois Administrative Procedure Act. The notice does not replace an emergency rule and states there is no automatic repeal date. It also states there are other proposed rulemakings pending on this Part, referenced by new section numbers 140.925–140.928 with publication citations in the Illinois Register.
bill
Regulation • 🇺🇸 United States • Illinois • Proposed Notice
The Department of Healthcare and Family Services proposes to update 89 Ill. Adm. Code 147.310 (Implementation of a Case Mix System) to revise the STRIVE per diem staffing add-on methodology within the nursing facility rate for facilities licensed under the Nursing Home Care Act as skilled or intermediate care facilities. The proposal aligns the STRIVE staffing calculation with a PDPM-based STRIVE staffing ratio, includes a staged (four-quarter) transition to full PDPM implementation, and adjusts per diem add-on amounts tied to facility staffing performance relative to facility-specific targets.
Under the proposed changes, the variable per diem staffing add-on is linked to STRIVE study staffing percentages determined using PBJ staffing hours adjusted for acuity using MDS (and CMS Provider Information/COMPARED data sources). Facilities are subject to guardrails that limit minimum add-on eligibility (no add-on below 70% of STRIVE-indicated staffing after December 31, 2022) and constrain reductions across consecutive quarters (beginning April 1, 2023, reductions are limited to no more than 5% over two consecutive quarters). The rule also provides for rate corrections when PBJ data are missing/inaccurate or miscalculated, and continues to allow payment determinations to be appealed under referenced provisions.
The proposal updates the staffing-percentage denominator starting October 1, 2024 and revises it again starting January 1, 2025 by defining the “PDPM STRIVE Staffing Ratio,” including facility PDPM STRIVE staffing targets and a calculation that changes the facility target multiplier (e.g., 0.82 times Illinois adjusted facility case-mix hours per resident per day, and later 0.7122 times that measure). It specifies a transitional blend for the staffing percentage denominator for quarters from October 1, 2024 through September 30, 2025 (using weighted combinations of PDPM STRIVE staffing target and case-mix total nurse staffing hours), and it retains a planned schedule for full PDPM-based payment of the nursing component per diem starting October 1, 2023.
A Medicaid Access Adjustment is included in the surrounding 147.310 framework (effective July 1, 2022 through December 31, 2027) but the notice’s core focus is the STRIVE staffing add-on modernization and transition. Interested parties must submit written comments within 45 days after publication of the notice; comments will be considered during the first notice period under the Illinois Administrative Procedure Act. The notice states the proposal is not an emergency rule and contains no automatic repeal date and no incorporations by reference.
Indiana
4
bill
Regulation • 🇺🇸 United States • Indiana • Regulatory Notice
This interim rule temporarily supersedes specified Indiana Administrative Code provisions governing Hospital Assessment Fees (HAF) for both outpatient and inpatient services, and establishes a Medicaid fee-calculation framework based on each hospital’s Indiana net patient revenue. It applies to fee periods beginning after June 30, 2025 (Sections 1–14). A public comment period is provided with a deadline of August 28, 2026.
For outpatient HAF (Section 1), and inpatient HAF (Section 2), the rule directs the Family and Social Services Administration’s Office (OMPP) to collect an assessment fee from hospitals meeting statutory definitions and specific licensing criteria, and to exclude multiple hospital categories (e.g., long term acute care, state-owned, federally operated, freestanding rehabilitation; most freestanding psychiatric hospitals meeting a >90% admission composition test; out-of-state hospitals; certain hospitals governed by other statutes; physician-owned hospitals as defined in statute; and respite-care-only providers under specific age/medical-fragility limits). It also sets reduced assessment fee rates for designated hospital types: 50% for LIUR acute care and LIUR freestanding psychiatric hospitals; 80% for rural obstetrics hospitals; and for outpatient, 55% for Perinatal Level IV hospitals (inpatient is 70% for Perinatal Level IV). It specifies notice/reconsideration/appeal mechanics by cross-referencing Sections 13 and 14, payment collection methods (offset against Medicaid payments or otherwise as determined), allowance of payment plans (Section 9), interest on late payment, and additional enforcement including reporting to IDOH for potential license revocation after 120 days, plus Medicaid sanctions under IC 12-15-22.
Sections 3–12 and 15–14 establish the calculation mechanics and related definitions. The HAF is assessed, calculated, and paid on a state fiscal year basis and computed separately for inpatient and outpatient services. “Indiana net patient revenue” is defined as net patient revenue less the portion attributable to services to non-Indiana residents, determined using patient days; inpatient and outpatient Indiana net patient revenue are calculated separately (Section 4). Net patient revenue is generally based on cost reports for a hospital fiscal year ending in state fiscal year 2023, with discretionary Secretary authority to elect a more recent state fiscal year beginning after June 30, 2026, subject to uniform application and federal health-care-related tax compliance constraints (including broad-based/uniformity waiver and the B1/B2 redistributive statistical test requirements) (Section 5). The rule requires cost-report adjustments for non-12-month periods and exclusion of closed hospitals, excludes certain newly licensed hospitals lacking required cost report data, and authorizes data submissions by hospitals not certified for Medicaid participation that lack cost reports (Section 5).
The standard inpatient and outpatient rates are set each fee period so aggregate assessment fees do not exceed the lesser of (i) 6% of total inpatient/outpatient net patient revenue of assessed hospitals, or (ii) the maximum amount permitted under federal law for taxes on inpatient/outpatient hospital services (Sections 10 and 11). It further establishes base and incremental HAF components using Medicaid “state share” and DSH-related computations (Section 7), deposits base amounts into the hospital Medicaid fee fund and incremental amounts into a separate incremental hospital fee fund (Sections 7–8), and makes the adjustment authority explicit (Section 12), including refunds if an adjustment creates an overpayment (Section 12(c)). Eligibility and rate reductions interface with an outpatient hospital adjustment factor (for outpatient rates) designed to approximate the federal Medicare upper payment limit without exceeding it; inpatient rates similarly use an inpatient adjustment factor to approximate the relevant Medicare upper payment limit (Sections 1(n) and 2(o), and cross-referenced Sections 10–11). After calculating HAF, the office must provide written notice and a calculation explanation (Section 13), and hospitals may request administrative reconsideration within 45 days with a deemed denial if no timely decision is issued; subsequent appeal is permitted under IC 4-21.5-3 (Section 14). The interim framework expires 425 days after acceptance of the interim final rule for filing (Section 17).
Enacted • 2026 Regular Session • Introduced: January 06, 2026
Sponsors: Julie McGuire (R), Lori Goss-Reaves (R), Martin Carbaugh (R), Victoria Garcia Wilburn (D), Elizabeth Brown (R), Michael R. Crider (R), Tyler Johnson (R)
The bill makes two main sets of insurance-related changes effective July 1, 2026. First, it expands hospital requirements in Indiana Code IC 16-21-9.5 by defining “collection action” and “payment assistance program,” and by creating a new hospital chapter requiring notice, signage, and electronic availability of payment assistance options (including charity care, financial assistance, and other payment plans). Hospitals must provide written notice of their payment assistance programs to patients (or representatives) during registration/intake, at discharge, and with the initial billing statement; the notice must include available program descriptions, eligibility criteria, application instructions, and contact information. Hospitals must also post conspicuous signage in registration areas and emergency departments, provide information electronically through any patient portal, and—before starting a collection action—make a reasonable effort to notify the individual and provide an application form. Nonprofit hospitals must annually report compliance in their community benefits plan report, and the state department may adopt rules and impose civil penalties up to $1,000 per violation, deposited in the state general fund.
Second, the bill creates new limits and process protections concerning “downcoding” of health benefits claims by insurers and health maintenance organizations (HMOs) under new IC 27-1-52 (effective July 1, 2026). The new chapter defines key terms (e.g., “downcode,” “health benefits claim,” “insurer/health maintenance organization,” and CARC/RARC) and generally prohibits practices that would prevent providers from submitting claims for actual services and collecting reimbursement for actual services performed. It prohibits insurers from using automated processes/system/tools (including AI) as the sole basis to downcode a medically necessary claim without review of the covered individual’s medical record by an insurer employee/contractor, and prohibits providers from submitting claims using automated tools without review by a provider or other claim-preparer. Insurers must disclose when AI is used to make adverse prior authorization determinations or to downcode; insurers may not downcode solely based on diagnosis codes; and if downcoding occurs, insurers must notify providers with appropriate CARC and RARC, provide the specific clinical reason and clinical criteria reference, list original and revised service codes and payment amounts, and include a notice of appeal rights. Providers must be afforded an appeal process with a submission timeline of at least 180 days and the ability to appeal in batches of substantially similar downcoding issues. The chapter also prohibits targeted/discriminatory downcoding against providers treating complex or chronic conditions and directs the department to adopt rules to implement it.
In addition to these new chapters, the bill makes related changes to existing claims adjustment and recoupment timing rules for both accident and sickness insurers and HMOs. For CPT code reimbursement rates, it adds restrictions that prevent retroactive reimbursement rate reductions for CPT codes and require at least 60 days’ written notice (mail/e-mail plus website posting) before prospectively reducing CPT reimbursement rates (for accident and sickness insurers and for HMOs). It also amends the existing insurer and HMO overpayment/recoupment and audit/correction timing limits by extending the referenced time periods (adding a “one hundred eighty (180) days” component to multiple thresholds). Finally, it adds new provisions in both the insurer and HMO chapters addressing recoupment due to coordination-of-benefits errors by allowing providers to submit claims to the appropriate insurer/HMO for the same services, while generally requiring submission within 90 days after recoupment (with documentation requirements for the original submission and the recoupment due to coordination-of-benefits errors, and allowing insurers/HMOs to grant more time). It includes applicability provisions limiting the new downcoding and rate/claim-adjustment protections to policies issued/renewed after specified dates, and it exempts Medicaid.
Enacted • 2026 Regular Session • Introduced: January 08, 2026
Sponsors: Chris Garten (R), Ryan D. Mishler (R), Edward Charbonneau (R), Travis Holdman (R), Eric Allan Koch (R), Tyler Johnson (R), Elizabeth Brown (R), Justin Busch (R), Aaron Freeman (R), Mike Gaskill (R), Stacey Donato (R), Gary Byrne (R), Cynthia Carrasco (R), Scott Alexander (R), Randy Maxwell (R), Scott A. Baldwin (R), Greg Goode (R), Jeff Raatz (R), Brett Clark (R), Daryl Schmitt (R), Michael R. Crider (R), Brian Buchanan (R), Linda Rogers (R), Blake Doriot (R), Michael Young (R), James Andrew Tomes (R), Rick Niemeyer (R), Bradford J. Barrett (R)
Co-sponsors: Jeffrey A. Thompson (R), Craig Snow (R), Joanna King (R)
The bill (Senate Enrolled Act No. 1) (1) adjusts Indiana’s framework for accepting and appropriating federal funds; (2) expands and tightens Indiana requirements tied to federal SNAP and Medicaid eligibility and verification; and (3) creates/updates Medicaid managed-care and “Healthy Indiana” program rules, including new funding-account, cost-sharing, eligibility verification, and reporting requirements.
For federal fund handling, it updates IC 4-12-1-18 so that (retroactively effective January 1, 2026) federal funds received by an “instrumentality” remain appropriated for purposes specified by federal government and the General Assembly, subject to budget-agency allotment, and it reiterates applicability of grant/loan/gift processing provisions to instrumentalities. It also adds language to IC 4-12-1-18 via an earlier-enacted P.L.213-2025 change, and separately amends IC 4-12-1-18 and IC 12-8-15-related federal-funds allotment timing language (retroactively effective January 1, 2026) so federal funds received as revenue by a state agency/department generally are not available for expenditure until budget-agency allotment.
For SNAP, it (effective July 1, 2026) adds definitions of “candy” and “soft drink” (tied to IC 12-14-30-10) and prohibits SNAP recipients from using SNAP benefits to purchase candy or soft drinks, with a secretary duty to request any needed federal waivers/authorizations. It also adds a new SNAP eligibility verification section (IC 12-14-30-9, effective July 1, 2026) requiring the division to verify U.S. citizenship/eligible alien status using SSA’s database or SAVE during enrollment and recertification, requiring specified acceptable proof when verification fails, requiring DHS referral/enforcement handling for certain unverified/inadmissible status situations, and—if an individual is determined ineligible based on citizenship/immigration status—it restricts household income/resource treatment by requiring the division to consider the entire income/resources of ineligible individuals and disallow proration/exclusion under the referenced SNAP rules.
For Medicaid and the Healthy Indiana plan, the bill adds a new dedicated “Indiana Rural Health Transformation Fund” (IC 12-8-15, new Chapter 15, retroactively effective January 1, 2026) funded with specified federal Section 71401 funds, continuously appropriated, administered by the Office of the Secretary; requires that beginning December 1, 2026 allotments/expenditures be subject to budget committee review; imposes administrative-expense payment limits to what federal law allows; provides for investment and non-reversion of end-of-year balances; requires periodic benchmark/status reporting to the budget committee; and sunsets the fund at December 31, 2032. It further amends Medicaid program operations by adding new/expanded verification, eligibility redetermination, and data-matching rules (including ongoing eligibility redeterminations on specified schedules; monthly/quarterly/annual data sources to identify eligibility-changing circumstances; and termination-based actions such as ending enrollment when verified lottery/gambling winnings trigger ineligibility thresholds). It adds Medicaid rules addressing immigration-status income counting and new referral/enforcement steps tied to applicants/recipients’ citizenship/immigration status verification, including requirements to include immigration-status fields on Medicaid presumptive eligibility applications and to require verified immigration-status eligibility before approving presumptive eligibility.
For the Healthy Indiana plan (IC 12-15-44.5 series), it revises eligibility/work and participation rules (including changes to hours-based “work” criteria language), updates plan benefit package requirements and exclusions (e.g., no abortion/abortifacients under family planning benefits), and adds/adjusts patient cost-sharing and administration constraints: it adds/enforces health care accounts with required minimum annual deductibles, requires contributions/payment mechanics and initial-payment gating before benefits begin, conditions continued participation on making contributions, provides rules on benefit reduction/termination for failure to pay (with different effects depending on income relative to the federal poverty level), governs enrollment renewal timing, and adds eligibility verification limits (the secretary cannot rely on self-attestation or managed-care-designations as sufficient verification; compliance must be verified by the secretary). It also updates emergency-room nonemergency use restrictions by setting minimum copay amounts (with exceptions for sudden, severe conditions) and imposes a cap on total quarterly cost-sharing to 5% of family income. Operationally, it requires actuarial analysis submission to the budget committee, imposes limits on managed care organization fees/profit and administrative allocations of plan funds (including an 87%/13% allocation rule for certain plan funds), requires specified reporting/notice before plan extensions or material amendments to HHS (including notice to Indiana Hospital Association), and modifies how the secretary may negotiate/alter the plan subject to specific prohibitions on reducing minimum contribution/deductible/work-hour requirements and on removing certain penalties or account requirements.
Effective timing appears in multiple provisions: the rural health fund is effective retroactively January 1, 2026; SNAP-related definitions and the new SNAP eligibility/prohibition on purchases are effective July 1, 2026; Medicaid-related immigration and verification sections are effective July 1, 2026 and/or October 1, 2026 in specific subsections; Healthy Indiana plan changes are effective upon passage with some sections effective July 1, 2026 and others tied to January 1, 2027 for certain Medicaid process items. The act also contains an “emergency is declared for this act” clause.
bill
Regulation • 🇺🇸 United States • Indiana • Proposed Notice
The rule establishes and implements Indiana’s Hospital Assessment Fee (HAF) under a CMS-approved, broad-based and uniformity waiver methodology that shifts the assessment from a day-based framework to a net-patient-revenue (NPR) framework for both inpatient and outpatient hospital services. It also consolidates and coordinates the procedural requirements for notification, reconsideration, and adjustments so that hospitals follow a single set of processes tied to the updated HAF calculations.
The rule amends three Indiana Administrative Code provisions that together govern HAF methodology: it replaces the day-based, projected-cost approach in 405 IAC 1-22 and amends 405 IAC 1-8-5 (outpatient) and 405 IAC 1-10.5-7 (inpatient). Key changes include (1) redefining what triggers and how the assessment is calculated using inpatient and outpatient portions of a hospital’s Indiana net patient revenue, (2) replacing the inpatient/outpatient allocation approach and related “projection and annual true-up” with an NPR determination from cost report data, and (3) setting standard inpatient and outpatient assessment rates as the lesser of 6% of net patient revenue or the maximum amount permitted under federal law. It also adds/clarifies defined terms (including “fee period,” “Indiana net patient revenue,” and several rate/classification terms), clarifies “state share,” and formally recognizes base and incremental fee components, including a cap related to a DSH payment component used in calculating the base fee when the state-directed payment program operates.
The rule changes assessment applicability and exemptions. It adds exempt categories including county or municipal hospitals, physician-owned hospitals, and hospitals providing only respite care services (with an age limitation for individuals served) to the list of hospitals that are not assessed. It also adds or ties reductions to hospital classifications (including low-income utilization rate hospitals, rural obstetrics hospitals, and Perinatal Level IV acute care hospitals with specified reduced percentages for inpatient vs. outpatient services), and establishes that assessment notification, reconsideration/appeal, and adjustment requirements are governed by the consolidated 405 IAC 1-22 procedures. The rule also adds a cross-reference related to optional payment plans (up to 12 months) and includes nonpayment sanctions by reference to IC 12-15-22.
Operationally, FSSA is proposing an interim rule that takes effect on the date/time accepted for filing and applies retroactively to fee periods beginning after June 30, 2025, aligning with the waiver’s July 1, 2025 effective date; the rule is described as applying to fees for periods after June 30, 2025. Fiscal impacts described in the analysis estimate aggregate assessment revenue of about $2,007,125,426 for state fiscal year 2026 under the NPR methodology versus $1,642,566,604 in state fiscal year 2025 under the prior methodology (an increase of about $364,558,822). The fee is described as a dedicated non-federal-share funding mechanism, with no new fine or civil penalty created by the rule itself (the fee increase is presented as a cost to assessed hospitals), and no new administrative expenses are imposed on hospitals; hospitals generally continue to remit when due using data already on file (cost-report based rate-setting by FSSA/its contractor).
Iowa
7
bill
Regulation • 🇺🇸 United States • Iowa • Final Notice
The document establishes Iowa Medicaid “conditions of eligibility” and related eligibility-factor rules within Iowa Administrative Code Chapter 75 (Human Services), covering both MAGI-related and non-MAGI-related eligibility pathways, definitions, eligibility categories, presumptive eligibility, medically needy eligibility and spenddown, and general requirements such as social security number, residency, citizenship/alienage verification, institutionalization rules, third-party liability, and estate recovery.
It contains an internal standards framework and operational details for multiple programs and eligibility mechanisms, including: family-related Medicaid categories (children, parents/caretakers, pregnant women, foster/subsidized guardianship/adoption groups, former foster care youth through age 26, and postpartum/continuous eligibility rules), breast/cervical cancer treatment coverage (including presumptive coverage), IHAWP eligibility and presumptive eligibility, refugee medical assistance (including extended coverage), SSI-related and other aged/blind/disabled pathways, medically needy coverage with defined spenddown methodology, and continuous eligibility rules for pregnant women and children. It also establishes presumptive eligibility processing through qualified entities using the Medicaid Presumptive Eligibility Portal, specifies attestation and verification rules for citizenship/qualified noncitizen status (including a 90-day “reasonable opportunity period” and limits on retroactive eligibility), sets conditions for public institution inmates, and provides extensive rules on third-party medical resources, medical assistance liens, and recovery.
Key program operations defined include: (1) transitional and extended coverage for certain FMAP discontinuations (up to 12 months transitional and up to four months extended, with fraud and income-change conditions), (2) MEPD (Medicaid for employed people with disabilities) with monthly premiums for specified income bands above 150% FPL, conditional eligibility requiring premium payment, due-date/cancellation rules, six-month retention when unable to work due to medical condition or job loss (with intent-to-return requirements), and (3) HIPP (health insurance premium payment) program rules governing cost-effectiveness thresholds, eligibility/payment timing, prohibited premium reimbursements for certain plan types/situations (including HDHP treatment), reporting/cancellation/reinstatement, and notice timing (including a 65-day decision deadline for cost-effectiveness).
The document also contains detailed asset-transfer and trust rules affecting Medicaid eligibility and/or long-term care services (e.g., disposal of assets for less than fair market value with look-back periods, penalty periods for institutional vs noninstitutionalized individuals, exceptions including home/spousal/disabled-child provisions, purchase of annuities/life estates/promissory notes treatment, and trust treatment for post–Aug. 10, 1993 trusts). It includes estate recovery and recovery/overpayment processes, specifying when debts arise (including estate recovery debt rules for members 55+ and for institutionalized members under 55 meeting criteria), possible waivers for undue hardship, and recovery appeals under Chapter 2506.
As indicated in the text for Chapter 75, it is part of a continuing regulation structure with recissions and editorial updates noted (e.g., multiple ARC entries and effective dates), and the text includes specific “effective” dates for referenced sections (notably including 1/1/26, with additional editorial changes and later effective dates such as 8/1/26 for certain ARC references).
A bill for an act relating to limitations on activities related to paid claims under the Medicaid pr... (View full title on source site)
label_outlineMedicaid Reimbursement
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
January 21, 2026
Failed (House)
January 21, 2026
Failed Sine Die • 2025-2026 Regular Session • Introduced: January 21, 2026
Sponsors: Eric J. Gjerde (D), Elizabeth Wilson (D), Bob M. Kressig (D), Jerome Amos (D), Heather Matson (D), Timi M. Brown-Powers (D), Ross Wilburn (D), Elinor A. Levin (D), J. D. Scholten (D), Beth Wessel-Kroeschell (D), Daniel Gosa (D)
The bill establishes a new Medicaid requirement limiting certain post-payment reviews of provider claims that are not tied to fraud or misrepresentation. It creates a new Iowa Code section (249A.42B) requiring that, for Medicaid fee-for-service and managed care administration paid claims without fraud/misrepresentation, any post-payment review may cover only claims paid within the prior 12 months.
For providers, the bill also bars recoupment for older overpayments: if an overpayment is identified for a claim where 12 months or more have elapsed since the date of payment, the overpayment is not subject to repayment and may not be recovered by offset against future reimbursement of claims by the provider.
The limitations do not apply to retroactive Medicaid cost settlements or to rate changes based on a Medicaid or Medicare cost report. Additionally, any improper payment identified through a covered review may be resubmitted by the provider as a claims adjustment (i.e., the provider is permitted to correct/adjust claims following the review).
The act takes effect upon enactment, and it is codified as the new section addressing limitations on activities related to paid claims (resubmission).
The bill creates new Iowa requirements governing health carriers’ (1) auditing of clean claims and (2) standards of conduct for interactions with health care providers, and it adds new, detailed rules governing prior authorization decisions by utilization review organizations (UROs) and health carriers, including clinical- and peer-review requirements, appeal procedures, and exemptions.
For claim audits, the bill establishes a new section requiring that if a health carrier audits a clean claim, it must reimburse the provider’s reasonable documented administrative costs to respond to the audit. The bill also sets timelines: the carrier must notify the provider within 15 calendar days after selecting the clean claim for audit; must complete the audit and issue an adverse determination within 45 calendar days after receiving all requested documentation; and must process an appeal initiated by the provider no later than 30 calendar days after receipt of the audit determination, issuing a final determination within 14 calendar days after notice of the appeal. If the carrier violates the audit timelines, the clean claim is automatically approved and promptly paid with interest at 10% per annum. The audit rules do not apply to claims under active fraud investigation by a state or federal authority or to federal programs where audits are mandated by federal law. Violations by a health carrier are treated as unfair or deceptive acts and may trigger civil penalties; providers may recover litigation costs, including reasonable attorney fees.
For standards of conduct, the bill adds new prohibitions for health carriers, including: (a) no financial penalties, reimbursement reductions, administrative fees, or network termination based on a provider’s referral to or affiliation with out-of-network providers; (b) no interference with a provider’s staffing and referral decisions (except as otherwise provided by law); and (c) no offering/enforcing contract terms requiring provider negotiation opportunity and no enforcement of provisions that impose unreasonable or unconscionable obligations (such terms are void and unenforceable). Violations constitute unfair or deceptive acts, can lead to civil penalties, and allow providers to recover litigation costs, including attorney fees.
For prior authorizations, the bill creates a new URO/health-carrier “peer review” framework. It defines key terms (e.g., clinical peer, qualified reviewer, downgrade) and provides that a URO may deny or downgrade only if decisions are made by an appropriately credentialed qualified reviewer (physician) or clinical peer (non-physician), with the organization supplying: a written reasons statement, an appeals process explanation, and a written attestation containing specified credentials/identifiers and specialty or experience requirements. It also requires, on provider request after denial, a consultation within seven business days. If the denial/downgrade is appealed, the appeal must be handled by a qualified reviewer or clinical peer not involved in the initial determination and must consider relevant clinical records and submitted medical literature. Violations are deemed unfair/deceptive practices subject to civil penalties and allow providers to recover litigation costs, including attorney fees. Separately, the bill creates exemptions preventing a health carrier from requiring prior authorization or imposing additional utilization review for (1) certain cancer-related screening/preventive services recommended under updated NCCN oncology clinical practice guidelines, and (2) life-threatening conditions that develop or become evident while a covered person is receiving inpatient care, unless immediate assessment and treatment is provided. Applicability limits apply to health benefit plans delivered/issued/continued/renewed on or after January 1, 2027, and to certain pending prior authorization requests made before that date but not finally determined by it.
The bill creates additional rate-review and reporting obligations for Iowa’s Department of Health and Human Services (HHS) covering three areas: shelter care and qualified residential treatment provider (QRT) costs/rates; medical assistance provider reimbursement rates; and home- and community-based services waiver provider rate limits.
First, it amends Iowa Code section 235.2 by adding a requirement that once HHS implements a uniform cost report for shelter care and QRT providers, HHS must conduct a biennial review comparing shelter care and QRT provider costs to current shelter care and QRT rates. HHS must then submit, on or before October 1 of the year immediately following the review, a report to the governor and the general assembly detailing the review results and recommendations for rate adjustments.
Second, it amends Iowa Code section 249A.4 by adding an annual review requirement for provider reimbursement rates for all medical and health services provided under the chapter. For each provider reimbursement rate, HHS must compare it to Medicaid reimbursement rates in (1) states contiguous to Iowa, (2) states with populations comparable to Iowa (based on the most recent decennial census), and (3) the federal Medicare program if applicable. HHS must submit an annual report summarizing this review to the general assembly on or before December 1.
Third, it adds a new section (249A.32C) establishing home- and community-based services waiver provider rate limits. Beginning July 1, 2026, HHS—using input from the public, providers, and other stakeholders—must conduct at least biennial reviews of provider reimbursement rates for services rendered under waivers during a review period specified by HHS. The review must include, at minimum, the aggregate cost to the state to reimburse providers for waiver services, utilization of waiver services by consumers, providers’ demonstrated capacity to meet consumer demand using available resources, and indicators of need for increased resources. Based on the review, HHS must develop proposed rate models and related changes to HHS policy and procedures, and must report to the general assembly on or before December 31 of the year the review is completed; the report must include the proposed rate models, the projected fiscal impact of implementing them, documentation supporting the actuarial soundness of the proposed models, and the proposed policy/procedure changes. The section also defines “consumer,” “provider,” and “waiver” by cross-reference to existing definitions in section 249A.29.
The bill creates a new Iowa statutory section, defining terms for “emergency services,” “out-of-network provider,” “participating facility/provider,” and “complicating factor,” and establishes new requirements for coverage and reimbursement of emergency care provided by out-of-network providers.
For policies, contracts, or plans providing third-party payment or prepayment of medical expenses, the bill requires coverage of services furnished by an out-of-network provider in two situations: (1) when the services are emergency services; or (2) when the services were provided at a participating facility and the covered person could not receive the services from a participating provider. It also limits patient billing by prohibiting an out-of-network provider from billing or collecting from the covered person any amount other than the covered person’s cost sharing under the health benefit plan.
The bill sets a claims and reimbursement process for out-of-network providers: the provider must submit a claim to the covered person’s health carrier within 60 calendar days after providing the services; the carrier must reimburse within 60 calendar days after receipt, and the reimbursement must be the greater of (a) the median amount that would have been paid to a participating provider in the same specialty (excluding cost sharing) or (b) 150% of the most recently published federal CMS fee schedule for the service (excluding cost sharing). For services involving a “complicating factor,” the out-of-network provider may seek additional reimbursement as part of the initial claim by submitting medical records/clinical documentation demonstrating the complicating factor; the carrier must either pay an additional amount equal to 25% of the initial reimbursement or issue a denial within 30 calendar days.
If the carrier denies the additional reimbursement, the provider may request binding arbitration with the commissioner, and the bill prescribes arbitration mechanics and timing: the commissioner notifies the parties within 30 days whether the request is accepted/denied; the carrier must submit reconfirmation or an alternative payment offer within 30 days after notice; the parties select an arbitrator from an approved list; and the arbitrator issues a written decision within 45 calendar days, considering specified documentation and payment offers. Arbitration costs must be split equally by the carrier and provider. The bill applies to enumerated types of specialized health-related insurance contracts/policies/plans delivered, issued, continued, or renewed in Iowa on or after January 1, 2027, and it excludes certain coverage types (e.g., accident-only, specified disease, short-term limited hospital/medical, disability income, workers’ compensation/similar supplements, and automobile medical payment insurance). The commissioner of insurance is authorized to adopt rules to administer the new section.
The bill creates a new Iowa statutory section, 514C.16A, establishing required insurance/health-plan coverage and a payment-and-dispute process for certain out-of-network emergency services. It defines key terms including “out-of-network provider,” “participating facility,” “emergency medical condition,” “emergency services,” “complicating factor,” “cost sharing,” and “arbitrator list” (a commissioner-approved list of arbitrators), and it requires coverage by a policy/contract/plan for services furnished by an out-of-network provider when the services are emergency services or when provided at a participating facility and the covered person could not receive equivalent services from a participating provider.
Under the new section, an out-of-network provider must submit a claim to the covered person’s health carrier no later than 60 calendar days after providing the services. Within 60 calendar days after receiving the claim, the health carrier must reimburse the out-of-network provider the greater of (1) the median amount that would have been paid to a participating provider in the same specialty for the same services (excluding cost sharing), or (2) 150% of the most recently published Medicare fee schedule amount for the service (excluding cost sharing). The bill prohibits the out-of-network provider from billing, attempting to collect from, or collecting from the covered person any amount beyond the cost sharing required by the covered person’s health benefit plan.
For out-of-network services involving a “complicating factor,” the provider may request additional reimbursement by submitting an initial claim that includes medical records and clinical documentation supporting the complicating factor and justifying the additional reimbursement. After receiving a claim for additional reimbursement, the carrier must, within 30 calendar days, either pay an additional amount equal to 25% of the initial-claim reimbursement or issue a denial letter explaining the denial basis. If denied, the provider may request binding arbitration with the insurance commissioner; the commissioner must notify both parties within 30 calendar days whether the request is accepted. The carrier then submits documentation within 30 calendar days reconfirming the denial or offering an alternative payment for arbitration consideration. The parties select an arbitrator from the commissioner’s arbitrator list, arbitration documentation is submitted, the arbitrator issues a written decision within 45 calendar days, arbitration costs are split equally between the carrier and provider, and the arbitrator considers specified documentation and the complicating factor.
The coverage/payment requirements apply to specified classes of third-party payment-provider contracts, policies, or plans delivered, issued, continued, or renewed in Iowa on or after January 1, 2027, including certain accident and sickness insurance, hospital/medical service contracts, health maintenance organization contracts, and public employee plans. The bill exempts specified specialized coverage types (e.g., accident-only, specified disease, short-term/hospital confinement indemnity, credit/dental/vision, Medicare supplement, long-term care, disability income, liability/worker’s compensation-related supplemental coverage, and automobile medical payment insurance) from the section’s requirements, and it authorizes the commissioner of insurance to adopt rules to administer the section. It also expressly allows private negotiation agreements that result in reimbursement greater than what the section requires.
bill
Regulation • 🇺🇸 United States • Iowa • Final Notice
The document establishes Iowa Medicaid provider payment procedure rules (IAC 5/27/26 Human Services, Chapter 80) covering submission of claims, payment rules (including third-party liability), time limits for submitting claims and claim adjustments, provider authorization/eligibility card practices, exceptions for payment to parties other than the provider, and the “health care data match” program requiring health insurers to provide eligibility/coverage information to the state under a signed data use agreement.
It also contains an internal update effective date tied to a specific rulemaking action (effective 7/1/26) for the cited Chapter 80 provisions, and it incorporates by reference a provider manual (Chapter IV, “Billing Iowa Medicaid,” as amended to July 1, 2026) for detailed claim submission procedures.
Key required changes/requirements reflected in the text include: mandatory electronic claim submission “whenever possible,” specific electronic claim forms for fee-for-service Medicare beneficiaries (UB-04 and CMS-1500, with EOMB required only if requested), “clean claim” and third-party liability rules including a “pay and chase” approach for certain categories, defined time limits (365 days for initial claims and for most adjustments/resubmissions; no payment if received beyond two years from date of service), rules on eligibility card issuance and validity tied to ELVS, limits/conditions for payments to clients/counties/business agents, and a health insurer data match obligation with confidentiality requirements consistent with HIPAA and its implementing regulations.
The document is intended to implement Iowa Code chapter 249A.
Kansas
1
bill
Legislation • 🇺🇸 United States • Kansas • Concurrent Resolution
Urging Congress to give state insurance regulators authority over Medicare Advantage plans.
Failed • 2025-2026 Regular Session • Introduced: March 12, 2025
Co-sponsors: William Sutton (R), Cindy Neighbor (D), Ron Bryce (R), Will Carpenter (R), Shannon Francis (R), Nick Hoheisel (R), Steven K. Howe (R), Jo Ella Hoye (D), Susan M. Humphries (R), Marty Long (R), Jim Minnix (R), John Resman (R), Charles Smith (R), Barbara Wasinger (R), Gary White (R)
The document presents a resolution urging Congress to empower state insurance regulators with authority over Medicare Advantage plans. It raises concerns about the absence of state oversight since the Medicare Modernization Act was enacted in 2003, which has resulted in aggressive and misleading marketing practices within the Medicare private plan marketplace.
Key issues highlighted include reports from state departments of insurance and consumer advocacy organizations regarding misrepresentations in the marketing of Medicare Advantage plans, particularly concerning provider networks and benefits. The resolution points out that aggressive sales tactics often target seniors and vulnerable adults, making it difficult for them to make informed decisions about their healthcare options.
The resolution advocates for Congress to acknowledge that states are better positioned to oversee Medicare plans and safeguard consumers from fraudulent practices, similar to their regulation of other health plans. It calls for legislation that would enable states to enforce their own marketing and consumer disclosure laws for Medicare plans.
The bill proposes adding a new section to the Kentucky Constitution to entrench Medicaid expansion coverage for non-disabled, low-income adults aged 19 through 64 with income at or below 138% of the federal poverty level (as authorized by federal law). It requires Kentucky to provide Medicaid benefits to eligible individuals and to ensure that the coverage meets or exceeds the applicable benchmark or benchmark-equivalent requirements defined by federal law.
The bill limits Kentucky’s ability to increase eligibility or enrollment barriers for people eligible under the constitutional provision. Kentucky may not impose greater or additional burdens or restrictions on eligibility or enrollment standards, methodologies, or practices than those applied to other Medicaid-eligible persons under Kentucky law, except that Kentucky may impose a work requirement or cost-sharing requirement to the extent required by federal law or regulation.
The amendment is submitted to Kentucky voters for ratification or rejection at the next regular election according to constitutional and statutory procedures referenced in the bill. It directs the Secretary of State to publish (at least once) the question posed in the act and the full proposed constitutional amendment text, and to publish notice that the amendment will be voted on at the next regular election (with publication timing tied to the first Tuesday in August preceding the election). It also provides ballot-implementation timing and requires certification of the complete text for placement on ballots, with dates tied to the August/September schedule depending on whether a presidential election is occurring.
The bill makes targeted changes to Kentucky Medicaid statutes and adds process requirements tied to federal authorization.
It amends KRS 205.520 and KRS 205.6312: (1) updates the declared policy language in KRS 205.520, including how the Cabinet may use federal funds, how Medicaid eligibility is provided, and reaffirming Medicaid’s status as payor of last resort and the primacy of Medicaid’s third-party recovery rights; and (2) modifies a Medicaid copayment/cost-sharing prohibition so that the cabinet or managed care organizations may not institute copayments, cost sharing, or similar charges to recipients (and their spouses or parents) for assistance provided under the chapter, federal law, or a federal Medicaid waiver except to the extent federally required, explicitly including reference to 42 U.S.C. § 1396o(k).
It also requires the Governor, within 30 days after the Act’s effective date, to commission an independent third-party analysis of Kentucky’s current Medicaid expansion and the Kentucky Health Benefit Exchange, including investigation of Kentucky’s uninsured rate, access to care, and improvements in health indicators.
Finally, if the Cabinet for Health and Family Services or the Department for Medicaid Services determines that state plan amendment, waiver, or other federal authorization is necessary to implement the Medicaid changes, the bill mandates that within 90 days after the effective date the cabinet/department request the necessary federal authorization/approval, and it permits delaying implementation only for provisions where federal authorization/approval is deemed necessary until that approval is granted. Sections 1, 2, and 4 are specified as the authorization required under KRS 205.5372(1).
The bill establishes a proposed amendment to the Kentucky Constitution that would require the Commonwealth to exercise any federally available option (currently existing or later made available) to expand eligibility for the Medicaid program. It specifies that individuals qualifying under the new constitutional section must receive Medicaid coverage that meets or exceeds federal “benchmark” or “benchmark-equivalent” coverage requirements (as defined by federal law).
The bill also restricts Kentucky’s ability to add state-level obstacles to Medicaid eligibility or enrollment. It would prohibit the Commonwealth from imposing greater or additional burdens or restrictions on eligibility or enrollment standards, methodologies, or practices for people eligible under the new constitutional section than those applied to other Medicaid-eligible persons under Kentucky law. A limited exception permits Kentucky to impose, to the extent required by federal law or regulation, a work requirement or cost-sharing requirement on people eligible under the section.
The bill provides for submission of the constitutional amendment to Kentucky voters for ratification or rejection at the next regular election in the manner required by referenced constitutional and statutory provisions. It further directs the Secretary of State to publish the question and the full text of the proposed amendment in a statewide newspaper and to certify the complete text to county clerks in time to be printed on ballots, with specific timing rules keyed to whether the relevant election year includes a President and Vice President election.
The bill requires Kentucky’s Medicaid program to implement a federal “demonstrated community engagement” eligibility requirement for specified Medicaid individuals, sets timelines for imposing the requirement and providing notice, and prohibits seeking certain federal exemptions/delays unless the General Assembly authorizes them. It also expands the statutory definition of “applicable individuals” and defines “demonstrated community engagement” through qualifying monthly activities (including work, community service, education participation, combinations, and specified income thresholds) while enumerating categories excluded from the requirement.
It amends Medicaid cost-sharing rules to apply copayment cost sharing (starting October 1, 2028) only to Medicaid enrollees with income above 100% of the federal poverty line who are enrolled under a specified Medicaid eligibility pathway, and it exempts numerous services from cost sharing unless federal law requires otherwise. It also amends Medicaid presumptive eligibility procedures for hospitals (including training, notification, and limits on presumptive eligibility periods for pregnancy), modifies lottery/unemployment/vital statistics data-matching language for eligibility monitoring, and adds new requirements governing Medicaid managed care contracts and related managed care obligations. New provisions include: (1) semiannual Medicaid eligibility redeterminations beginning January 1, 2027 for specific non-exempt populations; (2) enhanced data systems usage and conditional “ineligibility” initial findings with appeal rights based on inconsistent data; (3) a programmatic framework to assess Medicaid nonemergency medical transportation (NEMT) eligibility determinations;
A major new NEMT section establishes a regional brokerage delivery model with capitated payments to regional brokers, regional medical-loss-ratio targets that increase over successive state fiscal years (from 85% beginning July 1, 2026 to 90% for 2029 and later), GPS-equipped vehicles at broker expense, performance-based withholds/recoveries (2%), and reporting requirements starting in 2027. It creates a Medicaid managed care organization compliance fund, financed by specified penalties/fines, and it tightens managed care obligations on claims processing, grievance/appeal timelines, internal appeals/grievances procedures, provider audit and recoupment rules, and required reporting to the Department of Insurance and legislative bodies. The bill also creates new Medicaid waiver administration requirements, including required waiver-specific level-of-care assessment tools, standardized waiver application contents (provider recommendation and provider attestation), a transitional 12-month deadline for certain existing waiver waitlist placements, and additional reporting obligations for waiver expenditures/utilization.
Finally, the bill creates or changes Medicaid governance/oversight mechanisms: it requires the Medicaid Oversight and Advisory Board to manage data access/transparent oversight via new provisions for continuous machine-readable access to Medicaid data and records by a legislative commission, and it creates a web-based healthcare transparency dashboard. It also directs the board to evaluate the NEMT program during the 2026 interim and to form a waiver waitlist management subcommittee with recommendations and a required cabinet report by October 1, 2026. Operationally, it extends existing managed care contracts through December 31, 2028 and prohibits initiating procurement for managed care delivery before January 1, 2028, establishes a future transition plan to an administrative services organization (ASO) for Medicaid-covered dental services beginning January 1, 2029, repeals specified statutory provisions, declares an emergency with immediate effect upon passage/approval, and includes provisions for requesting federal approvals when needed to implement enumerated sections while limiting the duration of any delayed implementation pending federal authorization.
AN ACT relating to the establishment of a Medicaid state-directed payment program.
label_outlineMedicaid Reimbursement
1st Chamber
2nd Chamber
Executive
check_circle_outline
check_circle_outline
check_circle_outline
check_circle_outline
Introduced
February 20, 2026
Passed (House)
March 18, 2026
Passed (Senate)
March 31, 2026
Signed
April 13, 2026
Enacted • 2026 Regular Session • Introduced: February 20, 2026
Sponsors: Amy Neighbors (R), Kim Banta (R), George Brown (D), Beverly Chester-Burton (D), Mike Clines (R), Stephanie Dietz (R), Robert Duvall (R), Kevin Jackson (R), DJ Johnson (R), Kim King (R), Scott Lewis (R-KY), Shawn McPherson (R-KY), Michael Meredith (R-KY), Kimberly Poore Moser (R-KY), Steve Riley (R)
The bill establishes a new Medicaid state-directed payment program within Kentucky’s Medicaid framework by requiring the Department for Medicaid Services (DMS) to develop Medicaid programs to improve quality of and access to care by increasing Medicaid reimbursement rates for specified “qualifying hospitals,” subject to federal law.
KRS 205.6412 is revised to require enhanced add-on payments from Medicaid managed care organizations to qualifying hospitals (1) that participate in the existing hospital rate improvement program under KRS 205.6406, (2) that are Level II, III, or IV trauma centers, (3) that are located in counties whose Medicaid enrollment percentage exceeds the statewide median for the prior calendar year as shown in a Cabinet report, and (4) that have agreements to train providers with specified graduate medical education programs (either university-affiliated or, in the pediatric teaching hospital path, with limitations described below). The revised statute also expands eligibility for “pediatric teaching hospitals” (as defined in KRS 205.565) by allowing enhanced add-on payments, but limits eligibility to services delivered to patients age 18 or younger. In addition, for a separate qualifying pathway authorized under federal approval, enhanced add-on payments may be based on an “equivalent Medicare rate” for certain physician and nonphysician professional services provided through affiliated or contracted physician groups or professionals, provided the hospital has an agreement to train providers with a state-owned university-affiliated graduate medical education program.
The program’s financing and implementation are conditioned on CMS requirements: the nonfederal share must come from an identified funding source separate from the KRS 205.6406 assessment and not from the general fund; qualifying hospitals must report quality measures tied to the state university teaching hospital Medicaid directed payment plan and existing applicable Medicaid directed payment plan measures; and reimbursement applies only to Medicaid managed care organization-covered patients. The new state-directed payment program must be separate and distinct from any state-directed payment program authorized under KRS 205.6406, and DMS may implement only after CMS approves the federal Medicaid documentation, agrees to consider the program through a dedicated CMS preprint without affecting other directed payment programs, and confirms the availability of compliant nonfederal/state match funding. If federal recoupment is sought after implementation, the state is not liable and qualifying hospitals are liable for any reimbursement owed to CMS or other federal agencies. DMS must promulgate administrative regulations under KRS Chapter 13A to implement the program.
Within 60 days after the Act’s effective date, DMS must submit a Medicaid preprint to CMS seeking authorization to implement the program with a January 1, 2026 effective date. If CMS approves the preprint with a retroactive effective date of January 1, 2026, DMS must direct contracted Medicaid managed care organizations to make retroactive enhanced add-on payments to qualifying hospitals for previously paid claims (beginning January 1, 2026) for physician and nonphysician professional services provided by the hospitals’ affiliated physician groups or contracted employed professionals.
The bill establishes requirements for a Kentucky Medicaid state-directed payment program administered by the Department for Medicaid Services. It requires (subject to federal approval under applicable Medicaid requirements) enhanced “add-on” payments funded through a non-general-fund nonfederal share source separate from the assessment authorized in KRS 205.6406, and it limits the program to services and patients meeting specified eligibility rules.
KRS 205.6412 is revised to direct the department to develop Medicaid managed-care-based enhanced add-on payments for qualifying hospitals. Eligibility to earn enhanced add-on payments includes hospitals that (a) participate in the KRS 205.6406 hospital rate improvement program, (b) are Level II, III, or IV trauma centers, (c) are located in counties where Medicaid enrollment exceeds the statewide median (as defined by a Cabinet posted “Monthly Medicaid Counts by County” metric for the prior calendar year), and (d) have agreements for clinical rotations to train providers with a university-affiliated graduate medical education program; or alternatively (e) are pediatric teaching hospitals (with an added age limitation). Under the pediatric teaching hospital pathway, enhanced add-on payments are restricted to services delivered to patients age 18 or younger.
For federal implementation, within 60 days after the Act’s effective date the department must submit a Medicaid preprint to the federal Centers for Medicare and Medicaid Services (CMS) seeking authorization to implement the program with a January 1, 2026 effective date. If CMS approves the preprint, the qualifying hospitals may earn enhanced add-on payments from Medicaid managed care organizations based on the hospitals’ equivalent Medicare rates for services, including physician and nonphysician professional services provided by affiliated physician groups/physicians or other professionals employed by or contracted with the qualifying hospital, provided the qualifying hospital has an agreement to train providers with a state-owned, university-affiliated graduate medical education program.
The bill also sets program design and implementation conditions: the state-directed payment program must be separate and distinct from any state-directed payment program authorized under KRS 205.6406; reimbursement applies only to patients covered by a Medicaid managed care organization; qualifying hospitals must report the same quality measures applicable under (i) the state university teaching hospital Medicaid directed payment plan and (ii) similarly approved payment programs active in Kentucky; and the department must promulgate administrative regulations under KRS Chapter 13A to implement the program. Finally, if CMS approves the required preprint with a retroactive effective date of January 1, 2026, the department must direct each contracted Medicaid managed care organization to make retroactive enhanced add-on payments to qualifying hospitals for previously paid Medicaid claims for physician and nonphysician professional services provided on or after January 1, 2026 by the qualifying hospital’s affiliated professionals.
The bill establishes a proposed constitutional amendment to Kentucky’s Constitution creating a new section that “enshrines and protect[s] the current expansion of Medicaid eligibility for non-disabled, low-income adults.” The proposed new constitutional language directs the Commonwealth, to the extent permitted by federal law, to provide Medicaid benefits to people aged 19 through 64 with income at or below 138% of the federal poverty level for the applicable family size, as authorized by federal law.
It requires that coverage provided under this constitutional eligibility group meets or exceeds the applicable Medicaid benchmark (or benchmark-equivalent) coverage requirements, as those terms are defined by federal law. It also prohibits Kentucky from imposing greater or additional burdens or restrictions on eligibility or Medicaid enrollment standards, methodologies, or practices for individuals eligible under the new constitutional provision than those imposed on other Medicaid-eligible persons under Kentucky law, except that Kentucky may impose, to the extent required by federal law or regulation, a work requirement and/or cost-sharing requirement on people eligible under the section.
The amendment is submitted to Kentucky voters for ratification or rejection at the next regular election at which General Assembly members are voted for, following the timing and voter-submission procedures tied to Sections 256 and 257 of the Kentucky Constitution, KRS 118.415, and Sections 4 and 5 of the Act.
Administrative election steps are added/modified for ballot and publication purposes: the Secretary of State must publish the question and the entirety of the proposed constitutional amendment at least once in a newspaper of general circulation and must publish notice that the amendment will be on the next regular election ballot; and the Secretary of State must certify the complete text and amendment to county clerks by specified deadlines so that the text is indicated on paper or electronic ballots used in each county or precinct.
bill
Regulation • 🇺🇸 United States • Kentucky • Proposed Notice
The regulation sets Kentucky Medicaid reimbursement rules for physicians’ services, including baseline reimbursement methodology (lesser of usual and customary charge or the Medicaid Physician Fee Schedule), rate-setting formulas using relative value units and dollar conversion factors, and numerous service-specific reimbursement rules (e.g., Medicare Part B services, CPT modifiers, laboratory and venipuncture rules, delivery-related anesthesia caps, anesthesia direction limitations, vaccine reimbursement, physician assistant reimbursement, and other reimbursement limits and conditions such as E/M visit requirements and non-reimbursement for provider preventable conditions).
It also establishes reimbursement-related program rules and governance items: supplemental payments for qualifying medical school faculty physicians (and resident-provided services under their supervision) with conditions on licensure, enrollment/participation, employment by specified teaching entities, and assignment of Medicaid reimbursement; rules allowing managed care organizations to elect—though not being required—to reimburse the same amounts as the department; contingency on federal financial participation and CMS approval; and appeal rights tied to recipient, provider, and eligibility decisions.
The document contains an explicit amendment update with three targeted changes: it updates the timeline for Medicaid Physician Fee Schedule updates to align with CMS’ annual update schedule; revises the definition of “provider group” (changing it from a “group of at least two individually licensed physicians” concept to “at least one licensed physician” who is enrolled individually and as a group and shares a Medicaid group provider number when more than one physician is in the group); and updates which vaccinations are eligible for reimbursement by providers (including clarifying reimbursement for department-approved vaccines and maintaining flu vaccine reimbursement for any age).
For public process, the regulation provides for a public hearing if requested on March 23, 2026 at 9:00 a.m. (virtual), with notice of intent to attend due by March 16, 2026 and written public comments due by March 31, 2026.
The bill enacts the “Preservation Act for Other Rural Hospitals” by creating new Louisiana statutes (R.S. 40:1190.1 through 1190.5) to govern Medicaid reimbursement and potential directed/state supplemental payments for certain qualifying “other rural hospitals,” and to set implementation and funding guardrails for the Louisiana Department of Health (LDH).
It defines “other rural hospital” as a hospital licensed by LDH with no more than 60 beds (excluding certain distinct-part beds) as of October 1, 2024, located outside Louisiana metropolitan statistical areas, with an operational emergency room, located in a municipality with fewer than 23,000 residents, and not classified as a rural hospital under existing law, a long-term care hospital, a rehabilitation hospital, or a free-standing psychiatric hospital. The bill also defines key terms used in payment administration (including “prospective rate approximating cost” and “reasonable cost”) and assigns LDH authority and duties tied to Medicaid state plan implementation under Title XIX.
LDH must adopt regulations providing for Medicaid reimbursement upgrades for other rural hospitals. Specifically, LDH must (1) allow other rural hospitals to certify eligible expenditures as a contributing public agency for Medicaid federal financial participation; (2) maximize allowable funding and the use of intergovernmental transfers/certified expenditures for state match to increase access for Medicaid/LaCHIP beneficiaries and indigent individuals; and (3) by September 1, 2026 file a Medicaid state plan amendment with CMS to reimburse other rural hospitals at a rate comparable to rural hospitals, targeting approximately 110% of appropriate reasonable cost (with CMS-driven maximum reductions not below 100% of reasonable cost) for inpatient and outpatient services, including services from rural health clinics licensed as part of an other rural hospital. For inpatient acute and inpatient psychiatric services, the new methodology must use prospective rates approximating costs at the time of service; outpatient payments must ensure that outpatient services in the aggregate are paid at 110% of reasonable cost (or lower amounts approved by CMS but not below 100% of reasonable cost). The bill requires interim outpatient payment mechanisms, quarterly supplemental payment estimates, and final cost-settlement true-ups so outpatient services reach the required aggregate level.
For cost reporting periods ending after July 1, 2026, LDH must pay 75% of interim outpatient settlement amounts and pay 100% of final outpatient settlement amounts within 14 days after receipt of Medicaid audit contractor reports. The bill also requires LDH, effective for services on or after July 1, 2026 (or as soon as federal law permits), to develop and implement via emergency rule a payment methodology comparable to rural hospital payments (including directed payments) to optimize Medicaid inpatient/outpatient payments, distributing calculated payments to qualifying hospitals no less than quarterly (or as authorized by federal law). Eligibility for additional payments is conditioned on providing minimum documentation; no payments increase/supplements/directed payments/authorized payments are allowed for any other rural hospital that is not current on all assessment payments or is delinquent/in arrears, and LDH must withhold/offset/recoup payments until assessment obligations are satisfied. The bill further creates funding protections: annual funding for other rural hospitals must be separately appropriated by the legislature and must be sufficient to hold rural hospitals harmless from negative financial effects; other rural hospital funding must not be used to offset or substitute other hospital funding streams; and implementation must not reduce Medicaid reimbursement received by small rural hospitals. It adds an applicability provision tied to state plan amendment TN 24-0022 (ensuring net economic benefit for affected reconciliation periods) and provides procedural requirements for rulemaking and for submitting state plan amendments after CMS approval. The bill’s effective date is upon gubernatorial signature or, if not signed, upon lapse of time for enactment without signature; if vetoed and later approved by the legislature, it becomes effective the day after that approval.
MEDICAID MANAGED CARE: Provides relative to Medicaid coverage for continuous glucose monitoring devi... (View full title on source site)
label_outlinereproductive health
1st Chamber
2nd Chamber
Executive
check_circle_outline
check_circle_outline
check_circle_outline
check_circle_outline
Introduced
May 05, 2026
Passed (House)
May 05, 2026
Passed (Senate)
May 27, 2026
Signed
June 09, 2026
Enacted • 2026 Regular Session • Introduced: May 05, 2026
Sponsors: Stephanie Hunter Berault (R-LA)
Co-sponsors: Tehmi Jahi Chassion (D-LA), Mandie Landry (D-LA), Regina Ashford Barrow (D-LA), Gerald Boudreaux (D-LA), Gary Michael Carter (D-LA), Katrina R. Jackson-Andrews (D-LA), Samuel Lee Jenkins (D- LA ), Mary Beth Sherman Mizell (R-LA), Brach Jared Myers (R-LA), Thomas A. Pressly (R-LA ), Glen D. Womack (R-LA)
The law amends and reenacts Louisiana Medicaid’s continuous glucose monitor coverage rule in R.S. 46:450.8(A)(1), expanding the covered enrollee conditions for which a continuous glucose monitor is provided.
Under the amended provision, the Louisiana Medicaid program must provide coverage for a continuous glucose monitor for an enrollee who has “any type of diabetes,” expressly including but not limited to gestational diabetes. Coverage is conditioned on either (1) the need for insulin use more than two times daily or (2) evidence of level 2 or level 3 hypoglycemia.
The enrolled text shown indicates the change occurs within R.S. 46:450.8(A)(1) by altering the eligibility criteria described above; the provision remains subject to an exception still referenced in the surrounding statute (Subsection B), but the operative coverage conditions in Subsection A(1) are the focus of the modification.
The act establishes Medicaid reimbursement “equality” between independent rural health clinics (type one) and provider-based rural health clinics (type two and three). It directs the Louisiana Department of Health (LDH) to increase, for fiscal years 2026–2027 and 2027–2028, the encounter rate in effect for independent type one clinics by $41.50 over the prior year’s encounter rate, and to apply the annual Medicare Economic Index inflationary adjustment to that rate.
The act also expands facility need review requirements by adding “types one and two rural health clinics” to the list of healthcare provider types subject to facility need review under Louisiana’s facility need review statute (R.S. 40:2116(B)(8)).
LDH must prepare a state plan amendment or promulgate and adopt any necessary rules to implement the new Medicaid reimbursement equalization and related changes, and the provisions are conditioned on approval by the Centers for Medicare and Medicaid Services (CMS). LDH must also provide a monthly report to the legislature including, for each individual type one clinic, the number of encounters per month and the total amount of monthly expenditures.
Implementation timing is set so that LDH must take necessary actions within 90 days after the act’s effective date. The act’s operative provisions take effect only when an act with a specific appropriation for implementation becomes effective; the remaining effectiveness provisions follow standard Louisiana timing based on gubernatorial signature (or lack of signature) and override approval, as provided in the Louisiana Constitution.
The bill establishes a new Louisiana statutory Chapter 2 in Title 28 (R.S. 28:301–308) focused on Medicaid behavioral health administrative requirements, including provider enrollment/credentialing standards and documentation and staffing rules intended to reduce administrative barriers while maintaining patient safety.
Key new requirements and prohibitions include: (1) prohibiting the Louisiana Department of Health (LDH) and Medicaid managed care entities from requiring pre-employment reference letters as a condition of provider enrollment, staff credentialing, or delivery of Medicaid behavioral health services (while allowing primary-source verification of employment history, licensure, education, and required work experience) (R.S. 28:303); and (2) prohibiting LDH and managed care entities from requiring CPR, first-aid certification, or seizure-assessment training for behavioral health staff as a condition of enrollment, credentialing, or reimbursement, except that LDH may require such training only for staff providing services in settings where federal law, state law, or applicable licensing rules require it (R.S. 28:304).
The Chapter also changes administrative alignment and documentation: (3) supervision of provisionally licensed or otherwise supervised staff is deemed to satisfy Medicaid clinical supervision requirements when it meets or exceeds applicable program standards, and LDH is barred from requiring duplicative supervision when licensing-board supervision overlaps program requirements (R.S. 28:305); and (4) LDH must revise Medicaid provider progress-note documentation requirements for CPST and PSR services to align with federal guidance requiring documentation to be completed during the service or as soon as practicable after service, allows a general timeliness standard with reasonable exceptions (including state or federal declared emergencies or other department-defined exceptions), and requires late-entry attestation (date of entry and reason for delay) when documentation is completed outside the general standard (R.S. 28:306).
Additional new staffing/clinical director rules require that when a CPST/PSR provider must maintain a nurse on staff or a written nursing-services agreement solely for medication administration, the requirement is satisfied by having a licensed physician, psychiatrist, advanced practice registered nurse, or physician assistant whose duties include medication administration—without authorizing practice outside the scope of professional licensure (R.S. 28:307). The bill also expands the allowable medical director options for CPST/PSR by permitting a medical director to be a physician, advanced practice registered nurse, medical psychologist, or physician assistant, subject to criteria including an unrestricted Louisiana license, at least two years of qualifying experience treating psychiatric disorders, and practice pursuant to a collaborative practice agreement or required supervision arrangement under state law (R.S. 28:308), and directs LDH to revise rules and provider manuals accordingly. LDH must promulgate implementing rules under the Administrative Procedure Act (Section 2) and must submit to CMS by October 1, 2026 any necessary state plan amendment, waiver, or other request to authorize reimbursement for psychosocial rehabilitation services delivered via telehealth, with CMS submission follow-up notice obligations to specified legislative committees (Section 3). The bill’s effective date is upon gubernatorial signature or, if unsigned, at the constitutional end of the bill-signing period, or the day after legislative approval if vetoed and overridden (Section 4).
bill
Regulation • 🇺🇸 United States • Louisiana • Final Notice
The document promulgates a new Louisiana Administrative Code framework (Title 50, Part I, Subpart 5, Chapter 41–46) governing Medicaid program integrity fraud, waste, and abuse recovery. It repeals the existing Subpart 5 and replaces it with a new Subpart and chapter structure establishing definitions, rules on applicability/waivers, payment review and overpayment recovery, investigative and compliance review authorities, provider recordkeeping and reporting obligations, prohibited conduct, a sanctions regime (including exclusions, suspensions/withholding, and repayment rules), and related procedural protections (informal hearing and administrative appeal), plus confidentiality and severability provisions.
Key operational requirements include: (1) payment review authority allowing pre-payment, post-payment, and compliance reviews at the department’s discretion (including statistical sampling and extrapolation); (2) “materiality” of incorrect claim submissions at 5% or more of the reviewed claims universe when determining materiality; (3) provider obligations to maintain documentation supporting quantity, quality, medical necessity, authorization/qualified service delivery, sign/date requirements and correction rules for records, record retention, and cooperation with audits/investigations; (4) explicit time-bound provider reporting and repayment duties, including notifying the department of discovered overpayments within 60 days and repaying identified overpayments within 60 days of a final overpayment decision (or under an agreed longer schedule); and (5) presumptions that providers know applicable rules and that ignorance is not a defense.
The rule establishes mandatory and permissive exclusion and suspension/withholding mechanisms. It specifies a mandatory exclusion triggers list (e.g., certain criminal offenses tied to publicly funded healthcare programs, exclusions from publicly funded healthcare programs, patient abuse/neglect-related offenses, agreement to be excluded, and failure to meet payment-related agreement/judgment terms), with limited appeal rights (typically only to contest identity) and automatic/retroactive effect tied to the triggering event. It also creates payment withholding rules (including for credible allegations of fraud, failure to cooperate, suspected fraud/abuse, and written notice from a prosecuting authority) with notice content requirements and time limits on continuation, and it provides that exclusions and sanctions generally remain effective through administrative process subject to timing rules for when sanctions become “final.”
For enforcement, the document defines a broad prohibited-conduct list (e.g., failure to comply with Medicaid laws/enrollment terms, failure to disclose excluded persons, administrative/criminal/civil reporting failures within 10 business days, false statements during applications/claims reviews, various fraudulent billing conduct, failure to repay overpayments, record-audit noncompliance, failure to cooperate, systematic abusive billing, and abuse/neglect/exploitation). It establishes sanctions available for violations, including program prior authorization requirements, manual claim review, bonding/security, termination of associations, restrictions on tasks/locations/recipients/referrals, recovery, exclusion/suspension, monetary penalties up to $10,000 per violation, and administrative fines up to three times the overpayment, plus offsetting payment remedies. It also provides procedures for informal hearings (request within 15 calendar days; rebuttal/document access; non-adversarial process) and administrative appeals to the Division of Administrative Law (typically within 30 calendar days of notice or informal-hearing results), while clarifying that many corrective actions/education/warning letters/initial findings reports and certain actions (e.g., referrals to licensing or law enforcement, prepayment review, manual review placement, prior authorization requirements) are not treated as sanctions and are not subject to informal hearing or appeal. Finally, it adds confidentiality protections for investigatory/review contents until final sanction, a severability clause, and a supersession clause for conflicting departmental regulations.
The 132nd Maine Legislature has proposed legislation to increase the MaineCare reimbursement rate for ambulance services to 140% of the average allowable reimbursement rate under Medicare. This change is intended to address critical funding issues identified by recent blue ribbon commissions, which have raised concerns about the financial viability of emergency medical services providers.
To support this initiative, the bill includes a transfer of $15,000,000 from the Department of Public Safety's Emergency Medical Services Stabilization and Sustainability Program to the Department of Health and Human Services. Additionally, there will be a one-time allocation of $7,300,000 from the Federal Expenditures Fund and $5,000,000 from Other Special Revenue Funds for the fiscal years 2025-26 and 2026-27.
The overall financial impact on the Department of Health and Human Services is projected to total $12,300,000 across all funds for the same period. The urgency of this funding increase is underscored by an emergency clause in the legislation, allowing it to take effect immediately upon approval to ensure the preservation of public health and safety.
bill
Regulation • 🇺🇸 United States • Maine • Final Notice
The regulation establishes an expanded uniform reporting system for financial data under Maine Health Data Organization (MHDO) Chapter 300. It changes the scope of entities required to report financial data by adding multiple facility types beyond the existing coverage for hospitals and parent entities. It also adds a new annual reporting template requirement for covered facilities, including patient counts and specific payor category financial data, and adds a specific filing obligation for hospitals to submit an IRS Form 990 copy to MHDO. The rule becomes effective Sunday, August 16, 2026.
The bill requires health maintenance organizations (HMOs) to pay certain nonparticipating (out-of-contract) health care providers within 30 days after receiving a claim and sets specific minimum reimbursement rates for covered services delivered to HMO enrollees by providers without a written contract.
For noncontract hospital services, the HMO must pay the rate approved by the Health Services Cost Review Commission. For trauma care, the bill sets a minimum payment standard for trauma physicians as the greater of (1) 140% of the Medicare rate for the same service to a similarly licensed provider, or (2) the HMO’s January 1, 2001 rate in the same geographic area, with both standards applying to the same covered service to similarly licensed providers. For other noncontract providers, reimbursement must be at least the greater of specified Medicare-inflated thresholds and/or Medicare-based thresholds: for evaluation and management services, no less than either (A) 125% of the HMO’s average contracted rate as of January 31, 2019 (rather than the previously referenced “January 1 of the previous calendar year”), inflated by the change in the Medicare Economic Index from 2019 to the current year, or (B) 140% of the Medicare rate as of August 1, 2008 inflated by the Medicare Economic Index from 2008 to the current year; and for services that are not evaluation and management services, no less than 125% of the HMO’s average contracted rate as of January 31, 2019 inflated by the Medicare Economic Index from 2019 to the current year.
The bill also clarifies how HMOs calculate the “average rate” for similarly licensed contracted providers: it requires summing the contracted rate across all occurrences of the relevant Current Procedural Terminology (CPT) code and dividing by the total number of occurrences. It maintains disclosure rights for noncontract providers by requiring HMOs, on request, to disclose the reimbursement rate required under the trauma provider and nontrauma provider minimum-payment provisions.
Beyond payment rules, the bill retains and/or adjusts operational and enforcement mechanisms applicable under the same section: HMOs may require trauma physicians to submit adjunct claims documentation and include an HMO-assigned provider number (with the HMO required to assign a provider number on request). It preserves restrictions on HMOs requiring referral or preauthorization for covered trauma services delivered by a trauma physician. It also maintains provider enforcement through complaints to the Maryland Insurance Administration or civil actions in court, attorney-fee awards when the provider’s complaint is sustained, annual compliance review and reporting by the Maryland Health Care Commission, enforcement authority for the Maryland Insurance Administration, and a civil penalty cap (up to $5,000) for violations that reflect a general business practice. The act takes effect October 1, 2026.
Maryland Medical Advisory Committee - Duties and Workgroup to Study the Adoption of a Fee-for-Servic... (View full title on source site)
label_outlineMedicaid Reimbursement
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
February 06, 2026
Failed (House)
March 03, 2026
Failed Sine Die • 2026 Regular Session • Introduced: February 06, 2026
Sponsors: Jamila J. Woods (D), Kristopher G. Fair (D), Terri L. Hill (D), Julian Ivey (D), Aaron M. Kaufman (D), Jeffrie E. Long (D), Susan K. McComas (R), Edith Jerry Patterson (D), Kent Roberson (D), Denise Roberts (D), Malcolm P. Ruff (D), Sheila S. Ruth (D), Deni Taveras (D)
The bill requires the Maryland Medical Assistance (Medicaid) Advisory Committee to form workgroups and subcommittees as necessary to carry out the Committee’s duties. It also establishes a new “Workgroup to Study the Adoption of a Fee-for-Service Model for All Medicaid Services” to study the feasibility of implementing a direct care payment model statewide across Maryland’s Medicaid program.
The Medicaid Advisory Committee’s membership and general duties remain tied to managed-care advising, including advising the Secretary on implementation and evaluation of managed care programs, reviewing and recommending regulations and contract standards, reviewing oversight of quality assurance, reviewing managed-care performance and related data, promoting dissemination of performance information to enrollees, assisting with evaluation of enrollment processes, and reviewing ombudsman reports. The bill adds an explicit requirement that the Committee “form workgroups and subcommittees as necessary” to perform its duties.
The newly created Workgroup consists of designated legislative members (one Senate member appointed by the Senate President; one House member appointed by the Speaker), a Maryland Health Care Commission representative appointed by the Commission Chair, and appointees by the Governor including one Medicaid provider representative, one representative of a Medicaid advocacy organization, and any other member considered necessary. The Maryland Medicaid Advisory Committee must provide staff for the Workgroup. Workgroup members may not receive compensation but may receive expense reimbursement under State travel regulations. The Workgroup must (1) review Connecticut’s Medicaid experience with a fee-for-service model, including cost, provider participation, and access impacts; (2) review Maryland’s experience using fee-for-service rather than managed care; (3) examine other states’ fee-for-service or direct care model efforts in response to federal funding/enrollment changes; (4) review evidence-based studies on direct care payment model benefits and outcomes; (5) examine feasibility of implementing a direct care payment model throughout Maryland’s Medicaid program; and (6) propose a potential transition timeline.
By on or before January 1, 2027, the Workgroup must report its findings and recommendations to the Maryland Medicaid Advisory Committee and to specified recipients under State Government Article § 2–1257, including the President of the Senate, the Speaker of the House of Delegates, the Senate Finance Committee, and the House Health Committee. The Act takes effect July 1, 2026; Section 2 (the Workgroup provisions) remains effective for one year and is abrogated after June 30, 2027.
The bill revises the payment obligations of health maintenance organizations (HMOs) for covered services provided to enrollees by health care providers that are not under written contract with the HMO, specifically altering the reimbursement-rate requirements and the formulas used to determine them.
For noncontracted trauma care, the HMO must continue to pay a trauma physician (for trauma rendered to a trauma patient in a trauma center) at the greater of: (1) 140% of the Medicare program rate for the same covered service to a similarly licensed provider, or (2) the HMO’s rate as of January 1, 2001 (as published by CMS) for the same covered service to a similarly licensed provider.
For other noncontracted providers, the bill changes the “evaluation and management service” reimbursement floor and the benchmark date used for inflation calculations. Instead of using the HMO’s average rate paid as of “January 1 of the previous calendar year,” it uses the average rate paid as of “January 31, 2019.” For evaluation and management services, the HMO must pay no less than the greater of (A) 125% of that January 31, 2019 average rate, inflated by the change in the Medicare Economic Index from 2019 to the current year, or (B) 140% of the Medicare rate as of August 1, 2008 inflated by the change in the Medicare Economic Index from 2008 to the current year. For non-evaluation-and-management services, the HMO must pay no less than 125% of the January 31, 2019 average rate (inflated by the Medicare Economic Index change from 2019 to the current year).
An HMO must still disclose, on request of a noncontracted provider, the reimbursement rate required under the noncontracted-provider provisions, and it must continue using a defined method to calculate average contracted rates by summing contracted Current Procedural Terminology (CPT) code rates and dividing by total occurrences. The bill also retains enforcement and administration provisions, including provider enforcement through complaints to the Maryland Insurance Administration or civil action, annual compliance review by the Maryland Health Care Commission, regulatory implementation by the Maryland Insurance Administration, and civil penalties for HMO violations. The Act takes effect October 1, 2026.
Massachusetts
18
bill
Regulation • 🇺🇸 United States • Massachusetts • Proposed Notice
101 CMR 614.00 establishes the rules governing Massachusetts Health Safety Net payments and funding for dates of service beginning October 1, 2025. It specifies that the Health Safety Net office may issue administrative bulletins to clarify policies and implementation documentation for these payment and funding requirements.
101 CMR 614.00 defines key terms used across Health Safety Net payment calculations, including eligibility-related payment concepts (allowable Health Safety Net payment, shortfall amount), provider and payer terms (acute hospital, community health center, Disproportionate Share Hospital (DSH), public payer mix), and clinical/service concepts (emergency services and urgent care; emergency bad debt; administrative days; medically necessary service). It also clarifies administrative-day and partially eligible day payment principles, and defines provider and fund concepts (Health Safety Net Trust Fund and Health Safety Net office).
For funding allocation, 101 CMR 614.03 sets a graduated shortfall allocation methodology that differs by fiscal-year period. Through fiscal year 2024, if projected Health Safety Net payments exceed available funding, the Health Safety Net office allocates the shortfall via a graduated payment system: DSH hospitals are paid the greater of 85% of allowable Health Safety Net payments or a revised amount calculated through a relative public payer mix adjustment factor, subject to limits based on allowable payments; non-DSH hospitals follow with an initial cap of 75% and similar relative public payer mix adjustments; remaining funding (if any) is distributed proportionally by remaining allowable payments. Beginning with fiscal years on or after October 1, 2024, the same core graduated approach is retained but applied to those fiscal years, and a further additional reserved “Payments from the Health Safety Net Trust Fund beginning Fiscal Year 2026” section is added that extends the funding allocation framework using a data-driven estimate of projected reimbursable services, medical hardship, emergency/urgent care bad debt, and administrative expenses. The regulation also authorizes (i) final reconciliation of Health Safety Net payments with acute hospitals and community health centers, to be completed no later than two fiscal years after the end of the reconciled fiscal year, including notification that no further adjustments occur after final reconciliation, and (ii) post-reconciliation recoupment of overpayments through payment offsets, with discretionary underpayment adjustments.
101 CMR 614.06 and 614.07 establish how Health Safety Net pays acute hospitals and community health centers, respectively. Acute hospital payment rules include: monitoring claim volume and withholding/adjusting payments for suspected billing maximization or substantial service pattern changes; specific payment types (primary/secondary payer rules, offsets for emergency bad debt recoveries and free care endowment investment income); inpatient pricing using Medicare IPPS for non-psychiatric claims and IPF-PPS for psychiatric claims (with specified alternative pricing for Critical Access Hospitals, PPS-exempt hospitals, hospitals with fewer than 20 discharges, sole community hospitals, and Medicare Dependent Rural Hospitals); outpatient per-visit pricing based on source-year adjudicated eligible claims with exclusions (e.g., low-dollar visits and visits closely preceding admission) and a hospital-specific Medicare payment on account factor, plus a transitional add-on for DSH and non-teaching acute hospitals; separate physician and other outpatient service pricing using Medicare fee schedule/rate methodologies; secondary payer payment limitations including a “95% Rule” and a payment cap tied to what would have been paid under primary payer rules; emergency bad debt pricing rules with special conditions for hospitals with fewer than 20 emergency bad debt claims and for what bad debt categories are payable; medical hardship payment reduction rules; and an “Other” provision authorizing an additional $3.85 million payment to freestanding pediatric hospitals with specified Medicaid discharges criteria.
Community health center payment rules (101 CMR 614.07) require payment based on claims submitted, reduced by cost sharing, with monitoring and withholding/adjustment for suspected billing maximization. Reimbursable services are generally paid using Medicare-based PPS per-patient-per-day rates with specified geographic adjustments and coverage for defined visit types only once per patient per day (subject to listed exceptions), while services not included in the PPS rate are paid using a service-specific table (e.g., urgent care, selected diagnostic technical components, behavioral health categories, radiology, lab, dental, 340B pharmacy services, vision care, family planning services, preventive services/risk factor reduction, immunization-related services, and vaccine administration with conditions). Reporting requirements (101 CMR 614.08) require providers to file or make available data reasonably necessary for administering 101 CMR 614.00, allow the office to revise data specifications by administrative bulletin, permit audits, and authorize payment denial for noncompliance after advance notice to acute hospitals or community health centers. A severability clause applies to 101 CMR 614.00, and regulatory authority is stated under M.G.L. c. 118E.
bill
Regulation • 🇺🇸 United States • Massachusetts • Final Notice
101 CMR 614.00 establishes the Health Safety Net payment and funding rules for acute hospitals and community health centers for dates of service beginning October 1, 2025, and includes the related payment mechanics, definitions, and provider reporting obligations. The regulation authorizes the Health Safety Net office to issue administrative bulletins to clarify policies, specify documentation needed to implement the rules, and clarify billing/payment specifications. It also provides a structured approach to eligibility-determined payments, severability, and a final reconciliation process with subsequent post-reconciliation adjustments (recoupments and potential underpayment true-ups).
The regulation defines key terms used throughout the payment framework, including “Allowable Health Safety Net Payment,” “Shortfall Amount,” “Disproportionate Share Hospital (DSH),” “Public Payer Mix,” and “Relative Public Payer Mix Adjustment Factor,” as well as provider/payment concepts such as “Bad Debt,” “Emergency Bad Debt,” and “340B Provider.” It sets payment-year mechanics for funding shortfalls (projected reimbursable services, medical hardship services, emergency/urgent bad debt, and administrative expenses) and establishes that acute-hospital payments may be adjusted for additional available funding or shortfall allocations, with the Health Safety Net office allowed to reserve up to 10% to ensure full-year funding.
Starting with fiscal years beginning on/after October 1, 2024 (covering the shift from FY2024 to FY2025 and beyond), the regulation changes how shortfall allocations are distributed: when projected acute-hospital payments exceed available funding, funding is allocated through a graduated payment system that first applies DSH caps (initially up to 85% of allowable payments) and then applies non-DSH caps (initially up to 75%), using relative public payer mix adjustment factors when total funding is insufficient to meet those caps. For FY2026 and later (i.e., fiscal years beginning on/after October 1, 2025), the regulation further specifies cap-and-redistribution methods for DSH and non-DSH and then distributes any remaining funding across all hospitals proportionally to remaining allowable Health Safety Net payments.
Operational payment rules are set out for acute hospitals (101 CMR 614.06) and community health centers (101 CMR 614.07), including claim monitoring/possible withholding for suspected billing maximization (e.g., unbundling, upcoding), pricing methodologies using Medicare payment systems (IPPS/IPF-PPS for inpatient; outpatient per-visit pricing based on source-year outpatient charges and a hospital-specific Medicare payment on account factor), exclusions/non-payments (e.g., claims for outpatient visits ≤ $20.00 are handled through a specific pricing rule; outpatient visits within 72 hours of inpatient admission are not payable; provider preventable conditions and certain serious reportable events are not paid), secondary-payer rules (including a 95% rule and a “payment not to exceed primary” limit), bad debt and medical hardship handling, and specific add-on/other payments (including an additional payment for certain freestanding pediatric hospitals). Community health center payments are set primarily on a Medicare-based rate per patient per day (or less-than-or-equal charge amount under the PPS framework), with rules for service-specific payments outside the PPS rate table (including separate pay for defined services) and bad debt urgent-care payments limited to emergency bad debt and urgent-care bad debt at 75% of the specified payment rates. Reporting requirements require each provider to file or make available data deemed necessary by the Health Safety Net office (with administrative bulletin authority to revise specifications/schedules) and authorize audits and payment adjustments; failure to comply can lead to payment denial after notice. Final reconciliations must be completed no later than two fiscal years after the end of the fiscal year reconciled, with a defined closure rule after which no further adjustments occur for that fiscal year.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill establishes a new reimbursement obligation for Massachusetts health care carriers regarding “uncollected” patient cost-sharing amounts (co-payments, co-insurance, and deductibles) that remain unpaid after specified provider collection efforts. It adds Chapter 176O, Section 7A, requiring carriers to reimburse health care providers at no less than 65% of each qualifying unpaid co-payment/co-insurance/deductible amount that is not collected after reasonable efforts.
Section 7A defines “co-payment” as a fixed dollar amount owed under a health benefit plan; “co-insurance” as a percentage of the allowed amount (after any co-payment); and “deductible” as a specific dollar amount owed before the plan’s obligation begins (excluding any portion of premiums). The bill deems reimbursement for qualifying unpaid amounts as recovery of an “uncollectible bad debt,” and permits providers to request reimbursement if (i) the claim derives from unpaid cost-sharing amounts under the insured’s plan, (ii) each claim is at least $250 and reflects a unique covered service for the insured, (iii) the provider made reasonable collection efforts with documentation, including that the claim is not subject to an ongoing payment plan for more than 120 days from the date the first bill was mailed, (iv) the provider submits an aggregate reimbursement request on or before May 1 for claims meeting criteria in the prior calendar year with specified documentation (insured identifiers, date of service, amounts collected, and contact details), (v) the carrier may audit eligibility/coverage and the provider’s collection-effort documentation, must complete audits and dispute notifications within 120 days of receipt, and pays 65% of “undisputed” amounts within 120 days, and (vi) any amounts recovered by the provider after carrier reimbursement must be offset against future submissions.
The bill also prevents a carrier from prohibiting providers from collecting the insured’s cost-sharing at the time of service. It requires the Division of Insurance to promulgate regulations within 90 days of the act’s effective date consistent with CMS rules for reasonable collection efforts; if the division does not issue regulations in time, Section 7A is self-implementing and carriers must use the CMS bad-debt collection-efforts process documented in the most recent Medicare Provider Reimbursement Manual (CMS Pub. 15-1 and 15-2 (HIM-15)) as in effect within 90 days of the act’s effective date. Finally, it requires each carrier to provide an annual public report (posted on the division’s website) identifying the total number and amount of reimbursed and denied uncollected co-payments, co-insurance, and deductibles.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill creates a new Section 3C in Massachusetts General Laws chapter 176D to govern how insurers must pay ambulance service providers for emergency ambulance services when the provider is not under contract with the insurer covering the insured.
In defining the rule, the bill specifies key terms for “ambulance service provider” (licensed by the Department of Public Health), “emergency ambulance services” (emergency services rendered under an ambulance service license where immediate medical attention is needed), “insurance policy”/“insurance contract” (coverage for ambulance transportation services issued within Massachusetts), “insured,” and “insurer” (a list of Massachusetts-regulated insurance and health plan entities).
Operationally, if an ambulance service provider furnishes emergency ambulance services to an insured but is not under contract with the insurer providing the insured’s policy/contract, the insurer must pay the ambulance service provider directly and promptly. Payment must occur even if the insured’s policy/contract prohibits benefit assignments, so long as the insured executes an assignment; if the insured cannot practically execute an assignment because the policy would otherwise prohibit it, payment is still required. The bill also provides that the provider is not considered paid if the insurer instead pays the insured for the emergency service, and it grants the provider a right of action against an insurer that fails to pay under this requirement.
Payment rate and billing consequences are set out: except for nonprofit corporations licensed to operate critical care ambulance services that do both ground and air transports, payment under the direct-pay rule must be at the rate established by the municipality where the patient was transported. The bill deems the provider paid in full once paid under these subsections and prohibits further billing of the insured for the ambulance service, except for amounts the insured remains responsible for under the policy (coinsurance, co-payments, or deductibles). The bill further clarifies that it does not limit an insured’s existing rights to ambulance coverage and does not create entitlement to ambulance coverage where the insured’s policy provides none.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill establishes a new Massachusetts public health insurance option administered through the Commonwealth Connector. It adds a new chapter 176S creating the “Public Health Insurance Option,” requiring the Commonwealth Connector Authority to offer a public health benefits plan exclusively through the Connector to eligible individuals and groups, alongside Connector “seal of approval” plans. The public option must meet the Connector’s seal-of-approval requirements, minimum creditable coverage standards, and applicable requirements from ch. 176Q; it is required for eligible individuals and eligible small groups by no later than January 1, 2027, and for eligible large groups by no later than July 1, 2027.
The bill sets administration and oversight requirements for the public option, including permitting the Connector’s executive director to contract with managed care organizations or other health benefits administrators. It requires collaboration among the executive director, the Secretary of Health and Human Services, and the Commissioner of Insurance so that (as of January 1, 2026) only Medicaid managed care organizations already under contract with the Commonwealth may administer aspects of the public option; it allows applications from non-Medicaid managed care organizations after January 1, 2027. It requires annual reporting in the Connector’s annual reports on activities, receipts, expenditures, and enrollments, with oversight by the Connector Board and the state auditor as specified in ch. 176Q. It directs the Connector to set premium rates sufficient to fully finance the costs of benefits and related administrative costs.
For provider reimbursement and participation, the bill requires the Connector Board to set payment rates for public-option services and providers based on Medicare parts A and B, with Board discretion to adjust those base Medicare rates to maintain fair reimbursement and a strong provider network. It provides an opt-out mechanism for health care providers participating in Medicare so that no provider faces a penalty for not participating, the Connector must provide information on how providers can opt back in, and there must be an annual provider enrollment period to decide participation.
The bill also creates a related financing and risk-adjustment structure by amending multiple provisions of Massachusetts law. It authorizes the Commissioner of Insurance (by inserting new ch. 26 §8K) to assess risk-adjustment payments among “risk-adjusted health plans” and to make payments when a plan’s actuarial risk exceeds the average actuarial risk across risk-adjusted plans; self-insured group health plans under ERISA are exempt. It requires the Commissioner to set criteria and methods, allows use of actuarial and utilization/diagnosis and cost data (in a confidentiality-limited way), and includes a technical amendment to remove two specified last sentences of a prior 2006 session law section. The bill creates a new “Public Health Insurance Option Trust Fund” in ch. 29, requiring that amounts credited to the fund be expended without further appropriation for operation of the public option, and requires an updated revenue report by the Comptroller not later than January 1 to multiple specified offices and committees. Finally, it amends ch. 176Q to add definitions and cross-references expanding Connector “seal of approval” and underwriting-related provisions to “eligible large groups,” and it requires that no later than July 1, 2026 the Connector Board extend its seal of approval to large group plans and offer such plans alongside the public health insurance option for large groups through the Connector.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill directs the Massachusetts secretary of health and human services to make monthly enhanced Medicaid payments to “eligible hospitals” through enhanced Medicaid payments, supplemental payments, or other mechanisms, overriding contrary state law.
Each enhanced payment to an eligible hospital must be equal to 5% of the hospital’s average monthly Medicaid payments for inpatient and outpatient acute hospital services as determined by the secretary for the preceding year (or the most recent year with available data). The bill bars using these enhanced payments in later years to recalculate the hospital’s average monthly payment, and it prohibits the enhanced payments from offsetting existing Medicaid payments the hospital would otherwise qualify to receive. It also caps total payments to all eligible hospitals under the section in any fiscal year at $35,000,000.
The secretary may impose reasonable payment conditions to help ensure the availability of federal financial participation, and the bill allows the secretary and comptroller to take payment-related actions in anticipation of expected federal participation. The executive office of health and human services is authorized to promulgate regulations necessary to carry out the section.
For purposes of the bill, an “eligible hospital” is defined as a non-profit or municipal acute care hospital licensed under specified law that received enhanced Medicaid payments under the 2020 act in calendar years 2021 and 2022.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill requires the Massachusetts Health Policy Commission, working with the Center for Health Information and Analysis and the Division of Insurance, to conduct an analysis and issue a report on the use of prior authorization for health care services and its impact on cost, quality, and access.
The required report must cover: (1) an inventory of admissions, items, services, treatments, procedures, and medications that require prior authorization, focusing on items with high approval/denial rates for both standard and expedited requests (including after appeal); (2) review and adjudication timelines for standard and expedited requests, including the time to adjudicate appeals; (3) total health care expenditures associated with submitting and processing prior authorization determinations, including appeals; and (4) how prior authorization affects patient access and cost by patient demographics, geographic region, and service type. It also requires identification of services with low utilization variation across providers/carriers, low denial rates across carriers, and chronic-disease-related prior authorization items that negatively impact chronic disease management.
In addition, the bill directs analysis of operational and policy mechanics of prior authorization, including the integration of standardized electronic prior authorization attachments, standardized forms, requirements, and decision support into electronic health records and practice management software to promote transparency and efficiency; and whether “gold-carding”/waiver of prior authorization based on a carrier’s standards or policies is available to all providers in a carrier’s network. The bill further requires recommendations to simplify health insurance prior authorization standards and processes to improve access and reduce provider burden.
The bill specifies that the report be informed by data and information carriers submit to the Division of Health Insurance and must include, for both standard and expedited requests and for standard denials/expedited denials at least through appeal outcomes: lists of all prior-authorization-required admissions/items/services/treatments/procedures/medications; approval and denial rates (including denials later approved after appeal); frequency of extended review timeframes and how often such requests were approved; and average and median processing times for initial determinations and for appeals for standard and expedited prior authorizations. The report (and any legislative recommendations) must be submitted to the chairs of the joint committee on health care financing and the House and Senate committees on ways and means within one year of the act’s effective date.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill creates a new licensing and participation framework for dentists seeking to practice in Massachusetts under MassHealth. It adds a new General Laws section (Chapter 112, Section 52H) requiring that no person be licensed to practice dentistry unless the dentist agrees to accept a minimum percentage of MassHealth patients as part of the dentist’s active patient base.
The minimum MassHealth patient requirement is set by the Department of Public Health in consultation with the Executive Office of Health and Human Services and may not be less than 5% of a dental provider’s total patient caseload; it is also adjusted based on regional needs and the dental provider’s capacity. Dentists must provide annual documentation to the department verifying compliance. The department must also establish an application process for hardship exemptions or adjustments based on factors including practice size, geographic location, and other department-determined considerations.
Noncompliance triggers enforcement and penalties: the Board of Registration of Dentistry may suspend a dentist’s license until compliance is achieved (pursuant to Section 52D), and/or the department may assess administrative penalties as determined by the department. The Executive Office must develop an online portal to help MassHealth recipients locate participating dental providers by region and to publish transparency information on participation rates and available services. To incentivize participation, the Executive Office must (subject to appropriation) offer student loan forgiveness to newly licensed dentists who meet or exceed the required MassHealth percentage for at least 3 years, and must increase reimbursement rates for services rendered to MassHealth patients to support participating dentists’ financial sustainability.
The bill provides an emergency-care exception: in emergencies (as defined by the department, including acute dental pain, infection, or trauma requiring immediate intervention to prevent significant complications), any licensed dentist may treat a MassHealth recipient regardless of participation status and will be reimbursed at the standard MassHealth rate plus 10% for services provided within 60 days. The Executive Office must promulgate implementing rules, and it must issue an annual report (due December 31 each year) including the number of participating dentists by region, the percentage of MassHealth patients served relative to the state’s dental care needs, and recommendations for addressing access gaps. The act takes effect 180 days after passage.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
An Act to increase access to healthcare for ostomy patients
label_outlineMedicaid Reimbursement
1st Chamber
2nd Chamber
Executive
check_circle_outline
play_circle_outline
remove_circle_outline
remove_circle_outline
Introduced
May 29, 2025
Considering (House)
January 28, 2026
In House • 2025-2026 Regular Session • Introduced: May 29, 2025
Sponsors: Rob Consalvo (D)
Co-sponsors: John J. Marsi (R), Estela A. Reyes (D), David F. DeCoste (R), Edward R. Philips (D), John F. Keenan (D), Michelle L. Badger (D), Carmine Lawrence Gentile (D), Kathleen R. LaNatra (D), Margaret R. Scarsdale (D), Richard G. Wells (D), Joshua Tarsky (D)
The bill adds new requirements across Massachusetts health insurance and healthcare settings to improve coverage and continuity of access to ostomy care supplies and related fistula management. It inserts new provisions in Chapter 32A (Group Insurance Commission), Chapter 111 (acute-care hospitals), Chapter 112 (physician licensing/clinical prescribing rules), Chapter 118E (Medicaid managed care), and the major commercial insurance statutes (Chs. 175, 176A, 176B, and 176G), with largely parallel requirements.
For insureds under the Group Insurance Commission and for Medicaid managed care and contracted insurers/administrators (Chs. 32A and 118E), the respective commissions/division must provide coverage of all medical supplies for management of surgically created or spontaneous fistulas and supplies related to ostomy care, and may not require “non-medical” supplies as a condition of coverage. Each entity must make publicly available information about its ostomy-supply coverage. The bill also requires transfer of ostomy care information, patient history, and prescriptions to a new insurer within 72 hours when a person obtains new health insurance coverage, and prohibits delaying ostomy supply orders/shipments during the transition period.
Across the physician and pharmacy/supplier workflow, the bill requires that an ostomy-related prescription issued by a licensed physician be valid for at least 1 year without disruption. It allows physicians to prescribe ostomy supplies in quantities exceeding any legal/regulatory/insurance-policy limits when the physician determines it is necessary and expedient for patient care. It prohibits delaying fulfillment based on approval/appeal processes and requires ostomy suppliers to provide 1 month of advanced notice of prescription expiration to both patients and prescribers.
It also limits substitution (“non-medical switching”) of ostomy supply brands/products: suppliers must dispense as written and provide 1 month of advanced notice of intended substitution by mail, with the notice including samples of the proposed substitute for the patient to try; if the substitute fails to meet or exceed the quality of the original and compromises ostomy care, the patient may return to the original product or receive a product that matches the original quality. In addition, healthcare payers must reimburse ostomy supply suppliers at a rate not less than the Medicare reimbursement rate, and the bill requires acute-care hospitals performing ostomy surgery to employ and provide access to certified healthcare professionals specializing in ostomy care, including appropriate outpatient follow-up with such specialists.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill establishes new rules under Massachusetts’ One Care and Senior Care Options (SCO) program requirements for dually eligible individuals, adding a new continuity-of-care and access protection provision to Section 9d of Chapter 118E.
It requires that any dually eligible individual residing in Massachusetts be permitted to receive health care services from any specialist or hospital provider in the Commonwealth that participates in and is enrolled in Medicare or MassHealth, without regard to health plan or provider-network limitations, while subject to the other terms and conditions of the member’s benefit plan. If the health plan has no existing contractual relationship with the specialist or hospital provider, the One Care or SCO plan must reimburse the provider at the Medicare or MassHealth fee-for-service amount for the rendered service, unless the plan and provider already have a contract agreement in place for the covered service or mutually agree to a different reimbursement amount.
The bill also requires primary and ongoing service continuity when a One Care or SCO plan terminates a provider contract that includes services to One Care or SCO members. MassHealth must require the affected plan and provider to allow impacted members to continue receiving services from their primary care provider, specialist provider, or any inpatient or outpatient hospital covered by the terminated contract under the terms of the pre-existing contract for 12 months after the expiration of any continuity-of-care requirements that follow the contractual termination. During that 12-month period, plans must maintain contractual terms and conditions that were in effect before notice of termination was sent, including reimbursement terms, unless the plan and provider mutually agree otherwise.
Finally, the bill prohibits plans and providers from using the continuity provisions to avoid good-faith efforts to negotiate new contractual arrangements.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill creates new Massachusetts requirements to limit “facility fees” and to protect insureds from “surprise billing,” primarily by adding new sections to Chapter 111 (health care provider/facility fee rules), updating a notice-and-billing restriction in Chapter 111 for non-emergency out-of-network services, revising definitions and enforcement/payment rules in Chapter 175H, and adding carrier reimbursement and out-of-network surprise-billing standards in Chapters 176J and 176O.
For facility fees, Chapter 111 is expanded by inserting new Sections 51P and 51Q. Section 51P defines key terms including “campus” (hospital buildings and adjacent areas within specified geographic parameters), “facility fee” (separate hospital/health-system operational charges distinct from professional fees), “hospital,” and “professional fee.” It prohibits a health care provider from charging, billing, or collecting facility fees except for specified settings: services on a hospital’s campus, services at a facility with a licensed hospital emergency department, or emergency services at a licensed satellite emergency facility. It also requires the Department of Public Health to promulgate regulations and provide penalties for noncompliance (fine up to $1,000 per occurrence) and allows the Department to identify services that may reliably be provided safely/effectively outside hospital settings, for which facility fees may not be charged. Section 51Q requires notice to patients when facility fees are charged/billed/collected, including timing rules (e.g., if appointments are scheduled at least 10 days out, notice/explanation must be sent at least 3 days after scheduling by specified methods; otherwise notice must be given on premises or prior to care where practicable). It also requires facility identification as being associated with a hospital and requires posted notice that patients may incur higher liability than at non-hospital facilities. If a location’s status changes such that facility fees become permissible, Section 51Q requires notice to prior patients within a set period and bars charging facility fees until at least 30 days after the required written notice is provided; notices must be filed with the department within set timelines. It further provides that violations constitute an unfair trade practice under Chapter 93A and can be subject to Department-imposed penalties.
The bill also amends existing surprise/out-of-network billing rules. In Chapter 111, it revises Section 228(e) (as appearing in the 2022 Official Edition) by striking the prior subsection (e) and inserting a new version that requires participating status determination and patient notification for non-emergency services: if the provider does not participate in the patient’s health benefit plan and the service is scheduled more than 7 days in advance, written and verbal notice must be given at least 7 days prior; if scheduled less than 7 days in advance, verbal notice must be given at least 2 days prior (or as soon as practicable) with written notice upon the patient’s arrival. If the provider fails to provide required notifications, or if the provider renders unforeseen out-of-network services, the provider may not bill the insured except for applicable copayment/coinsurance/deductible that would apply if the insured received the service from a participating provider. The bill clarifies that this does not remove the provider’s continuing obligations under other subsections of Section 228(b)–(d).
In related insurance enforcement and reimbursement provisions, the bill adds definitions to Chapter 175H: “impermissible facility fee” (a facility fee not charged in accordance with Chapter 111’s new facility fee requirements) and “surprise bill” (bills received by an insured for unforeseen out-of-network services). It replaces Chapter 175H Sections 5 and 6 with updated enforcement language: it authorizes the Attorney General to investigate alleged violations, commence proceedings, and bring civil actions; and it requires notifying relevant licensing authorities when violations are determined, allowing those authorities to impose penalties. The bill also inserts a new civil-liability rule in Section 6 that holds knowing fraudulent claim submitters/recipients liable for full benefits/payments plus attorneys’ fees/costs, including investigation costs, with a civil action available in superior court. It adds new Section 6A prohibiting forwarding of a “surprise bill” to a person covered by an insured health plan, imposing penalties and attorneys’ fees/costs and authorizing civil actions.
Finally, the bill updates carrier reimbursement and surprise-billing standards. In Chapter 176J, it adds Section 18 requiring carriers to reimburse evaluation and management services delivered by specified off-campus hospital outpatient departments/clinics/ambulatory surgical centers/stand-alone emergency departments and certain ambulatory services (including lab tests, imaging/diagnostics, and identified clinician-administered drugs) at an equivalent rate to the Medicare physician fee schedule non-facility rate applicable to physician offices. In Chapter 176O, it adds Section 31 establishing “unforeseen out-of-network service” categories (emergency and defined non-emergency scenarios, including services rendered by specific specialty types, cases without advanced knowledge, no in-network provider available at the facility, referred-out situations such as off-network laboratory/radiologist/pathologist, and unforeseen services that must necessarily be rendered by an out-of-network provider; plus ambulance services). It limits insured cost-sharing to in-plan applicable coinsurance/copayment/deductible/out-of-pocket amounts as if rendered by a participating provider, and requires the carrier to reimburse the out-of-network provider at the carrier’s median contracted rate for the service in the geographic region/market, treating that payment as payment-in-full and prohibiting additional billing to the insured except for applicable in-network cost sharing. For certain self-funded plans under ERISA, coverage under the section applies only if the plan elects in the manner prescribed (annual notice to the division and plan-document amendments). Section 31 also includes coverage/charge limits tied to legal and plan terms and an insured-consent opportunity concept for nonemergency services, including possible reliance on a signed consent waiver; the commissioner must promulgate regulations to implement the section.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill establishes uniform, clinician-determined “medical necessity” standards for specific mental health services across multiple Massachusetts health coverage regimes. It creates new definitions for “Mental health acute treatment,” “Mental health crisis stabilization services,” “Community-based acute treatment (CBAT),” and “Intensive community-based acute treatment (ICBAT)” within each cited insurance/health chapter, and ties service coverage to (1) no preauthorization requirement and (2) a specified outer limit on covered durations (14 days for crisis stabilization; 21 days for CBAT; 14 days for ICBAT), with utilization review permitted to begin on defined day thresholds.
In Massachusetts Chapter 32A (group insurance commission coverage), it inserts a new Section 17AA after existing Section 17Z defining the terms above and requiring the commission to provide coverage for medically necessary mental health acute treatment without requiring preauthorization; medical necessity must be determined by the treating clinician in consultation with the patient and recorded in the patient’s medical record. For medically necessary crisis stabilization services, CBAT, and ICBAT, it requires coverage up to 14/21/14 days respectively without preauthorization, but requires facilities to notify the carrier of admission and provide the initial treatment plan within 48 hours, and allows utilization review to be initiated on day 7 (crisis stabilization), day 10 (CBAT), and day 7 (ICBAT).
In parallel provisions, it amends Chapter 118E (MassHealth managed care/Medicaid managed care plan context), Chapter 175 (insurers and employers’ health/welfare funds subject to specified insurance policy types), Chapter 176A (hospital service plans), Chapter 176B (medical service agreements), and Chapter 176G (health maintenance contracts) by inserting substantially similar new sections that (a) define the same set of mental health service categories and (b) mandate coverage for medically necessary mental health acute treatment and the three step-down/alternative service categories without preauthorization. Each regime repeats the same operational rules: clinician-and-patient determination of medical necessity with documentation in the medical record; crisis stabilization coverage up to 14 days with 48-hour admission/initial plan notice and utilization review beginning on day 7; CBAT coverage up to 21 days with utilization review beginning on day 10; and ICBAT coverage up to 14 days with utilization review beginning on day 7.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill establishes expanded insurance coverage requirements for “medically necessary mental health services” across multiple payer types (state group insurance under G.L. c. 32A; Medicaid managed care and related arrangements under G.L. c. 118E; commercial insurance products under G.L. c. 175, 176A, 176B, and 176G). In each amended provision, carriers and contracted entities must cover specified mental health services delivered in enumerated settings (including inpatient psychiatric facilities, community health/behavioral/mental health centers, hospital outpatient departments, outpatient substance use disorder providers, community-based acute treatment and intensive community-based acute treatment, crisis stabilization services, and youth crisis stabilization services) without requiring preauthorization; if a patient is admitted, facilities must notify the carrier within three business days (and services provided prior to notification must be covered), with notification limited to patient name, facility name, time of admission, diagnosis, and the initial treatment plan. Medical necessity is determined by the treating clinician in consultation with the patient and is recorded in the member/patient medical record.
It amends the Massachusetts mental health provider framework by (1) revising who qualifies as a “licensed mental health professional” in multiple statutes (G.L. c. 111 and parallel definitions in G.L. c. 175, 176A, 176B, 176G), broadening the enumerated categories and explicitly including additional licensed clinicians and supervised post-master’s clinical behavioral health trainees pursuing licensure under supervision; and (2) adjusting the definition of “Emergency services programs” under G.L. c. 175 to more clearly cover contracted acute-care hospital and community-based emergency behavioral health services, including specified 24/7 crisis assessment/intervention/stabilization delivered through mobile crisis intervention and adult/youth community crisis stabilization services. It also exempts certain Mental Illness (MIH) programs focused on behavioral health services from application and registration fees under G.L. c. 111O.
The bill also modifies facility planning and funding triggers for acute psychiatric services by inserting a new basis under G.L. c. 111 (s. 25C ½) that authorizes a health facility to make capital expenditures for development of acute psychiatric services (inpatient, community-based acute treatment, intensive community-based acute treatment, partial hospitalization programs, and crisis stabilization services) if the facility demonstrates a need for a Department of Mental Health license under the referenced chapter-19 provision.
Finally, it makes changes to Massachusetts civil commitment and restraints law in G.L. c. 123: it replaces the hospital application/admission restraint process sections (s. 12, s. 21, and s. 22) with updated text governing 3-day hospitalization applications, admission authority, required notices (including committee for public counsel services), emergency transport restraint limits, stricter rules on when restraint and seclusion may occur (including time limits, examination requirements, documentation/reporting, and review procedures for minors), and civil immunity for specified actors when acting in accordance with the chapter. It also requires prompt insurance reimbursement-related regulations: the Division of Insurance, in consultation with the Division of Medical Assistance, must promulgate regulations or guidance within 30 days to require carriers to reimburse acute care hospitals for emergency behavioral health services (including via telemedicine/electronic/telephonic consultation) at contractual rates no less than the prevailing MassHealth rate for behavioral health emergency department crisis evaluations, while stating additional reimbursement obligations for other emergency department-related medically necessary services and for inpatient placement delays; these behavioral health services are deemed medically necessary and cannot require prior authorization.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The order authorizes the Massachusetts Senate committee on Health Care Financing to conduct an investigation and study of numerous pending Senate documents numbered 111, 154, 168, 465, 472, 622, 679, 683, 692, 694, 695, 696, 698, 709, 712, 715, 716, 718, 724, 726, 728, 742, 756, 758, 759, 774, 776, 777, 778, 791, 792, 796, 798, 802, 805, 806, 809, 814, 818, 822, 823, 824, 827, 832, 839, 840, 841, 844, 845, 846, 847, 848, 849, 852, 853, 856, 859, 860, 861, 863, 864, 865, 871, 873, 874, 877, 878, 879, 880, 881, 883, 884, 885, 886, 888, 890, 891, 892, 893, 894, 896, 897, 898, 899, 902, 903, 905, 906, 907, 908, 910, 911, 912, 913, 914, 915, 916, 917, 1042, 1289, 1362, 1388, 1411, 1418, 1480, 1481, 1488, 1505, 1511, 1514, 1515, 1535, 1538, 1551, 1554, 1554, 1565, 1578, 1582, 1583, 1586, 1601, 1602, 1621, 1791, 1792, 1847, 2587, 2599, and 2600, all described as relating to health care financing matters.
The order directs that the committee “make an investigation and study” of the listed Senate documents and report back through the normal legislative process; the text does not specify substantive policy changes, new regulatory requirements, or amendments to existing statutes.
The accompanying committee referral text (pages 1–6) lists the subject areas covered by the referenced Senate documents (e.g., behavioral health access, Medicaid/health safety net eligibility, health insurance coverage rules, hospital and long-term care issues, workforce and public health initiatives, and health care cost and transparency measures), but the operative action taken in this document is the authorization to study/investigate those proposals collectively.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill establishes statewide requirements that health care payers and certain insurance contracts treat certified registered nurse anesthetists (CRNAs) equivalently to physicians for anesthesia-related participation, coverage, and reimbursement, when the CRNA is acting within the scope of practice under licensure/certification.
It changes Massachusetts General Laws by adding new CRNA-inclusive nondiscrimination and reimbursement protections across multiple insurance/payer regimes. In Chapter 32A (state health insurance commission), the commission’s coverage cannot distinguish between physicians and CRNAs acting within scope; however, it may vary reimbursement rates using quality/performance measures if those measures are the same for both provider types. For claims, the bill requires submitted payment claims to identify the National Provider Identifier (NPI) of the physician or CRNA who provided the service. The bill also requires that when a CRNA is contracted, the commission must reimburse at an amount not less than the allowed amount it would reimburse for the same service if provided by a contracted physician, and prohibits reducing physician reimbursement to comply.
Similar parallel provisions are added to Chapter 118E (Medicaid-related managed care/ACO/primary care clinician plans and the division and contracted entities), Chapter 175 (accident and sickness insurance with hospital/surgical expense coverage), Chapter 176A (individual and group hospital service plan contracts), Chapter 176B (including related definitions and a new contract reimbursement section), and Chapter 176G (including definitions, a new HMO contract rule, and NPI identification plus reimbursement equivalence and physician non-reduction). The bill also adds provisions to Chapter 176I for preferred provider arrangements, requiring no distinction between physicians and CRNAs (subject to scope of practice), requiring NPI identification on claims, and requiring reimbursement at not less than the allowed amount for the physician-equivalent service without reducing physician reimbursement.
In addition to nondiscrimination/reimbursement terms, the bill makes conforming definition changes in Chapters 176B and 176G to include CRNAs and adds an operational rule stating that where existing law or rules require physician authorization/involvement as a condition of reimbursement or coverage of anesthesia services, that requirement may be satisfied by a CRNA practicing in an advanced role under the referenced nursing authorization statute. Finally, it directs the commissioner of insurance to promulgate rules and regulations to implement and enforce the act.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill creates a new statutory requirement in Massachusetts for certain health insurance carriers to reimburse health care providers for specified, uncollected patient cost-share amounts (co-payments, co-insurance, and deductibles) that become unpaid after the provider undertakes “reasonable collection efforts.” A carrier must reimburse a provider not less than 65% of each qualifying unpaid co-pay/co-insurance/deductible amount under the insured’s health benefit plan.
The statute defines key terms (co-payment as a fixed dollar amount; co-insurance as a percentage of the allowed amount after any co-payment; deductible as a specific dollar amount owed before the carrier’s obligation attaches, excluding premiums). It treats each qualifying unpaid co-pay/co-insurance/deductible amount as an “uncollectible bad debt,” but allows providers to request reimbursement only if multiple conditions are met, including that the amount is from an unpaid co-payment/co-insurance/deductible under the health benefit plan; each claim reflects a unique covered service per insured; each claim is at least $250; and the provider documents genuine, continuous attempts to contact the member and that the claim has remained partially or fully unpaid and not on an ongoing payment plan for more than 120 days from the first bill mailed (with documentation including dates and methods of contact). Providers must submit an aggregate annual request by May 1 for the prior calendar year with specified documentation (including insured identifiers, date of service, unpaid amount, amounts collected, and contact details), and the carrier may audit eligibility/coverage and reasonableness of efforts.
Carrier payment and dispute timing are also established: the carrier must complete any audit and notify the provider of disputes within 120 days of receipt; the carrier must pay 65% of undisputed amounts within 120 days. Amounts the provider collects after reimbursement must be recorded and reported as an offset to future submissions to that carrier. The bill also states that no carrier may prevent a provider from collecting any co-pay/co-insurance/deductible amount at the time of service.
The bill directs the Division (state insurance regulator) to promulgate regulations within 90 days of the act’s effective date consistent with federal Centers for Medicare & Medicaid Services rules on “reasonable collection efforts” for bad debt. If the division does not issue regulations, the reimbursement provisions are to operate using the CMS process documented in the most recent Medicare Provider Reimbursement Manual (CMS Pub. 15-1 and 15-2 (HIM-15)) applicable within 90 days of enactment. The division must require each carrier to submit an annual public report on the total number and amounts of reimbursed and denied uncollected co-payments/co-insurance/deductibles, and the report must be posted on the division’s website.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill establishes requirements across multiple Massachusetts health insurance and health plan structures that certified registered nurse anesthetists (CRNAs) be treated equivalently to physicians for purposes of participation, coverage, and payment when the CRNA is acting within the scope of practice under licensure/certification. It also requires that payment claims identify the National Provider Identifier (NPI) of the physician or CRNA who provided the service.
It amends Chapter 32A to add new Section 34 prohibiting the Commonwealth’s insurance commission from distinguishing between physicians licensed under Chapter 112 and CRNAs authorized under Chapter 112, Section 80B for participation/coverage/payment, while allowing varying reimbursement rates only if they rely on quality/performance measures that are the same for both provider types. It further requires that the commission reimburse contracted CRNAs at not less than the “allowed amount” it would reimburse for the same service when provided by a contracted physician, and bars reducing physician reimbursement to comply with this CRNA parity requirement.
The bill applies the same functional parity framework to Medicaid-managed care (Chapter 118E, added Section 83), and to private insurance arrangements under Chapter 175 (added Section 108O), Chapter 176A (added Section 39), Chapter 176B (adds CRNA-related definitions, removes “certified registered nurse anesthetist or” from Section 4T), adds a CRNA parity/reimbursement section (added Section 26), and amends Chapter 176G to define CRNAs, add CRNA parity/payment rules (added Sections 34 and 35), and clarify that physician authorization/involvement requirements for anesthesia reimbursement/coverage can be satisfied by a CRNA practicing under Section 80B. It also extends CRNA parity to preferred provider contracts and arrangements under Chapter 176I (added Section 14), requiring equivalent participation/coverage/payment treatment, NPI identification on claims, and not-less-than reimbursement with no physician pay reduction to achieve compliance.
bill
Legislation • 🇺🇸 United States • Massachusetts • Bill
The bill amends Massachusetts General Laws Chapter 118E, Section 9d by adding a new paragraph (r) (page 2) establishing that dually eligible individuals residing in Massachusetts may receive health care services from any specialist or hospital provider in the Commonwealth that participates in and is enrolled in Medicare or MassHealth, regardless of health plan or provider-network limitations, and subject to the other terms and conditions of the member’s benefit plan.
The new paragraph (r) (page 2) also provides a reimbursement rule when no existing contractual relationship exists between the health plan and the specialist or hospital provider: the provider must be reimbursed by the One Care or SCO plan at the Medicare or MassHealth fee-for-service amount for the services rendered, unless the plan and provider already have a contract agreement for the covered service or mutually agree to a different reimbursement amount.
The bill further amends Section 9d by adding paragraph (l) (page 3) requiring MassHealth to impose continuity-of-care protections on One Care and SCO plans and providers that terminate contracts covering services for One Care or SCO members. If a plan or provider terminates such a contract, affected members must be allowed to continue receiving their primary care, specialist, and inpatient or outpatient hospital services under the terms of the provider’s pre-existing contract for twelve months after the expiration of any continuity-of-care requirements that may follow the contractual termination.
During the twelve-month continuation period (page 3), plans are required to maintain all contractual terms and conditions that were in effect prior to the notice of termination being sent—including reimbursement—unless the plan and provider mutually agree to different terms. Plans and providers are prohibited from using the continuity provision to avoid good-faith efforts to negotiate new contractual arrangements (page 3).
The bill amends Michigan’s no-fault auto insurance personal protection insurance (PIP) selection framework in MCL 500.3107c (as added by 2019 PA 22) by adjusting terms and adding an insurer offering requirement tied to attendant care coverage.
For coverage selection under MCL 500.3107c, the bill revises certain cross-references in the operative language (including references to the security required under MCL 500.3101) while maintaining the structure that allows an applicant/named insured to select among coverage limits for benefits under MCL 500.3107(1)(a). It preserves the existing option set ($50,000; $250,000; $500,000; or no limit) and the special eligibility conditions for the $50,000 option that require the applicant/named insured to be enrolled in Medicaid and that the spouse/household relative either has qualified health coverage, is enrolled in Medicaid, or has coverage for PIP benefits under MCL 500.3107(1)(a).
The bill also expands insurer obligations for certain policies: for any policy providing the required no-fault security in MCL 500.3101(1)–(which corresponds to the bill’s revised cross-references) where a limit under MCL 500.3107c(1)(a) to (c) applies, the insurer must offer a rider providing attendant care coverage in excess of the applicable selected limit. It further aligns/clarifies definitions used for transportation network company (TNC) coverage by changing the definition of “Transportation network company vehicle” and ensuring the associated defined terms reflect the relevant statute cross-references.
The amendatory act is conditional on enactment of either Senate Bill No. __ (request S01782’25) or House Bill No. 5298 (request H01782’25) of the 103rd Legislature; it does not take effect unless one of those bills is enacted.
The bill adds a new section (Sec. 106c) to Michigan’s Social Welfare Act requiring the Department to publicly report Medicaid performance metrics.
Beginning October 1, 2026, the Department must annually report (1) the “medical assistance error rate” and (2) the “improper payment rate” on its website and submit those rates to the standing committees of the House of Representatives and Senate on oversight.
The new section defines “error rate” as the total of specified categories of payments, including (i) payments under Michigan’s Medicaid plan made on behalf of ineligible individuals or families; (ii) overpayments to behalf of eligible individuals arising from errors in determining required medical-care expenditures for eligibility or where insufficient information exists to confirm eligibility; and (iii) payments for items/services furnished to individuals not eligible under the Medicaid plan or a waiver, or where insufficient information is available to confirm eligibility.
The bill defines “improper payment” by reference to the federal definition in 31 USC 3351.
The bill establishes a “hospital cost review board” within Michigan’s Department of Licensing and Regulatory Affairs and creates a framework for annual hospital cost and pricing oversight. It defines key terms (including “nonprofit hospital,” “qualified hospital,” “Consumer Price Index,” and exemptions and third-party payers) and provides for board appointment and governance (5 members appointed from lists submitted by legislative leaders; quarterly meetings; quorum of 3; open meetings compliance; confidential business information protections for information whose release could harm hospitals).
Starting January 1, 2027, nonprofit hospitals must annually submit extensive budget and cost data to the board, including financial statements (expenditures, operating costs, revenues, assets, liabilities), scope/volume/utilization information, Medicare cost report material, and estimates of property tax, sales and use tax, and income tax exemptions received; methodology for those estimates; number of beds (and beds by prosperity region); and information about other health facilities owned/operated/governed. Hospitals must also submit an audited financial statement within 30 days after it is finalized. The board must analyze submitted information and hold meetings with each nonprofit hospital to review budgets, consider publicly disclosed executive/clinical compensation, and provide a public opportunity for comment; it may issue written recommendations to the legislature about reducing nonprofit hospital spending while maintaining quality and financial obligations.
The bill regulates nonprofit hospital price increases and certain patient charges. For price increases applied to third-party payers and other contracted payers, hospitals must justify increases by demonstrating that increases are directly caused by increased costs, with a cap that the total price increase for all health services may not exceed the rate of inflation (defined using the annual percentage change in the Consumer Price Index for the preceding year), and an exception for “qualified third-party payer.” If the board believes a violation exists, it must notify the hospital, attempt informal correction, and—if unresolved—conduct a contested-case hearing; if a violation is found, the board must order an assessment equal to the estimated tax exemptions received by the hospital as reported to the board. Separately, nonprofit hospitals must reduce total prices for covered health services by 10% within 14 days of the act’s effective date (with documentation due within 120 days), subject to an exception for qualified third-party payers. For patient charges, if a third-party payer is not paying (in whole or part), hospitals may not charge more than 150% of the amount Medicare would pay; if a third-party payer is paying (in whole or part), hospitals may not charge more than 200% of the Medicare amount, except where no Medicare payment information exists for the service.
The bill creates a “health care cost grant program” administered by the board to award grants to “qualified hospitals” experiencing unsustainable losses, defined as negative operating profit margin of at least 3% for at least three consecutive years and without clear recovery signs (investment income losses excluded from the margin calculation). The board must prioritize grant awards based on patient volume, service uniqueness/access barriers if the hospital closes, size/duration of losses, likelihood grants could prevent closure, and likelihood of returning to sustainable operations without a grant. Grant recipients must agree not to transfer the award, to enter a performance improvement agreement, and to provide information about the grant’s impact on operating losses. The department deposits assessments into a “health care cost reduction fund,” and the board must submit an annual report by April 1 (with required elements such as grant details, violation counts, price increases and justifications, and bed market share by region) that the department posts online. Implementation requires promulgation of rules, including a submission schedule and uniform criteria; the act’s effectiveness is conditioned on enactment of two companion bills (House Bills 6117 and 6118).
The bill makes changes to Michigan’s Medicaid (medical assistance) governance and managed-care requirements by adding new statutory sections 111o, 111p, and 111q and revising existing sections 105d, 109, 111i, and 111j within the Social Welfare Act.
Section 105d is revised to expand and operationalize managed care for certain Medicaid beneficiaries eligible under title XIX citizenship provisions, including requirements to enroll eligible individuals into contracted health plans, give enrollees plan choice, ensure access to primary care and preventive services (including initial appointment within 60 days), protect enrollee privacy under HIPAA, and set cost-sharing as approved by HHS. The department is required to implement high-value/low-value service incentives, develop fraud/abuse detection incentives with an annual legislative report, allow telemedicine across state of patient location, and implement a pharmaceutical benefit emphasizing high-value low-cost prescriptions (e.g., generics and 90-day supplies). The bill also requires a framework of enrollee/provider incentives tied to improved health outcomes and healthy behaviors/screenings, establishes performance bonus targets (3–5 objectives) set by the department, requires actuarial soundness of capitation payments, withholds at least 0.75% of payments (excluding specialty prepaid health plans) to expand the performance bonus pool contingent on compliance metrics, and permits performance measurement standards relating to substance use disorder care and reduction. It further requires the department to make at least three years of state medical assistance data available without charge to qualified vendors for proposals, limits definitions (“legislature” and telemedicine), and adds a specific policy in connection with a new section (effective on the amendatory act adding section 111o): automatic disenrollment of individuals in skilled nursing facilities enrolled under the Michigan Coordinated Health Plan after 45 days of care, with automatic re-enrollment into fee-for-service.
Section 109 is revised to add Medicaid benefit-payment and information requirements. It includes additional detailed service coverage language and adds/clarifies that certain services must include specific clinical reporting (e.g., creatinine tests must include eGFR as a percentage). It also requires public notice and legislative committee approval if statewide reimbursement methodology/levels are changed and are expected to change payments by at least 1% in the following 12 months. The section also adds managed-care organization enrollment-time notice requirements to enrolled individuals (provider identity/availability and qualifications; rights/responsibilities; grievance/appeal procedures; and covered items/services) and updates certain cross-references.
The bill substantially revises managed-care claims processing and utilization management. Section 111i establishes or updates a timely claims processing and payment procedure for Medicaid contracted plans/qualified health plans, including defining “clean claim,” requiring standardized coding and electronic transmission, imposing billing deadlines (within one year of service), requiring non-resubmission rules, and setting adjudication/payment timelines (generally 45 days for clean claims, with a specific rule for pharmaceutical clean claims referenced to the “industry standard” as of June 20, 2000, and 12% simple interest for late payment). It also creates structured rules for notifying defects (30 days), correcting defects (30 days), paying after correction (30 days), and an external review process for adverse determinations, including assignment of an independent review organization, written recommendations, decision timing (with principal reasons within specified days), and immediate payment/interest upon reversal; additionally it requires penalties and licensing-entity notification systems. The bill adds a future performance requirement beginning January 1, 2027 that Medicaid managed care organizations adjudicate 99% of clean claims within 14 calendar days and 100% within 30 calendar days for covered services rendered in skilled nursing facilities, with 12% interest for claims not paid within 14 days.
Section 111j is revised to set prior authorization decision timing for Medicaid director requirements (approval/rejection timelines; additional-information requests; exceptions for transplantation/extraordinary services; and limits on prior authorization for routine/ordinary medical services/equipment and certain supplies). The bill adds section 111o requiring Medicaid managed care organizations to provide standard prior authorization decisions for nursing facilities within 7 calendar days and expedited decisions within 72 hours, to provide specific information about prior authorization denials, and to treat requests not decided within required timeframes as approved. Beginning no later than January 1, 2027, section 111o requires quarterly reporting to the department of detailed prior authorization, concurrent review, and postservice denial/activity metrics for skilled nursing facilities, disaggregated by provider type, with department publication on a website in searchable/downloadable quarterly format protecting personal information/trade secrets. It also requires the department to publish a consumer-facing summary for each managed care organization including denial rates, overturned-denial appeal percentages, postservice denial percentages, decision timeliness, and relevant compliance/corrective action plans.
The bill adds sections 111p and 111q. Section 111p requires Medicaid managed care organizations to ensure nursing facilities and long-term supports and services providers are paid no less than the current Medicaid fee-for-service rate, and adds provider network contracting/participation protections: an MCO must be ready and willing to contract with qualified providers that meet defined requirements; it may terminate/refuse renewal only with notice and an opportunity to cure (immediate termination allowed for willful breach, fraud, or immediate public health/safety danger); it must establish provider grievance procedures; and it restricts contractual terms that would require providers to prevent patient access, refuse to treat patients when the provider has stopped contracting, or renegotiate reimbursement in ways prohibited by the section. It also requires disclosures of provider reimbursement rates from other payors and prohibits refusal to contract/compensate solely because a provider in good faith communicated with current/former/prospective patients about plan products, and it allows contracting providers to advocate for patients without termination/penalty solely for advocacy; contract application is limited to participation contracts entered into beginning January 1, 2027. Section 111q requires quality assurance supplement payments to be paid monthly and requires Medicaid managed care organizations to be ready and willing to contract under the conditions described above (including licensing, desire to participate, meeting MCO requirements, and practicing within the area served).
Patient-Centered Care program established, direct state payments to health care providers authorized... (View full title on source site)
arrow_upwardHigh Priority
thumb_upSupport
label_outlineAccess to Care
label_outlineSystem Funding
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
February 10, 2025
Failed (House)
February 17, 2026
Failed Sine Die • 2025-2026 Regular Session • Introduced: February 10, 2025
Sponsors: Tina Liebling (DFL-MN), Robert Bierman (DFL), Liz Reyer (DFL), Andrew Smith (DFL), Kristi Pursell (DFL), Peter Fischer (DFL), Kim Hicks (DFL), Luke Frederick (DFL), Bianca Virnig (DFL), Jessica Hanson (DFL), Anquam Mahamoud (DFL), Pete Johnson (DFL), Samantha Vang (DFL), Athena Hollins (DFL), Samantha Sencer-Mura (DFL), Nathan Coulter (DFL), Alicia Kozlowski (DFL), Alexander Falconer (DFL), Larry Kraft (DFL)
The document outlines the establishment of a Patient-Centered Care program in Minnesota, designed to enhance health outcomes and reduce healthcare costs. A key feature of the program is the authorization for direct payments to licensed healthcare providers for services rendered to medical assistance and MinnesotaCare enrollees, focusing on individual providers and clinics rather than hospital systems. Additionally, primary care providers will receive compensation for coordinating care, with provisions for patients to select their care coordinators and additional support for clinics serving populations facing health disparities.
To support vulnerable populations, the program includes funding for community health clinics and county-based purchasers to hire community health workers and deliver outreach and care coordination services. The commissioner of human services, in collaboration with the commissioner of health, is also tasked with developing a payment system that provides per-person care coordination payments to licensed health care homes and community health workers, particularly for individuals requiring intensive care coordination.
The document emphasizes the importance of cost neutrality in implementing care coordination payments, with potential reallocations within the healthcare system if initial savings are insufficient. Furthermore, it highlights the need for federal waivers and approvals to implement various health care initiatives, including the expansion of demonstration projects to include more enrollees from medical assistance and MinnesotaCare, as well as Medicare recipients and privately insured individuals.
Integrated health partnerships may be authorized to provide patient incentives for engaging in preventive health measures, fostering ongoing relationships with primary care providers. Overall, these initiatives are expected to significantly impact the healthcare industry, particularly in areas related to care coordination, community health services, and patient engagement strategies.
The bill establishes a “Patient-Centered Care” program within Minnesota’s medical assistance (Medicaid) and MinnesotaCare system. The commissioner must pay licensed health care providers directly (fee-for-service) for services provided to eligible medical assistance and MinnesotaCare enrollees, and is authorized to use administrative services organizations (ASOs) to process claims, pay bills, and perform specified administrative functions; ASOs may not bear financial risk and may only be paid for those administrative functions. For counties using a county-based purchasing (CBP) system, the commissioner must allow counties to form or join a CBP and must have the CBP serve as the ASO for the county unless the county requests the commissioner take over. In addition to care coordination activities, the commissioner may contract with CBPs, counties, FQHCs, and community-based interdisciplinary teams to provide care coordination services (including patient navigation, eligibility assistance, transportation, interdisciplinary care planning, chronic disease management, specialist consults to primary care, case management for complex needs such as serious mental illness and substance use disorders, discharge planning/transitional care and medical respite, behavioral health integration, and culturally competent outreach), with budgets based on cost of operations and community needs rather than risk-based financial arrangements. The commissioner is also prohibited from renewing managed care plan contracts (and integrated health partnership contracts) for providing services to medical assistance and MinnesotaCare enrollees.
The bill requires (1) direct billing of the state or the CBP by providers, with a prohibition on shifting risk to providers or any other entity; (2) flat care coordination payments for a primary care practice designated by an enrollee as primary care provider, with the primary care provider providing general oversight and coordinating with any case manager; (3) community outreach grant authority for clinics, FQHCs, and CBPs to hire community health workers, nurses, and/or social workers to conduct outreach and deliver care coordination and medical care, including assistance with enrollment; and (4) commissioner duties for enrollees (timely/equitable medically necessary care; recruitment of culturally competent geographically distributed providers; data analytics/utilization monitoring; a hotline and website for provider location; 24/7 nurse consultation helpline; and claims-based outreach to help select a primary care provider after lack of preventive visits). Provider-related duties include recommendations to legislative health finance leadership to ensure fair reimbursement rates, ensuring timely reimbursement, and collaborating with frontline providers to improve quality and reduce costs.
To ensure transparency, all ASO contracts must include compliance with Minnesota public records/data access laws and must prevent private entities from asserting proprietary rights over publicly funded program data. The department must create and maintain a publicly accessible dashboard with de-identified medical assistance and MinnesotaCare data for research/oversight/community engagement, updated quarterly with metrics on usage, trends, and disparities, plus an annual public report. Fraud prevention is strengthened by granting the Office of Inspector General full access to ASO records/data for auditing the patient-centered care program, with the inspector general required to annually report audit results to the legislative auditor. The bill appropriates general fund money (amounts unspecified in the text provided) for: transitioning infrastructure and administrative systems from PMAP to patient-centered care and contracting with ASOs; establishing and maintaining a care coordination fund (including provider outreach, enrollment, and performance monitoring); expanding culturally competent provider recruitment/training/retention; and other implementation needs, plus additional appropriations for care coordination services under the ASO-custodied care coordination provisions and for grants to community health clinics and CBPs for outreach and delivery of care and care coordination services.
Conforming changes in a second article adjust existing Minnesota statutes to align with the new patient-centered care model. These include amendments to care coordination and performance-measure statutes (revising definitions and cross-references, including provisions related to care coordination payment systems, legislative oversight timelines, and care coordination quality-metrics adjustments), and a statutory repeal of prior integrated care/health partnership demonstration authorities under Minnesota Statutes 2024 sections 256B.0753 and 256B.0755. Finally, multiple provisions in the bill specify an effective date of the day after final enactment for the patient-centered care section, with provider direct payments becoming effective when current managed care plan contracts expire on January 1, 2027; other conforming changes take effect upon enactment according to their statutory amendment structure.
The bill establishes definitions and a new prompt-payment obligation tied to very high deductible health plans (VHDHPs) for hospital emergency room and ambulance charges that remain unpaid when an enrollee has not yet met the annual deductible.
Effective August 1, 2026, it amends Minnesota law to define “VHDHP” as a high deductible health plan with an annual maximum out-of-pocket expense exceeding $3,000 for individual coverage or $6,000 for family coverage. It also adds a new statutory subdivision requiring payment of emergency and ambulance charges under specified conditions.
For enrollees in plans meeting the VHDHP definition, and for the health plan company that issues such plans, the new requirement applies when the enrollee incurs charges for hospital emergency room care or ambulance service that are not payable at the time because the annual deductible has not been satisfied. In that situation, the VHDHP must require the health plan company to pay those charges directly to the hospital or ambulance service licensee within 15 days after receiving notice from the licensee that the enrollee has not paid the charges within 30 days after the date of treatment.
The bill permits the health plan company to seek reimbursement from the enrollee for payments it made, but requires the company’s collection procedures to comply with the same restrictions that would apply to the health care provider when collecting from the patient. The added provisions also prohibit the health plan company from canceling, terminating, suspending, nonrenewing, or otherwise limiting or reducing an enrollee’s (or the enrollee’s family’s) coverage as a collection penalty or as a consequence of failure to reimburse the health plan company for these payments, and require the provider/licensee to inform the health plan company in writing of any special collection restrictions applicable to the provider.
The bill establishes Minnesota’s “Patient-Centered Care” program in a new section (Minn. Stat. § 256.9632). The Department of Human Services (the commissioner) must pay health care providers directly (on a fee-for-service basis) for covered medical assistance and MinnesotaCare services for eligible enrollees. The commissioner may contract with administrative services organizations (ASOs) to process claims, pay bills, and perform specified administrative functions, but ASOs must not bear financial risk and must be paid only for contracted administrative functions. The bill allows counties using county-based purchasing to form or join a county-based purchasing arrangement that serves as the ASO for the county unless the county requests the commissioner take over.
The bill requires the program to include care coordination, community outreach, and enumerated commissioner duties for enrollees and providers. Care coordination payments are structured to include flat payments to an enrollee-designated primary care practice, with the primary care provider providing general oversight and coordinating with any case manager; providers bill the state or the county-based purchaser directly, and neither may shift risk to providers or other entities. The bill also authorizes care coordination services delivered by interdisciplinary teams through specified entities (including counties, FQHCs, and community-based programs) with budgets based on cost of operations and community needs rather than risk-based financial arrangements. Community outreach funding is authorized through grants to community health clinics, FQHCs, and community-based programs to employ community health workers, nurses, or social workers for community outreach and care delivery, and to assist individuals with enrollment.
The bill imposes transparency and oversight requirements for ASO activity: ASO contracts must include full compliance with Minnesota public access laws for government records and data, and no private entity may assert proprietary rights over data generated through publicly funded programs. It also requires a publicly accessible, de-identified data dashboard updated quarterly with metrics on usage, trends, and disparities, plus an annual trend report. Fraud prevention is addressed by granting the Department of Human Services Office of Inspector General full access to ASO records/data for auditing and fraud investigation, with an annual report to the legislative auditor. Effective date rules provide that the new patient-centered care section is effective the day after final enactment, while direct provider payments become effective when current managed care plan contracts expire on January 1, 2027.
Conforming changes in Article 2 align existing statutes with the new patient-centered approach: it amends provisions in multiple health-care payment and oversight statutes, including updates to definitions and cross-references and modifications to quality/performance measurement requirements. The bill repeals Minn. Stat. §§ 256B.0753 and 256B.0755. It also amends MinnesotaCare-related definitions (including the definition of “participating entity”) to reflect the new framework, and makes technical or conforming changes to several other statutes (e.g., care coordination, legislative oversight timing/cross-references, and specialty drug prompt filling and other program provisions). Appropriations are provided for transitioning infrastructure/administrative systems, establishing a care coordination fund, expanding provider recruitment/training/retention, funding care coordination services and additional community outreach grants, with amounts left blank in the text provided.
bill
Regulation • 🇺🇸 United States • Minnesota • Regulatory Notice
The document contains a public notice under 42 CFR § 447.205 describing planned Medicaid (Medical Assistance) payment and methodology changes, including (1) physician payment rate methodology updates tied to Medicare’s 2026 resource-based relative value scale values and adjusted conversion factors, and (2) an effective-date affirmation of the all-inclusive rate for residential SUD services furnished by IHS and Tribal health care providers.
Effective February 1, 2026, the Department will implement Medicare resource-based relative value scale calculated values for 2026 and adjust conversion factors for evaluation and management and obstetrics to $26.24, while maintaining the conversion factor for all other physician services at $25.73. The notice states these conversion-factor adjustments are made in response to annual Medicare changes to the 2026 relative values in order to maintain budget neutrality and that the changes have no fiscal impact.
Effective March 1, 2026, the Department will affirm payment of the all-inclusive rate for residential SUD services provided by IHS and Tribal health care providers. The notice explains CMS requested this change because residential services do not align with the federal clinic definition in 42 CFR § 440.90, and it indicates the “proposed language” moves Tribal residential SUD services into the rehabilitative services benefit category (the same category used for non-Tribal SUD services), with state payment at the all-inclusive rate.
No comment deadline or hearing date is stated in the text provided; the notice directs questions/comments to dhs.spa.comments@state.mn.us and provides contact information for additional inquiries.
Mississippi
17
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill creates a new “Mississippi Medicaid Commission” to administer Medicaid and replaces the existing “Division of Medicaid” within the Governor’s Office. It establishes a seven-member commission whose members are appointed by the Governor and Lieutenant Governor (with Senate advice and consent), sets member qualifications and conflicts (members may not be providers or have financial interests in Medicaid providers), creates appointment rules for congressional and Supreme Court districts, provides for a rotating chair and meeting/quorum/removal/per diem rules, and establishes that the commission appoints a full-time executive director (with eligibility criteria excluding recent legislators). The bill also confirms continuing federal-advisory/oversight structures within the Medicaid administration framework, including a Medical Care Advisory Committee, a Drug Use Review Board, and a Pharmacy and Therapeutics Committee, with specified composition, duties, confidentiality safeguards, public meeting requirements, and reporting.
The bill abolishes the “Division of Medicaid” effective with a July 1, 2026 transfer of records, property, contracts, balances of appropriations, and employees to the Medicaid Commission, and replaces references in statutes/rules/documents so that “Division of Medicaid” (or similar terms) means the Medicaid Commission. It also updates numerous existing Medicaid-related code sections to substitute the new Commission for the former administrative entity and to align governance, rulemaking, eligibility administration, fiscal processing, provider payment timelines, administrative hearings, services authorization, state plan amendment handling, provider enforcement, and related program provisions.
Operatively, the bill requires Medicaid eligibility determinations to be performed by the Medicaid Commission, with eligibility redeterminations at least as required by federal law and administrative hearing procedures to protect applicants/recipients (including timing rules, rights to records and representation, continuation of benefits pending appeal under specified notice-window rules, and finality/judicial review). It also transfers responsibility for provider-facing fiscal functions—such as claim receipt/payment timelines and interest for unpaid-but-undisputed claims—to the Commission’s fiscal agent structure. Additionally, it preserves and codifies major Medicaid program mechanisms that must be followed by the Commission, including: managed care restrictions and conditions (e.g., level-of-care guideline consistency; prior authorization/utilization management limitations; prohibited practices like pharmacy lock-ins), a legislative notice/objection process for rate changes and for state plan amendments, and enforcement authority over providers (including investigation, suspension/termination effects on claims, and denial/revocation grounds). The bill further updates hospital supplemental payment financing and assessments under the Medicaid program, including nursing facility and psychiatric residential treatment facility assessments, and revises detailed hospital assessment mechanics and related DSH/UPL supplemental payment timing and conditions.
Effective July 1, 2026, the bill takes effect and is in force from and after that date.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill amends Mississippi Code § 43-13-117 to require an increased Medicaid reimbursement rate for certain hospitals’ inpatient and outpatient services when specific geographic and staffing conditions are met. The increased rate must be set at not less than 80% of the applicable Medicare reimbursement rate for the same services.
The higher reimbursement applies to hospitals located in counties that (1) had an average monthly unemployment rate of at least 8% for the 12 months of the previous state fiscal year (as determined by the U.S. Bureau of Labor Statistics) and (2) have a critical shortage of physicians and nurses (as determined by a specified committee made up of representatives from the Mississippi Hospital Association, Mississippi Nurses Association, and Mississippi Primary Care Association, and the Chairs of the House and Senate Medicaid Committees). The Division of Medicaid must implement the increased inpatient reimbursement rate no later than September 1, 2026; the rate must be adjusted each year thereafter not later than September 1, with each year’s rate remaining in effect until the next adjustment.
For outpatient hospital services, the bill’s amendment section includes the existing outpatient framework and authorizes the Division to cover outpatient services (including emergency services and other medically necessary outpatient hospital services), while also incorporating the same increased-rate concept for qualifying counties. Separately, the bill includes standard Medicaid rate-change governance provisions within § 43-13-117 (notice, objection, and review procedures) and maintains existing managed care constraints; no additional managed-care-specific requirements are added in the provided text beyond those already in the statute.
The act takes effect July 1, 2026.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill establishes the “Small Community Hospital Pilot Program” and defines “small community hospital” as a hospital in counties without a municipality above 15,000 (based on the 2020 census) and without any municipality portion above 15,000, or located within the Delta Public Health Region designated by the Mississippi State Department of Health as of January 1, 2026. It excludes federally designated Rural Emergency Hospitals. For qualifying small community hospitals, the State Health Officer must license geriatric psychiatric units, limited to the main campus as of January 1, 2026 and a five-mile radius around that campus.
Each small community hospital receives certificate-of-need (CON) exemptions for qualifying activities that would otherwise require a CON. Hospitals in the “no municipality over 15,000” category receive one exemption; hospitals in the Delta Public Health Region category receive two exemptions. Each exemption is limited to the main campus as of January 1, 2026 and a five-mile radius, does not extend to off-campus clinics or other facilities, and does not apply to services covered by general CON moratoriums. Exemptions also do not apply to CON applications that would place the exempted licensed hospital within 35 miles of another licensed hospital or that would otherwise jeopardize a federal Critical Access Hospital designation. A special pathway allows the State Health Officer to license end-stage renal disease (ESRD) facilities for no more than eight small community hospitals statewide (no more than two ESRD facilities within each of the four public health regions as of January 1, 2026); ESRD licenses count toward a hospital’s exemption allotment, and if an ESRD license is not granted the hospital may use its exemption for another service. Exemptions/licenses are non-transferable (except through transfer of the hospital), expire if not applied for by June 30, 2027, and the State Health Officer’s licensing decision is final and not subject to judicial review. A limited reconsideration process is provided: challenges must be filed within seven calendar days, followed by an informal hearing within 14–21 days with no discovery; the final licensing decision after such process remains non-reviewable.
The bill directs the Mississippi State Department of Health, in conjunction with the Division of Medicaid, to biennially review Medicaid-relevant capacity/utilization data, Medicaid expenditure trends, evidence of excess capacity or unmet need, five-year fiscal projections under continuation and removal scenarios, and state fiscal exposure related to health care. It requires a final joint report to the Legislature before December 1, 2026 and on December 1 of each second year thereafter. Legislative findings are set regarding moratorium rationale for specific service categories (skilled nursing facilities, intermediate care facilities, ICF-IID, and home health agencies).
It amends CON law in two ways. First, it amends Section 41-7-191 to exempt any activity conducted or undertaken in Issaquena County or Humphreys County that would otherwise require a CON, while specifying that certain subsections still apply to activities in those counties; the exemption does not apply if it would establish a licensed hospital within 35 miles of another licensed hospital or if it would jeopardize a Critical Access Hospital designation. Second, it amends Section 41-7-201 to require, beginning July 1, 2026, parties aggrieved by a final agency order approving a CON (and exercising the statutory right of appeal, including further appeal to the Supreme Court) to reimburse the successful applicant for all reasonable attorney, consultant, and other fees related to the appeal if the final order is not vacated or set aside by the chancery court or the Mississippi Supreme Court. The bill takes effect upon passage.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill revises Mississippi Medicaid reimbursement for durable medical equipment (DME). It amends Section 43-13-117 to change how Medicaid calculates reimbursement for the purchase of new DME: reimbursement for new equipment becomes the lesser of the provider’s usual and customary charge or a statewide uniform fee schedule updated annually and effective for services provided on or after January 1, calculated using 100% of the Medicare DMEPOS Rural Fee Schedule in effect on January 1 of each year.
The bill also amends the DME reimbursement framework for hospital disproportionate share and related supplemental payment provisions by adding/adjusting a subsection that links additional reimbursement eligibility and related requirements to the Medicaid state plan amendment process as defined in Section 43-13-145(10), and by clarifying that any DME payment changes are tied to specific Medicaid state plan amendment(s).
Effective July 1, 2026, the amended Section 43-13-117 applies. The rest of Section 43-13-117 remains as codified, including the existing Medicaid service categories and the broader Medicaid managed care and payment governance provisions set out in the same section.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill establishes an increased Medicaid reimbursement rate for eligible hospitals’ inpatient and outpatient services. For inpatient hospital services, the Division of Medicaid must reimburse at a rate that is not less than 80% of the Medicare reimbursement rate for the same services for hospitals located in counties meeting two conditions: (1) an average monthly unemployment rate of at least 8% for the 12 months of the previous state fiscal year (as determined by the U.S. Bureau of Labor Statistics), and (2) a critical shortage of physicians and nurses (as determined by a committee with representatives from the Mississippi Hospital Association, the Mississippi Nurses Association, and the Mississippi Primary Care Association, plus the Chairs of the House and Senate Medicaid Committees). For outpatient hospital services, the Division must provide a similar increased reimbursement rate (not less than 80% of Medicare) for hospitals that meet the same criteria used for the inpatient increased-rate eligibility.
The Division must implement the increased reimbursement rate for inpatient services no later than September 1, 2026, and then adjust it each year no later than September 1; the rate set for each year remains in effect until the next annual adjustment. The bill also ties outpatient reimbursement to the same eligibility criteria used for inpatient services, with outpatient services included as part of the increased-rate requirement.
The bill amends Section 43-13-117 of the Mississippi Code of 1972 to reflect these requirements within the Medicaid “types of care and services” reimbursement framework. It takes effect July 1, 2026, and applies for the reimbursement changes described above.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill revises Mississippi’s Medicaid eligibility and covered benefits to align with the ACA eligibility and benefit structure for newly covered individuals. It amends Section 43-13-115 of the Mississippi Code to reframe the ACA-based eligibility category (existing text references this category starting July 1, 2026) so that eligible individuals under the ACA framework are limited to receiving “essential health benefits,” and it maintains a repeal date for that ACA category (December 31, 2028).
In Section 43-13-115, the added/edited operative eligibility category is paragraph (29), which specifies that beginning July 1, 2026, individuals under age 65 who are not pregnant, not entitled to and not enrolled in Part A (and not enrolled in Part B) and not covered elsewhere in the Medicaid eligibility list, and whose income does not exceed 133% of the Federal Poverty Level for the applicable family size, are eligible. The eligibility determination is by the Division of Medicaid, and the services are restricted to essential health benefits as described in the ACA. The paragraph is set to stand repealed on December 31, 2028.
The bill amends Section 43-13-117 to add an explicit Medicaid covered-benefits provision for this ACA eligibility group. Specifically, it amends Section 43-13-117(A) by adding paragraph (62) requiring that, beginning July 1, 2026, essential health benefits under the ACA (for individuals eligible under Section 43-13-115(29)) be covered only while the Medicaid federal matching percentage for this population is not less than 90%. Paragraph (62) is also set to stand repealed on December 31, 2028.
The act takes effect July 1, 2026 and is enacted for the related purposes described in the bill’s scope (Medicaid eligibility and essential health benefits coverage for ACA-entitled individuals).
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill requires the Mississippi Division of Medicaid to collect and report additional data for any Medicaid expansion program enacted by the Legislature, specifically adding information related to mandatory Medicaid work reporting requirements beyond what federal law requires.
It requires the Division of Medicaid to record and provide, for study purposes upon request, the specific reason(s) for terminations of Medicaid benefits to the expansion coverage group, in addition to the same information required under federal law. It also mandates that the Division, in conjunction with the Board of Trustees of State Institutions of Higher Learning (IHL), conduct an implementation and impact study of any enacted Medicaid expansion program and its work reporting requirements.
The study must select subgroups reflecting important characteristics of the coverage group (including residence type, English proficiency, education/literacy, work experience, household composition, teen parentage, and parents’ status around age 18), and assemble statistically valid samples of cases entering the program and work reporting requirements at least six months after implementation and before July 1, 2027. The study must continue until July 1, 2032, with interim study findings reported to the House and Senate Medicaid Committees and the Governor starting March 1, 2028 (and annually thereafter, per the text), and final findings due by August 1, 2032; reports must be available to the public upon request.
The bill directs that, by November 1, 2032, the Division (with an advisory panel) design the study and identify factors to study, including demographic breakdowns such as race, gender, and number of children at the beginning of Medicaid services. It sets subject eligibility criteria (ages 19–64, income up to 138% of the federal poverty level, received Medicaid in the past year and were subject to new work requirements, and either lost eligibility in the past six months due to work requirement rules or regained coverage by reporting work activities or receiving employment assistance). It requires informed permission and HIPAA privacy protections (using pseudonyms/codes and guaranteeing anonymity while still enabling access to non-identity study data), includes ongoing tracking of subjects as feasible (including potential disenrollment tied to compliance), and requires the evaluation to review outreach/education, training/employment resources, the work reporting system, exemptions, enrollees’ understanding, and implications of coverage loss for health care providers and health plans. The study must also examine impacts on employment and earnings/job tenure/unemployment (including effects of employability/education/training programs and unplanned life events such as illness/injury, transportation issues, evictions, and domestic violence), reasons for benefit/coverage loss (including administrative/noncompliance factors), reenrollment services/programs and job-loss/next-job characteristics, and the link between mandatory work reporting requirements (including the types of work activities) and sanctions/employment/earnings/job tenure/unemployment; it further requires tracking Medicaid benefit utilization patterns (including preventive/sick visits, surgeries, ER visits, and number of cases) and establishing an objective third-party evaluation ideally before, but at least at the start of, any Medicaid work requirements demonstration. The bill provides that the study section repeals January 31, 2033, and takes effect after passage.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill establishes mandatory coverage requirements for biomarker testing under health benefit plans, including Medicaid and the State and School Employees Health Insurance Plan, for tests ordered or renewed on or after July 1, 2026, when the test is supported by medical and scientific evidence for diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee’s disease or condition.
It defines key terms including “biomarker,” “biomarker testing,” and establishes what qualifies as evidence supporting coverage: FDA-approved/cleared labeled indications, FDA-approved drug-related indications and warnings/precautions, CMS National Coverage Determinations/MAC Local Coverage Determinations and related articles, and recommendations/considerations from nationally recognized clinical practice guidelines or consensus statements. It requires coverage in a way that limits disruptions in care, including avoiding the need for multiple biopsies or biospecimen samples, and requires plans/issuers to update and publicly post medical policies and coverage guidelines within defined timelines after enactment; updated/changed policies that impact coverage must be publicly available in advance of their effective date.
For adverse coverage actions, the bill requires specific written justifications for denials tied to the individual for whom the test was ordered. If prior authorization or utilization review is required, entities must approve or deny within existing Medicaid/utilization review timing provisions for nonurgent/urgent requests and must notify the enrollee, provider, and requester. Requests may be submitted by the ordering/treating provider, the laboratory provider, or the enrollee/representative, and patients and prescribing practitioners must have a clear, accessible process to request an exception to a coverage policy or adverse utilization review determination, available on the plan/issuer website. The Department of Insurance is authorized to audit and review compliance, and the requirements apply to all relevant plans/contracts entered into or renewed on or after July 1, 2026.
The bill also amends Mississippi Code provisions to conform to the new biomarker testing coverage rules, specifically adding Medicaid language addressing mandated biomarker testing coverage and requiring the Division of Medicaid to update Medicaid fee schedules to include appropriate CPT and PLA codes for mandated biomarker tests within 60 days after the act’s effective date. It further amends the definitions section of Mississippi’s health insurance utilization review statute by updating the statutory definition of “adverse determination” to align with the act’s broader utilization review and coverage framework. The act takes effect July 1, 2026.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill amends Mississippi Medicaid law to (1) extend interim provider credentialing and payment options in managed care while a credentialing decision is pending, and (2) limit the Division of Medicaid’s ability to suspend reimbursement during the appeal period after a post-hearing violation finding.
First, Section 1 amends Section 43-13-117 to authorize a specific managed-care credentialing workaround: the “direct on-site supervisor” of a provider in a capitated managed care organization (or similar managed-care contractor under Medicaid) may sign off on the provider’s work while credentialing is pending. This is allowed only if the provider has begun the credentialing process and has not previously been denied credentialing. The bill also provides that the provider may receive reimbursement from the organization for work that the supervisor has signed off on during the period awaiting a credentialing decision.
Second, Section 2 amends Section 43-13-121 to restrict reimbursement suspension during appeals. When the Division determines after a hearing that a provider violated Medicaid law, the Division may not suspend reimbursement payments during the time the decision is on appeal by the provider. The restriction includes a fraud-based exception: it does not apply if the provider previously has been convicted of fraud in connection with the Medicaid program. A further exception applies when the provider is a company or other entity and certain specified associated individuals (agent, managing employee, or an owner with at least 5% ownership) previously have been convicted of Medicaid fraud.
The bill takes effect July 1, 2026.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill creates a restriction on beneficiary “transfers” within Mississippi’s Medicaid managed care delivery system. It adds a limit on a health maintenance organization, coordinated care organization, provider-sponsored health plan, or other capitated contractor under the Division of Medicaid: such organizations may not transfer a beneficiary enrolled with the organization to another managed care organization or to fee-for-service Medicaid more often than once in a 12-month period.
The transfer limit may be exceeded only when there is a “significant medical reason” for another transfer within the 12 months, and that determination is made by the Division of Medicaid. The prohibition is placed within the managed care program authorization provisions of Mississippi Code Section 43-13-117.
In addition, the bill updates the statute’s operational timeline by setting a new repeal date for the managed care provisions in Section 43-13-117: the section is to stand repealed on July 1, 2028.
The act’s effective date is July 1, 2026.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill establishes requirements for (1) Mississippi Medicaid’s preferred drug list practices regarding nonopioid pain drugs versus opioids and (2) health insurance insurers’ coverage and access plans for pain management alternatives to opioid prescribing, including approval and ongoing education/public access obligations.
For Medicaid, the bill requires that when establishing and maintaining the preferred drug list, the Division of Medicaid ensure that no FDA-approved nonopioid drug for pain treatment/management is disadvantaged or discouraged in preferred drug list coverage relative to any opioid or narcotic drug on the preferred drug list. It specifies examples of impermissible disadvantaging/discouragement, including designating the nonopioid as nonpreferred when opioids are preferred and imposing more restrictive or more extensive utilization controls on the nonopioid (including prior authorization or step therapy) than those applicable to the opioid/narcotic. The requirement applies immediately upon FDA approval of the nonopioid for pain, regardless of whether the Division has reviewed it for preferred drug list inclusion, and also applies to drugs provided under Medicaid contracts with managed care organizations.
For commercial health insurance, the bill requires any health insurance insurer offering a policy or health benefit plan to develop and implement a plan providing adequate coverage and access to a broad spectrum of pain management services that serve as alternatives to opioid prescribing. The plan must include, at minimum, nonopioid medicinal drugs/drug products for pain (along with nonpharmacologic, nonoperative modalities), must align with additional Department of Insurance guidelines, and must be filed with the Department of Insurance for approval. In reviewing the plan, the Department of Insurance must assess compliance with the specific coverage/access requirements and whether insurer policies create unduly preferential coverage/access to opioid drugs.
Operational requirements for insurers include: providing coverage for at least two (2) alternative FDA-approved pain treatment prescription medication options that are not Schedule I, II, or III controlled substances, and at least three (3) alternative nonpharmacologic treatment modalities; prohibiting utilization controls (including prior authorization and step therapy) on clinically appropriate FDA-approved nonopioid pain drugs that are more restrictive or extensive than the least restrictive or extensive controls applicable to any clinically appropriate opioid drug; and requiring annual distribution of educational materials to in-network providers and plan members about the pain management access plan, with plan information made publicly available on the insurer’s website. The bill takes effect July 1, 2026.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill amends Mississippi Code § 47-5-901 to clarify how medical providers must bill for medical services provided to incarcerated persons housed in county jails under the state-custody/counties-holding provisions. It specifically requires that medical providers submit medical claims at the applicable Mississippi Medicaid reimbursement rate (and sets a payment/ceiling rule tied to the Mississippi Medicaid reimbursement rate when there is no negotiated discounted fee schedule).
As part of the reimbursement framework for counties housing state prisoners due to lack of space, the Department of Corrections pays counties for actual food/contract costs (not exceeding $25 per day per offender, subject to existing exceptions) and pays medical service providers either using negotiated fees or, if none exist, in an amount “no greater than” the Mississippi Medicaid reimbursement rate. The bill further specifies that the provider billing limitation applies to all medical care services and to durable and nondurable goods, prescription drugs, and medications, and that counties are not liable for medical costs exceeding the greater of (i) the Mississippi Medicaid reimbursement rate or (ii) the rate/amount provided by the Department.
The act also includes a July 1, 2026 effective date.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill creates a new Mississippi statutory section (codified as Mississippi Code § 43-12-10) that restricts eligibility for SNAP and Medicaid for individuals who are not U.S. citizens or U.S. nationals, and imposes verification, reporting, and data-sharing requirements across state agencies and Medicaid-participating hospitals.
For SNAP, no non–U.S. citizen/national may participate unless the individual meets the federal definitions of an “eligible alien” under 7 U.S.C. § 2015(f) and a “qualified alien” under 8 U.S.C. § 1641(b). For Medicaid, the same restriction applies, using the “eligible alien” definition under 42 U.S.C. § 1396b(v) together with the “qualified alien” definition under 8 U.S.C. § 1641(b). The Department of Human Services and the Division of Medicaid must verify citizenship/eligible alien status during enrollment and eligibility redeterminations using the SAVE system or by requiring acceptable proof (examples listed include certified birth certificates, U.S. passports, and USCIS documentation). If a household member is determined to be unlawfully present, the department/division must submit information to appropriate law enforcement authorities (including DHS). If eligible alien status cannot be verified, the department must provide information to the U.S. Department of Agriculture (for SNAP-related cases), and the division must provide information to the U.S. Department of Health and Human Services (for Medicaid-related cases).
The bill directs how SNAP household income/resources are treated for certain ineligible individuals: the entire income and financial resources of an individual rendered ineligible for SNAP under 7 U.S.C. § 2015(f) are counted in determining the eligibility and benefit allotment of the household. It also sets Medicaid verification rules through a “reasonable opportunity period”: when status cannot be verified through available data sources, the division must provide only a single opportunity period consistent with federal minimum requirements; Medicaid may be provided only on a provisional basis during that period; failure to submit acceptable documentation within the federally required period results in denial or termination (subject to required notice); and no further opportunity period may be granted to applicants previously denied due to failure to verify citizenship/eligible alien status.
For presumptive eligibility and hospital data collection, the bill requires the division to include a citizenship/eligible alien status field on all presumptive eligibility applications and to require hospitals/clinics/other authorized entities to collect and transmit attestations; presumptive eligibility approval requires certification by the applicant that they are a U.S. citizen, U.S. national, or eligible for Medicaid under 42 U.S.C. § 1396b(v). Medicaid-participating hospitals must (1) ask patients or their representatives to indicate whether the patient is a U.S. citizen/lawfully present or not lawfully present, (2) inform the patient at the time of collection that submission will not affect patient care as required by federal law, and (3) submit quarterly reports to the division (within 30 days after each quarter) counting admissions or emergency department visits during the quarter by category: U.S. citizen/lawfully present, not lawfully present, or declined to answer. The division must then submit an annual report by April 1 to the Governor, Senate President, and House Speaker with totals for the prior year and must include additional information on costs of uncompensated care for aliens not lawfully present, the impact on costs/ability to provide services, hospital funding needs, and other related information; the division must also adopt rules governing report formats and hospital request formats for immigration-status information. The act takes effect July 1, 2026.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
Medicaid; expand eligibility to include individuals entitled to benefits under federal Patient Prote... (View full title on source site)
label_outlineExpansion
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
January 19, 2026
Failed (Senate)
February 03, 2026
Failed • 2026 Regular Session • Introduced: January 19, 2026
Sponsors: Derrick T. Simmons (D)
Co-sponsors: David Blount (D), Johnny L. DuPree (D), Sollie B. Norwood (D), Hob Bryan (D), Joseph Thomas (D), Sarita Simmons (D), Kamesha Mumford (D), Reginald Jackson (D), Justin L. Pope (D), Albert Butler (D), Gary Brumfield (D), Hillman Terome Frazier (D), Theresa Gillespie Isom (D), Juan Barnett (D), Rod Hickman (D), Bradford Blackmon (D), Angela Turner-Ford (D)
The bill revises Mississippi Medicaid eligibility and coverage for individuals under the federal Patient Protection and Affordable Care Act (ACA). Beginning July 1, 2026, it adds a new Medicaid eligibility category for certain nonpregnant, non-Medicare-part-A adults under age 65 with incomes up to 133% of the Federal Poverty Level (FPL), limited to receipt of “essential health benefits” as defined under the ACA; this category is repealed on December 31, 2028. In addition, it updates the list of “recipients of Medicaid” under Mississippi Code Section 43-13-115 to include the ACA-related eligibility approach and associated essential health benefits limitation.
To implement the ACA-related coverage described above, the bill amends Medicaid “types of care and services” under Section 43-13-117 by adding a new provision (paragraph (62)) beginning July 1, 2026: essential health benefits for individuals eligible for Medicaid under ACA-related eligibility as described in Section 43-13-115(29). This essential health benefits coverage is available only as long as the Medicaid federal matching percentage for this population is at least 90%, and the paragraph (62) provision is repealed on December 31, 2028.
The bill amends existing Mississippi statutes rather than creating a standalone new program outside the Medicaid framework. The act takes effect July 1, 2026.
bill
Legislation • 🇺🇸 United States • Mississippi • Bill
The bill makes multiple changes to Mississippi Medicaid eligibility, covered services, provider reimbursement, program administration, and rate/State Plan amendment notice procedures, with several updates intended to align with federal requirements and current criteria.
On eligibility (Miss. Code § 43-13-115), it revises technical provisions governing Medicaid recipient categories and updates age/income criteria for women and men of reproductive age so they are eligible under the family planning program (with family planning services limited to those covered under § 43-13-117(13), while preserving eligibility for any other Medicaid benefits the person qualifies for). It also changes foster care eligibility to extend Medicaid coverage for children in foster care until age 26. It eliminates a requirement for the Division of Medicaid to apply to CMS for certain waivers for specified populations (described in the bill’s intro), and it adds/adjusts other federal-conformity items, including technical updates tied to federal compliance.
For Medicaid services and reimbursement (Miss. Code § 43-13-117), it (1) confirms an option for rural hospitals (≤50 licensed beds) regarding outpatient hospital reimbursement under the APC methodology, (2) adjusts nursing facility and intermediate care facility home-leave payment limits to authorize payment for each day absent on home leave up to 21 days/year for nursing facilities and 31 days/year for intermediate care facilities, including specified additional holidays, (3) directs the Division to update the case-mix and fair rental reimbursement systems as necessary to maintain federal-law compliance, (4) authorizes a quality or value-based component in the nursing facility payment system, (5) updates physician/pediatric primary-care reimbursement requirements to establish 100% of Medicare-established rates for certain defined services, (6) authorizes reimbursing ambulatory surgical care at 85% of the Medicare ASC payment system rate in effect July 1 of each year, (7) authorizes alternative models for distribution of inpatient/outpatient hospital medical claims and supplemental payments, (8) authorizes perinatal high-risk management/infant services via contracting with the State Department of Health for eligible beneficiaries who cannot receive services under other programs, (9) authorizes reimbursement for services at certified community behavioral health centers (CCBHCs), and (10) deletes a previously existing outpatient hospital reimbursement provision for eligible beneficiaries under 21 by border-city university-affiliated pediatric teaching hospitals (repealed by operation of law in 2024 per the bill’s intro).
Key administration and related-law changes include: (a) reducing the notice period the Division must provide to Medicaid committee chairmen for proposed rate changes and for proposed State Plan amendments, while allowing expedited legislative notice; (b) authorizing, effective July 1, 2027, ambulance transportation provider reimbursement when providers provide assessment/triage/treatment for eligible Medicaid beneficiaries, with the bill setting reimbursement levels and requiring the Division to consult with the Mississippi Ambulance Alliance in setting the initial approach (within the limits stated); (c) amending Medicaid enterprise-system/fiscal agent contracting authority so existing contracts through June 30, 2026 can be extended for additional periods at the Division’s discretion, and authorizing a two-year contract ending no later than June 30, 2028 for eligibility-system support; (d) revising third-party payer rules in Miss. Code § 43-13-305 so that when a third-party payor requires prior authorization, the payor must accept Division-provided authorization (that the item/service is covered under the state plan) as if it were the payor’s own prior authorization; and (e) prohibiting Medicaid reimbursement/coverage for gender transition procedures under Miss. Code § 43-13-117.7. The bill also changes hospital assessment mechanics and related Medicaid supplemental hospital payment provisions in Miss. Code § 43-13-145 (including a quarterly assessment increase cap and conditions for exceeding it to maximize federal funding), establishes a Medicaid advisory committee and beneficiary advisory council consistent with federal law (including transferring members from the Medical Care Advisory Committee and setting service until July 1, 2029), and updates committee-related processes. The act takes effect July 1, 2026.
bill
Regulation • 🇺🇸 United States • Mississippi • Proposed Notice
The regulation sets and revises Mississippi Medicaid provider-enrollment requirements in Part 200 (General Provider Information), Chapter 4 (Provider Enrollment), including conditions of participation (Rule 4.2), provider-agreement effective dates and termination consequences (Rule 4.4), licensure/certification maintenance (Rule 4.5), procedures for changing tax ID (Rule 4.7), baseline enrollment requirements for all providers (Rule 4.8), and additional requirements for group providers (Rule 4.9).
It establishes that providers must complete enrollment applications/agreements; be appropriately licensed/certified; provide business-transaction documentation within 35 days upon request; comply with ACA provider screening requirements (including denial of enrollment for expired licenses, disciplinary limitations, and certain exclusions); complete Medicaid re-validation at least once every five years; maintain Medicaid service/billing records for at least five years; accept Medicaid reimbursement terms and “payment in full” rules (including limits on beneficiary cost sharing and restrictions on splitting services); take reasonable third-party recovery actions before filing Medicaid claims (with exceptions cross-referenced to Part 306); comply with federal civil-rights requirements; remain eligible given federal exclusion rules administered through DHHS-OIG; verify Medicaid covered services for non-emergency transportation via the NET Broker; and be subject to disenrollment if they have not rendered services as evidenced on claims for one year (with limited exceptions for maintaining access).
It governs enrollment timing by setting an “effective date” framework for provider agreements (Rule 4.4), including: earliest effective dates based on completion/verification of screening; possible retroactivity; special handling for providers subject to CMS/state surveys and for nationally accredited providers; effective dates for out-of-state providers tied to emergency or endangerment scenarios; a prohibition on Medicaid payments before a valid provider agreement effective date; and continued payment for certain state-plan services for up to 30 days after termination (to permit orderly beneficiary transfer). It also requires specified facilities/entities to give written notice within 48 hours and to submit beneficiary rosters and assist with transitions, and it provides for reinstatement after termination if sanctioning entities lift/resolve conditions.
It updates/clarifies specific enrollment compliance mechanics: providers must maintain current licensure and remain ineligible when licenses/permits/certifications (including those of employees upon which eligibility depends) are suspended/revoked/surrendered/expired or limited by disciplinary action; the Division processes license renewals to avoid eligibility gaps if the update is provided within one year and compliance conditions are met; providers must re-enroll if their Medicaid number was closed due to license expiration for more than one year; and speech-language pathology providers and audiologists may satisfy the “in lieu of” licensure/permit requirement only by providing specified ASHA-related or supervised-practicum/credential evidence, with CLIA certificates required as appropriate. Rule 4.7 requires written requests for tax ID changes (effective date, tax ID and type, legal name, and attestation no change of ownership occurred). Rule 4.8 sets detailed “all providers” submission requirements, including direct deposit documentation restrictions (voided check/deposit slip/bank letter; starter checks not acceptable), IRS name/FEIN/SSN consistency, W-9/tax confirmation documentation (including IRS confirmation copies upon request within 60 days), EDI agreement requirements for electronic submissions, civil-rights attestation document availability upon request within 60 days, reporting for non-CHOW information changes (including W-9 and related forms), mandated ownership/control disclosure using a Mississippi Medicaid Provider Disclosure Form (signed by Authorized Official at specified times, including within 35 days after change of ownership), and collaboration-availability attestations for CRNAs/NPs/CNMs/PAs (available within 60 days upon request unless collaboration/supervision is not required). Rule 4.9 adds group-provider requirements: group enrollment must use a business/entity tax ID (not a sole proprietorship), must link at least one active individual provider, and must submit NPI verification and specified IRS “written confirmation” and CLIA documentation when applicable.
bill
Regulation • 🇺🇸 United States • Mississippi • Final Notice
The document contains Mississippi Medicaid provider participation and enrollment rules in Part 200, Chapter 4 (including Rules 4.2, 4.4, 4.5, 4.7, 4.8, and 4.9). It establishes baseline conditions providers must satisfy to participate, including completion of enrollment agreements, licensure/certification, documentation of business transactions upon request, compliance with Affordable Care Act (ACA) provider screening (with enrollment denial triggers such as expired or disciplined licenses and certain exclusions), periodic revalidation screening at least once every five years, record retention/disclosure obligations, Social Security Act ownership/disclosure requirements, acceptance of Medicaid payment rules and “payment in full” requirements (with limits for authorized patient cost-sharing), third-party liability identification and billing, civil rights non-discrimination obligations, claim accuracy requirements, continued maintenance of Medicaid Administrative Code copies, DHHS-OIG exclusion screening/ineligibility consequences, NET (non-emergency transportation) verification steps, disenrollment of providers that have not billed for one year (with exceptions for access needs), and substantive requirements for out-of-state provider enrollment and closing/discontinuing service notice to beneficiaries.
It also specifies how and when provider agreements become effective and when Medicaid payments begin. The effective date is tied to screening completion verification, timing of the enrollment application relative to Medicare “Tie-in Notice” issuance, Medicare certification timing limits, and (for survey/certification providers) onsite survey completion and compliance outcomes (including plan-of-correction/waiver receipt rules). For CMS-surveyed providers, agreement effective dates depend on substantial compliance or defect severity with an earlier-of/receipt approach for correction plans/waivers. Additional provisions cover accredited national-accreditor scenarios (including possible retroactivity), out-of-state application/claim submission timing (120 days of service) and emergency/endangered-travel service rules, a prohibition on Medicaid payments before a valid provider agreement effective date, continuing payment for certain “admitted before termination” state plan services for up to 30 days after termination, and notice/beneficiary transfer duties for facilities upon termination. A reinstatement pathway is included after termination by a licensing/certification board, DHHS-OIG, CMS, or the Division of Medicaid when sanction conditions are satisfied.
Licensure and specialty credentialing requirements are set out, requiring providers to keep current licensure/specialty certificates/permits/certifications on file and making providers ineligible to furnish services when licenses/certifications are suspended, revoked, surrendered, expired, limited by disciplinary action, or when the credentialing employee loses covered status or employment. The Division of Medicaid will process license renewals to avoid eligibility gaps if renewal information is supplied within one year of expiration, supported by a current license copy or electronic data match, and all other participation conditions remain satisfied. Providers must re-enroll if Medicaid enrollment is closed due to license expiration for more than one year. Additional alternative credential evidence is required for speech-language pathology providers (evidence that licensure/permitting is not required plus ASHA competence or equivalent/education-and-supervised-experience pathways) and for audiologists (ASHA competence or specified supervised practicum and testing pathways), and CLIA certificates apply as appropriate.
The document sets rules for provider administrative changes and participation disclosures. For tax ID changes not involving change-of-ownership, providers must request the change in writing, specifying effective date, tax ID, tax ID type (FEIN/SSN), legal name, and attest no change of ownership occurred; no ownership-change application is required and the provider number remains unchanged (a new taxpayer identification segment is created). It requires all providers to submit specified enrollment documents (provider agreement, direct deposit/EFT with voided check/acceptable bank documentation, legal name and tax ID matching IRS records with an IRS confirmation available upon request within 60 days, and EDI enrollment materials where applicable), and it adds civil-rights-related attestation and supporting policy documents to be provided upon request within 60 days. It also requires submission of change information not treated as CHOW, and detailed provider disclosure forms on enrollment, during revalidation (upon request), and within 35 days after any ownership change—covering ownership/control identifiers, dates of birth and SSNs (for individuals), relationships, managing employees/authorized/delegated officials, subcontractor ownership/control disclosures, and additional disclosures required by state/federal law. Failure to comply can result in rejection of the enrollment application, revocation of enrollment, or suspension of claim payments. Finally, it adds group-provider enrollment criteria, including that group enrollments must use the group’s tax ID, not enroll solely proprietors, include at least one active individual servicing provider, and satisfy the same provider requirements plus group-specific items such as NPI verification, legal business name and tax ID, and CLIA documentation when applicable.
Montana
3
bill
Regulation • 🇺🇸 United States • Montana • Proposed Notice
The rulemaking proposes changes to multiple Montana Administrative Rules (ARM) governing Medicaid youth mental health services, including Comprehensive School and Community Treatment (CSCT) and Home Support Services (HSS), along with related Behavioral Health and Developmental Disabilities requirements. It is accompanied by a virtual public hearing scheduled for April 10, 2026 at 11:00 a.m. and requires comments to be received by April 17, 2026 at 5:00 p.m. Requests for disability accommodations must be submitted by March 27, 2026 at 5:00 p.m. The department intends the amendments to take effect May 9, 2026.
The proposal would revise ARM 37.85.105 and CSCT/HSS-related provisions primarily to restructure services and rate-related billing mechanics: it updates fee schedule effective dates (ARM 37.85.105), updates the “youth” definition to align with CMS and removes the requirement that youth ages 18–20 be enrolled in secondary education (ARM 37.87.102 and corresponding definition changes in ARM 37.106.1902), updates the Children’s Mental Health Medicaid Services Provider Manual incorporation date (ARM 37.87.903), and aligns out-of-state PRTF pharmacy/lab reimbursement rules with in-state requirements (ARM 37.87.1226). It also updates HSS service coordination and care planning requirements with CSCT and therapeutic foster care settings (ARM 37.87.1404), and modifies HSS service provisions by removing monthly summary requirements while adding explicit limits on role separation (HSS team members cannot provide Targeted Case Management (TCM) and HSS to the same youth) (ARM 37.87.1414). The family support specialist caseload range is updated (ARM 37.87.1415).
For CSCT, the proposal changes the billing unit and related utilization limits from a service-days approach to 15-minute units and adjusts the claim-suspension threshold mechanics accordingly. Specifically, ARM 37.87.1803 would update CSCT allowable per-team monthly billing limits (from “service days/units” to “15-minute units”), update the maximum allowable sum total daily units per youth that triggers clinical review claim suspension, and update the allowable brief intervention/assessment/referral (IAR) unit limits and how IAR units are applied within the monthly team total. Related CSCT staffing and recordkeeping rules are also updated to align with these service delivery changes, including updates to CSCT summer service minimums (ARM 37.106.1956) and the removal of a date associated with the CSCT Data Collection Template form (ARM 37.106.1961). ARM 37.106.1902 and ARM 37.106.1956 also reflect the operational shift from service-days to 15-minute units for CSCT services in summer months and associated daily unit limit definitions.
The notice includes a General Reasonable Necessity Statement explaining the policy rationale: requesters (CSCT providers via schools contracting with mental health centers, and the Behavioral Health Alliance of Montana) asked for changing CSCT reimbursement methodology “due to unintended financial consequences,” including moving away from a current daily-rate structure toward a 15-minute unit approach. The notice also states the department anticipates no fiscal impact to the state general fund from the rate restructuring goal of increasing access to CSCT, and provides estimated impacts for CSCT and HSS (state, federal, and total) for SFY 2026 and SFY 2027. Finally, the department states the proposed program changes are not subject to the Medicaid performance-based measures requirement because they are not appropriate for performance-based measurement under MCA 53-6-196.
bill
Regulation • 🇺🇸 United States • Montana • Proposed Notice
The notice proposes rule changes to update Montana’s Medicaid and non-Medicaid provider rate rules, fee schedules, and effective dates in three ARM sections: 37.79.304 (HMK services covered), 37.79.326 (HMK dental benefits), and 37.85.105 (Medicaid provider fee schedules effective dates, conversion factors, policy adjusters, and cost-to-charge ratios). It also sets procedural timelines for comment submission and a virtual public hearing.
For ARM 37.79.304, the department proposes to incorporate by reference an updated Healthy Montana Kids (HMK) Evidence of Coverage (EOC) dated July 1, 2026 (replacing an October 1, 2025 date reference). For ARM 37.79.326, the proposal eliminates the HMK dental annual limit and updates related dental benefit provisions: it would change maximum benefit coverage mechanics and aligns the covered dental procedures list with updated benchmark plan changes and add/delete/revise/description updates, including updating the CDT (Current Dental Terminology) codebook from 2023 to 2026. It also updates the CDT citation in the rule to reflect CDT 2026.
For ARM 37.85.105, the proposal updates reimbursement methodology inputs and fee schedule effective dates. Key changes described include adopting a newer CMS resource-based relative value scale (RBRVS) reference for the RBRVS methodology (based on the Medicare Physician fee schedule version referenced in the notice), updating RBRVS conversion factors and the payment-to-charge ratio (including new percentages reflecting the proposed payment-to-charge ratio), and updating optometric services provider rate of reimbursement (PRR). It also updates multiple fee schedules and program-specific fee schedules (including inpatient and outpatient hospital fee schedules, dental-related references, outpatient drug dispensing fees and vaccine administration add-on fees, and various other service-specific fee schedules) so they are effective on or after July 1, 2025/2026 dates as specified in the rule text. The proposal additionally includes a change to allow automatic incorporation of Medicare updates for the prosthetic devices/durable medical equipment/medical supplies fee schedule pursuant to Montana’s cross-reference statute (2-4-307(9), MCA is referenced for future updates without additional rulemaking).
Procedurally, comments must be received by Friday, August 21, 2026, at 5:00 p.m. A virtual hearing is scheduled for Thursday, August 13, 2026 at 11:00 a.m. Accommodation requests for accessibility must be submitted by Thursday, July 30, 2026 at 5:00 p.m. The department states an intent to apply the proposed rule amendments retroactively to July 1, 2026. The document’s rulemaking actions indicate the changes are “AMEND” actions to the specified ARM provisions; it contains a general reasonable necessity statement and impact discussions, including small business and fiscal impact narrative and tables (including provider-count and budget-impact tables for HMK dental limit elimination and for various fee schedule/proposed-rate categories).
bill
Regulation • 🇺🇸 United States • Montana • Proposed Notice
The Department of Public Health and Human Services proposes updates to Montana Medicaid and non-Medicaid provider reimbursement rules and fee schedules and adopts new targeted case management rules for specific federal/waiver programs. It would amend ARM 37.27.106, 37.27.902, 37.85.106, 37.86.3306, and 37.88.101, and adopt NEW RULES 1 and 2, with the stated intent to align rule effective dates and update provider-rate-related references and the BHDD Medicaid Services Provider Manual for Substance Use Disorder and Adult Mental Health.
Among the rule amendments, ARM 37.27.106 is updated with clarifying language about which entities must hold SUD scope-of-practice (federally qualified health centers, rural health clinics, Indian Health Service providers, and Tribal 638 providers) even though they do not need licenses for certain outpatient/intensive outpatient levels. ARM 37.27.902 updates the referenced date/link for the BHDD Division Medicaid Services Provider Manual and adds HEART Waiver/CAA-related content within the manual reference; it also updates the incorporation date and the location for the manual. ARM 37.85.106 updates and expands the referenced Medicaid Behavioral Health Targeted Case Management fee schedule effective date to align with updated rules/policies, and adds fee-schedule coverage for targeted case management related to re-entry from state-operated secure facilities as provided in NEW RULE 1 (in addition to other existing TCM categories). ARM 37.86.3306 expands the eligibility groups for Medicaid case management services by adding populations corresponding to HEART Waiver eligibility and Consolidated Appropriations Act (CAA) Section 5121, including specified re-entry populations exiting state-operated secure facilities. ARM 37.88.101 updates the effective date for the BHDD Medicaid Services Provider Manual for Adult Mental Health to incorporate an amended version.
NEW RULE 1 establishes reimbursement for HEART Waiver services for targeted case management (TCM) for adults with serious mental illness or substance use disorder exiting state-operated secure facilities, specifying that a “unit of service” equals 15 minutes and that reimbursement rates are set in the department’s fee schedule (referencing ARM 37.85.106). NEW RULE 2 establishes reimbursement for CAA Section 5121 TCM on a fee-per-unit basis, also using a 15-minute unit of service, with rates set in the same ARM 37.85.106-referenced fee schedule.
The manual update is described as extensive and includes added definitions and revised/added policy sections covering assessments, individualized treatment plans for certain behavioral health situations, integrated service delivery and concurrent billing guidance (including SUD CBPRS and HEART/CAA targeted case management), multiple SUD outpatient and ASAM policy clarifications, and new/revised HEART and CAA re-entry and targeted case management policies (including federal home-and-community-based service settings and critical incident reporting for specified services). The effective date the department intends is retroactive to October 1, 2025. A public hearing is scheduled for May 14, 2026 at 3:00 p.m. (virtual), and written comments must be received by Friday, May 22, 2026 at 5:00 p.m. The department projects administrative fiscal costs of $3,521.00 in SFY 2026 and $4,225.20 in SFY 2027 (with additional quantified fiscal impact tables for HEART and CAA TCM), and it states rate increases will benefit small-business Medicaid providers while also asserting the changes will not significantly and directly impact small businesses. The department determines the proposed program changes are not subject to Medicaid performance-based measures under MCA 53-6-196 because they are implementation of rate increases/federal law-related changes.
Nebraska
3
bill
Regulation • 🇺🇸 United States • Nebraska • Proposed Notice
The document establishes and governs Nebraska’s Medicaid hospital services requirements under Title 471, Chapter 10. It defines numerous hospital and Medicaid-relevant terms and sets provider and service requirements for hospital inpatient, outpatient, emergency, diagnostic/therapeutic services, radiology, ancillary services, ambulance services, pre-admission testing, and specific specialty services (e.g., dialysis, anesthesiology, infant monitoring, home phototherapy, psychiatric services). It also establishes coverage limitations/non-covered services, medical review/utilization review processes (including medical necessity determinations and review timelines for admissions/continued stays), hospital billing/documentation requirements (including POA reporting and claim documentation), and payment methodologies for hospital services using prospective rates/peer groups and APR-DRG-based calculations, including outlier payments, DME/IME add-ons, capital-related payments, and transplant payment rules.
The document includes multiple substantive payment and coverage rules that are operationally binding on hospitals: prior authorization is required for specified services (including medical transplants, abortions, cosmetic/reconstructive surgery in specified circumstances, bariatric surgery, certain drug products, attended sleep studies, ventricular assist devices, and outpatient/in-state exceptions), and claims without required written/electronic approval will not be paid. It specifies that medical necessity is a coverage condition, clarifies the treatment of outpatient services that convert to inpatient prior to midnight, limits outpatient observation to 48 hours, and defines when emergency room charges require specific approval conditions for payment (including reduced payment for non-emergent ER use). It also imposes hospital-acquired condition (HAC) and other provider-preventable condition (PPC/OPPC) non-payment rules tied to diagnosis codes/POA indicators and APR-DRG grouper impact, including denial when HAC results in death or serious disability and exclusion of HAC codes from APR-DRG determination.
For selected services, it establishes detailed clinical and billing requirements. These include covered physician direction/technical component rules for anesthesia; radiology component separation and mammography certification/coverage limitations; portable x-ray certification and covered/non-covered categories; ambulance billing rules (attendants, standby time documentation, air ambulance limitations/medical necessity prerequisites, emergency vs non-emergency transport definitions, and special limitations such as medical team transport not separately reimbursed); and infant home technologies—home infant apnea monitoring and home phototherapy—requiring approved providers, coordination plans (not individual patient plans), daily bilirubin monitoring and specific bilirubin thresholds for continuing/discontinuing coverage, required documentation/progress reports for extended rental, covered component limitations (e.g., rechargeable battery restriction), and specific daily visit/training and billing rules.
Finally, the document establishes prospective hospital payment frameworks and rate-setting mechanics. It defines peer groups, operating cost payment amount calculations based on peer-group base payments and APR-DRG national weights, cost outlier thresholds, transplant diagnosis-related group payment mechanics (including special treatment of bone marrow transplant DRGs), DME/IME/capital-related cost payment formulas, interim/final payment processes for long-stay beneficiaries, facility upper payment limits (generally 110% of Nebraska Medicaid cost for specified peer groups) with reconciliation/refund timelines, transfer payment rules, and readmission and utilization review controls (including requirements to certify inpatient admissions prior to payment and timelines for UR determinations/notifications and recertification). It also contains hospital records requirements (EHR integrity, retention for five years, confidentiality procedures, and required record content/sign-off timing) and additional administrative provisions including access to records/audit rights, provider appeals timing (within 90 days of rate notification), and hospital quality assurance and access assessment payment/penalty provisions (quarterly payment due within 30 days).
LB 942 establishes new Medicaid provider requirements governing (1) how emergency department services must be classified as “emergency medical conditions” and (2) when a hospital patient may be treated as an inpatient for reimbursement purposes. It creates definitions for “emergency medical condition” and “prudent layperson,” and it requires that emergency/nonemergency determinations be made using only the recipient’s presenting symptoms/clinical presentation at the time care was sought, as perceived by a prudent layperson.
Key changes require the department or a managed care organization to: (a) determine whether emergency department services constitute an emergency medical condition solely on the recipient’s initial presentation (not on later clinical outcomes); (b) prohibit using final diagnosis, discharge code, post–medical screening exam conditions, or a payment/screening tool/algorithm/diagnosis list based on final diagnosis to classify services as emergent or nonemergent; and (c) prohibit reducing reimbursement for emergent services to any fractional amount based on classification as nonemergent. The bill also requires that emergency services provided by a hospital or emergency care provider be reimbursed at a rate no less than the Medicaid fee-for-service rate in effect at the time the services were provided, while allowing the department/managed care organization to negotiate a higher rate so long as it is not below the minimum.
For inpatient reimbursement, the bill defines when a Medicaid recipient is an inpatient: formal admission pursuant to an order by an admitting physician or other qualified practitioner with admitting privileges (knowledgeable about the patient’s hospital course, medical plan of care, and current condition). It sets a general “two consecutive midnights” expectation standard for appropriateness of inpatient reimbursement, requiring documentation of the medical factors supporting that expectation (medical history/comorbidities, severity of symptoms, current medical needs, and risk of adverse event). It provides that if an unforeseen circumstance (including death or transfer) results in a shorter stay than the two-midnights expectation, the recipient may still be considered treated on an inpatient basis with reimbursement consistent with Medicare regulations; it also allows inpatient admission reimbursement when the two-midnights expectation is not met, based on clinical judgment and documented medical factors.
Finally, the bill repeals the original version of section 68-901, Revised Statutes Cumulative Supplement 2024, and substitutes the amended statutory structure incorporating the new sections and reimbursement standards described above.
bill
Regulation • 🇺🇸 United States • Nebraska • Proposed Notice
The document establishes and governs Nebraska Medicaid coverage rules for physician services within Title 471, Chapter 18. It sets Medicaid-specific definitions (e.g., emergency medical condition, feeding/swallowing clinic, independent clinical laboratory) and details provider participation and service requirements, with extensive attention to when services are covered, when prior authorization is required, and how claims must be coded and billed.
Key coverage and authorization requirements include: (1) prior authorization for specified services for non-managed-care beneficiaries (including medical transplants and related donor services, abortions, cosmetic/reconstructive surgery, bariatric surgery for obesity, out-of-state services except emergencies, certain questionable/ redundant/ unproven clinical efficacy procedures, certain drug products, all attended sleep studies, ventricular assist device, and additional categories such as specified radiology scans for non-emergency outpatient settings); (2) specific prior authorization “procedures” such as submission by the physician, written notice to relevant parties, verbal authorization in emergencies with a follow-up form submission deadline (14 calendar days), and a requirement that claims for prior-authorization-required services not be paid without written or electronic approval; and (3) additional, service-specific authorization standards for bariatric surgery (including BMI threshold and enumerated comorbidities plus preoperative evaluation components), transplant services (including required information and specialized screening documentation), cosmetic/reconstructive surgery (including required narrative/photographs where appropriate), and comprehensive interdisciplinary treatment for severe feeding disorders (including referral and medical record documentation requirements).
Beyond authorization, the regulation defines service-specific clinical coverage rules and non-coverage limitations. These include: coverage conditions and exceptions for facility-based physician clinics; how hospital diagnostic procedures are treated for medical necessity and duplication avoidance; reimbursement coverage restrictions tied to obesity treatment (e.g., non-coverage of intestinal bypass surgery; obesity is not covered when it is the sole diagnosis, but treatment may be covered when integral to management of covered comorbidities); coverage and exceptions for cosmetic/reconstructive surgery; detailed sterilization consent and timing requirements (including general non-coverage under age 21 or legal incapacity; consent timing/validity and emergency/premature-delivery exception); hysterectomy coverage requirements (consent-informed capability); limitations on infertility coverage; and numerous therapeutic/service limitations (e.g., biofeedback, sleep disorder clinic conditions and diagnostic/therapeutic coverage criteria, portable x-ray coverage and non-covered portable x-ray categories, and explicit non-covered services such as influenza injections in LTC, injectable estrogens for depression/menopause-associated osteoporosis, liver and vitamin injections, and autopsies).
The document also establishes billing, reimbursement, and compliance mechanics. It requires physician claims to use Nebraska-approved claim forms or electronic transactions, prohibits hospitals from billing physician services, requires physician approval/date for paper claims and specific claim coding rules (HCPCS for physician procedures; modifiers and NDC details for billing practitioner-administered injectable medications; and separate handling for services with professional/technical components). It sets reimbursement principles such as “lower of submitted charge or allowable amount” (with an out-of-state specialized-services exception), site-of-service adjustments, and explicit denial of payment for certain other provider preventable conditions (wrong procedure/body part/beneficiary). It includes additional program rules such as PDMP checks before prescribing certain controlled substances. No explicit amendment markers to prior named Nebraska regulations were identifiable from the provided text extract; the document primarily contains a comprehensive set of substantive requirements, eligibility/coverage standards, and billing/payment rules for physician services under Nebraska Medicaid.
In the question’s terms: the document primarily contains established regulatory requirements for what Nebraska Medicaid covers for physician services, what providers must do (especially prior authorization, documentation, and billing), and what is excluded from coverage; it does not clearly present itself as a targeted amendment to a separately identifiable existing regulation in the excerpt provided.
New Hampshire
5
bill
Legislation • 🇺🇸 United States • New Hampshire • Bill
(New TItle) relative to health carrier recordkeeping requirements in utilization review, including s... (View full title on source site)
label_outlineArtificial Intelligence
label_outlinePayor
1st Chamber
2nd Chamber
Executive
check_circle_outline
check_circle_outline
play_circle_outline
remove_circle_outline
Introduced
December 04, 2025
Passed (House)
March 11, 2026
Considering (Senate)
August 05, 2026
In Senate • 2025-2026 Regular Session • Introduced: December 04, 2025
Sponsors: Alicia Gregg (D)
Co-sponsors: Sanjeev Manohar (D-NH), Nancy A. Murphy (D-NH), Gaby Grossman (D), Trinidad Tellez (D-NH), Jessica LaMontagne (D), Suzanne M. Prentiss (D), Mark A. Pearson (R-NH), David Nagel (R-NH), Regina Birdsell (R), Santosh Salvi (D), Patrick T. Long (D)
The bill establishes new managed-care utilization review recordkeeping and decision requirements for health carriers that involve or rely on algorithms or artificial intelligence.
It changes RSA 420-J:6 by adding (1) a new recordkeeping requirement specifying what records must be kept about the carrier’s use of algorithms/artificial intelligence/machine-based systems, including the functions AI is used for and protocols for qualified human review of determinations affecting provider coding decisions; (2) new provisions governing adverse determinations—requiring that they be made by a qualified health care provider, requiring written notice to the covered person and the covered person’s provider with reasons, requiring the carrier to maintain specified records (including whether AI assisted the reviewer and the clinical rationale); and (3) a contracting liability rule making the health carrier responsible for monitoring a contracted entity’s activities (including AI developed by others) and ensuring compliance with the section and applicable rules.
The act also sets an effective date of January 1, 2027.
bill
Legislation • 🇺🇸 United States • New Hampshire • Bill
relative to oversight and reporting requirements for health insurance carriers regarding mental heal... (View full title on source site)
label_outlineBehavioral Health
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
December 17, 2025
Failed (House)
March 11, 2026
Failed • 2025-2026 Regular Session • Introduced: December 17, 2025
Sponsors: Tim Hartnett (D-NH)
Co-sponsors: Lucinda Rosenwald (D), Anita D. Burroughs (D-NH), Heather Raymond (D-NH), Mark A. Pearson (R-NH), Mary Jane Wallner (D-NH), Patrick T. Long (D)
The bill creates new statewide reporting and oversight requirements focused on mental health and substance use disorder coverage by health insurance carriers offering health benefit plans in New Hampshire. It requires each carrier to submit an annual report to the insurance department by March 1 each year, in a commissioner-prescribed form and with de-identified aggregate data; reports must detail the carrier’s policies, procedures, and data regarding (1) utilization management practices (including prior authorization, step therapy, and medical necessity criteria), (2) claims denial rates for mental health/substance use disorder services compared to medical/surgical services, (3) average wait times for in-network mental health provider appointments, (4) mental health/substance use disorder provider network adequacy, and (5) efforts to comply with federal mental health parity laws. The insurance commissioner must review the reports annually for compliance with state and federal requirements; the commissioner may adopt rules to enforce the requirement, including establishing penalties for failure to submit complete or timely reports; and the commissioner must prepare a biennial report to the general court summarizing trends, compliance status, and recommendations for legislative action.
In parallel, the bill also adds a new recurring reporting requirement for the state Medicaid program. Beginning March 1, 2027 and annually thereafter, the commissioner of the Department of Health and Human Services must prepare and publish (on the department’s website) a detailed report submitted to the speaker of the house, the senate president, and the governor. The report must cover the scope and adequacy of mental health coverage and substance use disorder treatment available under the Medicaid state plan, Medicaid managed care waivers, and 1115 demonstrations, using the same specified categories of information: utilization management practices, comparative claims denial rates, average wait times for in-network mental health appointments, provider network adequacy for mental health/substance use disorder care, and parity-law compliance efforts.
The bill makes the carrier reporting provisions apply to health carriers providing coverage under the New Hampshire Granite Advantage Health Care Program. It takes effect 60 days after passage.
bill
Legislation • 🇺🇸 United States • New Hampshire • Bill
The bill creates a new managed care law subdivision in RSA 420-J establishing definitions and safety/care requirements for “clinician-administered drugs” (outpatient prescription drugs, other than vaccines, that cannot reasonably be self-administered and are typically administered by authorized professionals in a clinical setting such as a physician’s office or infusion center).
It prohibits health insurers and pharmacy benefit managers (PBMs) from mandating “white bagging” (dispensing by a pharmacy selected by the insurer/PBM for delivery to the provider for administration) unless (1) there is a written agreement between the provider and dispensing pharmacy covering delivery, handling/storage, and liability responsibilities, and (2) the provider has provided prior written consent to use the arrangement.
It also prohibits health insurers and PBMs from mandating “brown bagging” (pharmacy dispensing to the patient for transport to the provider for administration) unless (1) there is a written attestation from both patient and provider that transporting the medication will not compromise care, and (2) both patient and provider have provided prior written consent.
Under the foregoing white-bagging and brown-bagging rules, the bill bars insurers/PBMs from interfering with an enrollee’s right to obtain clinician-administered drugs from the provider or pharmacy of choice, from limiting/excluding coverage solely because the drug is obtained from a non-selected pharmacy if it would otherwise be covered, from requiring extra patient cost-sharing (e.g., additional fees, higher copays/coinsurance, or other price increases) when the drug is not dispensed through an insurer/PBM-selected pharmacy, and from conditioning, denying, restricting, refusing to authorize, or reducing payment to participating providers for covered clinician-administered drugs and related services when medical necessity criteria are met, based on where the provider sources the drug (including if from a pharmacy not participating in the network or managed/owned by the PBM). The act takes effect January 1, 2027.
bill
Legislation • 🇺🇸 United States • New Hampshire • Bill
prohibiting Medicaid premiums and limiting Medicaid expansion cost sharing.
arrow_upwardHigh Priority
thumb_downOppose
label_outlineMedicaid Reimbursement
label_outlineExpansion
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
November 21, 2025
Failed (Senate)
February 19, 2026
Failed • 2025-2026 Regular Session • Introduced: November 21, 2025
Sponsors: Lucinda Rosenwald (D)
Co-sponsors: Donovan Fenton (D), Laura Telerski (D), Rebecca Perkins Kwoka (D), Mary Hakken-Phillips (D-NH), Suzanne M. Prentiss (D), Debra Altschiller (D), Alexis Simpson (D-NH), Mary Jane Wallner (D-NH), David Watters (D), Lucy M. Weber (D-NH), Patrick T. Long (D)
The bill establishes a $5 maximum for any cost-sharing requirement imposed under the New Hampshire Granite Advantage health care program for covered individuals, beginning October 1, 2028 (subject to federal limitations).
It repeals premium requirements under (1) the Granite Advantage health care program by repealing RSA 126-AA:2-a, and (2) the children’s health insurance program by repealing RSA 126-A:3, IX, which related to premiums.
To offset the resulting state Medicaid program funding reduction from repealing the premiums, the bill appropriates a sum necessary to compensate the Department of Health and Human Services for that reduction for the biennium ending June 30, 2027, and authorizes the Governor to draw the warrant from available treasury funds.
The act’s effective date is July 1, 2026.
New Jersey
12
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
The bill establishes Medicaid reimbursement-rate requirements for certain primary care and mental health services by tying them to the payment rates for comparable services under Medicare (Part B). Beginning July 1, 2023, and annually thereafter, the Medicaid reimbursement rate for covered primary care and mental health services must be no less than 100% of the applicable Medicare Part B payment rate.
It defines “primary care services” to include services furnished by: (1) physicians with primary specialty designations of family medicine, general internal medicine, general pediatric medicine, or obstetrics and gynecology; (2) specified health care professionals (including advance practice nurses or physician assistants) working in those same areas; or (3) midwives. It defines “mental health services” to include services furnished by providers with specified mental health-related specialty designations (licensed clinical social worker, psychologist, licensed professional counselor, licensed marriage and family therapist, licensed clinical alcohol and drug counselor, or psychiatrist), or by providers included within the primary care categories.
The bill includes protections and scope limits: it cannot be construed to require a decrease in Medicaid reimbursement for the same primary care or mental health service from the previous fiscal year’s reimbursement level. The rate requirements apply to services reimbursed under both Medicaid fee-for-service and Medicaid managed care, but only when delivered by an approved Medicaid provider. It directs the Commissioner of Human Services to: (1) apply for any state plan amendments or waivers necessary to implement the requirements and secure federal financial participation; (2) adopt rules under the Administrative Procedure Act to implement the provisions; and (3) no later than one year after the effective date, submit a report to the Governor and the Legislature on implementation, including data on changes in access and quality for Medicaid beneficiaries following any required rate increases and recommendations for further enhancements for underserved areas. The act takes effect immediately.
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
The bill supplements New Jersey’s FY2026 annual appropriations act by adding new authorization language in section 1 (P.L.2025, c.74) allowing transfers of General Fund appropriations within a specified line item in the Department of Health, Grants-in-Aid.
Specifically, for amounts appropriated from the General Fund to a licensed hospital or health care entity, the bill permits those amounts to be transferred to the Division of Medical Assistance and Health Services. The transfer must be consistent with Centers for Medicare and Medicaid Services (CMS) guidelines and is limited “solely” to maximize federal Medicaid payments for faculty physicians and non-physician professionals affiliated with the licensed hospital or health care entity under New Jersey’s Medicaid Access to Physician Services (MAPS) program.
The bill also requires approval from the Director of the Division of Budget and Accounting before such transfers can occur.
The act takes effect immediately.
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
The bill establishes multiple new requirements and definitions to expand reproductive health care coverage in New Jersey and to protect providers and insureds from certain insurance consequences. It adds definitions for key terms including “abortion” (including aspiration and medication abortion), “carrier,” and several terms used to implement coverage obligations. It also states legislative findings/policy emphasizing access to reproductive autonomy, affordability, and the goal of enabling qualified practitioners to provide abortion services.
For private and state-purchased insurance, the bill creates new coverage mandates for contracts providing hospital or medical expense benefits delivered/issued/renewed on or after the bill’s effective timeframe. These contracts must provide coverage for abortions and must not impose deductibles, coinsurance, copayments, or other cost-sharing for the required abortion coverage (with an exemption for catastrophic plans and a special timing rule for qualified high-deductible health plans paired with health savings accounts). Contracts may not impose restrictions, delays, or prior authorization for the required abortion coverage. The Commissioner of Banking and Insurance may grant limited exemptions if enforcement would minimally and adversely affect allocation of federal funds to the State.
The bill includes a religious-employer opt-out framework: a religious employer may request an exclusion if the required abortion coverage conflicts with bona fide religious beliefs and practices; if granted, notice must be provided to covered and prospective covered persons. For the State Health Benefits Program and the School Employees’ Health Benefits Program, the bill requires that contracts purchased by the relevant commissions provide abortion coverage and applies similar cost-sharing limits and no-restriction/no-prior-authorization requirements (with health-savings-account plans set at the minimum level necessary to preserve tax treatment). For Medicaid, the Department of Human Services must ensure abortion service expenses are provided with no cost-sharing, and any copayment/coinsurance/deductible in the relevant contract terms may not apply.
Separately, the bill revises existing law and provides insurance protections for medical malpractice insurers. It amends Section 2 of P.L.2021, c.375 (C.10:7-2) to clarify/enhance reproductive rights and enforceability provisions and to extend/require protections related to abortion access (including electronic billing provisions for abortion services, permitting rules requiring such billing by January 1, 2025). It amends Section 17 of P.L.2004, c.17 (C.17:30D-22) to bar medical malpractice insurers from adverse actions (including loss/denial of coverage, sanctions, fines, penalties, or rate increases) against an insured for providing or facilitating legally protected reproductive health care services (or gender-affirming health care services) when the adverse action is based solely on the patient’s out-of-state residency where the services are illegal. The bill repeals three specified sections of P.L.2021, c.375 (sections 3, 4, and 5). Effective dates are staggered: sections 1–3 apply to policies/contracts delivered/issued/executed/renewed on or after the third month following enactment; sections 4–9 generally take effect immediately, except the amendment to P.L.2021, c.375, section 2(b) takes effect six months after enactment.
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
The bill establishes a higher minimum reimbursement standard under NJ FamilyCare for certain out-of-state hospitals that provide care to NJ FamilyCare pediatric beneficiaries.
It amends P.L.2021, c.276 (codified at C.30:4D-7ff), adding a new reimbursement-rate requirement: an out-of-state, state-licensed hospital that delivers care to 10,000 or more unique NJ FamilyCare pediatric beneficiaries within its hospital system annually must receive an NJ FamilyCare reimbursement rate that is at least 125% of the Medicaid fee-for-service reimbursement rate paid in the state where the hospital is licensed.
The bill retains and continues to reference existing pediatric network-adequacy requirements within the Medicaid managed care contract framework, while also preserving related operational provisions (e.g., waiver processes for specific network adequacy provisions, grievance processes for network adequacy, and timely negotiations with non-participating providers when network standards are not met or waived).
The bill directs the Commissioner of Human Services to pursue any needed State plan amendments or waivers to implement the act and obtain federal financial participation for Medicaid expenditures, and allows the Commissioner to take anticipatory administrative action before the act’s effective date. The act takes effect on the first day of the third month following enactment, with that anticipatory-action exception.
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
The bill establishes the “Clinical Laboratory Services Reimbursement and Vulnerable Patient Discount Act.” It defines key terms for its provisions, including “Division” (the Division of Medical Assistance and Health Services), “Laboratory” (as defined in federal regulation at 42 CFR 493.2), “financial hardship,” and “NJ FamilyCare.” The Legislature’s findings describe concerns that existing NJ FamilyCare laboratory reimbursement rules—requiring lowest professional charge and limiting charges to not exceed what a provider charges others—may deter laboratories from offering discounted testing to uninsured, underinsured, underserved, or otherwise vulnerable patients.
For NJ FamilyCare reimbursement, a laboratory’s reimbursement is set at the lesser of: (1) the maximum fee schedule amount in N.J.A.C. 10:61-3 or a subsequent fee schedule set by the Division, or (2) the laboratory’s usual charge to the general public for the identical item or service. The bill also deems certain laboratory discounts permissible if consistent with federal anti-kickback and rebate law (42 U.S.C. § 1320a-7b(b) and related regulations). Importantly, it authorizes a laboratory, for a non–NJ FamilyCare enrollee, to charge or accept a lesser amount for an item or service based on demonstrated financial hardship without affecting NJ FamilyCare reimbursement for the same or substantially similar service and without constituting a violation of the State’s anti-rebate rule (N.J.A.C. 10:61-2.4). It specifies acceptable evidence to demonstrate financial hardship, including proof of income tied to the federal poverty level, documentation of exceptional and unforeseen circumstances, or other evidence supporting a hardship determination.
The bill further directs retroactive relief for laboratories. On the bill’s effective date, all pending Division audits, investigations, recoupments, or actions under NJ FamilyCare related to alleged violations of N.J.A.C. 10:61-1.7 and/or N.J.A.C. 10:61-2.4 that are later found to be permissible under the new discount framework must be dismissed, and administrative record actions that occurred earlier for such now-permissible conduct must be vacated by operation of law and expunged from the administrative record. Separately, it amends criminal anti-fraud/anti-kickback provisions in N.J.S.A. 30:4D-17 (Section 17 of P.L. 1968, c. 413) by creating an explicit carve-out stating the kickback/rebate prohibition does not apply to discounts or reductions properly disclosed and reflected in claims under existing law, and adds a specific exception for laboratory discounts that comply with Section 4 of this bill.
The bill requires the Department of Human Services to adopt rules and regulations as necessary to implement the act and provides that the act takes effect immediately (Section 8).
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
Establishes minimum Medicaid reimbursement rates for certain ambulance transportation services.
label_outlineMedicaid Reimbursement
1st Chamber
2nd Chamber
Executive
check_circle_outline
play_circle_outline
remove_circle_outline
remove_circle_outline
Introduced
January 13, 2026
Considering (Senate)
January 13, 2026
In Senate • 2026-2027 Regular Session • Introduced: January 13, 2026
Sponsors: Troy Singleton (D-NJ), Joseph F. Vitale (D-NJ)
Co-sponsors: Brian P. Stack (D-NJ), Vin Gopal (D-NJ), Robert W. Singer (R-NJ), Kristin M. Corrado (R-NJ), Paul A. Sarlo (D-NJ), Angela V. McKnight (D-NJ), Latham Tiver (R-NJ), Raj Mukherji (D-NJ)
The bill requires New Jersey’s Medicaid program to pay minimum reimbursement rates for specified emergency ambulance services, applies in both Medicaid fee-for-service and managed care delivery systems, and directs the relevant state agencies to implement the requirements through rules and federal Medicaid plan actions.
Beginning July 1, 2024, reimbursement for basic life support (BLS) emergency ambulance transportation services in Medicaid must be no less than $300 per transport. Also effective July 1, 2024, the ground ambulance mileage reimbursement rate for emergency transportation of a Medicaid beneficiary must be no less than $8.94 per loaded mile. The bill further requires that, for each subsequent fiscal year, the ground ambulance mileage rate be annually adjusted to match the Medicare ground ambulance mileage rate in effect as of July 1 of the corresponding fiscal year.
The Commissioner of Human Services must adopt implementing rules under the Administrative Procedure Act and must apply for any necessary state plan amendments or waivers to secure federal financial participation for these Medicaid expenditures. The bill takes effect immediately.
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
The bill requires New Jersey’s Medicaid program to cover emergency contraceptives obtained over the counter without requiring a prescription or any other authorization for the specific product. Specifically, the Division of Medical Assistance and Health Services must provide this coverage, and must require each Medicaid managed care organization to include such coverage as a benefit in its Medicaid managed care contract.
“Authorization” is defined as a fiscal order or any other approval or order from a health care professional, and “Medicaid managed care contract” is defined by reference to contracts for services for individuals eligible under the Medicaid program (P.L.1968, c.413) or the NJ FamilyCare program (P.L.2005, c.156).
To implement the requirement, the Commissioner of Human Services must apply for any necessary state plan amendments or waivers to secure federal financial participation, and must adopt rules and regulations under the Administrative Procedure Act to effectuate the bill’s purposes. The bill takes effect immediately, notwithstanding any requirement for federal approval.
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
The bill requires contracts governing managed care arrangements to give participating health care providers advance notice of certain coverage-impacting policy changes. Specifically, the contract between a participating health care provider and a carrier or the State Medicaid program (established under P.L.1968, c.413) or the FamilyCare Health Coverage Program (established under P.L.2005, c.156) that offers a managed care plan must require the carrier or program to provide the provider notice at least six months in advance of any change in the policy that could result in denial of coverage for services the provider furnishes to a covered person.
The bill defines “carrier” for this notice requirement to include insurance companies and specified health entities authorized to issue health benefits plans in New Jersey, expressly including the State Health Benefits Program and the School Employees’ Health Benefits Program. This definition governs who must provide the advance notice through the managed care plan contract.
The requirement applies to contracts that are entered into or renewed after the bill’s effective date. The bill takes effect on the 120th day following enactment.
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
Establishes minimum Medicaid reimbursement rate for structured day program services provided to bene... (View full title on source site)
1st Chamber
2nd Chamber
Executive
check_circle_outline
play_circle_outline
remove_circle_outline
remove_circle_outline
Introduced
January 13, 2026
Considering (Senate)
May 11, 2026
In Senate • 2026-2027 Regular Session • Introduced: January 13, 2026
Sponsors: Brian P. Stack (D-NJ), Maria Teresa Ruiz (D-NJ)
Co-sponsors: Anthony M. Bucco (R-NJ), Patrick J. Diegnan (D-NJ), Holly T. Schepisi (R-NJ), John F. McKeon (D-NJ), Jon M. Bramnick (R-NJ), Robert W. Singer (R-NJ), Joseph Pennacchio (R-NJ), Carmen F. Amato (R-NJ), Angela V. McKnight (D-NJ), Vincent Joseph Polistina (R-NJ), Declan Joseph O'Scanlon (R-NJ), Douglas J. Steinhardt (R-NJ), Michael L. Testa (R-NJ), Latham Tiver (R-NJ), Troy Singleton (D-NJ), Parker Space (R-NJ), Gordon M. Johnson (D-NJ), James W. Holzapfel (R-NJ)
The bill requires minimum Medicaid per diem or encounter reimbursement rates for “Structured Day Program Services” furnished to Medicaid beneficiaries who require treatment for a brain injury by an approved brain injury service provider.
It amends Section 2 of P.L.2022, c.78 (codified at C.30:4D-7kk) by changing the minimum rate schedule so that Structured Day Program Services are reimbursed at no less than the average of the rates for “Day Habilitation Services – Tiers D and E” (services provided through the Division of Developmental Disabilities in the Department of Human Services). The minimum rates for community residential brain injury services remain set as described in the existing framework (e.g., Low Supervision tied to Tier B, Moderate Supervision tied to Tier C, and High Supervision tied to the average of Tiers D and E).
The bill also maintains the definitions governing the minimum-rate requirement, including “brain injury service” (covering community-based, residential, day care, and home care services) and “brain injury service provider” (a licensed facility to provide traumatic or non-traumatic brain injury services), and it retains definitions for “traumatic brain injury” and “non-traumatic brain injury.”
The Commissioner of Human Services must adopt any rules and regulations necessary to implement the act. The act takes effect 30 days after enactment and applies to services provided on or after the effective date and to Medicaid managed care contracts executed or renewed on or after the effective date.
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
The bill establishes requirements for payment and reimbursement of clinical laboratory services when provided through managed care arrangements for health insurance and Medicaid, and it prohibits Medicaid’s division from conditioning reimbursement on participation in a managed care delivery system. It contains operative rules directing (1) “carriers” offering managed care plans to pay licensed clinical laboratories even if they are not participating providers, (2) managed care organizations’ Medicaid contracts to include the same payment and rate parity terms, and (3) medical necessity review rights for the services.
Concretely, the bill requires carriers to provide payment for laboratory services furnished by clinical laboratories licensed under the New Jersey Clinical Laboratory Improvement Act regardless of participation status in the managed care plan, and to pay at the same rate that would be paid to a participating clinical laboratory for comparable services (while allowing review for medical necessity). For Medicaid, it requires any laboratory-services contract/arrangement entered by a managed care organization to provide both regardless-of-participation payment and reimbursement at the participating-laboratory comparable-service rate, and it prohibits the Division of Medical Assistance and Health Services from requiring a licensed clinical laboratory to participate in the managed care delivery system (or to transition from fee-for-service to managed care) as a condition of Medicaid reimbursement. The bill defines “carrier” for its applicability and defines “Medicaid” by reference to the governing Medicaid program statute.
The bill takes effect on the 180th day after enactment and applies to health benefits plans, contracts, or arrangements that are entered into or renewed on or after that date.
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
The bill establishes Medicaid reimbursement minimums for two adult behavioral health/addiction outpatient service categories—partial care services and intensive outpatient services—when provided in-person, including specific inclusions of related clinical components (e.g., intake and counseling services).
It changes the required Medicaid payment levels by requiring that reimbursement rates for in-person partial care and intensive outpatient services be no less than the applicable State Medicaid rate as of the act’s effective date, increased by 35%, across both Medicaid fee-for-service and Medicaid managed care delivery systems. It also establishes a separate minimum aggregate reimbursement for transportation and mileage to and from partial care or intensive outpatient providers of at least $10 per one-way trip, again applying to both delivery systems.
The bill contains implementation mandates for the Commissioner of Human Services: (1) apply for any necessary state plan amendments and waivers to implement the reimbursement changes and secure federal financial participation; and (2) adopt rules and regulations under the Administrative Procedure Act to implement the act.
It also sets an effective date for applying the reimbursement rates to services provided to adult Medicaid beneficiaries on or after the effective date, with the act taking effect on the first day of the fourth month after enactment (while permitting anticipatory administrative action in advance).
bill
Legislation • 🇺🇸 United States • New Jersey • Bill
The bill establishes the “New Jersey Respect for Physicians Act” and makes changes to the existing “Health Claims Authorization, Processing and Payment Act” relating to health-insurance prior authorization. It requires payers to respond to hospital or physician prior-authorization requests faster in most scenarios (reducing the outer response deadline from 15 days to 48 hours for inpatient requests expected to be received and for outpatient/other settings), while keeping the 24-hour deadline for requests involving patients already receiving inpatient services or care in an emergency department.
Under the revised authorization-timing rules, when additional information is needed, payers receive shorter additional periods to approve or deny: the additional maximum beyond receipt of the requested information is reduced from 15 days to 48 hours for inpatient and outpatient/other settings (while remaining capped at 24 hours for emergency-department/inpatient-in-progress situations). The bill also requires payers to notify the hospital/physician and identify specific needed information, and it retains deeming rules under which a failure to respond within required timeframes results in the physician/hospital request being deemed approved and the payer being responsible for payment for covered services delivered.
The bill retains/clarifies operational requirements, including that payers and hospitals must have appropriate staff available between 9 a.m. and 5 p.m., seven days a week, to respond within the established authorization timeframes, and that if a hospital/physician fails to respond to a payer’s request for additional information within 72 hours, the authorization request is deemed withdrawn. It also includes a requirement (in connection with certain prior authorization requests) that the payer make reasonable attempts to contact the hospital and physician by telephone to discuss the request within four hours of the request being made.
The bill takes effect immediately.
New Mexico
7
bill
Regulation • 🇺🇸 United States • New Mexico • Final Notice
8.308.2 NMAC is amended (effective July 1, 2026) with updates across multiple managed care organization (MCO) provider-network, access, credentialing, transition, and delegation provisions, including replacing references to “HSD” with “HCA.” The amendments clarify provider participation mechanics (including using a medical assistance division provider web portal and provider participation agreements), add/confirm requirements for network and subcontractor screening, and adjust language to refer to “their” rather than “his or her.”
The amended 8.308.2.9 strengthens and specifies MCO general network obligations: providers must be enrolled through fully executed provider participation agreements with HCA’s medical assistance division; provider location/licensure/status changes must be reported to MAD via a web portal and by email; and the MCO must require screening of subcontractors/contract providers under New Mexico caregiver criminal history and facility screening laws plus federal exclusions databases (LEIE and EPLS/SAM). It also reiterates identifier requirements (NPI and unique billing/rendering identifiers), requires network adequacy planning that accounts for enrollment, provider capacity to accept patients, geography/access (including disability access), and requires contracted providers to offer hours no less than their commercial hours. The section also maintains requirements for prior authorization protections for emergency care, access to non-contracted providers when network coverage fails, and member protections against higher member cost when non-contracted providers are used.
The amended 8.308.2.10–8.308.2.12 expand access standards and service-availability requirements. The PCP section confirms assignment rules and details member-initiated and MCO-initiated PCP changes and notice timing (including effective dates for member-requested changes and a 15-calendar-day notice/assignment process after a contracted provider termination). The access standards section (8.308.2.11 and 8.308.2.12) preserves the county-based travel-distance thresholds for PCPs and other provider types, minimum PCP availability (at least one PCP per 2,000 members and no more than 2,000 members per PCP unless approved), and defines appointment/request-to-appointment timeframes for routine, symptomatic, urgent, and behavioral health crisis services (including urgent outpatient appointments within 24 hours and face-to-face behavioral health crisis appointments within two hours). It also includes operational requirements for DME and medical supplies (timelines for approval/denial, delivery windows for standard vs. urgent vs. customized DME, repairs, emergency response planning, and instruction requirements) and transportation access (appropriate modes, CPR-certified drivers, authorization without advance notification under unusual circumstances, and accompaniment rules for minor age members).
The amended 8.308.2.14, 8.308.2.16–8.308.2.18 address family planning access, credentialing/re-credentialing, network transition, and delegation oversight. Family planning providers: members may use their own PCP or any family planning provider without a referral; female members may self-refer to a contracted women’s health specialist for covered routine/preventive services; family planning providers must be reimbursed for covered services regardless of whether they are contracted; and the MCO’s responsibilities regarding confidentiality are clarified (non-contracted providers retain confidentiality obligations; the MCO must notify them of confidentiality requirements). Credentialing/re-credentialing: the MCO must verify licensing/certifications, conduct primary source verification, use the HCA-approved credentialing form, complete credentialing within 45 calendar days from a completed application (unless extenuating circumstances), and re-credential at least every three years with defined primary-source checks and use of specific sanction/monitoring sources; the MCO also must update systems to recognize network providers no later than 45 calendar days after credentialing when required. Provider transition requires notification to HCA within five calendar days for unexpected network changes affecting access, and within 30 calendar days (or as soon as aware) for anticipated material changes, including transition narratives and plans per the MCO policy manual. Delegation requires documented MCO oversight, contractual terms describing responsibilities, reporting, evaluation processes, remedies up to delegation revocation, and compliance with 42 CFR 438.214 when applicable, plus evidence to HCA that the MCO evaluated delegate capacity pre-delegation, monitors performance with corrective action, and performs annual evaluations.
bill
Regulation • 🇺🇸 United States • New Mexico • Proposed Notice
The regulation establishes requirements for provider networks under New Mexico’s Medicaid managed care program, applying to the general public and administered by the New Mexico Health Care Authority (HCA). It sets out baseline managed care organization (MCO) obligations on network adequacy, nondiscrimination, subcontractor/provider screening, unique identifier requirements, and mechanisms to ensure timely access to covered services.
Key operational requirements include: establishing a comprehensive provider network sufficient to make all covered benefit services available under access standards; requiring providers to enroll via an HCA medical assistance division participation agreement and allowing providers to participate in managed care, fee-for-service, or both; routing provider-location/licensure/status changes to the HCA provider web portal and requiring MCO email notifications to MAD; prohibiting provider discrimination for high-risk-serving/specialty providers and restricting discrimination based solely on license/certification within scope of practice; providing written notice when declining to include providers; screening contracted/subcontracted providers against state caregiver criminal record screening requirements and against federal exclusion databases (LEIE/EPLS/SAM); requiring NPI use (with CMS-defined atypical provider exception) and unique identifiers for providers billing/rendering MCO services.
The regulation also establishes detailed primary care provider (PCP) and access-to-care standards: each eligible member must be assigned a PCP (with special coordination for Medicare–Medicaid dual-eligible members); PCP options include specified provider types (including FQHCs/RHCs/IHS/I/T/U and team-based arrangements in teaching facilities) and written processes for member choice and changes (including effective dates tied to monthly calendar cutoffs). It requires access standards for urgent/emergency services (including no clinically significant delay from utilization controls, no prior authorization for emergency services, reimbursement at an HCA-approved rate, and rights to use any licensed emergency setting), time-and-distance standards for PCPs/dentists and other provider types by county category, and appointment/request-to-appointment timing limits across primary medical, dental, non-urgent care, urgent care, behavioral health, diagnostics, and follow-ups, plus pharmacy, durable medical equipment, medical supplies, and transportation access requirements.
Additional substantive provisions address specialty provider contracting and referrals to non-contracted providers when necessary, family planning provider self-referral rights (including self-referral for women’s routine/preventive health services to a contracted women’s health specialist, without requiring referral, with Title X providers reimbursed for covered services regardless of contracting status), Indian health services/tribal/urban Indian provider access rules, and comprehensive standards for provider credentialing and re-credentialing (including primary and external source verification, HHS/OIG exclusion checks, structured site/record evaluations for certain providers, re-credentialing at least every three years, and decision inputs including grievances/appeals and quality management activities). It further requires HCA notification and transition planning for both expected and unexpected material changes in provider network composition, and it defines delegation: when a MCO delegates functions, it remains fully accountable, must document oversight, and must obtain explicit written HCA approval to delegate certain key management functions; delegation agreements must specify responsibilities, reporting, performance evaluation, remedies (including revocation), and must include applicable federal delegation requirements when delegated entities secure/provide covered services.
bill
Legislation • 🇺🇸 United States • New Mexico • Bill
The bill establishes a Medicaid reimbursement framework for toxicology services furnished by independent reference laboratories.
It creates new statutory requirements in a new Public Assistance Act section requiring the New Mexico Health Care Authority to (1) set Medicaid reimbursement codes for qualifying independent reference laboratory toxicology services, (2) reimburse those services at an amount equal to the average Medicaid fee-for-service rate schedule for specified Healthcare Common Procedure Coding System (HCPCS) codes used for billing definitive drug testing, and (3) condition reimbursement on medical necessity (determined by the treating health care provider) and on performance consistent with evidence-based clinical protocols adopted by the authority and aligned with behavioral health or substance use disorder treatment standards. The authority must promulgate rules establishing the reimbursement protocols, using nationally accepted clinical guidance as part of the rulemaking.
The bill also defines key terms used for eligibility and reimbursement, including “financially affiliated” and “independent reference laboratory,” and defines “toxicology services.” The “independent reference laboratory” definition includes operational and in-state physical presence requirements, federal and accreditation/licensure conditions, Medicaid provider enrollment, independence from certain other entities (no ownership/control/financial affiliation with hospitals, physician practices/groups, managed care organizations, or insurers), and requirements that specified revenue-cycle and billing activities occur physically within New Mexico. It further authorizes the authority to request tax filings and certificates of good standing to verify eligibility for reimbursement.
Finally, the bill appropriates $100,000 from the general fund to the Health Care Authority for fiscal year 2027 to administer Medicaid reimbursement for toxicology services by independent reference laboratories, with any unexpended balance reverting to the general fund. The effective date is July 1, 2026.
bill
Legislation • 🇺🇸 United States • New Mexico • Bill
The bill establishes a new statutory section in New Mexico’s Public Assistance Act that sets minimum Medicaid reimbursement rates for personal care services and imposes a required allocation of that reimbursement toward direct care workforce costs. It also creates recordkeeping and audit/inspection authority for the Health Care Authority (to verify compliance).
It changes Medicaid reimbursement policy by requiring the authority to implement two minimum hourly fee rates (different amounts depending on consumer-directed vs. consumer-delegated personal care service arrangements), excluding gross receipts taxes. It further requires provider agencies receiving Medicaid reimbursement for personal care services to use at least 70% of Medicaid reimbursement for direct care workforce expenditures, with gross receipts tax costs deducted before calculating the 70% threshold. Provider agencies must maintain accounting records demonstrating compliance and make those records available to the authority upon request.
The bill also contains an appropriation: $51.4 million from the general fund for fiscal year 2027 to the Health Care Authority to update the Medicaid personal care services fee schedule and increase Medicaid reimbursement for personal care services under the new requirements.
bill
Legislation • 🇺🇸 United States • New Mexico • Bill
The document establishes a new Public Assistance Act provision requiring the Health Care Authority (HCA) to set minimum Medicaid reimbursement rates for “personal care services,” and it mandates how provider agencies must allocate that reimbursement.
The document creates a new section that defines key terms including: two personal care delivery arrangements (consumer-delegated and consumer-directed), “direct care worker,” and “direct care workforce expenditures,” along with subcomponents such as “wages,” “employee-related expenses,” and “training and supervision costs.” It then requires HCA to implement minimum reimbursement rates—$23.50 per hour (excluding gross receipts taxes) for consumer-delegated personal care services and $19.78 per hour (excluding gross receipts taxes) for consumer-directed personal care services.
The document also requires each personal care services provider agency that receives Medicaid reimbursement for personal care to use at least 70% of the Medicaid reimbursement to cover direct care workforce expenditures, with gross receipts taxes deducted before calculating the minimum reimbursed amount subject to the 70% requirement. Provider agencies must maintain accounting records to document compliance and must make those records available to HCA upon request within a reasonable time.
Finally, the document contains an appropriation of $51.4 million from the general fund to HCA for fiscal year 2027 to update the Medicaid personal care services fee schedule and increase Medicaid reimbursement for personal care services under the new requirements; any unexpended balance at the end of FY2027 reverts to the general fund.
bill
Legislation • 🇺🇸 United States • New Mexico • Bill
The bill establishes new Medicaid reimbursement requirements for toxicology services provided by independent reference laboratories, including how reimbursement rates are calculated, conditions for coverage (medical necessity and evidence-based protocols), and authority rulemaking on reimbursement protocols and testing frequency.
It creates a new section in the New Mexico Public Assistance Act requiring the Health Care Authority to establish Medicaid reimbursement codes for eligible independent reference laboratories and to set reimbursement equal to the average Medicaid fee-for-service rate schedule for specified HCPCS codes used for billing definitive drug testing. Reimbursement is tied to (1) treating-health-care-provider determination of medical necessity and (2) performance in accordance with evidence-based clinical protocols adopted by the authority that are consistent with applicable behavioral health or substance use disorder treatment standards. The bill also directs the authority to consider nationally accepted guidance (including American Society of Addiction Medicine recommendations) while developing reimbursement rules, describes example guidance on testing frequency (weekly at initiation unless documentation supports otherwise; monthly in stable recovery unless provider assessment indicates otherwise; and randomized testing when feasible/appropriate), and authorizes the authority to request documentation (tax filings and certificates of good standing) to verify laboratory eligibility.
The bill defines key terms for the new section, including “financially affiliated,” “independent reference laboratory” (with criteria such as in-state facility and staffing, CLIA certification, CAP accreditation, Medicaid enrollment, no ownership/control/financial affiliation with specified entities, and in-state performance of billing/coding/claim submission/revenue-cycle activities; plus compliance with New Mexico gross receipts tax laws), “medicaid,” and “toxicology services” (laboratory testing of biological specimens for presence of drugs or alcohol). It clarifies that the section does not create a mandatory minimum or maximum frequency for reimbursement and does not restrict providers from ordering testing at a clinically necessary, documented frequency.
Finally, the bill appropriates $100,000 from the general fund to the Health Care Authority for fiscal year 2027 to administer Medicaid reimbursement for toxicology services provided by independent reference laboratories, with any unexpended balance reverting to the general fund, and sets an effective date of July 1, 2026.
bill
Legislation • 🇺🇸 United States • New Mexico • Bill
The bill establishes a new statutory requirement within New Mexico’s Public Assistance Act governing Medicaid reimbursement for personal care services, including definitions, minimum reimbursement rates, and mandatory allocation and documentation rules.
It creates a new section (“Medicaid reimbursement for personal care services”) that defines key terms for personal care service reimbursement models and workforce cost categories: consumer-delegated and consumer-directed personal care arrangements, “direct care worker,” and “direct care workforce expenditures,” including “employee-related expenses,” “training and supervision costs,” and “wages.”
The bill requires the Health Care Authority to implement minimum Medicaid reimbursement rates for personal care services, excluding gross receipts taxes: $23.50 per hour for consumer-delegated services and $19.78 per hour for consumer-directed services. It further requires any personal care services provider agency receiving Medicaid reimbursement to use at least 70% of that reimbursement to cover direct care workforce expenditures, after deducting gross receipts tax costs for purposes of calculating the 70% amount. Provider agencies must maintain accounting records demonstrating compliance and provide the records to the Authority upon request within a reasonable time.
Finally, the bill appropriates $51.4 million from the general fund to the Health Care Authority for expenditure in fiscal year 2027 to update the Medicaid personal care services fee schedule and increase Medicaid reimbursement under the new requirements. Any unexpended balance at the end of fiscal year 2027 reverts to the general fund.
The bill enacts major components of the 2026–2027 state health and mental hygiene budget, including multiple provisions that extend or revise the “effectiveness” windows of prior Medicaid and public health initiatives. It directs quarterly assessment of known and projected Department of Health state fund Medicaid expenditures by category and geography and extends/adjusts various expiration dates for Medicaid-related authorizations, program effectiveness, and rate methodologies. It also updates provider-reimbursement and funding formulas tied to Medicaid expenditures, including continuing and adjusting general hospital and indigent care pool mechanisms, extending eligibility-related timeframes, and revising certain supplemental rebate negotiation provisions, while specifying that some provisions expire or are deemed repealed on later dates.
For medical infrastructure and emergency care, the bill extends the quarterly framework for assessing Medicaid expenditures and makes multiple targeted changes affecting health care payment systems. It provides for extended operation timelines and technical corrections across telehealth, electronic prescribing, managed care, hospital quality pool allocations, and other Medicaid-related policy components; it also revises eligibility and coverage rules for specific populations (including changes to managed care use of certain waiver services and adjustments related to biomarker testing requirements). The bill further extends and restructures portions of the Health Care Reform Act funding streams by updating dates, available fund amounts, and distribution allocations into specific state funds and accounts, and it expands certain quantified payment components for programs such as uncompensated care, tobacco control and insurance initiatives pool distributions, and related public health and payment-support accounts through later periods.
The bill modifies several non-Medicaid health system and insurance provisions. It extends the hospital excess liability pool’s coverage period through June 30, 2027 and correspondingly updates the schedule for excess malpractice insurance purchasing, rate setting, and reimbursement rules. It also changes public access automated external defibrillator (AED) requirements by redefining the device’s capabilities in operative terms, allowing operation under department-prescribed authorization and regulations, requiring AED providers to train individuals and register each AED with the Department, requiring the Department to maintain a public electronic database, requiring immediate reporting of AED use to a public safety answering point, requiring AED providers to report usage data for quality improvement, and requiring sellers/transferors to provide written or electronic notice of applicable obligations; parallel changes are made to school AED requirements by updating reporting and registration obligations and aligning training requirements with department-approved standards.
The bill expands or redefines portions of health coverage and regulatory requirements relating to behavioral health and substance-related and addictive disorder parity by replacing “substance use disorder” terminology with “substance-related and addictive disorder” and ensuring the parity provisions apply accordingly across insurance and utilization-review frameworks. It also revises health plan and contract requirements to include defined “health care services” elements (including specified cancer center and dental/vision service inclusion), adjusts certain Medicaid eligibility and coverage rules (including changes to presumptive eligibility references and treatment coverage for specified pregnancy and cancer categories), and updates managed care/fee-for-service transition mechanics for particular eligibility groups. Finally, it establishes a state fiscal year 2026–2027 targeted inflationary increase—effective April 1, 2026—for specified mental health, developmental disabilities, addiction services and supports, temporary assistance, children and family services, and aging programs, with funding contingent on available appropriations, a stated 2.7% targeted inflationary increase (inclusive of other inflationary factors), certification and recoupment requirements for misallocated funds, and defined reporting and compliance consequences for providers and local governments.
Failed Sine Die • 2025-2026 Regular Session • Introduced: January 14, 2025
Sponsors: Amy R. Paulin (D-NY)
Co-sponsors: Linda B. Rosenthal (D-NY), Alex Bores (D-NY), Rebecca A. Seawright (D-NY), Christopher Burdick (D-NY), Karl A. Brabenec (R-NY), Andrew D. Hevesi (D-NY), Donna A. Lupardo (D-NY), Manny De Los Santos (D-NY), Demond L. Meeks (D-NY), Phara Souffrant Forrest (D-NY), Angelo L. Santabarbara (D-NY), Marcela Mitaynes (D-NY), Maritza Davila (D-NY), Sarahana Shrestha (D-NY), William Colton (D-NY), David G. McDonough (R-NY), Steven Raga (D-NY), Jo Anne Simon (D-NY), Karines Reyes (D-NY), John Zaccaro (D-NY), Judy A. Griffin (D-NY), Grace Lee (D-NY), Tommy John Schiavoni (D-NY), MaryJane Shimsky (D-NY), Christopher W. Eachus (D-NY), Anna R. Kelles (D-NY), Phillip G. Steck (D-NY), Dana Levenberg (D-NY), Tony Simone (D-NY), Jessica Gonzalez-Rojas (D-NY), Diana C. Moreno (D-NY), Emily E. Gallagher (D-NY), Robert C. Carroll (D-NY), Vivian E. Cook (D-NY), Amanda N. Septimo (D-NY), Jeffrey Dinowitz (D-NY)
The bill increases the minimum wage for New York home care aides and establishes a new minimum reimbursement framework tied to those wages.
It amends Public Health Law § 3614-f(2) by changing the scheduled minimum wage amounts for home care aides for specified periods, including replacing the prior “January 1, 2025 through December 31, 2025” schedule with a shorter period running through April 1, 2025. It also amends the statewide cap/ceiling language for home care aide wages so that, beginning on and after April 2, 2027, the minimum wage must be no less than 150% of the applicable statewide or regional minimum wage under Labor Law § 652.
It amends Public Health Law § 3614-f by adding new subdivisions 5 through 9. These require the commissioner to establish, by region, a “regional minimum hourly base reimbursement rate” for providers employing covered home care aides, with regions based on commissioner-defined areas (and for areas governed by Public Health Law § 3614-c, each area with a different prevailing total compensation rate must be its own region). The reimbursement rate must reflect average combined direct-service costs and include listed cost categories (e.g., overtime, transportation, benefits, payroll taxes, wage-linked increases such as compression, reasonable administrative costs, capital costs, allowable profit/reserves, and supplemental payments). The commissioner must annually adjust rates using a trend factor, publish and post rates annually, and take steps to ensure payers reimburse at the regional minimum rate. The bill prohibits deeming provider payments inadequate if they meet at least the regional minimum base reimbursement rate for authorized services, permits providers and payers to agree to higher rates, and provides rules for carrying forward the prior year’s rate when new calculations are not completed and for making retroactive adjustments as a pass-through within 60 days if needed.
To ensure compliance, it adds a new Public Health Law § 3614-f(4) authority giving the comptroller power to review managed care organization contracts with home care service agencies/fiscal intermediaries (and other relevant entities) to verify offered rates meet the department of health’s actuarial standards. The comptroller may develop an audit process to protect proprietary information and contracts, and if evidence suggests managed care organizations are not paying sufficient adequate rates, the bill requires referral/enforcement follow-through and makes the comptroller’s report and the department of health’s response public on the comptroller’s website. The bill also requires a study by the departments of taxation and finance, health, and labor (in consultation with the office of temporary and disability assistance) on using an expanded state earned income tax credit to improve the home care aide workforce, including a public hearing and reporting by no later than nine months after the act’s effective date or December 31, 2026, whichever is sooner. The act takes effect immediately, except that the minimum wage schedule change in section 2 takes effect January 1, 2027.
Ensures that temporary protected status beneficiaries continue to receive Medicaid benefits
label_outlineAccess to Care
label_outlineMedicaid
label_outlineMedicaid Reimbursement
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
February 12, 2025
Failed (Assembly)
January 07, 2026
Failed Sine Die • 2025-2026 Regular Session • Introduced: February 12, 2025
Sponsors: Michaelle C. Solages (D-NY)
Co-sponsors: Jo Anne Simon (D-NY), Clyde Vanel (D-NY), Maritza Davila (D-NY), Nily D. Rozic (D-NY), Jaime R. Williams (D-NY), William Colton (D-NY), David I. Weprin (D-NY), Charles D. Lavine (D-NY), Rodneyse Bichotte Hermelyn (D-NY), Jeffrey Dinowitz (D-NY), Crystal D. Peoples-Stokes (D-NY), Alfred E. Taylor (D-NY), Harvey D. Epstein (D), Catalina Cruz (D-NY), Andrew D. Hevesi (D-NY), Nader J. Sayegh (D-NY), Alicia L. Hyndman (D-NY), Karines Reyes (D-NY), Deborah J. Glick (D-NY), Erik M. Dilan (D-NY), Robert C. Carroll (D-NY)
The bill establishes new State protections in the Social Services Law to ensure continuity of New York Medicaid benefits for certain immigration-status groups when federal eligibility/designations end.
It adds a new section (§ 364-k) directing the New York Department of Social Services not to cancel, suspend, or rescind medical assistance for (1) individuals who are temporary protected status (TPS) beneficiaries if the federal government ends TPS designation for their country of origin, and (2) individuals enrolled in the federal Deferred Action for Childhood Arrivals (DACA) program when the program is ended by the federal government.
The new section also requires Medicaid eligibility extension to individuals who were formerly granted TPS or who were formerly enrolled in DACA, so long as they meet all other eligibility requirements except those tied to immigration status.
The provisions take effect immediately upon enactment.
The bill establishes a patient-protection rule for New York Medicaid managed care: it amends Social Services Law § 364-j (clause (F) of subparagraph (iii) of paragraph (a) of subdivision 4) to strengthen/clarify when a managed care enrollee can obtain coverage from an out-of-network health care professional through a “single patient agreement.”
Specifically, the amended clause authorizes coverage even when the requested health care professional is not a recurring provider in the enrollee’s managed-care network, provided the enrollee has a qualifying “long term relationship” with that professional. The bill defines “long term relationship” as a treatment relationship of ninety days or longer in which the professional provided Medicaid at least ten times. It also states that the health care professional must be paid the managed care provider’s in-network rates.
The clause is conditioned by a fraud/abuse/malpractice limitation: the requested coverage does not apply if the managed care provider has been made aware of reported allegations of fraud, abuse, or malpractice from that professional.
The bill also provides timing and billing/benefit structure: the coverage must be included when applying for medical assistance, or for existing coverage, on an anniversary date, subject to evidence of eligibility. Coverage may be subject to annual deductibles and coinsurance as determined by the commissioner, consistent with how other medical assistance benefits are established under the article.
The bill takes effect on the ninetieth day after enactment, and includes a technical provision stating the amendment to § 364-j will not affect the repeal of that section (the amendment is deemed repealed with the section).
The bill establishes a new requirement in the New York Public Health Law for certain health insurance companies to issue “joint checks” when paying for out-of-network services. It adds a new section (Public Health Law § 4406-j) directing an insurance company subject to Article 32 of the Insurance Law to issue and provide an insured with a single check made payable to both the insured and the health care provider for the purpose of paying that health care provider for out-of-network services rendered to the insured. The check must display the insured’s full name followed by the word “and,” and then the health care provider’s name or the provider’s group practice name.
The bill further specifies the formatting/content requirement for the joint check’s payee line (insured full name + “and” + provider name or group practice) and limits the trigger to out-of-network services rendered to the insured. No other circumstances, payment amounts, timing requirements, or exceptions are stated in the provided text.
The bill provides that it takes effect immediately upon enactment.
The bill makes the telehealth reimbursement provisions in prior law permanent by revising a deadline/expiration clause. It also creates a new rural workforce incentive framework in New York’s Public Health Law by adding Article 9-C, establishing (1) a rural healthcare professional loan repayment award program and (2) a refundable rural healthcare professional tax credit program, both administered through the Department of Health with related authority for program rules, certification, and compliance monitoring. Finally, it amends the Tax Law to add a new refundable personal income tax credit subsection tied to the Public Health Law certification process, and specifies how the credit may be claimed and what happens when the credit exceeds tax.
Under the new Public Health Law Article 9-C, “rural” practice is defined using existing law concepts, with additional definitions for “small town” (town population under 5,000) and “rural municipality” (specified political subdivisions located within a rural area). The loan repayment program authorizes the Commissioner of Health, subject to appropriation and notwithstanding specified state finance law provisions, to award loan repayments to eligible healthcare professionals who agree to practice full-time for five consecutive years in a rural area/small town/rural municipality. Awards are limited to qualifying outstanding eligible student loan debt for tuition and related educational expenses (as specified federal/state/approved sources), must be used solely for that purpose, and are disbursed over the five-year commitment (20% each year through the fourth year, with remaining balance paid in the fifth year subject to a maximum). If the five-year commitment is not completed, the recipient must repay amounts paid under a repayment calculation referenced to an existing statutory formula. The Commissioner sets eligibility criteria, can require site/service eligibility, may postpone/change/waive obligations in individual hardship circumstances, can reallocate undistributed funds, and may use department funds as matching funds for federal loan repayment grants.
The rural tax credit program requires the Commissioner to certify eligible healthcare professionals for a refundable credit under Tax Law § 606(uuu). Eligibility includes licensure under specified education-law articles and a pledge to practice for at least five years in a rural area/small town/rural municipality, with “wages earned” tied to gross taxable wages attributable to direct patient care services in the underserved area. Failure to complete the service period triggers rules for repayment of previously claimed credits, potentially prorated by completed service years. The Commissioner issues a “certificate of tax credit” specifying the credit amount and service year; the taxpayer must submit that certificate as part of the tax filing and may not claim the credit without Department certification.
For credit amounts, the bill sets different caps and percentages by healthcare professional category: for specified professional categories (including physicians, physician assistants, dentists, physical therapists, pharmacists, occupational therapists, and mental health practitioners), the credit equals 15% of wages earned in an underserved area, capped at $15,000 per year; for registered nurses, licensed practical nurses, and other designated professionals, the credit equals 10% of such wages, capped at $10,000 per year. The total aggregate credits issued in any taxable year are capped at $100 million, and the Commissioner must allocate credits prioritizing areas with the highest documented provider shortages. The bill also requires an annual written report (by December 31) to multiple legislative and executive officials detailing aggregate credit usage, number of recipients, amounts (excluding identifying personal information), purposes, geographic distribution, compliance rates, and other deemed-appropriate information.
The Tax Law amendment adds new § 606(uuu), allowing taxpayers with a Department of Health certificate to claim a refundable credit against tax in the certified amount, subject to the caps/percentages in the Public Health Law certification. Credits generally cannot be claimed without valid certification, and if the credit exceeds tax liability, the excess is treated as an overpayment to be credited or refunded under existing overpayment rules, with no interest. The bill takes effect immediately and applies to wages earned in taxable years commencing on or after January 1 following the effective date.
Strengthens transparency regarding Medicaid network adequacy and protecting beneficiaries from disru... (View full title on source site)
label_outlineNetwork Adequacy
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
December 10, 2025
Failed (Assembly)
May 19, 2026
Failed Sine Die • 2025-2026 Regular Session • Introduced: December 10, 2025
Sponsors: Matt Slater (R-NY)
Co-sponsors: Joshua Jensen (R-NY), Brian Manktelow (R-NY), Karl A. Brabenec (R-NY), Stephen M. Hawley (R-NY), Scott A. Gray (R-NY), Joseph P. DeStefano (R-NY), Matthew J. Simpson (R-NY), Alec Brook-Krasny (R-NY), David G. McDonough (R-NY), Scott Bendett (R-NY), Christopher W. Tague (R-NY), Andrew M. Molitor (R-NY), Kenneth D. Blankenbush (R-NY)
The bill establishes new state requirements intended to strengthen transparency and continuity protections for Medicaid managed care and Medicare Advantage enrollees regarding network adequacy and provider disruptions.
It adds a new Public Health Law section (4403-h) requiring the commissioner—after consultation with specified commissioners—to (1) annually update network adequacy guidelines, and (2) quarterly publicly post on the department’s website the results of network adequacy surveys of managed care organizations, with the department also publishing a summary within 30 days of the initial posting; any personally identifiable information of patients and providers must be removed before publication. The bill also requires any organization withdrawing from a Medicaid managed care organization or Medicare Advantage network to provide at least 90 days’ notice to the department, the Department of Financial Services, and affected patients who received services from the organization in the past year.
The bill amends existing continuity-of-care provisions for enrollees when a provider leaves a health maintenance organization network, extending certain transitional periods from “ninety” days to “one hundred eighty” days. It also amends the transitional protection for new enrollees whose provider is not initially in-network by changing the transitional period cap from “sixty” days to “one hundred eighty” days, while retaining conditions for life-threatening/degenerative disabling conditions and for enrollees in the second trimester of pregnancy (including coverage of pregnancy and post-partum care directly related to delivery).
The bill creates new Medicaid rate-adjustment authority requiring the state commissioner to provide reimbursement for language interpretation services for medical-assistance patients with limited English proficiency when such services are provided by hospital inpatient/outpatient departments, general hospitals’ outpatient and emergency services, and diagnostic and treatment centers.
It amends the Public Health Law to add (1) a new subdivision 36 to Section 2807-c directing the commissioner to adjust inpatient medical assistance payment rates for the costs of interpretation services for eligible patients, available at all patient-care locations and times, provided the services are documented to enable reporting and audit; it specifies eligibility based on patients whose primary language is not English and who cannot speak/read/write/understand English sufficiently to interact effectively. It also defines “interpretation services” to include language assistance provided by individuals with proven bilingual skills and, for interpretation during clinical encounters, individuals trained and skilled in medical interpreting techniques, ethics, and terminology. These services must be available for discharges on and after April 1, 2027. (2) It amends Section 2807’s subdivision 2(g) by adding a new subparagraph (iv) requiring the commissioner to adjust rates for general hospital outpatient and emergency services for eligible interpretation services, with the same April 1, 2027 effective date and reimbursement conditions; it adds conditions specifying that hospitals must initially use a skilled interpreter or translation service until the commissioner promulgates rules, after which hospitals must use individuals meeting the criteria to receive reimbursement. It prohibits reimbursement if the patient, having been informed in their primary language about free interpretation and translation services, requests use of family, friends, or others not formally trained in translation or interpretation. (3) It amends Section 2807 by adding a new subdivision 22 requiring rate adjustments for diagnostic and treatment centers licensed under the article for interpretation services for eligible medical-assistance patients, effective for services on and after April 1, 2027, with the same documentation requirement and location/timing scope.
It further amends Section 2807 by adding subdivision 8(g), making rates computed under subdivision 8 subject to an additional adjustment under Public Health Law subdivision 20, but only “subject to receipt of all necessary federal approvals.” Separately, it amends Social Services Law Section 368-a(1) by adding paragraph (aa) directing that the full amount expended for qualifying interpretation services is payable under the state’s reimbursement framework after deducting federal funds properly received or to be received for those expenditures.
Operationally, the bill suspends certain existing notice/approval/certification effectiveness provisions for specified prior time frames and prior-notice requirements for rates effective April 1, 2027 through March 31, 2028, deeming them without force and effect for implementing the act. It provides an effective date of the 120th day after enactment, while authorizing any necessary rule/regulation changes effective immediately on the act’s effective date (to be completed on or before that date).
Relates to the functions of the Medicaid inspector general with respect to audit and review of medic... (View full title on source site)
1st Chamber
2nd Chamber
Executive
check_circle_outline
check_circle_outline
stop_circle
remove_circle_outline
Introduced
January 07, 2026
Passed (Senate)
June 01, 2026
Failed (Assembly)
June 01, 2026
Failed Sine Die • 2025-2026 Regular Session • Introduced: January 07, 2026
Sponsors: Pete Harckham (D-NY)
Co-sponsors: Joseph P. Addabbo (D-NY ), George M. Borrello (R-NY ), Nathalia Fernandez (D-NY ), Patrick M. Gallivan (R-NY), Pamela A. Helming (R- NY ), Robert Jackson (D-NY), Rachel May (D-NY), Shelley B. Mayer (D-NY ), Steven D. Rhoads (R-NY), Gustavo Rivera (D- NY), Robert G. Rolison (R- NY), Luis R. Sepulveda (D-NY), Sam Sutton (D-NY), Lea Webb (D-NY )
The bill expands the Medicaid Inspector General’s audit/review standards for provider cost reports, claims, bills, and medical assistance payments by adding a new section (§37) to the New York Public Health Law. It requires audits/reviews to apply “applicable standards” and to give providers access to those standards before commencing; prohibits treating an “applicable standard” as effective if federal approval was pending or denied at the time services were provided; mandates publication of current audit/review protocols on the Inspector General website before starting the audit; requires the Inspector General to consider specified factors when determining repayment amount (including whether errors suggest sustained/high payment error, whether errors are clerical/minor, impacts on provider financial solvency, and potential negative impacts on access to services); and requires sampling/extrapolation methods to follow accepted auditing/statistical practice.
For overpayments based on “clerical or minor error or omission,” the bill defines that term to include categories such as mathematical/computational mistakes, transposed procedure/diagnostic codes, inaccurate data entry, computer errors, duplicate claims, and incorrect data fields (e.g., provider number, modifier, or date of service). The bill further limits extrapolation and recoupment where clerical/minor errors are isolated and occur in three or fewer cases, restricting recoupment to each affected audited claim. It also specifies that draft audit reports must include a detailed written explanation of any extrapolation methodology (sample size/methodology, claim universe, specific sampled claims, sample results, assumptions, confidence level, and steps to calculate alleged overpayment and any offsets), requires consideration of provider-submitted supporting documentation prior to issuance of final reports (including attestations for missing documentation/signatures), requires written explanation if such documentation is rejected, and requires the final audit report or final notice of agency action to include a specific explanation of consideration of the repayment factors.
The bill adds procedural repayment protections affecting timing and settlement: it allows providers to settle through repayment at the “lower confidence limit plus applicable interest” even if a hearing is requested, until the hearing determination is issued; and it prohibits both inspector recoupment and provider repayment from commencing earlier than 60 days after the issuance date of the final audit report, or—if a hearing is requested—60 days after issuance of the hearing determination. It also clarifies that the new section does not prevent compliance with Medicaid audit requirements or binding federal guidance.
In addition to adding §37, the bill amends the annual reporting requirement in §35 of the Public Health Law: it replaces the existing bracketed requirement that the inspector submit an annual report “summarizing the activities of the office during the preceding calendar year” with a requirement to consult with the commissioner on preparing the annual report and to include additional required narratives. It amends the existing content of §35(1) to require reporting that includes: (1) the number/subjects/outcomes and dollar value identified for recovery and actual recovery, including how many overpayments used extrapolation; (2) an evaluative performance narrative; (3) a department-provided fraud/waste/abuse mitigation narrative; and it adds a new §35(1)(h) narrative describing steps taken in the past year to comply with §32(6)’s requirement to consider quality/availability and the best interests of both the Medicaid program and recipients when pursuing civil and administrative enforcement actions. The bill takes effect on April 1 of the first year next succeeding the date it becomes law.
Failed Sine Die • 2025-2026 Regular Session • Introduced: February 20, 2025
Sponsors: Nathalia Fernandez (D-NY )
Co-sponsors: Joseph P. Addabbo (D-NY ), Cordell Cleare (D-NY ), Leroy G. Comrie (D-NY ), Jeremy A. Cooney (D-NY), Pete Harckham (D-NY), Robert Jackson (D-NY), Jessica Ramos (D- NY), Julia Salazar (D-NY), Jeremy J. Zellner (D-NY)
The bill strengthens protections for insured/enrollees in New York health plans regarding utilization review and claim audits by limiting what can be reversed after an initial determination of medical necessity, and by adding definitions and procedural standards for review criteria.
First, it amends Insurance Law § 3224-b(b) by renumbering existing paragraphs and adding two new provisions: (1) absent fraud, retrospective claim review or audit by or on behalf of a health plan may not reverse or otherwise alter a medical-necessity determination previously made by a utilization review agent or an external appeal agent; and (2) absent fraud, review or audit may not “downgrade” or “bundle” coding of a claim if doing so would reverse or alter a medical-necessity determination, including any level-of-care determination made by or on behalf of the health plan.
Second, it expands and adjusts terminology and utilization-review standards in Insurance Law § 4900 and § 4902. It adds a new definition of “Mental health and substance use disorders” tied to specified diagnostic categories in the World Health Organization’s ICD and/or the American Psychiatric Association’s DSM, while clarifying that future reorganization/classification changes do not affect covered conditions so long as the condition is commonly understood as such by clinicians in relevant specialties. It also updates the “peer-reviewed” support for utilization review by adding peer-reviewed practice guidelines, criteria, or recommendations from non-profit clinical specialty associations generally recognized by clinicians.
Third, it amends the definition of “medically necessary” in § 4900(g-6) to require that covered services/products address the insured’s specific needs and satisfy conditions relating to medical/scientific evidence, clinical appropriateness (type, frequency, extent, site, duration), and being not primarily for the insurer/insured’s economic benefit or for convenience. It adds a new Insurance Law § 4903(j) requiring a utilization review agent to authorize a request for a covered health care service or product when it is medically necessary. It further amends utilization review requirements for emergency services (removing language that made such services non-reviewable/deniable only if they were medically necessary, and instead limiting denial to situations where a health plan reasonably determines the emergency services were never performed to stabilize or treat an emergency condition). It changes multiple utilization review criteria standards by removing references to “evidence-based” and requiring peer-reviewed clinical review tools/criteria instead, including for substance use disorder treatment, mental health coverage, step therapy protocols, and step therapy override determinations; it also updates how inter-rater reliability testing timing is expressed, and adds/updates requirements about publicly identifying authors/reviewers/editors involved in development and review of the criteria. The public health law’s parallel provisions in § 4902(h)–(j) are similarly conformed.
The bill amends Section 18-c of New York’s Public Health Law to change how patient consent for “treatment” versus “payment” for health care services must be handled and to impose new requirements for the payment-consent process.
It removes the prior requirement (shown as struck-out text within the amended section) that consent to pay “shall not be given prior to the patient receiving such services and discussing treatment costs.” Instead, any consent for payment must be completed using a uniform patient liability form. The form must be developed by the Superintendent of Financial Services in conjunction with the Commissioner, may not include language requiring patients to assume unlimited financial liability, and must specify that the patient is liable only for the cost of services actually provided. The bill also directs that the consent-payment form include specified language beginning with “I understand that I may request a ‘good faith estimate’ of any current or future visit, or procedure,” and requires that good-faith estimates be provided to patients upon request, subject to regulations developed by the Superintendent of Financial Services together with the Commissioner.
The bill further requires that the consent-for-payment form be signed by the patient or their legal representative, and provides that any form that does not comply with the section is prohibited and unenforceable. It defines “consent” for purposes of the section as an action that: (a) clearly and conspicuously communicates authorization; (b) is made in the absence of any user-interface mechanism that has the purpose or substantial effect of obscuring, subverting, or impairing decision-making or choice; and (c) cannot be inferred from inaction.
Relates to fair pricing for low-complexity, routine medical care
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
January 08, 2025
Failed (Senate)
May 12, 2026
Failed Sine Die • 2025-2026 Regular Session • Introduced: January 08, 2025
Sponsors: Liz Krueger (D-NY)
Co-sponsors: Jabari Brisport (D-NY), Cordell Cleare (D-NY ), Leroy G. Comrie (D-NY ), Jeremy A. Cooney (D-NY), Patricia A. Fahy (D-NY), Nathalia Fernandez (D-NY ), Kristen Gonzalez (D-NY ), Andrew S. Gounardes (D- NY), Pete Harckham (D-NY), Michelle Hinchey (D-NY), Brad Hoylman-Sigal (D), Robert Jackson (D-NY), John C. Liu (D- NY ), Rachel May (D-NY), Shelley B. Mayer (D-NY ), Zellnor Myrie (D-NY), Kevin S. Parker (D-NY), Jessica Ramos (D- NY), Christopher J. Ryan (D-NY), Julia Salazar (D-NY), Luis R. Sepulveda (D-NY), Jose Marco Serrano (D-NY), James G. Skoufis (D-NY), Toby Ann Stavisky (D-NY), Sam Sutton (D-NY), Lea Webb (D-NY ), Jeremy J. Zellner (D-NY)
The bill establishes New York’s “fair pricing” requirements for specified outpatient/ambulatory services that can be provided across ambulatory settings (“applicable services”) using a site-neutral payment approach tied to Medicare non-hospital rates. It creates definitions for a “site-neutral payment policy,” “applicable services,” “health care provider” (including exclusions for certain safety-net and specific hospital categories), “affiliated provider,” and “health benefit plan,” and it requires that providers and payers (including insurers and certain other plan types) limit reimbursement/charges for applicable services.
For providers, the bill bars charging, billing, or accepting payment for applicable services above the lesser of (i) 150% of the Medicare non-hospital rate or (ii) the negotiated rate between the provider and the health benefit plan, and it applies even if there is no contract (including self-pay). It also prohibits improper claim-form billing: institutional claims may not be filed for services when a professional claim form is appropriate, and it prohibits charging both professional and institutional claims for the same service. Providers that participate via a health care contract must offer to accept as payment in full rates not exceeding 150% of the Medicare non-hospital rate. Beneficiaries/self-pay individuals are barred from being held liable for amounts above these limits, including any copayments, deductibles, and/or coinsurance tied to prohibited charges.
To support enforcement and monitoring, the bill requires the Department of Health (in consultation with the Superintendent of Financial Services) to publish an annual public report beginning one year after the section’s effective date on multi-year spending trends and cost drivers for ambulatory services, including price comparisons to Medicare non-hospital rates, service volumes and total spending, an estimate of savings to payers/consumers, a list of general hospitals charging in violation and state actions taken, and recommendations to the Governor and Legislature. It also requires the department to annually post a public list of health care facilities exempt from the pricing section.
The bill creates enforcement and remedies: violations by providers trigger administrative penalties equal to the greater of (a) $100,000 per contract occurrence or (b) $1,000 per claim improperly billed. It declares provider violations (and certain related violations in the Insurance Law) to be unlawful deceptive acts or practices under the General Business Law, and authorizes persons/entities suffering loss to sue for available remedies. In parallel, it amends the Insurance Law to prohibit broad categories of payers (insurers, and other listed regulated entities such as specific corporation types and employee welfare funds, plus municipal cooperative health benefit plans and health care plans subject to another public health law section) from reimbursing or contracting for reimbursement above the applicable capped rates or for services billed in violation of the prohibited claim-form rule; the Superintendent (or Department) may impose penalties up to $50,000 per day per contract day of violation. The bill also requires joint regulations by the Commissioner of Health and the Superintendent of Financial Services to implement these provisions, and it specifies that the act takes effect January 1 next succeeding enactment and applies to policies/contracts issued, amended, or renewed on or after that date (with authorization to implement necessary rules/regulations by the effective date).
The bill requires certain health insurance coverage to include an electrocardiogram (EKG) test and an interpretation of the results for adults and children who have received a coronavirus vaccine. The requirement applies regardless of family history of heart disease or related conditions, when ordered by a physician or other licensed professional whose scope of practice under New York Education Law Title 8 allows administration of such a test, and is to be provided in accordance with prevailing clinical standards.
The bill implements this coverage mandate in three places within New York’s insurance and related health programs statutes: (1) it updates the benefit requirements for comprehensive major medical plans under Insurance Law § 3216 by amending the list of required essential health benefits to add a new item covering post-coronavirus-vaccination EKG testing and interpretation; (2) it updates the benefit requirements for individual and family health insurance policies under Insurance Law § 3221 by adding a parallel new item for adults and children who received a coronavirus vaccine; and (3) it updates the benefit requirements for health maintenance organizations under Insurance Law § 4303 by adding a corresponding new subparagraph.
In addition, the bill adds a matching requirement to the Social Services Law benefit provisions. Under Social Services Law § 365-a, it creates a new paragraph requiring the same EKG test and interpretation for adults and children who have received a coronavirus vaccine, again irrespective of family history, and conditioned on orders by an appropriately authorized licensed professional in accordance with prevailing clinical standards. However, the Social Services Law EKG coverage provisions are not to take effect unless all necessary federal approvals are obtained to receive federal financial participation in the costs of the services.
The bill takes effect immediately and applies to any policy issued, delivered, renewed, and/or modified on or after the effective date.
bill
Regulation • 🇺🇸 United States • New York • Proposed Notice
The document establishes a set of proposed amendments to New York’s Medicaid provider regulations (18 NYCRR Part 505) to explicitly authorize the use of electronic orders and forms by Medicaid providers and to update how providers access fee schedules and provider manuals. It also repeals 18 NYCRR § 537.3, which the Department states has been superseded by fee schedules posted by the Medicaid fiscal agent.
Key changes update multiple Part 505 provisions so that “written” order/referral/form requirements are expressly satisfied by “electronic” orders and forms. This includes: (1) allowing durable medical equipment, medical/surgical supplies, orthotic and prosthetic appliances/devices, and orthopedic footwear to be furnished only on a written or electronic practitioner order; (2) requiring providers to maintain written or electronic orders for audit for six years from date of payment; (3) requiring ophthalmic supply/services reimbursement to track the current New York State fee schedule approved by the Budget Director and directing providers to the Medicaid fiscal agent website rather than referencing § 537.3; and (4) revising laboratory service rules to permit fiscal orders, practitioner prescriptions/referrals, and qualifying facility-issued order forms to be hardcopy or electronic, including updating availability of fee schedules/manuals to the Medicaid fiscal agent website.
Additional Part 505 changes apply electronic-order concepts across other service categories: nursing services in home/school/natural settings must follow the attending physician’s written or electronic order (with initiation provisions retained), and orders for nursing services beyond initial two visits require a written or electronic physician order; rehabilitation services must be supported by a written or electronic order of a qualified physician; prior-authorization requests for ambulette/nonemergency ambulance and for ambulette/paratransit must be supported by written or electronic orders of specified ordering practitioners; laboratory-provider manual/fee schedule references are updated to direct providers to the Medicaid fiscal agent website; and several fee-schedule provisions for chemical dependence outpatient services and audiology/hearing aid-related services are likewise updated to use the fiscal agent website.
The proposal includes a compliance/timing statement: public comment is accepted until 60 days after publication of the notice, and the regulation is stated to take effect upon publication of a Notice of Adoption in the New York State Register (i.e., no earlier effective date is specified). It also explicitly repeals 18 NYCRR § 537.3 and replaces related internal cross-references with website-based directions for current fee schedules.
North Carolina
3
bill
Legislation • 🇺🇸 United States • North Carolina • Bill
Sponsors: Donny Carr Lambeth (R-NC), Jeff Zenger (R), Kyle Hall (R-NC), Tricia Ann Cotham (R)
Co-sponsors: Jennifer Balkcom (R), Brian Biggs (R), Celeste C. Cairns (R), Grant Campbell (R), Richard Carver (R), Dudley Greene (R), Chris Humphrey (R), Keith Kidwell (R-NC), Donnie Loftis (R), Jeffrey C. McNeely (R), Charles W. Miller (R), Howard Penny (R), A. Reece Pyrtle (R), Dennis Riddell (R-NC), Mitchell S. Setzer (R-NC), Phillip R. Shepard (R-NC), Larry C. Strickland (R-NC), Bill Ward (R-NC), Harry Joseph Warren (R-NC), Diane Wheatley (R), Donna McDowell White (R-NC), Shelly Willingham (D-NC), David Willis (R), Lowery
The bill establishes and expands North Carolina’s Medicaid provider enrollment and program-integrity controls within Chapters 108A and 108C of the General Statutes. It creates a new licensure limitation check that authorizes the Department of Health and Human Services to deny or retroactively terminate a Medicaid provider’s enrollment when the provider’s licensing entity takes adverse action that limits practice scope, service delivery parameters, or a provider’s authority to care for patients, including actions discovered through required self-reporting. It also creates a “Provider Enrollment Credentialing Committee” within the Department as the centralized administrative adjudication body for provider participation and requires confidentiality for specified screening/monitoring information (including health info, adverse licensure findings, malpractice judgments/settlements, fingerprints, and other protected nonpublic criminal information).
The bill adds new “grounds for adverse termination” provisions authorizing the Department to deny enrollment, deny revalidation, or terminate participation for specific integrity/safety failures: (1) submitting claims for services that could not have been and were not furnished to a specific individual on the date of service; and (2) billing for services furnished while the provider’s license is suspended. It also expands the Department’s enrollment denial/termination authority tied to licensure-related and conviction-related offenses by revising the criminal history check statute to cover providers and related individuals with specified ownership/role thresholds, and by allowing termination under additional offense categories (with exclusion periods tied to when providers (or responsible individuals) complete discharge requirements after convictions).
The bill requires the Medicaid provider administrative participation agreement to include operational electronic health record (EHR) controls: providers must identify their EHR vendor, notify the Division of Health Benefits of any vendor changes, ensure every EHR user has a unique login, and notify the Division when the provider becomes aware that any employee is newly convicted of criminal offenses identified under the revised Medicaid licensure/termination framework (covering both current employees and relevant employees within the preceding 12 months). Finally, it amends Medicaid managed care “provider network” rules by specifying mandatory closed networks for PHPs for peer support services and research-based behavioral health treatment services, expands the children and families specialty plan closed-network service categories, and adds a new eligibility category related to certain lawfully present individuals under CHIP reauthorization provisions. The bill’s general effective date is “when it becomes law,” with a specific licensure-limitation check effective October 1, 2026, and applying to adverse actions effective on or after that date.
bill
Legislation • 🇺🇸 United States • North Carolina • Bill
In House • 2025-2026 Regular Session • Introduced: March 17, 2025
Sponsors: Jim Burgin (R), Amy S. Galey (R), Benton Sawrey (R)
Co-sponsors: W. Ted Alexander (R), Lisa Stone Barnes (R), Philip Edward Berger (R), Bob Brinson (R), Kevin Corbin (R), Warren Daniel (R), Carl Ford (R), Robert Hanig (R), Ralph Hise (R), Mark Hollo (R), Michael V. Lee (R), Timothy D. Moffitt (R), Paul Newton (R), Brad Overcash (R), William Peter Rabon (R), Norman W. Sanderson (R), Eddie D. Settle (R), Jackson, Jones
The General Assembly of North Carolina is implementing significant changes to enhance transparency and affordability in healthcare. Rising healthcare costs have become a burden for individuals, families, employers, and taxpayers, prompting the need for price transparency. The new regulations require healthcare providers and insurers to disclose prices for services in advance, enabling consumers to make informed choices and fostering competition among providers.
Hospitals and ambulatory surgical facilities will be mandated to report financial information related to inpatient admissions and surgical procedures, including charges for Diagnosis-Related Groups (DRGs) and average negotiated settlements. These reporting requirements aim to improve transparency in healthcare costs and ensure compliance with federal regulations. Additionally, healthcare providers must provide written disclosures regarding potential separate billing for nonparticipating providers, enhancing consumer protection.
New provisions will also require healthcare facilities to provide patients with itemized lists of charges before referring unpaid bills to collections. Patients requesting good-faith estimates for shoppable services will not face final bills exceeding five percent of the provided estimate, and healthcare providers are restricted from charging facility fees for certain outpatient services. These changes are designed to improve patient experience and financial clarity.
The regulations also address the appeals process for health insurance claims, ensuring that insurers provide clear information about appeal coordinators and the qualifications of reviewers. Changes to prior authorization and utilization review procedures will require insurers to enhance their communication with covered persons and ensure that prior authorizations remain valid for specified periods.
Overall, these initiatives aim to create a more transparent and consumer-friendly healthcare environment in North Carolina, ultimately improving access and reducing unexpected costs for patients.
bill
Legislation • 🇺🇸 United States • North Carolina • Bill
The General Assembly of North Carolina has enacted significant changes to Medicaid funding and state agency operations, which will have substantial financial implications across various sectors. Key measures include the elimination of vacant positions in state agencies, with a target reduction of at least $19,742,243 in recurring funds by October 1, 2025. The Department of Health and Human Services (DHHS) is also mandated to achieve net General Fund savings of $32,613,493 through similar reductions. Additionally, Medicaid funding will be adjusted with an appropriation of $690 million for the 2025-2027 fiscal biennium, alongside specific allocations for managed care operations.
Changes to Medicaid eligibility processing have been introduced, requiring county departments of social services to make decisions on applications within set timeframes. The Department will enforce standards for processing times and initiate corrective actions if counties fail to meet these standards. A corrective action plan will be established for counties that do not comply, with the potential for the Department to temporarily assume Medicaid eligibility administration if necessary.
The document also outlines provisions for the administration of Medicaid and the Supplemental Nutrition Assistance Program (SNAP), emphasizing the importance of accuracy and quality assurance in eligibility determinations. The DHHS will oversee funding and compliance at the county level, with annual reporting requirements to monitor performance metrics. Performance audits will be conducted to ensure adherence to standards, with specific funding allocated for these audits.
Financial provisions affecting the state budget for the fiscal years 2025-2026 and 2026-2027 include a reduction in transfers from the General Fund to the State Capital and Infrastructure Fund and the management of unexpended bond proceeds for various capital improvement projects. These changes are expected to impact the healthcare and social services sectors, as well as businesses involved in state-funded infrastructure projects, due to adjustments in funding allocations and project financing.
Regards health insurance, Medicaid prior authorization
label_outlineprior authorization
label_outlineMedicaid Reimbursement
1st Chamber
2nd Chamber
Executive
check_circle_outline
check_circle_outline
play_circle_outline
remove_circle_outline
Introduced
April 01, 2025
Passed (House)
March 25, 2026
Considering (Senate)
April 15, 2026
In Senate • 2025-2026 Regular Session • Introduced: April 01, 2025
Sponsors: Heidi Workman (R)
Co-sponsors: Sean P. Brennan (D), Darnell T. Brewer (D), Gary N. Click (R), Christine Cockley (D), Jack K. Daniels (R), Chris Glassburn (D), Crystal Lett (D), Joseph A. Miller (D), Kevin D. Miller (R), Ismail Mohamed (D), Scott Oelslager (R), Beryl Brown Piccolantonio (D), Tristan W. Rader (D), C. Allison Russo (D), Jodi Salvo (R), Jean Schmidt (R), Bride Rose Sweeney (D), Daniel P. Troy (D), Andrea White (R), Joshua Williams (R)
The bill establishes new statewide requirements governing prior authorization (including electronic submission, response times, appeals, and limits on retroactive denials) for (1) health insuring corporation plans, (2) sickness and accident insurers/public employee benefit plans, and (3) Ohio Medicaid managed care/medical assistance programs. It sets definitions for key terms such as “chronic condition,” “clinical peer,” “emergency services,” “urgent care services,” and “prior authorization requirement,” and requires that prior authorization processes be administered through specified electronic methods and timelines.
For coverage subject to prior authorization, the bill requires secure electronic transmission for submitting and responding to prior authorization requests (with specified standards for prescription drugs and medical benefit requests) and provides for non-electronic processing when electronic submission is infeasible due to financial hardship or limited/unavailable internet. It also requires timely responses: within 48 hours for urgent care requests and within 10 calendar days for non-urgent requests (and specifies that emergency services are excluded from these response-time rules). The payer must indicate approval/denial and, if denied, provide specific reasons; if incomplete, the payer must specify additional information needed. For urgent care and other adverse prior authorization determinations, it requires a streamlined internal appeal process with set consideration periods (48 hours for urgent care; 10 calendar days for other matters), adjudication by the requesting practitioner and a “clinical peer,” identification of the clinical peer’s specialty/qualifications, and availability of external review where applicable. The bill also makes appeal fees prohibited for adverse prior authorization determinations.
For chronic-condition prescription drugs, the bill requires honor of prior authorization approvals for the lesser of 12 months or the end of the covered person’s eligibility (for commercial/sickness-and-accident/public plans) or eligibility for the medical assistance recipient (for Medicaid), beginning with approvals related to chronic conditions; it allows periodic requests for information to confirm the chronic condition has not changed (no more than quarterly) and allows termination if the practitioner does not respond within five calendar days. It includes automatic termination of the 12-month approval if laws/regulatory guidance/compliance information indicate the drug is no longer approved or safe, and it lists specific medication categories excluded from the 12-month chronic-condition rule (e.g., non-maintenance, shorter than one-year typical treatment, initial trial-period drugs, drugs without evidence supporting 12-month approval, certain controlled substances/opioids/benzodiazepines, and drugs not prescribed by an in-network provider in a care management program). It also permits medication substitution consistent with specified statutory interchangeability/therapeutic equivalence rules.
The bill further bars retroactive denial of a prior authorization (with exceptions for fraudulent or materially incorrect information) when the practitioner submitted and the payer approved a prior authorization request and the service/drug/device is rendered and claimed in accordance with the approved request and related conditions (including that the patient/recipient remains eligible and circumstances haven’t changed). Any contrary contractual provisions between payers and providers/beneficiaries are made unenforceable, and repeat violations are deemed an unfair and deceptive practice under specified law for the non-Medicaid contexts. Finally, it requires notice to practitioners of new prior authorization requirements (at least 30 days in advance) and requires publication of prior authorization requirement listings and the specific services/drugs/devices subject to prior authorization. The bill makes these changes effective January 1, 2028, and repeals existing versions of sections 1751.72, 3923.041, and 5160.34 on that effective date.
The bill establishes a major restructuring of Ohio’s Medicaid program by eliminating the “care management system” (a system of financial risk-bearing Medicaid managed care) and replacing it with a state-administered administrative services organization (ASO) / managed fee-for-service framework. It creates and revises multiple Medicaid provisions to: (1) convene a transition workgroup; (2) require procurement and federal approvals; (3) prohibit renewal/new contracts with financial risk-bearing Medicaid managed care organizations beginning the first day of the relevant fiscal biennium after ASO contracts; (4) direct the transition of enrolled Medicaid recipients from managed care plans to fee-for-service or managed fee-for-service; (5) require termination of those managed-care contracts after transition, with 30 days’ notice; and (6) mandate an annual report to the General Assembly and Governor and reinvestment of 100% of savings into the Medicaid program.
Operative Medicaid process changes include: updating Medicaid budget forecasting and state budget appropriation item requirements to explicitly separate “services provided under the care management system” and other service categories (with an “effective” state-budget timing requirement tied to the Sept. 30, 2025-introduced budget); modifying prior-authorization-related requirements for Medicaid service coverage (including electronic workflows, timelines, streamlined appeals, and limits on certain types of retroactive denials except for fraud/materially incorrect information); and modifying Medicaid third-party recovery administration to include cooperation and procedural protections (including hearings/administrative appeal mechanics, presumptions about allocation, escrow mechanisms, and new cooperation obligations tied to disclosure of third-party liability).
The bill also enacts new Medicaid program components and related definitions, including a “healthy Ohio program” (a medicaid waiver component for certain adults) with buckeye accounts and participation rules, and it creates an evaluation/reporting structure for program effectiveness. Separately, it creates an ASO transition framework at the statutory level, including definitions for ASOs, care coordination, and managed fee-for-service, and requires data collection/reporting from Medicaid managed care organizations during evaluation and transition. It also modifies or relocates provisions within Medicaid law by adopting a new section number (5162.73 (5162.74) is amended for renumbering) and enacts a new section number (5162.73), with related dental-program and evaluation requirements shown in the text.
In addition to Medicaid changes, the bill makes broad statutory edits outside Medicaid. It repeals a list of existing Revised Code sections that are directly tied to the care management/Medicaid managed care structure and related franchise fee components, and it repeals multiple non-Medicaid provisions across insurance/pharmacy/telecommunications tax definitions and other areas (as reflected by the repealer sections listing many Revised Code sections). It also adds extensive, detailed content affecting the state’s prescription drug monitoring database confidentiality/use rules, prior authorization/payment processes, and other regulatory definitions that are consistent with the bill’s broader “Medicaid Savings Act” objective. The act is named the “Medicaid Savings Act.”
The bill establishes new requirements for health plan issuers regarding health care claim decisions, creates a “medical claims consumer assistance program” under the Superintendent of Insurance, and expands health insurance claim review and reporting duties. It prohibits health plan issuers from “wrongfully” denying, reducing, or terminating requested covered health care services or payments, and subjects violations to enforcement procedures and enhanced penalties.
For issuer misconduct, the bill creates a new section (Sec. 3901.216) defining the prohibition on wrongful denials/reductions/terminations, and sets enforcement via the existing unfair/deceptive insurance enforcement framework (Sec. 3901.22), with additional remedies. If the superintendent finds a violation, the superintendent may request the attorney general to sue in the name of the state, and the court may order (among other remedies) double damages to the covered person plus reasonable expert/attorney expenses, damages determined by the court, and a civil penalty up to $25,000 per violation; it may impose additional penalties for repeated violations and requires consideration of specified penalty factors. It also directs the superintendent to increase penalty amounts annually beginning one year after the effective date based on health insurance premium rate changes or inflation (using CPI), and sets out a detailed list of factors the superintendent or court must consider when determining penalties.
The bill creates the medical claims consumer assistance program (Sec. 3901.97), which the superintendent must establish to assist consumers with adverse benefit determinations and insurance coverage concerns. The program must provide information on internal appeals and external review processes, assist with filing complaints and appeals, help settle disputed claims, collect and quantify consumer problems and inquiries, educate consumers on rights/responsibilities, assist with enrollment information/referrals, assist consumers obtaining premium tax credits, and provide public outreach (including electronic resources and a toll-free number). The bill requires each health plan issuer to place a prominent plain-language notice about the program on the front page of health plan communications (including explanations of benefits and adverse benefit determination notices). It also allows the superintendent to incorporate existing department programs into the assistance program and to contract with a nonprofit independent entity, while barring health plan issuers and their subsidiaries/affiliates from serving as the administering entity.
The bill also revises independent review organization (IRO) review requirements (Sec. 3922.07) by adding additional materials and evidence that the IRO must consider where available and appropriate, including the covered person’s medical records, treating professional recommendations, consulting reports/documents from parties, plan terms, practice guidelines, clinical review criteria used by the issuer, the clinical reviewer’s opinion, and evidence of intent by the issuer to improperly deny/reduce/terminate. Separately, it requires health plan issuer data submissions and reporting by the superintendent (Sec. 3922.171), including the number/percentage/type of adverse benefit determinations (overall and found wrongful under the new wrongful standard) and the number/types of consumer-reported issues to the assistance program, with the superintendent required to submit the annual report to multiple state leaders and post it publicly in machine-readable format. Finally, it repeals existing sections 3901.22 and 3922.07 of the Revised Code and names the act the “Fair Health Claims Act.”
The bill establishes the “Medicaid Savings Act” and directs Ohio Medicaid to eliminate the care management system. It creates/renumbers section 5162.73 (5162.74) and enacts new section 5162.73, and also includes the repeal of numerous Medicaid-related statutory sections, including the “care management system” provisions and definitions under Revised Code chapters 5167 and related sections.
Program budgeting and forecasting are modified to reduce reliance on care management-system reporting while still requiring Medicaid budget forecasting components to reflect enrollment and spending categories. Specifically, the caseload/expenditure forecast report to the Governor and General Assembly is updated to reflect the care management system’s enrollment and spending components (including member months and per member per month rates), and the bill changes the structure of Medicaid services general revenue fund appropriation items starting with the state budget introduced after the section’s effective date (including a dedicated item for services under the care management system and other specified service categories such as nursing facility services, hospital services, behavioral health services, waiver-administered services, prescriptions, physician services, and Ohio home care waiver services; it also adds OhioRISE waiver services and permits additional service items determined by the directors).
A major substantive operational change replaces risk-bearing Medicaid managed care with administrative services and fee-for-service (or a “managed fee-for-service” model) through an ASO-based transition. New/updated sections require: (1) convening a stakeholder workgroup to develop a transition plan for terminating the former care management system; (2) selecting one or more administrative services organizations through procurement and adopting implementing rules; (3) seeking necessary CMS federal approvals; (4) not renewing or entering new contracts with financial risk-bearing Medicaid managed care organizations beginning in the first fiscal biennium after ASO contracts are entered; (5) transitioning all Medicaid recipients from financial risk-bearing managed care plans to fee-for-service or managed fee-for-service; (6) terminating existing contracts and providing notice to managed care organizations; and (7) requiring that 100% of “cost savings” realized from terminating the care management system be reinvested into the Medicaid program. The bill also requires an annual report to the General Assembly and Governor, including savings metrics and clinical/resource utilization outcomes for recipients transitioning to the ASO system.
In parallel, the bill repeals large portions of current Medicaid care management law and related provider/administration provisions, including Revised Code sections governing the care management system and its components (notably in R.C. 5167 and specified related sections listed for repeal). It also amends several other statutory provisions not limited to Medicaid (e.g., medical records copying limits in R.C. 3701.741; parts of prescription drug monitoring/disclosure rules under R.C. 4729.80 and related sections; and updates to various insurance/credentialing and health care financing provisions), and it modifies Medicaid payment administration concepts such as electronic claims submission and drug maximum allowable cost and franchise fee framework that depends on member-months while the care management system is being terminated/transitioned.
bill
Regulation • 🇺🇸 United States • Ohio • Final Notice
The regulation sets forth Ohio Bureau of Workers’ Compensation (BWC) reimbursement methodologies for hospital outpatient services, including payment for dates of service on or after May 1, 2025/2026, using Medicare Outpatient Prospective Payment System (OPPS) rates with specified bureau-specific payment adjustment factors, defined exclusions, and add-on payments calculated using Medicare OPPS methodology.
For BWC (under the HPP pathway), reimbursement for most hospital outpatient services is based on the applicable Medicare OPPS reimbursement rate, multiplied by a bureau-specific payment adjustment factor (3.414 for children’s hospitals and 1.449 for other hospitals), plus applicable add-on payments. BWC will process outpatient bills using the Medicare integrated outpatient code editor and Medicare medically unlikely edits, but will not apply certain outpatient code edits identified in the rule’s appendix. The rule also specifies that certain Medicare reconciliation processes (annual OPPS outlier, hold harmless, and exempt cancer hospital reconciliation) are not applied. Hospitals’ payment designations (critical access, rural sole community, essential access community, and exempt cancer) and “children’s hospitals” are determined from the Medicare outpatient provider-specific file, and the rule lists recognized children’s hospitals.
The rule further details alternative payment methodologies for specific service categories: (i) fee schedule-based services (including how wage index adjustments are treated and when bureau-specific payment adjustments apply), (ii) services reimbursed at reasonable cost using hospital outpatient cost-to-charge ratios (with critical access hospitals generally reimbursed at 101% of reasonable cost for payable line items), (iii) add-on payments on a line-item basis (outlier, rural hospital, and hold harmless for exempt cancer centers and children’s hospitals) and the sequencing of these add-ons relative to the bureau-specific payment adjustment factor. It also establishes rules for hospitals not participating in Medicare (using FY25/FY26 urban or rural statewide average outpatient cost-to-charge ratios, with the Ohio average used for hospitals outside the United States) and for “new hospitals” (defined by 42 C.F.R. 412.300(b) using the published federal definition) as calculated under the non-Medicare methodology.
For QHPs or self-insuring employers (non-QHP), hospital outpatient services may be reimbursed at either (1) the applicable rate under the HPP methodology, or (2) the rate negotiated between the hospital and the QHP/self-insuring employer under a referenced administrative code rule. The “provider-based status” provision authorizes BWC to request information (including possible attestation) to determine whether a facility meets the provider-based criteria under 42 C.F.R. 413.65. The rule is effective May 1, 2026, and includes five-year review dates of February 13, 2026 and May 1, 2030.
bill
Regulation • 🇺🇸 United States • Ohio • Proposed Notice
The regulation establishes the payment methodology for workers’ compensation hospital outpatient services under an Ohio bureau framework, including how outpatient reimbursement is calculated for (1) hospital outpatient prospective payment system services, (2) services paid via fee schedules, (3) services paid at reasonable cost, and (4) add-on payments (outlier, rural hospital, and hold harmless). For dates of service of May 1, 2025 (or later), reimbursement generally ties to Medicare’s outpatient prospective payment system mechanics and specified bureau factors, with defined exclusions (e.g., no application of certain Medicare outpatient reconciliation processes) and specific treatment for different hospital types (including children’s hospitals and designated “children’s hospitals” by name).
It updates the bureau-specific payment adjustment factors used for Medicare outpatient prospective payment system-based outpatient reimbursement beginning with services dated May 1, 2025 (or later). Specifically, the factor for children’s hospitals changes from 2.161 to 3.414, and the factor for all non-children’s hospitals changes from 1.497 to 1.449. The rule also updates references to federal materials and CMS program documents incorporated by reference, including replacing October 1, 2024 with October 1, 2025 in the cited Code of Federal Regulations/final rule materials.
Beyond the prospective payment system methodology, it maintains/defines (for May 1, 2025 onward) separate reimbursement paths for services reimbursed via fee schedules (with certain fee-schedule categories not applying the bureau-specific payment adjustment factor), services reimbursed at reasonable cost (including special treatment for critical access hospitals at 101% of reasonable cost), and add-on payments. Add-on payments are applied after the bureau-specific payment adjustment factor and are calculated using outpatient prospective payment system methods; outlier add-ons apply to partial hospitalization and ambulatory payment class services for hospitals other than critical access hospitals, rural add-ons apply to rural sole community/essential access community hospitals with specified exclusions (e.g., drugs/biological/devices pass-through and reasonable cost items), and hold harmless add-ons apply to exempt cancer centers and children’s hospitals after outlier calculations.
For non-participating Medicare providers, “new hospitals,” reporting requirements, and coverage/status/editing tables referenced in the appendix, the rule prescribes how reimbursement is computed and what hospital coding/status information must be reported. For QHP/self-insuring employers (non-QHP), the rule permits either use of the hospital-outpatient rate under paragraph (A) or—where applicable—calculation using hospital-specific CMS cost-to-charge ratio information multiplied by billed charges and a payment adjustment factor of 1.16 (capped at 60% of allowed billed charges), or use of negotiated rates under the cited administrative rule. The rule’s effective date is identified as February 13, 2026.
bill
Regulation • 🇺🇸 United States • Ohio • Proposed Notice
The rule establishes comprehensive requirements for Ohio county boards of developmental disabilities for “service and support administration,” including designation of a primary service and support administrator for each individual and a structured process for person-centered planning, provider selection, plan coordination, monitoring, emergency response, records, and due process. It also defines key terms used throughout the rule (e.g., assessment, informed consent, natural supports, Ohio individual service plan, and service and support administrator).
Key operational requirements apply to the county board and service and support administrator: (1) provision of service and support administration to eligible individuals (including HCBS waiver applicants/enrollees and certain transitions/requests, and assistance to move from intermediate care facilities to community settings); (2) timely scheduling of an initial meeting within 30 calendar days of request with documentation of extenuating circumstances when delayed; (3) eligibility-determination responsibilities (with an option to assign eligibility determination to a different administrator while ensuring results are shared to support coordination); (4) assessment processes, including an initial assessment coordinated by the service and support administrator with active participation of the individual and team, reassessment at least annually (in-person unless mutually agreed virtual participation is necessitated by documented extenuating circumstances), and additional assessments triggered by changes or upon request; and (5) development, review, and revision of the individual service plan using person-centered planning, including integration of natural and alternative services, inclusion of at least one outcome to be advanced/achieved within 12 months, and ongoing updating as needed.
The rule requires budget development and approvals based on assessed needs and preferred ways of meeting those needs, and it establishes detailed provider-selection and implementation steps. Providers must be chosen through objective facilitation with the individual given the opportunity to select from all qualified and willing providers (subject to applicable federal/state laws and cited administrative provisions), with commitments secured from providers to support desired outcomes. Before plan implementation, the individual service plan must be finalized and agreed to in writing with informed consent as applicable and signed by all people/providers responsible for implementation; it must also specify each provider, frequency, funding source, and which provider delivers each service across all settings. The rule further mandates coordination practices: giving the individual and team copies of the current individual service plan (at least 15 days in advance of implementation unless extenuating circumstances make this impractical and there is agreement), documenting any dissenting team opinions in writing and attaching them to the plan, and reviewing/revising the plan at least every 12 months and more frequently under specified circumstances (e.g., upon request within 30 calendar days, changes in needs/status, new provider/service choices, monitoring results, trends in unusual incidents, and when services are reduced/denied/terminated by the department/Medicaid).
For implementation and accountability, the rule establishes monitoring and emergency-response obligations and recordkeeping: monitoring must be tailored and specified in the service plan, include (at minimum) in-person and remote contact elements as described, and allow only limited circumstances for unscheduled visits to family homes (with consent requirements and referral to protective authorities if consent is denied and health/welfare concerns persist). For HCBS waiver participants, monitoring must include at least one in-person residence visit every six months and one in-person adult day/employment-services visit every 12 months, and monitoring results must be shared timely with the individual/representatives and providers. The rule requires an on-call emergency response system available 24/7 to ensure immediate response and health/safety, including specified training and actions, and it requires maintenance of minimum records (including eligibility evidence, assessment info, current plan and budget, evidence of freedom of choice, incidents/investigation summaries, administrator name, emergency information, consent forms, case notes, and due process documentation). Due process requirements are expressly incorporated via statute for Medicaid-funded waiver services (and targeted case management) and via the administrative complaint/hearing rule for non-Medicaid services. The department monitors county-board compliance and provides technical assistance upon request, while the Ohio Department of Medicaid retains final authority to monitor targeted case management.
The document is an “original” rule and includes a “Replaces: 5123-4-02” indication on the final page; it contains no public comment dates or implementation/compliance deadlines in the provided text.
bill
Regulation • 🇺🇸 United States • Ohio • Emergency Notice
The regulation establishes a process under which the Ohio Department of Medicaid (ODM) must suspend Medicaid provider claims payments (without suspending the provider agreement) when certain fraud-related triggers exist and ODM determines that suspending the provider agreement would create risk of harm to Medicaid members. Triggers include (1) a credible allegation of fraud with an audit or investigation pending against the provider, and (2) receipt of notice and a copy of an indictment charging a non-institutional provider (or specified provider-related persons) with an offense specified in Revised Code section 5164.37(E).
When a payment suspension is imposed, ODM may also suspend claims payments to any other entity where the provider or its specified persons have ownership or similar roles. During the suspension period, the provider and specified individuals are prohibited from receiving reimbursement through direct payments from ODM or indirect Medicaid funds from managed care entities (or other entities delegated by ODM to administer portions of the Medicaid program). ODM must provide notice to the affected provider using the standards in 42 CFR 455.23(b) (effective October 1, 2025), and the provider must fully cooperate with ODM’s audit/review process, including responding to information/record requests within specified timeframes.
ODM may lift the suspension (in whole or in part) if it or a prosecuting authority determines there is insufficient evidence of fraud, waste, or abuse; when related criminal proceedings conclude via specified outcomes (dismissal of the indictment, conviction, guilty plea, or not guilty finding); or upon a determination of “good cause” under 42 CFR 455.23(e) or (f) (effective October 1, 2025). The rule also creates a reconsideration mechanism: affected providers (or owners) may request reconsideration in writing within 30 calendar days after receiving ODM’s notice; reconsideration is conducted by the ODM director (or a designee not involved in the original decision); the decision is not appealable and is not subject to further reconsideration; and the director may grant reconsideration and temporarily lift the suspension for good cause. If ODM initiates termination of the provider agreement, the payment suspension continues until the termination process concludes. If a suspension is lifted, payments owed are offset against debts to the Medicaid program, with any remaining amount paid to the provider.
The bill revises the Oklahoma Health Care Authority’s Medicaid minimum reimbursement rate rules for contracted entities that do not enter value-based payment arrangements, extending the sunset date for the current minimum-rate framework from July 1, 2027 to July 1, 2028. During the effective period, participating-network providers must receive reimbursement rates at least equal to 100% of the Authority’s applicable fee schedule rate, while non-participating providers or providers not in the contracted entity’s network must receive at least 90% of the Authority’s applicable fee schedule rate as of January 1, 2021.
For multistate contracts, the bill changes the reimbursement standard by providing that, for services delivered under a multistate contract, the reimbursement rate is the lesser of (1) the rate specified in the multistate contract or (2) the applicable fee schedule rate of the Authority. It also authorizes the Oklahoma Health Care Authority Board to promulgate rules to implement these multistate-contract provisions, including rules that further define the terms used.
The bill updates statutory terminology for the multistate-contract reimbursement rule by defining “multistate contract” (a contract under which services are provided throughout a service area including Oklahoma and at least one other state) and “parent company” (a company that directly or indirectly controls a contracted entity). It further extends/aligns this reimbursement framework with existing requirements on other provider categories and program mechanics that are already laid out in the amended section.
The document discusses the establishment of a Diabetes Prevention Program (DPP) within the Oklahoma Medicaid program, which aims to prevent or delay the onset of type 2 diabetes among members with prediabetes. The Oklahoma Health Care Authority will oversee the implementation of this program, engaging contracted entities to provide DPP services to enrolled members.
The program is expected to impact various business industries, particularly health care providers, including Medicaid providers and peer coaches, who will be directly involved in delivering DPP services. Additionally, entities that offer lifestyle change programs and training for peer coaches may experience increased demand for their services.
Monetarily, the Oklahoma Health Care Authority plans to develop reimbursement methodologies for DPP services, ensuring that payments do not exceed 80% of the federal Medicare program reimbursement for similar services. This may influence the operational costs and revenue structures of unlicensed peer coaches, who will need to establish reimbursement arrangements with Medicaid providers.
Overall, the DPP aims to improve health outcomes for Medicaid members while creating new opportunities and financial frameworks within Oklahoma's health care industry. The program is set to take effect on November 1, 2026.
The bill establishes a new Medicaid coverage decision framework in Oregon by replacing reliance on a “prioritized list of health services” with an approach centered on “clinical coverage policies” tied to an Oregon Health Authority (OHA) definition of medical necessity.
Key changes: OHA must define “medical necessity” and establish medical necessity criteria and standards for medical assistance coverage decisions (including outcome/quality measures), and OHA must adopt rules that (1) define the role of clinical coverage policies, (2) establish timelines for payment, and (3) provide an appeal process for coverage denials with individual medical review. The Health Evidence Review Commission (HERC) must develop and maintain clinical coverage policies that include diagnosis-and-treatment code pairings indicating when services are medically necessary and coverage guidelines; these policies must be consistent with OHA’s medical necessity definition and with federal Medicaid mandatory/optional services laws. HERC replaces the prior “prioritized list” concept, is restricted from relying on “quality of life in general measures” for certain coverage-value decisions (and other provisions align with removing such reliance), and must report changes to its clinical coverage policies to OHA on an even-numbered-year schedule and also provide interim reporting when changes require increased funding (in which case OHA may request additional funding from the Emergency Board). HERC’s public meeting and solicitation requirements are retained but updated to align with the clinical coverage policies.
The bill requires additional conformity and transition updates in related statutes: it revises statutory references so that “covered under the state medical assistance program” is determined under OHA’s medical-necessity approach (and ORS 414.690) rather than being tied to the old prioritized list; it removes ORS 414.694; and it adjusts definitions used in corporate/health equity and insurer-related provisions so “essential services”/service sets are based on clinical coverage policies. It also directs OHA, during transition away from the prioritized list and toward clinical coverage policies, to publish policies and guidance on a single webpage, develop tailored technical assistance, evaluate and leverage utilization data for clinical policy development, consult actuaries to ensure sufficient data for rate-setting after January 1, 2027, and report findings to specified advisory/committee bodies. The bill declares an emergency and takes effect on passage, with most operative amendments to specified ORS sections becoming operative January 1, 2027.
The bill establishes a new, transparent and data-driven process for the Oregon Health Authority to develop coordinated care organization capitation rates, including reconciliation of base data with organization-submitted data, disclosure of outlier trends, a requirement to provide 90 days’ notice of discretionary changes to fee-for-service reimbursement rates, and reporting preliminary capitation determinations (with documented community engagement) to the Oregon Health Policy Board. It requires plan-year applicability beginning with plan years on or after January 1, 2027.
The bill amends ORS 414.065 to incorporate this new capitation-rate determination process into the statute’s framework for global budget determinations for coordinated care organizations (including added cross-references). It also amends ORS 413.042 to narrow administrative rulemaking by requiring that, before adopting any permanent or temporary (non-procedural) rule, the authority prepare a medical assistance cost impact statement estimating the economic impact of the rule on the state medical assistance program, and to adopt a form for that statement.
The bill declares an emergency and takes effect on its passage.
House Bill 4040 (2026) establishes new and modified requirements across health care, insurance, licensing, and workers’ compensation. It includes: (1) hospital requirements for presumptive financial assistance screening and new limits/standards around documentation, credit impact, billing sequence, patient notice/appeals, and collection activity during appeals; (2) changes to Medicaid-related processes, including composition and timing/transition rules for the Medicaid Advisory Committee; (3) updates to residential care facility administrator licensure qualifications; (4) pharmacy/insurance reforms including mandated coverage for medically necessary anesthesia services (with timing rules for applicability), new “clean claim” definition and limits on dental insurer payment/denial/refund processes, and rules affecting third-party administrators and dental device coverage; (5) changes to psilocybin service facilitator training/licensing requirements, and expanded data collection/requirements for psilocybin service centers; (6) modifications to naturopathic physician licensure renewal/continuing education exemption and status conversion/age thresholds; (7) numerous statutory changes in Oregon’s workers’ compensation system, including terminology alignment around eligible authorized providers, modifications to medical services/benefit rules and administrative processes for claims, closure, vocational assistance, reinstatement/reemployment, and medical reporting; and (8) creation of a pilot insurance coverage mandate impact statement process managed by the Legislative Policy and Research Director, including required template content and reporting dates.
The bill changes multiple named Oregon Revised Statutes and adds new Insurance Code sections. Key operative changes include adjusting hospital presumptive financial assistance triggers (raising an encounter-balance threshold), requiring the Oregon Health Authority to set a rulemaking-based screening process that prohibits documentation demands, prevents negative credit score impact, requires hospitals to screen and apply assistance before billing, and requires patient notice and access to an appeal process that triggers suspension of collection activity while the appeal is pending. In Medicaid administration, it alters committee membership by increasing the number of Medicaid recipients and specifies disability/eligibility characteristics, extends member terms, and adds transitional rules phasing the minimum percentage of Medicaid recipients over specified periods before repeal.
In insurance, the bill mandates coverage of medically necessary anesthesia services (regardless of anesthesia duration and without denial/reimbursement limits based solely on exceeding preset time limits) and applies this mandate to policies issued/renewed/extended on or after January 1, 2027. For dental insurance, it adds a new “clean claim” definition, requires timely pay/deny timelines and notice/explanation for additional information, restricts contract provisions that limit provider rights, creates limits and procedures on requesting refunds (including contested refund timing, third-party coordination limits, and provider payment obligations upon deemed acceptance), and requires direct payment for covered services billed under a dental insurance plan. In licensing and health care delivery, it modifies dental practice exceptions, adjusts third-party administrator licensing scope related to pharmacy administrative organizations, and changes durable medical/orthotic/prosthetic device coverage rules and network access protections for certain managed care arrangements.
In workers’ compensation, it substantially revises multiple sections governing medical service authorization, reporting, benefit timing, vocational assistance eligibility and procedures, claim closure and reconsideration timelines/requirements, and reinstatement/reemployment rules, repeatedly substituting or broadening references to authorized attending providers (nurse practitioners and physician associates) within the statutory frameworks. It also defines/aligns additional administrative processes (e.g., independent medical examination location review and penalties) and updates procedural rules for vocational rehabilitation disputes. The bill declares an emergency and states it takes effect upon passage; other changes have specific operative dates (e.g., January 1, 2027 for certain licensure/commission rules; January 1, 2028 for certain insurance/dependent definitions; and January 1, 2027 for psilocybin facilitation/board changes).
The bill requires Oregon health insurers that conduct utilization review (or have utilization review provided on their behalf) to give health care providers specific written notice when the insurer uses artificial intelligence (AI), algorithms, or other automated technology to automatically “downcode” a claim for reimbursement.
Specifically, if AI/algorithm/software is used in utilization review to automatically downcode a claim, the insurer must provide the provider a written notice no later than two business days after the date payment intended to satisfy the claim is made. The notice must disclose the use of the technology, state the specific reason for the downcoding, and describe the insurer’s applicable appeals process and the time limits for requesting an appeal. If the downcoding is based on policy/certificate terms or a bill coding policy, the notice must cite the specific language used.
In addition, the bill amends ORS 743B.423 to make a provider eligible for a timely appeal when a claim is downcoded using AI/automated technology. The appeals process must be consistent with the process for requesting additional payment from a health insurer under ORS 743B.453. The bill also defines “downcode a claim” within ORS 743B.423 as changing a claim’s billing code to one with a lower reimbursement rate than the code in the original claim.
Applicability: the amendments apply to health benefit plans issued, renewed, or extended on or after the effective date of the 2026 Act.
Relating to Medicaid payments to reproductive health care providers; and declaring an emergency.
label_outlineMedicaid Reimbursement
label_outlinereproductive health
1st Chamber
2nd Chamber
Executive
check_circle_outline
check_circle_outline
check_circle_outline
check_circle_outline
Introduced
February 02, 2026
Passed (House)
March 04, 2026
Passed (Senate)
March 10, 2026
Signed
March 31, 2026
Enacted • 2026 Regular Session • Introduced: February 02, 2026
Sponsors: Ben Bowman (D), Tom Andersen (D), Deb Patterson (D), Farrah Chaichi (D), Willy Chotzen (D), April Dobson (D), Robert Nosse (D), Sue Rieke Smith (D), Wlnsvey Campos (D), Lew Frederick (D), Floyd Prozanski (D-OR)
Co-sponsors: Lisa Fragala (D), Mark Gamba (D), David Gomberg (D), Dacia Grayber (D), Zachary Hudson (D), Cyrus Javadi (D), Pam Marsh (D), Lesly Muñoz (D), Nancy Nathanson (D), Travis Nelson (D), Hai Pham (D), Lamar Wise (D), Sara Gelser Blouin (D), Jeff Golden (D), Kayse Jama (D), Courtney Neron Misslin (D), Khanh Pham (D), Jules Walters (D), Susan McLain (D), Jason Kropf (D), Sarah Finger McDonald (D), Nathan Sosa (D), Ricardo Ruiz (D)
The bill creates an Oregon Health Authority payment framework for certain nonprofit reproductive health care providers that participate in the state medical assistance program but are ineligible to receive federal Medicaid funds (“prohibited entities”). The authority must adopt a fee-for-service payment mechanism to pay prohibited entities (including for services to members of a coordinated care organization) and has sole responsibility for making those payments; the authority is barred from using federal Medicaid funds to pay under this framework. To implement the mechanism, the authority must update billing/claims systems as necessary and ensure provider enrollment and credentialing requirements align with existing state medical assistance standards. At least once each biennium, the authority must conduct a rate analysis to determine that the rates paid to prohibited entities are adequate to promote access to reproductive health services.
The new payment framework applies to state medical assistance claims for services provided on or after July 4, 2025, if (1) the claim is not eligible for federal financial participation and (2) the prohibited entity has not yet received payment on the claim. For claims submitted between July 4, 2025 and the bill’s effective date, if a coordinated care organization paid a prohibited-entity claim, the coordinated care organization may recover an overpayment for routine business reasons but may not recover solely because the prohibited entity is not eligible to receive federal Medicaid funds. The bill also establishes a separate grant program that becomes operative only if a state or federal action prohibits prohibited entities from maintaining enrollment in the state medical assistance program. The grant program is limited to prohibited entities defined as nonprofit reproductive health care providers that received more than $800,000 in Medicaid reimbursements in 2023 and are not eligible for federal Medicaid funds. Grants must support costs of providing services to medical assistance recipients, and—where practicable—the grant amount must be equivalent to what the prohibited entity would have received under the authority’s fee-for-service system; grants may not be funded with federal Medicaid funds.
The bill repeals the section addressing grant operation (Section 4) on January 2, 2028. The act takes effect immediately on passage based on an emergency clause.
bill
Regulation • 🇺🇸 United States • Oregon • Proposed Notice
The rule package establishes changes to Oregon Health Authority (OAR 410, Health Systems Division: Medical Assistance Programs) governing how eligibility and enrollment processes coordinate between Medicaid/CHIP and health insurance affordability programs when Oregon transitions from the Federally Facilitated Marketplace (FFM) to a State-Based Marketplace (SBM), effective by coverage year. It also adds/aligns definitions and updates verification and processing rules to distinguish FFM coverage year 2026 from SBM coverage years 2027 and later.
Public comment is requested through 09/21/2026 at 5:00 PM. A remote public hearing is scheduled for 09/15/2026 from 9:00 AM to 9:45 AM, with auxiliary aids available upon advance request. The stated need is compliance with Senate Bill 972, and the stated fiscal impact is “no anticipated fiscal impact.”
Substantive changes are proposed to four existing OAR sections and to updates across definitions and operational rules: (1) OAR 410-200-0015 (General Definitions) adds/clarifies references to the SBM and improves definition consistency (e.g., “Application” includes submission through the Authority, FFM, or SBM; “Date of Request (DOR)” references the SBM; “Electronic account” references the SBM; and the “SBM” definition is added/clarified as the marketplace operated by Oregon Health Insurance Marketplace within the Oregon Health Authority). (2) OAR 410-200-0100 (Coordinated Eligibility and Enrollment Process) requires coordinated content and screenings for individuals/applicants, and directs that individuals ineligible under MAGI standards be directed to the FFM for coverage year 2026 or the SBM for coverage year 2027 and later. (3) OAR 410-200-0110 (Application and Renewal Processing and Timeliness Standards) adds SBM/coverage-year distinctions, updates allowable application submission channels to include the SBM, and specifies transfer of electronic accounts from the FFM/SBM to the Oregon Department of Human Services when the marketplace determines potential Medicaid/CHIP or OHP Bridge-Basic eligibility. (4) OAR 410-200-0230 (Verification) updates income, citizenship/non-citizen, and related verification steps to continue using federal data services (FDSH) and electronic verification sources, and to maintain the marketplace referral structure by coverage year when income attestation exceeds eligibility thresholds for all EDG members.
The package also proposes stylistic and structural updates embedded in the rule text (spelling out acronyms, grammar corrections, capitalization of defined terms, and clarification/alignment of definitions), while specifying that the transfer/coordination processes for electronic accounts are retained with the FFM-to-SBM transition; the racial equity statement anticipates improved coordination between OHP and marketplace coverage and reduced churn/confusion for underserved populations, noting that requirements and conditions for account transfers remain unchanged and coverage-year transition starts with 2027.
Pennsylvania
3
bill
Regulation • 🇺🇸 United States • Pennsylvania • Regulatory Notice
The Department of Human Services announces its intent to establish a new additional class of disproportionate share hospital (DSH) payments for Fiscal Year (FY) 2025–2026 to fund qualifying Pennsylvania Medical Assistance (MA) enrolled hospitals, with the stated purposes of expanding access in inpatient and ancillary outpatient services and supporting academic medical programs for integrated patient-centered medical services.
A hospital is eligible for this additional class of DSH payment only if all specified qualifying criteria are met: it must be a general acute care hospital enrolled in the PA MA program; be accredited as a Level I Trauma Center and be a member of the Children’s Hospital Association; have PA Fee-for-Service and PA Medicaid Managed Care Medical Education costs exceeding $500,000; have an MA-336 reported Low-income Utilization Rate greater than 20%; be located in a county of the third class within a municipality (2020 census) with fewer than 5,000 residents; and operate campuses under the same license with acute care hospitals in a County of the Sixth Class and an acute care hospital in a City of the Third Class within a County of the Third Class as of State FY 2023–2024, as shown by licensure providing Medicaid patient services in those county classes.
The payment methodology states that existing DSH payment limitations continue to apply, including limits that the Commonwealth may not exceed its aggregate annual DSH allotment and that no hospital may receive DSH payments above its hospital-specific limit. It also specifies that DSH payments made under this additional class will not be redistributed to other qualifying hospitals if one qualifying hospital exceeds its hospital-specific DSH limit.
For FY 2025–2026, the Department will distribute $4.552 million total funds (Federal and State) for these DSH payments, subject to approval by the Centers for Medicare & Medicaid Services (CMS). Interested parties may submit written comments on the qualifying criteria and payment methodologies to the Department; comments received within 30 days will be reviewed and considered.
bill
Legislation • 🇺🇸 United States • Pennsylvania • Resolution
A Resolution directing the Joint State Government Commission and Legislative Budget and Finance Comm... (View full title on source site)
label_outlineMedicaid Reimbursement
In House • 2025-2026 Regular Session • Introduced: June 05, 2026
Sponsors: Justin C. Fleming (D-PA)
Co-sponsors: Arvind Venkat (D-PA), Manuel Guzman (D-PA), Benjamin Waxman (D-PA), Benjamin V. Sanchez (D-PA), Emily Kinkead (D-PA), Robert L. Freeman (D-PA), Tarik Khan (D-PA), La'Tasha D. Mayes (D-PA), Steven R. Malagari (D-PA), Kristine C. Howard (D-PA), Timothy Brennan (D-PA), Natalie Mihalek (R-PA), Liz Hanbidge (D-PA), John C Inglis III (D-PA), Michael H. Schlossberg (D-PA), Johanny Cepeda-Freytiz (D-PA), Mandy Steele (D-PA), Valerie S. Gaydos (R-PA), John A. Schlegel (R-PA), Aerion Abney (D-PA)
The resolution directs two Pennsylvania legislative entities—the Joint State Government Commission and the Legislative Budget and Finance Committee—to examine reimbursement mechanisms needed to expand and sustain a robust behavioral health crisis service system. It specifically requires analysis of how Medicaid, Medicare, and major private commercial health insurers pay for crisis services and how those payment practices affect the sustainability and accessibility of crisis care.
The required study must include: (1) current utilization of crisis services and capacity gaps tied to implementation of the Mental Health Procedures Act (1976) and the Mental Health Intellectual Disability Act (1966); (2) a review of current reimbursement methodologies, rates, and policies used by County Mental Health and Intellectual Disabilities Programs, Pennsylvania Medicaid (including both Behavioral HealthChoices managed care and fee-for-service), and Medicare (including Medicare Advantage) for specified crisis services such as 988 Lifeline responses, mobile crisis response, crisis walk-in services, and crisis stabilization services; (3) an analysis of comparable reimbursement methodologies, rates, and policies used by major private insurers operating in Pennsylvania, including parity relative to physical health services; (4) a comparison of Medicaid versus private payer reimbursement rates and practices, assessed against providers’ actual costs; (5) an evaluation of how current reimbursement affects crisis centers’ operational capacity, financial stability, and ability to provide accessible and comprehensive care (including staffing, service expansion, and technology integration); (6) an accounting of how crisis services rely on terminal federal grants and county dollars; and (7) a review of best practices and innovative out-of-state reimbursement models (including “firehouse reimbursement,” telecommunications tax, and “braided” public funding models).
The resolution also mandates that the entities develop specific recommendations for legislative and administrative actions, including provider education and billing training, aimed at improving crisis service financial viability, ensuring long-term sustainability and equitable access, and strengthening the overall crisis care continuum. It requires consultation with relevant stakeholders (including the Department of Human Services, the Insurance Department, crisis providers, managed care organizations, private insurers, consumers, mental health advocates, and other experts) and the establishment of an advisory committee with at least the enumerated representatives from multiple state agencies, hospital and emergency physician associations (rural/urban/suburban), county administrators and drug/alcohol administrators, provider and advocacy organizations, managed care oversight roles, and representatives of various crisis service types (including a mobile crisis service operator, stand-alone crisis intervention center provider, hospital-adjacent crisis center provider, and a 988 call center provider), plus any additional deemed appropriate by the two committees.
Finally, the resolution requires issuance of a report with findings and recommendations within 12 months of adoption to the relevant Senate and House health and human services committees. It also requires soliciting input from representatives across the health care sector and continuum of care to support the report’s findings and recommendations.
bill
Legislation • 🇺🇸 United States • Pennsylvania • Bill
An Act amending the act of November 21, 2016 (P.L.1318, No.169), known as the Pharmacy Audit Integri... (View full title on source site)
label_outlinePharmacist
1st Chamber
2nd Chamber
Executive
check_circle_outline
play_circle_outline
remove_circle_outline
remove_circle_outline
Introduced
March 12, 2026
Considering (Senate)
March 12, 2026
In Senate • 2025-2026 Regular Session • Introduced: March 12, 2026
Sponsors: Lisa M. Boscola (D-PA)
Co-sponsors: Judith Ward (R-PA), Maria Collett (D-PA), Christine M. Tartaglione (D-PA), Cris Dush (R-PA), Nickolas Pisciottano (D-PA), Amanda M. Cappelletti (D-PA), David G. Argall (R-PA), Timothy P Kearney (D-PA), John I. Kane (D-PA), Lindsey M. Williams (D-PA), Steven J. Santarsiero (D-PA), James Andrew Malone (D-PA ), Rosemary M. Brown (R-PA)
The bill makes two definitional and program-structure changes to Pennsylvania’s Pharmacy Audit Integrity and Transparency Act, and adds a new statutory section governing a “State pharmacy benefits manager” for Medicaid.
It amends the Act’s definitions of “specialty drug” and “spread pricing.” The “spread pricing” definition is changed so that it refers to a PBM model where the price charged to a health benefit plan or insurer is greater than the amount the PBM directly or indirectly pays the pharmacist or pharmacy (the text also reflects a shift from the prior formulation using “differs from”). The “specialty drug” definition is revised to broaden/clarify the concept as prescription medication for complex or chronic conditions that requires special handling, provider coordination, or patient education and monitoring for which retail community pharmacies are not reasonably equipped.
It adds a new Section 605 establishing a single, centralized State pharmacy benefits manager for Medicaid. By July 31, 2026, the Department of Human Services must select and enter into a master contract with a single third-party administrator to administer all pharmacy benefits for Medicaid recipients, including those in managed care organizations, through that date. Each managed care contract entered into or renewed by the Department must require the managed care organization to contract with and use the State pharmacy benefits manager to administer all pharmacy benefits for Medicaid recipients enrolled with that organization. The bill also requires a competitive procurement process for selecting the State pharmacy benefits manager and includes eligibility-criteria and applicant disclosure requirements (including conflicts of interest and specified common ownership/control relationships with managed care organizations, pharmacy/pharmacy services entities, drug wholesalers/distributors, third-party payers, and pharmacies).
The bill also sets master-contract requirements. The master contract must prohibit the State pharmacy benefits manager from engaging in several practices, including: steering Medicaid enrollees to affiliated pharmacies; misrepresenting that a particular pharmacy is required when nonaffiliated network options exist; requiring exclusive mail-order dispensing (with a narrow specialty-pharmacy exception); imposing requirements that differ from federal/state/pharmacy-board documentation standards; retroactively denying or reducing facially valid claims (for both prescription drugs and pharmacy services after adjudication); using “spread pricing”; and charging or recouping specified remuneration and fee arrangements to pharmacies (including multiple network reconciliation offsets and adjudication transaction fees). The contract must also require: payment at no less than the National Average Drug Acquisition Cost guidelines plus the professional dispensing fee (and set the professional dispensing fee at 100% of the Medicaid fee-for-service dispensing fee determined via an in-State cost-of-dispensing survey no more than every three years); establish the manager’s fiduciary duty to the Department and to any dispensing pharmacy or pharmacist; and require “pass-through pricing” (defined as charging the health plan the same price the pharmacy receives for the same prescription drug). The bill takes effect in 60 days.
Rhode Island
6
bill
Regulation • 🇺🇸 United States • Rhode Island • Proposed Notice
The document establishes a comprehensive Rhode Island Medicaid provider participation and payment framework within 210-RICR-20-00-1, including provider enrollment, screening, revalidation, payment conditions, and program integrity enforcement by the Executive Office of Health and Human Services (EOHHS). It incorporates specified federal Medicaid provider-enrollment and screening regulations by reference (42 C.F.R. § 424.518; Parts 431, 433, 438 Subpart H, 447; 42 C.F.R. § 489.18(a); and other referenced cross-sections), and defines key terms used throughout the provider eligibility and payment rules.
It requires providers to enroll as a condition of Medicaid payment (with enumerated exceptions), maintain practice locations and licensure/credentialing, cooperate with application and review processes (including fingerprints for high-risk providers), and comply with payment and claims rules. It sets Medicaid payment as the “payor of last resort,” prohibits charging Medicaid members membership fees and billing beyond permitted cost-sharing, requires claims submission within one calendar year from the date of service, limits Medicaid payment to services actually rendered, and restricts direct reimbursement to recipients to narrow circumstances to correct reversed denials. It also governs long-term care facility survey public availability and sets requirements for public disclosure and retention of survey materials.
For provider enrollment/revalidation, the rule establishes an electronic-only application process purged if not completed within 30 days, a per-application CMS-determined fee for specified organizational provider types (with conditions for non-refunding and limited exceptions, plus a CMS-approved hardship waiver process), and a screening regime aligned to limited-, moderate-, and high-risk classifications. Screening includes qualification and active licensure checks, federal database checks (DMF, NPPES, LEIE, SAM, CLIA, and DEX), mandatory in-person unannounced site visits for moderate- and high-risk providers (with up to two attempts, a 30-day opportunity to cure identified deficiencies, and denial/termination grounds for noncompliance or inaccessibility), and fingerprint-based criminal background checks for CMS-designated high categorical risk providers and other high-risk provider persons/entities. It also creates a “Good Moral Character” (GMC) exemption pathway when an individual receives a “Not Qualified” result, including eligibility criteria, required supporting documentation, and an EOHHS case-by-case review.
For ongoing participation, the document requires monthly LEIE/SAM/DEX checks, sets provider information change reporting timelines (generally within 35 days, with specific rules for ownership changes, practice-location changes requiring site visits for moderate/high-risk providers, adverse actions within 7 days, and closure/termination continuity-of-care notice at least 30 days in advance), and mandates revalidation at least every five years under 42 C.F.R. § 455.414 with a rolling calendar approach. It specifies additional revalidation frequency for CCBHCs (every three years) and different timing for fee-for-service waves versus managed care/OPR-only providers. It provides rules for suspending payments if revalidation due dates are missed, sets continuity-of-care duties upon termination, and details provider agreement obligations and EFT-based payment requirements.
It establishes provider ineligibility denial and termination criteria, including application incompleteness, failure to cooperate (including fingerprinting within 30 days and permitting site visit access), disqualifying criminal convictions, involuntary Medicare/Medicaid/CHIP termination on or after January 1, 2011, disqualifying convictions or other undue-risk affiliations, and submission of false/misleading information. It also creates a program integrity sanctions framework listing sanctionable violations (e.g., false/fraudulent claims, false information to obtain compensation or meet prior authorization, failure to disclose records, failure to submit required reports, poor quality of care meeting certain thresholds, abusive conduct, provider agreement breaches, overutilization, rebates/illegal fees, failure to correct deficiencies, failure to respond to information requests, and misuse of billing numbers/NPI), and authorizes progressive discipline sanctions such as written warning, corrective action plans, agreement transfers/shortening, prior authorization requirements, suspension/termination, and exclusion. Finally, it sets notice and provider appeal mechanics for denials/terminations/sanctions (hearing request within 15 days, availability of informal dispute resolution while formal hearing is pending, and “aid pending” limits for providers), and specifies reinstatement procedures for providers terminated or suspended at the state’s initiative under 42 C.F.R. § 1002.214(c).
bill
Legislation • 🇺🇸 United States • Rhode Island • Bill
An Act Relating To Businesses And Professions -- The Primary Care Preservation Act (Prohibits Health... (View full title on source site)
1st Chamber
2nd Chamber
Executive
check_circle_outline
check_circle_outline
stop_circle
remove_circle_outline
Introduced
January 30, 2026
Passed (House)
June 11, 2026
Failed (Senate)
June 11, 2026
Failed Sine Die • 2026-2026 Regular Session • Introduced: January 30, 2026
Sponsors: Marie A. Hopkins (R)
Co-sponsors: Jon D. Brien (I), Julie A. Casimiro (D), Ramon A. Perez (D), George A. Nardone (R), Richard Fascia (R), Earl A. Read (D), Michael W. Chippendale (R), David J. Place (R), Christopher G. Paplauskas (R)
Summary
AI Overview
FULL SUMMARY
The bill establishes a new set of rules within Title 5 (Businesses and Professions) called the “Primary Care Preservation Act” (new Chapter 37.9). It defines key terms including “administrative or operational fee,” “payor,” and “physician practice,” and then regulates how payors may contract with physician practices regarding the practice’s ability to charge patients reasonable non-clinical administrative/operational fees.
It prohibits payors from including in any physician participation contract, agreement, or participation document any clause that prohibits, restricts, penalizes, or interferes with the physician practice’s ability to charge, bill, or collect a reasonable administrative or operational fee directly from patients (Section 5-37.9-3(a)). It also prohibits payors from imposing conditions, penalties, or sanctions on physician practices for assessing such fees, as long as the fees are disclosed to patients in advance and are not billed to the payor (Section 5-37.9-3(b)). The bill clarifies that it does not require payors to reimburse physician practices or patients for these fees (Section 5-37.9-3(c)).
It preserves physician practice obligations related to patient access and continuity of care by stating that nothing in the chapter limits a practice’s obligation to provide emergency or urgent care regardless of whether the practice charges an administrative or operational fee (Section 5-37.9-4(a)). It requires physician practices to provide reasonable notice and access to patient medical records consistent with state and federal law (Section 5-37.9-4(b)).
For enforcement, any payor contract provision that violates the chapter is declared null and void and unenforceable as a matter of public policy (Section 5-37.9-5). The bill includes a severability clause (Section 5-37.9-6) and sets an effective date of “upon passage” (Section 2).
bill
Legislation • 🇺🇸 United States • Rhode Island • Bill
An Act Relating To Insurance -- Medicaid And Commercial Primary Care Rate Enhancement And Sustainabi... (View full title on source site)
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
March 20, 2026
Failed (House)
May 05, 2026
Failed Sine Die • 2026-2026 Regular Session • Introduced: March 20, 2026
Sponsors: Marie A. Hopkins (R)
Co-sponsors: Cherie L. Cruz (D), Jon D. Brien (I), Julie A. Casimiro (D), Megan L. Cotter (D), Jennifer Boylan (D), Evan P. Shanley (D), Robert D. Phillips (D), Charlene M. Lima (D), David J. Place (R)
Summary
AI Overview
FULL SUMMARY
The bill establishes a new Rhode Island statutory chapter (Title 27, Chapter 18.10) called the “Medicaid and Commercial Primary Care Rate Enhancement and Sustainability Act,” directing state agencies to expand patient-centered medical home (PCMH) coverage for independent primary care providers and to increase Medicaid and commercial/Medicare Advantage primary care payments using state-directed payments under 42 C.F.R. § 438.6(c).
EOHHS is required to expand the PCMH program to all Medicaid-accepting independent primary care practices and nurse practitioners, and to require managed care organizations (MCOs) to pay an enhanced per-member-per-month (PMPM) supplement of $10 to $20 for each attributed Medicaid patient to eligible independent providers who enroll in PCMH or meet equivalent criteria.
EOHHS must accelerate the FY2026 primary care rate increase to 100% of Medicare and add a temporary 25% bonus for independent (non-hospital-employed) practices. Through state-directed payments, EOHHS must also require MCOs to pay an automatic access payment supplement of $8 to $15 PMPM for every attributed Medicaid patient in qualifying independent practices.
The Office of the Health Insurance Commissioner must require commercial insurers and Medicare Advantage plans to align primary care reimbursement rates with those in Massachusetts and Connecticut via phased implementation: 15% by January 1, 2027 and full alignment by July 1, 2027. Eligibility is limited to independent primary care physicians and nurse practitioners accepting Medicaid and meeting minimal quality/reporting requirements set by EOHHS. On or after January 1, 2027, EOHHS must submit state-directed payment preprints to CMS, update MCO contracts, build on the existing multi-payer PCMH program (OHIC, with Care Transformation Collaborative of Rhode Island), and issue annual reports on access, retention, and cost savings; OHIC must amend regulations and insurer contracts to enforce commercial parity. The commissioner and EOHHS must enforce the chapter under existing authority, and non-compliant contract provisions are void. The act takes effect January 1, 2027.
bill
Legislation • 🇺🇸 United States • Rhode Island • Bill
An Act Relating To State Affairs And Government -- Medicaid Program Funding And Reallocation Of Enro... (View full title on source site)
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
May 15, 2026
Failed (House)
May 15, 2026
Failed Sine Die • 2026-2026 Regular Session • Introduced: May 15, 2026
Sponsors: Joseph J. Solomon (D)
Co-sponsors: Stephen M. Casey (D)
Summary
AI Overview
FULL SUMMARY
The bill establishes a new Rhode Island statutory framework governing how Medicaid savings attributed to enrollment decreases must be calculated and reallocated within the Medicaid program for provider reimbursement increases.
It adds Chapter 169 to Title 42 of the General Laws, defining “enrollment-driven savings” as reductions in Medicaid expenditures in the fiscal year ending June 30, 2028, attributable to enrollment decreases, using estimates adopted at the May meeting of the Rhode Island caseload estimating conference. It requires that all such savings be retained within Medicaid and not used for deficit reduction or other purposes. The bill directs that the savings be reallocated exclusively to increase Medicaid provider reimbursement rates for (i) hospital inpatient services, (ii) hospital outpatient services, (iii) physician services, and (iv) federally qualified health center services. It also specifies that these funds must be additive to existing Medicaid reimbursement levels and must not supplant, replace, or offset existing appropriations, rate structures, or payment methodologies in effect as of June 30, 2026.
The executive office of health and human services must implement the reimbursement increases by adjusting Medicaid fee-for-service rates as needed; for managed care, amend contracts and/or implement state directed payments so the rate increases flow to providers with a minimum provider pass-through of at least 90% of each rate increase, implemented within 180 days of each rate adjustment; and submit any required state plan amendments, waivers, or federal approvals to the Centers for Medicare & Medicaid Services. The bill further requires an annual report to the General Assembly due no later than October 31 each year, including: the calculation methodology and actuarial assumptions for the enrollment-driven savings; itemized provider rate adjustments; total federal financial participation generated by the rate investments; the status of any required CMS approvals (including pending or denied); and managed care organization compliance with the 90% pass-through requirement.
The act takes effect July 1, 2026.
bill
Legislation • 🇺🇸 United States • Rhode Island • Bill
An Act Relating To Insurance -- Accident And Sickness Insurance Policies -- Equal Pay For Healthcare... (View full title on source site)
label_outlineAPRN
label_outlinePA
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
March 04, 2026
Failed (Senate)
May 05, 2026
Failed Sine Die • 2026-2026 Regular Session • Introduced: March 04, 2026
Sponsors: Pamela J. Lauria (D)
Co-sponsors: Alana M. DiMario (D), Bridget Valverde (D), Melissa A. Murray (D), Lammis J. Vargas (D), Louis P. DiPalma (D), Tiara T. Mack (D), Walter S. Felag (D), Lori Urso (D), Ryan William Pearson (D)
Summary
AI Overview
FULL SUMMARY
The bill establishes “equal pay” reimbursement rules for health insurance when covered services are within the lawful scope of practice of licensed physician assistants or certified nurse practitioners. It requires that, whenever a health insurance policy reimburses services performed by licensed physicians, the insured is entitled to reimbursement for the same services when performed by a licensed physician assistant or certified nurse practitioner (including prescribing/dispensing and certain primary care or mental health services) as long as the services are within the practitioners’ lawful scope.
For physician assistants or nurse practitioners who are in an “independent practice,” the bill requires reimbursement to be paid “in the same amount” as reimbursement paid under the policy to a licensed physician performing the service in the area served. It defines “independent practice” as a setting where the physician assistant or nurse practitioner bills insurers for services using the practitioner’s own name and national provider identifier, and it directs that the equal reimbursement requirement applies to services provided by physician assistants and certified nurse practitioners who qualify under the stated scope conditions.
The bill contains two principal limitations and protections: (1) it does not apply to federally qualified group practice health maintenance organizations (and similar insurers) that do not compensate such practitioners on a fee-for-service basis; and (2) it prohibits an insurer from reducing reimbursement paid to licensed physicians in order to comply with the new equal-pay requirement.
These requirements are added in three insurance contexts—accident and sickness insurance policies and nonprofit medical service/corporations (new sections added to Chapters 27-18, 27-19, and 27-20)—and a Medicaid-related provision is added to the Medical Assistance chapter. For Medicaid, the executive office of health and human services (EOHHS) must provide for reimbursement starting January 1, 2027, and the bill requires submission of a Medicaid state plan amendment by October 1, 2026 after applying to the federal Department of Health and Human Services as needed. The act takes effect January 1, 2027.
bill
Legislation • 🇺🇸 United States • Rhode Island • Bill
An Act Relating To State Affairs And Government -- Medicaid Program Funding And Reallocation Of Enro... (View full title on source site)
arrow_upwardHigh Priority
thumb_upSupport
label_outlineMedicaid Reimbursement
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
May 27, 2026
Failed (Senate)
June 02, 2026
Failed Sine Die • 2026-2026 Regular Session • Introduced: May 27, 2026
Sponsors: David P. Tikoian (D)
Co-sponsors: Frank A. Ciccone (D)
Summary
AI Overview
FULL SUMMARY
The bill establishes a statutory framework in Rhode Island law that governs how Medicaid “enrollment-driven savings” are calculated, retained, and reinvested. It defines “enrollment-driven savings” as reductions in Medicaid expenditures in the fiscal year ending June 30, 2028 attributable to decreases in enrollment, using caseload estimating conference estimates adopted at the May meeting (Section 42-169-1, added as Chapter 169 to Title 42).
It creates mandatory reallocation rules for all such savings: the savings must be retained within the Medicaid program and may not be used for deficit reduction or other purposes (42-169-2(1)). The savings must be reallocated exclusively to increase Medicaid provider reimbursement rates, specifically for hospital inpatient services, hospital outpatient services, physician services, and federally qualified health center services (42-169-2(2)). The bill also requires additivity: funds must be additive to existing Medicaid reimbursement levels and cannot be used to supplant, replace, or offset existing appropriations, rate structures, or payment methodologies in effect as of June 30, 2026 (42-169-2(3)).
It requires the executive office of health and human services to implement the reimbursement increases through several mechanisms: adjusting Medicaid fee-for-service reimbursement rates, amending managed care contracts or using state directed payments so that the rate increases reach providers with a minimum provider pass-through rate of at least 90% of each rate increase within 180 days of each rate adjustment’s effective date, and submitting necessary state plan amendments, waivers, or federal approvals to CMS (42-169-3(1)-(3)).
Finally, it establishes annual reporting and compliance requirements: by October 31 each year, the executive office must report to the General Assembly the methodology and assumptions used to calculate enrollment-driven savings, the provider rate adjustments implemented (itemized by provider type and care setting), the total federal financial participation generated by the rate investments, the status of any required state plan/waiver/approval actions (including pending or denied CMS approvals), and managed care organization compliance with the provider pass-through requirement (42-169-4(1)-(5)). The act takes effect July 1, 2026 (Section 3).
South Dakota
1
bill
Regulation • 🇺🇸 United States • South Dakota • Regulatory Notice
The Department of Social Services intends to submit a South Dakota Medicaid State Plan Amendment (SPA) that adds a new Primary Care Program (PCP) value-based payment to Medicaid for qualifying providers currently enrolled in the Medicaid Primary Care Provider program.
The SPA establishes a $7 million quality-based payment pool supported by federal funding under the federal “One Big Beautiful Bill Act” (Public Law 119-21, Section 71401) and by appropriations in the 2026 South Dakota Legislature. Provider payments are to be based on performance on specified primary care quality metrics from 2026 and 2027, using the CY 2025 South Dakota Medicaid PCP Provider Scorecard as the metric set. Payments are anticipated to be made in Fall 2026 as part of phase one of the Medicaid Primary Accountable Care Transformation (PACT) initiative.
The SPA specifies nine performance metrics that drive payment, including: Adult Preventative Visit (adults 21–64 with a preventive visit), Breast Cancer Screening (BCS-AD), Colorectal Screening (CCS-AD), well-child visit rates at 15 and 30 months, Child and Adolescent Well-Care Visits (WCV-CH), Lead Screening (LSC-CH), and pediatric and adult emergency department utilization measured as ED visits per 1,000 beneficiary months (children ages 0–19; adults 20+).
The SPA is set to have an effective date of August 1, 2026 and would revise pages 1–3 of Attachment 3.1-F of the Medicaid State Plan. The department estimates the fiscal impact as $7,000,000 total in federal funds in Federal Fiscal Year (FFY) 2026 (with $0 state funds) and $7,000,000 total in federal funds in FFY 2027 (with $0 state funds). Public comment is scheduled to run from July 20, 2026 through August 19, 2026, with the SPA pages available for viewing online and at the Department of Social Services, Division of Medical Services.
Tennessee
9
bill
Regulation • 🇺🇸 United States • Tennessee • Final Notice
The document sets out the Tennessee Bureau of Workers’ Compensation “Medical Fee Schedule” rules (Chapter 0800-02-18), establishing a Medicare-based reimbursement system for covered workers’ compensation medical services. Reimbursement is generally based on CMS RBRVS/CMS RVUs adjusted by the Tennessee Geographic Practice Index (GPCI), using Tennessee-specific conversion percentages, with “gap-filling” for services not valued by Medicare using FAIR Health data reviewed annually by the Administrator in consultation with the Medical Payment Committee and Advisory Council. It adopts, by reference, related rules on medical payments (Chapter 0800-02-17) and inpatient hospital fee schedule rules (Chapter 0800-02-19), and requires use of current CPT®/HCPCS coding, NCCI edits, and applicable Medicare procedures and guidelines unless a specific exemption exists.
The rules set maximum reimbursement rules and billing/utilization requirements across service categories, including: (1) general reimbursement methodology (generally capping payment at the lesser of usual charge, fee schedule/rate table amounts after modifiers/methodologies/exceptions, 100% Medicare when applicable, or contracted prices); (2) state-specific modifiers (e.g., “ON” modifier for certain board-certified orthopedists/neurosurgeons with a specified cap on certain surgical codes; “NP” modifier for qualifying non-physician practitioners at 85% of rate table fees; requirements for modifier 22/25 medical-necessity documentation and cap on the additional amount); (3) anesthesia rules (including different percentages depending on whether CRNA is medically directed, limits on reimbursement per unit, and billing/data elements); (4) surgery rules addressing multiple procedures, concurrent physicians, surgical assistants and co-surgeons (with documentation and specific reimbursement limitations), and global-fee constraints; (5) chiropractic and outpatient therapy limits (including modality limits, denial of reimbursement for hot/cold packs, visit thresholds triggering utilization review, and therapy unit/time rounding rules); (6) outpatient hospital/ambulatory surgical center facility fee methodology using CMS OPPS/APC classifications with defined caps and packaging/outlier rules; (7) DME/implantable rules (rate caps at/around Medicare percentages, invoice requirements, rental vs purchase mechanics, and documentation thresholds for certain devices); (8) orthotics/prosthetics rules (coding approach, separate billing, and “higher of” invoice vs fee-table thresholds under specified conditions); (9) pharmaceutical schedule rules (formulary/reimbursement formula mechanics using AWP + a filing fee, substitution rules for brand vs generic with reimbursement consequences, requirements for dispensing documentation and NDC-related constraints for repackaged/compounded products, and limits on reimbursable dietary supplements); and (10) ambulance, clinical psychological treatment, and injection reimbursement rules, including pre-certification/retrospective review timing and utilization-review-trigger visit limits.
The document also establishes enforcement and remedies for fee schedule violations. Except where the Bureau grants a waiver, providers may not accept and employers/carriers may not pay amounts exceeding fee schedule maximums. It authorizes civil penalties for patterns or practice violations (subject to the Bureau’s penalty procedures), provides a 180-calendar-day period to refund/recover overpayments to avoid “violation” status for timely refunds/recoveries, and allows any violator to request a contested-case hearing by filing within 15 calendar days of a Notice of Violation (and penalty notice if applicable); failure to timely request hearing makes the Administrator’s decision a final order not subject to further review.
As to what the document changes: the text provided does not show discrete, explicit “strike/insert” amendments to another rule; rather, it appears to be the compiled/revised version of Chapter 0800-02-18 reflecting prior amendments. The provided “Administrative History” indicates amendments filed October 21, 2025 effective January 19, 2026 and earlier amendments (e.g., amendments filed June 27, 2023 effective September 25, 2023), but the excerpt does not include a change log identifying specific newly modified subsections for the January 19, 2026 revision date.
bill
Regulation • 🇺🇸 United States • Tennessee • Final Notice
The document establishes and governs Tennessee’s Workers’ Compensation medical payment framework through Bureau of Workers’ Compensation “Rules for Medical Payments” (Chapter 0800-02-17). It adopts a system of maximum allowable reimbursement for covered health care services and supplies, requires billing and coding using nationally recognized standards (ICD, CPT®, HCPCS, MS-DRG, RBRVS, and CMS guidance), and sets procedures for employer/provider bill review, deposition/witness fees, record/report obligations, fee schedule enforcement and civil penalties, preauthorization for certain non-emergency services, dispute resolution through a Medical Payment Committee, and related operational requirements (including electronic billing references and timing rules).
The rules define key terms used across Chapters 17 (medical payments), 18 (Medical Fee Schedule Rules), and 19 (Inpatient Hospital Fee Schedule Rules), including “maximum allowable payment,” “properly submitted and complete bill,” “reject,” and “preauthorization,” as well as detailed billing concepts (e.g., By Report “BR” procedures, modifier codes, follow-up days/visits, and stop-loss concepts for inpatient hospital payment methodologies). The chapter also sets how reimbursement is determined where codes/values are or are not listed (including BR for unlisted services), establishes telehealth reimbursement methodology (same rate; maximum is the lesser of billed charges or fee schedule amounts for services marked in the rate tables), and specifies billing/coding conventions for professional vs. technical components of diagnostic services (modifiers 26 and TC).
Operatively, the chapter requires reimbursement to be the lesser of (i) the provider’s usual billed charge, (ii) the fee schedule amount after applying applicable modifiers/methodologies/exceptions (or 100% of the Medicare rate when no fee methodology is set in the rules), or (iii) an agreed contracted/published rate with an MCO/PPO when applicable; it also sets timelines and processes for employer bill handling, provider reconsideration of disputes, and when payment/collection actions are permitted. It provides a missed appointment payment rule (with set dollar limits using state-specific codes depending on new vs. established patients), requires initial and progress narrative medical reports for non-inpatient hospital care (including content elements and reimbursement for report copies using specified state-specific codes), and authorizes charging for certain extra physician time and behavioral intervention under conditions tied to long-term Schedule II medication use.
It also establishes the preauthorization process for non-emergency hospitalizations, transfers between facilities, and non-emergency surgery (including deemed approval if timely notice is not provided), sets rules for employee-paid services reimbursement (full reimbursement if employer is later determined responsible, with medical fee schedule limits not applying), authorizes recovery and additional payment for amounts later determined properly due, and provides civil penalty and contested-case hearing procedures for fee schedule rule violations (including notice, timing, and penalty ranges). The impairment rating/evaluation rule (Rule .25) sets timelines for authorized treating physicians to determine maximum medical improvement and submit impairment rating reports, limits fees for the prescribed impairment analysis (with conditions requiring documentation of consultation with the AMA Guides™ and specific state code use), and authorizes civil penalties for late completion. The chapter further establishes Medical Payment Committee dispute submission requirements (time limits from date of service, documentation and redaction requirements), committee review procedures (notice, opportunities to submit evidence, meeting rules, decision by simple majority), and payment for depositions/witness appearances. Finally, it includes an effective date reference: amendments filed October 21, 2025 are effective January 19, 2026.
The bill authorizes Tennessee’s governor to expand Medicaid eligibility in accordance with the federal Patient Protection and Affordable Care Act (Pub. L. No. 111-148) and authorizes the governor to negotiate with the federal Centers for Medicare and Medicaid Services regarding the terms of that Medicaid expansion.
It changes existing Tennessee Code Annotated Section 71-5-126 by deleting the prior section and substituting the authorization language described above.
The act takes effect upon becoming law, with the statute stating that the public welfare requires immediate effect.
The legislation amends Tennessee Code Annotated, Title 71, Chapter 5, Section 71-5-2005(g), to allow the division responsible for the annual coverage assessment to submit reports more frequently than once a year.
This change provides increased flexibility in reporting frequency, enabling the division to better serve the public welfare.
The act takes effect immediately upon becoming law.
No specific monetary impacts or industries are explicitly mentioned in the provided text.
The bill creates a new Tennessee Code Annotated section (71-5-177) establishing the “Tennessee Medicaid Modernization and Access Act of 2025.” It defines key terms including “key services” (OB/GYN, primary care, outpatient mental health, and SUD services), “average commercial rate,” “Medicare fee schedule,” and the “CMS 2024 final rule,” and directs TennCare reimbursement changes tied to federal guidance.
Beginning in calendar year 2025 and in subsequent years, TennCare reimbursements for the defined key services must be updated to match either the Medicare fee schedule or the average commercial rate in the state, whichever is higher (with authority to phase in changes for specific key services if necessary). The department of health, in consultation with the Bureau of TennCare, must conduct an annual review to ensure alignment with changes to the Medicare fee schedule and average commercial rates and with the CMS 2024 final rule. Providers of key services who experience delayed payment or receive an erroneous reimbursement may, under rules promulgated by the commissioner of health, request a written administrative hearing; the decision after the hearing is final.
The bill authorizes incentive payments for providers receiving reimbursement increases, based on quality-of-care and improved-access metrics, with emphasis on rural and underserved areas. The department of health must consult the Bureau of TennCare to establish and enforce the quality/access metrics. The Bureau of TennCare must submit a request to CMS to modify the state Medicaid plan as needed to implement the reimbursement changes. The department of health and the Bureau of TennCare must also seek and apply for federal, private, or other available funds and direct available state funds to support the reimbursement adjustments, and the legislative intent is that funds be annually appropriated in the general appropriations act to cover implementation administrative costs, including benchmarking, annual fee updates, and oversight of the incentive program.
The bill requires an annual joint report: starting February 1, 2026 and no later than February 1 of each subsequent year, the department of health and Bureau of TennCare must report to specified legislative insurance committees on fiscal impacts, provider participation rates, access improvements, and outcome metrics for impacted key services. It authorizes the department and Bureau to promulgate necessary rules under the Uniform Administrative Procedures Act. The act states it is not an appropriation and prohibits obligating or expending funds unless specifically appropriated, and it applies to TennCare reimbursements for key services occurring on or after January 1, 2025; it takes effect upon becoming law.
The bill establishes new and expanded requirements governing Tennessee health insurance claim adjudication and related administrative practices, including protections against certain automated claim “downcoding,” restrictions on prior authorization for specified services and under certain circumstances, enhanced definitions for AI used in claims decisions, prompt-payment audits, and new rules addressing value-based contracts, payment mechanics, reimbursement for medical complexity and additional services during authorized care. It also directs the commissioner of commerce and insurance to promulgate rules and conduct periodic audits beginning in 2027.
Key changes to existing law include: (1) adding a definition of “artificial intelligence” in the health insurance practices code and expanding a downcoding-related personnel/credential disclosure requirement to include the National Provider Identifier, credentials, board certifications, and specialty expertise/training; (2) modifying prior authorization validity rules for chronic-condition services/prescription drugs so prior authorization remains valid unless the prescribing healthcare professional changes the enrollee’s prescription (and clarifying when clinical criteria may require otherwise); (3) revising the list of services for which prior authorization cannot be required (including specified opioid-use-disorder drugs, certain therapeutically equivalent/generic or biosimilar drugs with limited “first prescription” exception, outpatient mental health/substance use disorder treatment, specified antineoplastic therapy, USPSTF A/B preventive services and certain women’s preventive services, pediatric hospice, neonatal abstinence program treatment, all FDA-approved antiretrovirals for HIV/AIDS, and gynecological surgeries/procedures), while maintaining that the section does not apply to behavioral health inpatient services and does not require coverage for conditions excluded by policy terms unless required by law; (4) adding an additional protection prohibiting a health carrier from denying, delaying, or modifying care solely based on an AI/algorithmic tool determination and requiring an adverse medical-necessity determination to be made by a licensed physician competent to evaluate the specific clinical issues; and (5) requiring new audit rules and procedures for prompt-payment compliance effective for audits beginning in 2027.
The bill adds multiple new statutory sections. In the downcoding context (new Part 56-7-3901 through 56-7-3907), it defines AI and related terms; prohibits health insurance entities from downcoding unless a qualified reviewing licensed physician/appropriate healthcare professional makes the decision, conducts a documented clinical review, and satisfies required notifications; prohibits discriminatory or targeted downcoding against providers who routinely treat patients with complex/chronic conditions and subjects discriminatory patterns to enforcement including potential fines, restitution, and license suspension; requires remittance advice notifications for downcoded claims that include CARC/RARC codes, specific reasons tied to clinical criteria, original contracted amount, revised reimbursement, the downcoding-decision clinician identity/credentials/specialty training, and notice of the appeal right; mandates an appeal process with electronic/paper notice, an appeal decision within 30 days (and payment within 15 days if downcoding is reversed), and deems the claim approved/payable as originally submitted if no decision is made within the 30-day period; permits batch appeals for substantially similar issues; allows a provider to instead seek injunctive/declaratory/other appropriate court relief if arbitrary/capricious downcoding or other violations are reasonably believed; and provides enforcement by the commissioner including civil penalties up to $10,000 per violation and an additional 25% penalty on unpaid downcoded claim amounts paid to the healthcare professional within 15 days of notice, with contract/policy practices that attempt to waive/limit these protections declared void and unenforceable.
Other new requirements include: (1) “value-based contract” protections (new 56-7-3723) barring prior authorization for services reimbursed under value-based contracts that tie payment to quality, reward efficiency/effectiveness, and impose risk-sharing for failures to meet quality/efficiency/effectiveness requirements; (2) commissioner audits every three years beginning January 1, 2027 for compliance with the health insurance part, including access to carrier records, verified reports, a 30-day rebuttal period, corrective action with civil penalties upon violations, reporting of findings to legislative leadership and the legislative librarian within 90 days of each audit completion, and carrier payment of audit costs (new 56-7-3724); (3) changes to claim submission definition and prompt-payment timeframes for paper and electronic claims, including extended time calculations after requested substantiating documentation is submitted and an acknowledgment obligation within 10 business days of receiving such documentation (changes to 56-7-109); (4) new prompt-payment audit authority beginning January 1, 2027 (added to 56-7-109(c)); (5) payment and reimbursement provisions in Part 10 including requirements when switching payment methods via electronic funds transfer/virtual credit cards to notify providers of fees, advise available methods, and provide clear instructions, with a prohibition on charging transmission fees unless the provider consented (new 56-7-1022), a requirement that contracts and reimbursement policies after July 1, 2026 account for patient medical complexity and co-morbidity and reimburse for all medical services/procedures/devices, and reimbursement rules preventing denial solely because additional clinically appropriate services were separately subject to prior authorization when performed contemporaneously during the course of prior-authorized or medically indicated treatment (new 56-7-1024); and (6) effective dates: the bill takes effect upon becoming law for purposes of promulgating rules, with Section 12 effective July 1, 2026 and the remainder effective January 1, 2027.
The bill establishes the “Tennessee Medicaid Modernization and Access Act of 2025” by adding a new Tennessee Code Annotated section (71-5-177) requiring TennCare reimbursement updates for specified “key services” (OB/GYN, primary care, outpatient mental health, and substance use disorder). For calendar year 2025 and later, TennCare reimbursements for key services must be updated to match the Medicare fee schedule or the average commercial rate for the state, whichever is higher, with authority to phase in the update for particular key services.
The bill requires an annual review by the department of health, in consultation with the bureau of TennCare, to ensure TennCare reimbursement rates align with changes in the Medicare fee schedule, average commercial rates, and the CMS 2024 final rule (May 2024 CMS guidance on Medicaid reimbursement standards). It also creates a provider remedy: healthcare providers entitled to reimbursement who allege payment delays or erroneous reimbursement levels may request a written administrative hearing under rules promulgated by the commissioner of health, with the hearing decision becoming final.
The bill authorizes incentive payments for providers receiving reimbursement increases, tied to quality-of-care and improved-patient-access metrics (with emphasis on rural and underserved areas). The department of health must consult the bureau of TennCare to establish and enforce these metrics, and the bureau must request CMS modifications to the state Medicaid plan as needed to implement the section. It further directs the department of health and the bureau to seek and apply for federal, private, or other funds and to use available state funds to support reimbursement adjustments, while expressing legislative intent that the general appropriations act annually appropriate funds for administrative costs (benchmarking, annual updating of fees, and overseeing the incentive program).
The bill requires ongoing reporting: beginning February 1, 2026 and by February 1 of each subsequent year, the department of health and bureau of TennCare must submit an annual joint report to specified legislative committees detailing fiscal impacts, provider participation rates, access improvements, and outcome metrics for key services. It authorizes rules to implement the section under the Uniform Administrative Procedures Act, states that the act is not an appropriation and cannot be obligated or expended unless specifically appropriated, and applies the reimbursement requirements to TennCare reimbursements for key services occurring on or after January 1, 2025 (effective upon becoming a law, subject to constitutional limitations).
bill
Regulation • 🇺🇸 United States • Tennessee • Final Notice
The document establishes and sets out (in full, as a revised Jan. 2026 version) the Tennessee TennCare Medicaid rules in Chapter 1200-13-13. It defines numerous program terms and governs TennCare Medicaid eligibility mechanics, enrollment/reassignment/disenrollment with managed care, covered services and exclusions, provider and payment rules, third-party resource and subrogation framework, pharmacy abuse/overutilization controls (lock-in and prior authorization status), appeals and hearing rights, and related special programs.
Operative regulatory content covered in the provided text includes: (1) definitions that incorporate controlled substances/pharmacy lock-in concepts, prior authorization status (including PA status for controlled substances), and specific program definitions for entities (Bureau, MCC, MCO, PBM/DBM) and clinical items (e.g., home health services, private duty nursing, EPSDT); (2) eligibility program structure and timelines, including TennCare Medicaid redetermination/termination processes for core Medicaid enrollees and transition from discontinued categories, with specific notice and appeal timeframes; (3) covered services rules that include prior authorization rules, emergency service limitations, and a detailed service benefit chart (including dental/orthodontia limits and medical necessity criteria); (4) pharmacy and cost-sharing frameworks, including Medicaid adult pharmacy copays and pharmacy quantity limits for brand drugs, automatic/attestation-based medication exemptions, and explicit non-coverage for OTC drugs unless on a covered list; (5) exclusions that specify broad non-covered items and detailed service-by-service carve-outs; (6) provider payment conditions (payment in full, reimbursement rates for out-of-network authorizations, claim-filing deadlines), plus provider solicitation restrictions; (7) third-party resource disclosure/assignment and payor-of-last-resort rules; (8) appeal procedures for adverse benefit determinations, including requirements to present a “valid factual dispute,” notice/cure rules, and continuation/reinstatement rules pending appeal; (9) the TennCare Pharmacy Lock-in/PA program, describing qualifying abuse/overutilization triggers, lock-in provider selection rules, eligibility/removal criteria, and escalation to PA status; and (10) BESMART, which governs buprenorphine-based OUD treatment for specific adult participant populations, including dosing limits and visit frequency requirements.
Because the provided excerpt reads as a consolidated rules chapter rather than as a document containing explicit “amends/strike/insert” markers against a specific prior version, it functions primarily as a statement of the chapter’s contents (with historical administrative history noting prior amendments), rather than as a discrete amendment instrument in the excerpt itself.
bill
Regulation • 🇺🇸 United States • Tennessee • Final Notice
The document establishes and governs the Tennessee TennCare Standard program rules within Bureau of TennCare Chapter 1200-13-14, including definitions, eligibility categories, enrollment/reassignment/disenrollment processes, covered benefits, cost sharing, provider and managed care obligations, exclusions, and member appeal rights; it also specifies pharmacy lock-in/prior authorization controls and a BESMART medication-assisted treatment framework for opioid use disorder. Based on the provided text, it contains operative regulatory requirements across multiple sections (definitions through .15), but the excerpted material does not include explicit amendment markers indicating it amends a prior numbered regulation text; instead it presents the rule chapter content as a consolidated ruleset.
Key operational requirements include: TennCare Standard eligibility and renewal processes (Rule 1200-13-14-.02), including category rules for uninsured children, Standard Spend Down (SSD) for non-pregnant adults 21+ with an enrollment target and call-in application mechanics, and CHOICES/ECF CHOICES “217-like” and at-risk groups; TennCare enrollment/reassignment limits and hardship-based MCO changes (Rule 1200-13-14-.03); covered service obligations for managed care contractors, including limits/coverage conditions for pharmacy (formulary restrictions, drug exclusions, opioid and sedative restrictions, prior authorization rules) and home health/private duty nursing prior authorization and delivery limits (Rule 1200-13-14-.04); cost sharing rules for premiums/deductibles/copays and an aggregate cost-sharing cap for certain Standard children and families (Rule 1200-13-14-.05); provider payment/participation rules and claim-filing time limits (Rule 1200-13-14-.08); exclusions from covered services including geographic, investigational, and specific benefit exclusions (Rule 1200-13-14-.10); and detailed adverse benefit determination notice and appeal procedures, including SFH rights, timelines to request appeals, reconsideration and hearing processes, and limits on continuation/reinstatement (Rule 1200-13-14-.11).
The document also establishes pharmacy utilization controls: a Bureau-administered Pharmacy Lock-in Program targeting abuse/overutilization with criteria for lock-in status and escalation to Prior Authorization (PA) status, removal from lock-in/PA after sustained compliant utilization patterns, and emergency override procedures (Rule 1200-13-14-.13). Finally, it contains a BESMART specialty rule (Rule 1200-13-14-.15) that supersedes other office-based buprenorphine/OUD rules for BESMART-participating providers, defining the coordinated services package, buprenorphine dosing ceilings with specific eligibility populations for higher daily doses, visit frequency requirements, and reimbursement conditions (including that certain prescribers must participate in an MCO’s BESMART network for reimbursement).
Texas
4
bill
Regulation • 🇺🇸 United States • Texas • Proposed Notice
The proposal establishes a mechanism within the Texas Hospital Augmented Reimbursement Program (HARP) to distribute any unused “payment room” to other eligible hospitals within the same hospital class, after HHSC applies the existing payment limitation tied to Medicaid charges.
It proposes specific updates to 1 Texas Administrative Code (1 TAC) §355.8070, including additional clarifying drafting changes (grammar/punctuation and spelled-out acronyms) and, substantively, additions in §355.8070(d) and (e) that apply to non-state government-owned and operated hospitals and private hospitals. For program periods beginning on or after October 1, 2026, these changes add a new allocation step describing how remaining inpatient FFS Medicare payment gap amount is distributed proportionally based on calculated inpatient FFS excess Medicaid charges, with a continuing limit that total inpatient Medicaid payments (including supplemental payments and the portion of HARP payments related to the inpatient FFS Medicare payment gap) do not exceed Medicaid charges. Hospitals meeting the “nominal charge provider” definition are exempt from the Medicaid-charge limitation.
The broader rule framework (still in effect as described in the text) retains HARP’s participation requirements, the use of IGT funding for the non-federal share (with no state general revenue), the requirement for HHSC to issue IGT notifications at least 14 business days before IGT due dates, and other reconciliation/administration provisions (including semi-annual payments and proportional refunds if less non-federal money is expended than transferred).
A public hearing will be held via webinar (date/time posted on HHSC communication websites). Written comments are due no later than 14 days after the issue date of the Texas Register; comments must be submitted by postmark/shipment/hand-delivery or emailed by the applicable deadline, including an instruction to use the subject line “Comments on Proposed Rule 26R088.” The earliest possible adoption date is September 6, 2026.
bill
Regulation • 🇺🇸 United States • Texas • Regulatory Notice
This document establishes HHSC provider engagement meetings to collect Medicaid provider input on payment-rate topics that may be addressed at upcoming May 2026 rate hearings; it does not publish proposed rates at this time. The meetings are scheduled for April 9, 2026, and will be held online only via GoToWebinar, with a separate agenda time block for Acute Care and Hospital Services (10:00 a.m.–11:30 a.m.). HHSC will record the meetings and make the archived recording available on demand at the HHSC live/archived meetings webpage. HHSC may limit speaker time and may end a meeting early if no participants register to present public comments within the first 30 minutes.
HHSC will collect oral commentary only on the listed topic areas, which may be presented at the May 2026 rate hearing at HHSC’s discretion. For Acute Care Services (Calendar Fee Review), the topics include specific code categories and clinical payment areas such as renal dialysis medication, “R” and “G” codes, family planning, cardiovascular and urinary system surgery, proton therapy codes, “T” codes including T1019, digestive system surgery, MTP-NEMT-DRTS (T2003), and mileage rate S0215; it also includes Indian Health Services and physician administered drugs split into oncology, vaccines & toxoids, and non-oncology, plus vision devices and eye/ocular adnexa surgery and respiratory system surgery. Additional Acute Care topics include a Special Review for dental services and a Medical Policy Review for cranial molding orthosis, durable medical equipment and medical nutrition therapy, implantable infusion pumps, and the family planning program for tubal sterilization.
The document also provides for written comments on the listed topics: written comments may be submitted in lieu of or in addition to oral comments until 5:00 p.m. the day following the meetings (April 10, 2026). Comments may be sent by U.S. mail, overnight mail, fax, or email, with specific submission addresses provided, and emails must use the subject line “April 2026 Provider Engagement Meeting.” HHSC prefers email or telephone communication for outreach. Individuals with disabilities who require auxiliary aids or services must contact Provider Finance at least 72 hours before the hearing (phone number provided) to arrange accommodations.
bill
Regulation • 🇺🇸 United States • Texas • Regulatory Notice
The Texas Health and Human Services Commission (HHSC) will hold an online public hearing on April 24, 2026, at 9:00 a.m. to receive public comments on proposed Medicaid reimbursement updates for a Medical Policy Review covering Radiation Oncology.
The proposed payment rates for the listed topic are set to take effect January 1, 2026. The notice states that the proposed payment rates were calculated under Texas Administrative Code Title 1, Section 355.8085 (Reimbursement Methodology for Physicians and Other Practitioners). HHSC will make a briefing packet describing the proposed payment rates available at https://pfd.hhs.texas.gov/rate-packets on or before April 14, 2026, and it can be obtained afterward by contacting Provider Finance.
Written comments may be submitted in lieu of or in addition to oral testimony until 5:00 p.m. on the day of the hearing. Comments may be sent by U.S. mail, overnight mail, fax, or email to Provider Finance at HHSC (email: PFDAcuteCare@hhs.texas.gov; fax: (512) 730-7475), with addresses provided in the notice. Persons needing auxiliary aids or services due to a disability must contact Provider Finance at least 72 hours before the hearing.
The notice states the hearing is conducted in compliance with Texas Human Resources Code Section 32.0282, which requires public notice and hearings on proposed Medicaid reimbursements, and it indicates that a hearing recording will be archived on demand on HHSC’s live meeting archive webpage under the “Archived” tab.
bill
Regulation • 🇺🇸 United States • Texas • Regulatory Notice
The document establishes a Texas Health and Human Services Commission (HHSC) public hearing to receive public comment on proposed updates to Medicaid payment rates—specifically a Rural Hospital Obstetrics and Gynecology (OB-GYN) Standard Dollar Amount (SDA) add-on—based on Texas Government Code 526.0301(b) and (c).
It sets a hearing date and logistics: July 24, 2026, from 9:00 a.m. to receive comments; the hearing will be held both in person (Public Hearing Room 1.401–1.404 at the North Austin Complex) and online (via GoToWebinar), with live streaming and later archived recording posted on HHSC’s Live and Archived Meetings webpage. The document states the hearing is conducted in compliance with Texas Human Resources Code Section 32.0282, and directs interested parties to HHSC’s Meetings and Events webpage for any updates to hearing details.
For the proposed rate action, it specifies the effective date for the legislative rate update as September 1, 2026. It references the calculation methodology and justification as being determined under Texas State Plan Amendment pages 4.19-A 8h and 8h.1. A briefing packet describing the proposed updates is to be made available starting July 10, 2026, through HHSC’s Rate Packets website and is obtainable by contacting the Provider Finance Department.
It allows public participation through written comments submitted instead of, or in addition to, oral testimony until 5:00 p.m. on the day of the hearing, with submission methods including U.S. mail, overnight/special delivery, fax, and email to Provider Finance (pfd_hospitals@hhs.texas.gov). It also includes a request process for auxiliary aids/services for persons with disabilities (requesting accommodations at least 72 hours before the hearing) and identifies the filing date as June 30, 2026.
The bill establishes and revises Utah’s Medicaid “expansion” framework under Title 26B, Chapter 3, including eligibility program structure, cost-containment triggers, and reporting requirements. It also creates new operational requirements tied to changes in federal match rates and adds specific administrative actions and planning proposals when expansion financing is threatened.
Key eligibility/program changes are made in 26B-3-109 (Medicaid expansion) and 26B-3-113 (Expanding the Medicaid program) by shifting Medicaid expansion eligibility to align with the populations authorized under Sections 26B-3-113 and 26B-3-210 and by updating internal cross-references. The targeted adult Medicaid program in 26B-3-207 is revised to clarify definitions and eligibility/certification processes, including CMS approval conditions for allowing continued enrollment for up to a 12-month certification period and the department’s related waiver-application process. The bill also retains/updates provisions that coordinate Medicaid enrollment with state prisons or county jails and that clarify that counties do not have to provide matching funds for newly enrolled individuals in the expansion programs.
The most substantive policy change occurs in 26B-3-210 (Medicaid expansion) concerning termination timing and federal-funding reductions: (1) expansion authority sunsets the day after the Legislature adjourns sine die following the determination that the expansion FMAP rate is reduced below 90%; (2) the department must commence termination and system-change processes based on that sunset; and (3) within 60 days after a state determination that the expansion FMAP rate will be reduced below 90%, the department must create and submit a proposal to specified budget/legislative offices. The proposal must outline options to maintain Medicaid expansion within projected funding and must consider enumerated cost-containment efforts (e.g., suspending certain administrative cost growth, suspending or reversing provider payment increases paid with general fund/income tax funds, suspending/limiting general-fund-funded benefits and optional populations, and closing enrollment to new members). The bill also directs that the Medicaid expansion program be closed to new enrollment if projected expansion costs exceed legislatively authorized fiscal-year appropriations.
Additional changes adjust Medicaid hospital-financing provisions and reporting detail. 26B-3-506 (hospital share) is revised to update the hospital share calculation and caps (including specified cap amounts and an increased fixed component for the Medicaid waiver expansion if approved), and 26B-3-606 is revised to align net-cost calculations with the Medicaid expansion terminology. Finally, the bill adds/clarifies an annual reporting obligation in 26B-3-113 for the number of expansion enrollees, state costs, estimated future state costs, cost-control recommendations, and the state’s net cost of Medicaid expansion, with the report due on or before November 1 each year, and sets an effective date of May 6, 2026.
The bill establishes the Health Care Reform Task Force and creates a new Utah Code section (36-29-113) to govern it. The task force consists of three state senators appointed by the president of the Senate (with no more than two from the same political party), five state House members appointed by the speaker of the House (with no more than three from the same political party), the Insurance Department commissioner (or designee), the state Medicaid director (or designee), and two members appointed by the governor.
The task force is co-chaired by a Senate member designated by the Senate president and a House member designated by the House speaker. The task force is required to study the creation of one or more multistate coalitions to develop joint strategies and uniform compacts addressing health care systems, including pharmacy benefit manager regulations, drug purchasing, health care costs reporting and transparency, Medicaid, and the health care work force.
The Office of Legislative Research and General Counsel must provide staff support, and a majority of members constitutes a quorum. Members may not receive compensation or benefits for service, but may receive per diem and travel expenses as allowed under specified Utah statutes and related Division of Finance rules.
By September 1, 2027, the task force must report its progress and recommendations to the Health and Human Services Interim Committee. The bill takes effect May 6, 2026.
The bill creates new Medicaid provider quality-measure requirements for Utah’s Department of Health and Human Services (department) and establishes a new “closed loop referral system” for health-related social needs care. It also updates contract administration procedures for providers under the Division of Services for People with Disabilities (division) by requiring advance notice to providers when the division amends a contract.
For Medicaid provider quality measures, the bill enacts a new statute (26B-3-143) requiring the department to: (1) define “quality measures” and establish them through administrative rulemaking; (2) create provider-type-specific quality measures; (3) adopt rules for a participating provider to submit documentation of completion/progress, the methodology for evaluating that progress, and exclusions based on adverse findings or disciplinary actions; and (4) annually report before October 31 to the Social Services Appropriations Subcommittee on participating provider-type evaluation, including guidance for legislative selection/prioritization of provider types eligible for incentive payments. In addition, the bill authorizes and structures one-time incentive fee-for-services payments to “participating Medicaid providers” (including managed care entities and fee-for-service providers) based on the department’s performance evaluation, with distribution required to be proportional to participating providers, consistent with legislative appropriations, and compliant with CMS rules.
To support social needs care coordination, the bill enacts a new closed-loop referral statute (26B-3-144) requiring the department to implement a system for referrals for delivery of social needs care to Medicaid-eligible individuals. The system must (a) notify authorized users of requests/referrals, (b) allow secure access to relevant information, (c) restrict access to the individual’s consent and consistent with privacy laws, (d) use a secure chat function to facilitate communication, (e) send referrals on behalf of the receiving individual, and (f) track and store outcomes of referrals and services in a single record. The department must also make implementing rules, including authorized use/user requirements.
For the division’s contract amendments, the bill amends 26B-6-403 to require the division to notify a contracted provider at least 30 days before the effective date of contract amendments, while allowing waiver of the 30-day notice upon a contractor request for change, a service rate increase, or in response to a natural disaster or public health emergency. The bill appropriates $42,778,300 in fiscal year 2027 (additions to previously appropriated amounts), including $16,888,300 from the General Fund, with specific legislative intent to use portions of the funding to raise Medicaid provider reimbursement rates for multiple provider categories (e.g., private duty nursing, New Choices Waiver, Division of Services for People with Disabilities providers, personal care, foster care/proctor/congregate providers, nursing homes and intermediate care facilities for individuals with intellectual disabilities, home health, and others). The bill takes effect on May 6, 2026.
The bill establishes a state-operated single-payer style health financing structure in Utah (“Utah Cares”), including a Utah Health Services Commission and a Utah Cares Health Financing Program. It directs the Department of Health and Human Services to transition Medicaid administration and payment of Medicaid services to the Utah Cares Health Financing Program once required CMS approvals and waiver/state-plan amendments are in place, and requires managed care benefits under Medicaid to be delivered by Utah Cares after CMS approval. It also transitions the Public Employees’ Benefit and Insurance Program into Utah Cares coverage that is open to public enrollment by allowing state residents to enroll in the program.
The program’s financing and enrollment are defined through new Title 26C provisions, including creation of a Utah Cares Trust Fund funded by legislative appropriations, payments under new Utah Cares Act financing provisions, federal savings from specified CMS authority, and tax revenue from a newly created “Utah Health Care Tax” (a gross receipts tax on corporations and pass-through entities with defined rates and a gross-margin limitation when tax would exceed gross margin). The bill sets out program governance and duties for the Commission (budgeting, quality assurance, audits/evaluations, dispute adjudication, public meetings, rulemaking, and creating advisory boards), and duties for the program’s executive director (enrollment system, self-insurer administration, claims processing, formulary and price negotiation, actuarial reviews, budgeting/audited financial reporting, benefit/rate adjustments, and operations including electronic clinical records exchange with notice and an opt-out option).
Provider payment and billing rules are changed to make Utah Cares the primary payer for covered services. Beginning November 1, 2029, health care facilities may not bill individuals for services, and the program is required to negotiate and set provider/facility rates (with a requirement that—except for operating/capital budget facilities—rates are at least the Medicare fee amount plus 10%). Utah Cares must begin billing on behalf of facilities, pay claims promptly, set Medicare Advantage as soon as practicable for eligible individuals, and provide covered benefits meeting federal health benefit plan requirements and minimum equivalence to the benefits offered to state employees as of January 1, 2026, while generally requiring no cost-sharing for non-pharmaceutical services.
The bill creates and restructures health workforce planning and medical education functions by moving/renumbering related councils and functions into the Commission framework, including a Commission-based Utah Health Workforce Advisory Council and a Utah Health Workforce Information Center responsible for data collection/analysis and reporting. It creates or refines specific clinical/coverage programs within Utah Cares (e.g., SBIRT reimbursement for controlled substance prescribers; expanded infertility treatment coverage; coverage for exome sequence testing; in-vitro fertilization and genetic testing; pregnancy and childbirth services including limits/reporting; and additional medical education grant programs such as residency and forensic psychiatrist fellowship grants). It also imposes a prohibition on premiums for program-covered services beginning January 1, 2029, and expands Medicaid-related administrative structure via a created Medicaid Division within the Utah Cares program (effective upon approval of the necessary Medicaid waivers/state-plan amendments). Finally, it repeals numerous existing statutes in Titles 26B and 49-20 associated with the former Medicaid/public employee insurance framework and sets staggered effective dates, with general effectiveness January 1, 2028 and earlier actions for specified sections beginning January 1, 2027 and July 1, 2027.
The bill establishes changes to Utah’s Medicaid hospital provider assessment framework and the Medicaid accountable care organization (ACO) rate structure to incorporate quality incentive arrangements, and updates the Hospital Provider Assessment Expendable Revenue Fund uses to reflect the revised quality-monitoring and quality-strategy funding limits. It also makes conforming/technical adjustments to the relevant assessment and rate-setting statutes.
Under Utah Code § 26B-1-316, the Hospital Provider Assessment Expendable Revenue Fund may be used to (1) support capitated ACO rates; (2) implement quality strategies described in § 26B-3-707(2), with the annual cap set at $211,300; (3) implement § 26B-3-707(1)(c), including monitoring Medicaid ACOs’ distribution of funds to hospitals, with the annual cap set at $200,000; and (4) reimburse the division for money collected from a hospital due to a mistake under the hospital provider assessment provisions.
Under Utah Code § 26B-3-705, the uniform hospital assessment rate must be determined using hospital discharges divided into the total non-federal portion in an amount consistent with § 26B-3-707 needed to support capitated ACO rates and payments for Medicaid hospital services. The quarterly changes to the uniform assessment rate must be applied uniformly to all assessed hospitals. The annual uniform assessment rate is capped at (i) $1,000,000 for offsetting Medicaid mandatory expenditures, and (ii) the non-federal share needed to seed amounts supporting capitated rates for Medicaid ACOs. The section also clarifies discharge data sources and procedures: discharges are based on Medicare Cost Report data from a CMS file; if absent, hospitals must submit their cost report to the division; if not Medicare-certified and not required to file cost reports, hospitals must submit discharge data with documentation (and failure to submit discharge information results in an audit and a penalty equal to 5% of the calculated assessment). Ownership and assessment-payment rules remain in place, with an exception allowing aggregate assessment payment when multiple hospitals share the same Medicaid provider number.
Under Utah Code § 26B-3-707, the ACO rate structure directed payment calculation adds a new component: up to the maximum amount under 42 C.F.R. § 438.6(b)(2) quality incentive arrangements if Medicaid ACOs distribute at least 90% of those funds to hospitals. The division must amend quality strategies required under 42 C.F.R. § 438.340 to include quality measures selected from CMS hospital quality improvement programs and may adopt different quality standards for rural and specialty hospitals. The division must make rules to adopt the selected quality measures and prescribe penalties for failure to meet quality standards, and it must apply the same quality measures and penalties to new directed payments to the University of Utah Hospital and Clinics. The bill takes effect May 6, 2026.
Virginia
7
bill
Regulation • 🇺🇸 United States • Virginia • Final Notice
The regulation establishes a permanent regulatory framework for Medicaid-covered private duty nursing delivered under the Early and Periodic Screening, Diagnosis, and Treatment (EPSDT) benefit, specifying that private duty nursing is not covered unless delivered under EPSDT or a § 1915(c) waiver. It also sets out (newly added as a dedicated section) detailed service descriptions, exclusions, provider and supervisor qualifications, service limits, and service authorization/hours methodology tied to DMAS authorization processes.
The document contains changes that (1) amend the “services not provided” lists for both categorically needy and medically needy populations to reinforce that private duty nursing is excluded except when provided under EPSDT or a § 1915(c) waiver, and (2) add a new section (12VAC30-50-132) that codifies private duty nursing services under EPSDT for fee-for-service individuals, stating that managed care recipients receive the service through their health plans. The new section clarifies what private duty nursing is (continuous/regularly scheduled skilled nursing care with medically necessary assessment/monitoring/teaching), defines congregate private duty nursing, and specifies service components, including exclusions from DMAS coverage such as custodial/personal care that can be performed by trained nonmedical personnel, monitoring as “maintenance of care” for medically-controlled disorders, and respite services.
Private duty nursing provider qualifications are established in the new EPSDT section: providers must operate from a business office, disclose ownership if requested, and attest to records documentation. Nursing must be provided by an RN or LPN employed by (or subcontracted with) and supervised by an enrolled provider; RN and LPN requirements include Virginia licensure, work-history reference checks without evidence of abuse/neglect/exploitation of vulnerable individuals, criminal record checks via Virginia State Police, and (for minors) searches of the VDSS Child Protective Services Central Registry and restrictions on barrier crimes and founded complaints. The section also establishes RN supervisor requirements, including minimum experience, supervision frequency (at least a visit every 30 days, with monthly assessments and specific conditions for additional visits), documentation expectations, plan-of-care duties, coordination and education responsibilities, and a failure-to-meet standard that may permit DMAS recovery of payments.
The new section codifies service limits and authorization: private duty nursing hours are limited to skilled nursing and medically necessary supervision in a physician-signed Plan of Care and capped by the number of hours approved via the DMAS service authorization form (DMAS-62), with authorization based on medical and support needs (e.g., respiratory function, medication/central access, wound care, feeding, assessments requiring professional skills, toileting, and other licensed-clinician needs). For eligible individuals under age 21, EPSDT allows services beyond State Plan limits up to 24 hours per day when medically necessary and prior authorized. It also establishes a specific condition that certain family members (e.g., parents/guardians, spouses, siblings, grandparents, adult children, or others in the same household) cannot provide private duty nursing for purposes of Medicaid reimbursement.
The bill establishes and revises Virginia requirements for health insurance carrier conduct and contracting, focusing on (1) minimum “fair business” standards for claim processing and downcoding/retroactive denials, including electronic notice requirements, and (2) required contract provisions governing prior authorization turnaround times, communication methods, supplementation, limits on revoking approved authorizations, and public posting of prior authorization lists and data. It also amends 2023 session laws by requiring a coordinated Bureau of Insurance work group to monitor federal developments and evaluate options for electronic prior authorization and prescription drug prior-authorization process changes.
It amends and reenacts two Code of Virginia provisions—§ 38.2-3407.15 (ethics and fairness in carrier business practices) and § 38.2-3407.15:8 effective Jan. 1, 2027 (carrier contracts; required provisions regarding prior authorization)—and incorporates additional contract, dispute, enforcement, and electronic-delivery obligations in those sections. Separately, it amends and reenacts parts of the second enactments of Chapters 474 and 475 (2023 Acts of Assembly) by updating the work group’s scope, including evaluating whether prior authorization metrics reporting should expand to prescription drugs, and adding a reporting deadline structure with interim and final reports.
The bill revises Virginia’s health insurance “ethics and fairness in carrier business practices” statute (Va. Code § 38.2-3407.15), with particular emphasis on claim-payment timelines and electronic communications for providers.
It updates carrier and provider obligations in the provider-contract minimum fair business standards, including: (1) adding explicit requirements for carriers to deliver required notifications and related provider responses electronically starting January 1, 2026 (for the notice-of-defect/impropriety process tied to making a claim a “clean claim”); (2) likewise requiring electronic delivery for written communications and explanations for retroactive denials/recoveries/refunds related to previously paid claims, beginning no later than January 1, 2026; (3) adding an express requirement that carriers make available through electronic means, beginning July 1, 2025, a way for providers to determine whether an enrollee is covered by a health plan subject to the State Corporation Commission’s jurisdiction; and (4) tightening electronic-format contracting and notice flows by requiring that (a) beginning no later than July 1, 2025, carriers deliver provider contracts, related amendments, and notices exclusively in an electronic format other than electronic facsimile, and (b) beginning no later than January 1, 2026, providers submit provider contracts, amendments, and notices to carriers exclusively in such electronic format.
The bill also clarifies/strengthens enforcement and provider remedies tied to the statute’s existing framework: providers may sue to recover actual damages for carrier violations/breaches; if gross negligence and willful conduct are found, damages may be increased up to three times actual damages; and violating claims are treated as separate violations for damages/fee purposes (attorney fees and court costs may be awarded). It preserves prohibitions on carriers terminating/penalizing providers for invoking rights under the section, maintains the Commission’s limited role (no adjudication of individual controversies), and directs that the Commission may promulgate rules to implement the section.
The bill sets an effective date of January 1, 2027.
The bill amends and reenacts Virginia Code § 32.1-325, directing the Virginia Department of Medical Assistance Services’ Board to prepare and submit (and periodically update) Virginia’s Medicaid state plan to the U.S. Secretary of Health and Human Services under Title XIX, and to include a set of specified mandatory/required state-plan provisions. The newly emphasized operational change is the creation/expansion of Medicaid state-plan requirements covering a wide range of eligibility rules and service benefit expansions, as well as Medicaid delivery/administration requirements.
Key additions/requirements in the amended state-plan content include: (1) Medicaid coverage provisions for specific clinical services and benefit categories (e.g., additional maternal/perinatal services such as expanded postpartum treatment and postpartum doula care; breast reconstruction and related breast cancer–treatment coverage; prostate and colorectal cancer screening requirements; low-dose mammogram schedule; family planning limited to non-abortion purposes; telemedicine and remote patient monitoring including originating-site and provider participation rules; remote ultrasound and remote fetal non-stress tests; complex rehabilitative technology/wheelchair base accessories for nursing-facility residents with medical-necessity contingencies and limits on patient cost-sharing; and coverage for particular oncology, transplant, autoimmune neuropsychiatric, and genetic testing services). (2) Eligibility/administration rules tied to Medicaid eligibility determinations and provider/vendor operations (e.g., requirements that entities determining medical assistance eligibility obtain accurate contact information and provide advance directive information; specific medically needy “home” disregards and burial-expense resource disregards; and benefit delivery rules for Medicaid-eligible students, including telemedicine reimbursement rules without requiring proprietary technology).
The bill also establishes a Tribal Medicaid Advisory Group within the Board’s planning function. The group must include the Director (or designee), an Indian Health Service representative, and representatives from each federally recognized tribe administering a tribal health program; it must collaborate on tribal health program plan amendments/waiver requests/policies at least 60 days before public notice-and-comment submission and on a tribal health program billing manual; and it must meet in person at least quarterly. Separately, the bill adds consultation/participation requirements for tribal health programs in the state plan, requiring the Department to consult with participating tribal health programs at least 60 days prior to adverse actions such as suspension of payments or investigations relating to participation.
Beyond the state-plan benefit and tribal consultation changes, the amendment includes specified administrative and governance directives within § 32.1-325. These include maintaining federal-grant eligibility through conforming state-plan amendments to changes in federal law/regulations/court constructions (with specific rulemaking-notification and emergency/conformance constraints), prescribing/expanding provider participation and contracting enforcement approaches (including appeal/hearing timelines when agreements are terminated/denied), continuing rules for pharmacy and telehealth reimbursement eligibility, and requiring annual reporting to the Governor and General Assembly on implementation and outcomes for expanded pregnancy dental services and postpartum doula care (including utilization counts and maternal/infant health impacts, barriers/feedback, and recommendations).
The bill amends Virginia’s health insurance claim-processing and provider-contract requirements by revising §§ 38.2-3407.15 and 38.2-3407.15:8. It establishes detailed “ethics and fairness” standards for carrier handling of provider claims (including payment timing, clean-claim rules, notice of defects, dispute and downcoding requirements, limits on retroactive denials/recoupment, required contract contents, and electronic communication requirements beginning in 2025–2026) and creates/updates requirements governing required prior-authorization contract provisions for health care services, effective January 1, 2027.
Section 38.2-3407.15 (ethics and fairness in carrier business practices) requires provider contracts to include minimum fair business standards: pay claims within 40 days of receipt with specified exceptions; maintain claim-receipt records and allow provider inspection; require notice within 30 days of claim defects preventing clean-claim status; mandate payment after receipt of required additional information; ensure interest is paid without demand; require offering alternative payment methods without transaction fees; establish medically-necessary/covered-benefit verification mechanisms during business hours; require carriers to implement and disclose bundling and downcoding policies and to downcode only using correct coding standards that consider all relevant patient data, with provider notice, explanation-of-payment codes, and a dispute process (including natural-person review of downcoding dispute decisions and minimum dispute timelines); require providers be given applicable policies within 10 business days (or a compliant copyright workaround explanation); and require payment of previously authorized/medically necessary covered services unless specific enumerated grounds apply.
The bill further tightens restrictions on retroactive denial/recoupment by prohibiting such actions unless the carrier specifies the affected claim(s), provides a written explanation, and satisfies fraud/incorrect-payment/12-month timing limits (with an exception allowing written agreement to offset after 12 months); requires 30-days advance notice for retroactive denials/recovery; requires provider contracts to include required fee/reimbursement information; restricts effectiveness of contract amendments/new policies unless the provider receives the material at least 60 days before effective date and has at least 30 days to notify intent to terminate; requires establishment of the claims payment dispute mechanism and treats overturn of denials as clean claims; prohibits provider discrimination based on enrollee status as a litigant; and requires electronic means for providers to determine enrollee coverage beginning July 1, 2025. It also requires that a provider generally make a reasonable effort to confer with the carrier before filing a Commission complaint for failure to pay claims (subject to timing/responsiveness conditions), provides Commission and Board mechanisms for patterns of potential subdivision B 13 violations, and defines enforcement/relief including actual damages (and up to treble where gross negligence and willful conduct are found), attorney fees/costs, and a no-termination/penalty protection for providers invoking rights. Electronic-only delivery of provider contracts/amendments/notices is mandated beginning July 1, 2025 for carriers (and January 1, 2026 for providers), with agreed electronic method/location in the contract.
Section 38.2-3407.15:8 (effective January 1, 2027) requires provider contracts to include prior-authorization process rules for carriers, distinguishing expedited vs. standard requests. Contracts must require electronic/telephonic decisions within 72 hours (including weekends) for expedited requests and within seven calendar days for standard requests, including supplementation timelines; prohibit revocation/limitation/modification of approved authorizations except for enumerated circumstances (provider-requested changes, fraud/misrepresentation evidence, or certain federal/manufacturer market removals/limits impacting the authorization, or patient safety communications), and clarify that carriers need not authorize if the enrollee is no longer enrolled. Denial communications must also occur within the same expedited/standard timeframes; carriers must establish and maintain a prior-authorization application programming interface (API) consistent with CMS requirements (42 C.F.R. § 422.122(b)) and must be implemented by January 1, 2027 (or other subsequently issued CMS effective date), while providers must ensure their electronic health records/systems can access the API within one year after the API implementation requirement date, with a possible waiver for undue hardship determined by the appropriate HHS Secretariat-designated regulatory authority. The section also requires carriers to publish and update a central list of services/codes requiring prior authorization (with provider notice at least 30 days before changes) and prohibits denial of claims for failure to obtain prior authorization when the requirements for that date of service were not posted accordingly; it permits removal of prior authorization requirements without the 30-day notice in pandemics/natural disasters/emergencies; and requires annual posting (by March 31) of prior authorization data at the health plan level for required metrics.
Finally, the bill amends reenactment language from 2023 by directing the State Corporation Commission’s Bureau of Insurance, in coordination with the Secretary of Health and Human Resources, to establish a work group to monitor and evaluate federal developments and readiness for electronic prior authorization, assess the state prior-authorization process (including potential shift toward less retrospective to more prospective processes for prescription drugs), evaluate whether metric reporting scope should expand to prescription drugs, include specified stakeholder groups, and submit periodic reports: an initial final report findings/recommendations due by November 1, 2025 (with final assessment and a recommended implementation date for electronic prior authorization for medical items/services) and an eventual final report due by November 1, 2028.
The bill changes Virginia Code § 38.2-3407.15 (“Ethics and fairness in carrier business practices”) by amending and reenacting it, replacing the full section text.
Key established/changed contents within § 38.2-3407.15 include: (1) definitions for AI, carrier/enrollee/provider, claim/clean claim, and related terms; (2) minimum “fair business standards” that provider contracts must include, including claim payment timing, electronic claim processing/communications, notice requirements for non-clean claims, limits on retroactive denial/recoupment, required contract attachments and amendment effectiveness rules, dispute/clean-claim treatment after overturn, and anti-discrimination provisions for enrollee litigant status; (3) new requirements tied to electronic exchange of contracts and notices between carriers and providers; (4) new AI governance duties for carriers using AI in claims/coverage decisions (public disclosure to the Bureau if applicable, submission of information upon request, documentation retention, and notice/appeal process for adverse determinations); (5) restrictions on when providers may file Commission complaints for nonpayment (requiring reasonable effort to confer and timing conditions); (6) Commission authority to refer patterns of potential subdivision B 13 violations to other health/medicine authorities for enforcement; (7) provider remedies for losses from carrier violations or breach (actual damages, possible treble damages for gross negligence/willful conduct, and fee/cost shifting); (8) prohibitions on carrier termination/nonrenewal/penalization of providers for invoking rights under the section; (9) jurisdictional limits (no Commission adjudication of individual controversies), with rulemaking authority for implementation; and (10) general exemptions where carrier failure is caused by the claimant or is beyond the carrier’s reasonable control.
The bill also contains explicit effective timing triggers for several electronic-notification/delivery and electronic contract-exchange requirements (including July 1, 2025 and January 1, 2026, and one provision beginning no later than January 1, 2026; plus an AI-related disclosure/notice framework contained in subsection B 15).
The bill requires the Virginia Department of Medical Assistance Services (DMAS) to provide training to local school division staff on Medicaid billing navigation for reimbursable services provided at school sites. The training must cover how to understand and navigate current federal Medicaid billing and reimbursement processes, teach school division staff the billing/reimbursement procedures for services delivered by school personnel or contracted providers, and address compliance with state and federal Medicaid billing requirements.
DMAS must also tailor training to help schools identify services eligible for Medicaid reimbursement that may become available through any expansion of eligibility under applicable state or federal law, policy, rules, regulations, or guidelines. The training is required to include development of best practices and documentation templates intended to streamline school divisions’ Medicaid billing processes.
The bill authorizes DMAS to include direct support activities such as holding training sessions and workshops for school administrators and financial officers about new Medicaid billing opportunities; providing technical assistance on submitting Medicaid claims (explicitly including mental health services and physical/occupational therapy and speech/language pathology, along with other reimbursable health-related services) for services delivered at school sites; advising schools on strategies to expand Medicaid-reimbursable services based on student needs and available resources; and creating and distributing guidance documents, toolkits, and other resources to promote consistent Medicaid billing practices across the Commonwealth.
DMAS must deliver the training virtually and provide it no less than semi-annually. DMAS is directed to coordinate with the Virginia Department of Education, which must provide notice to local school divisions as necessary to facilitate the training opportunities for school staff.
Washington
7
bill
Regulation • 🇺🇸 United States • Washington • Proposed Notice
The rule amends Washington Health Care Authority (HCA) Medicaid rules governing “Maternity care and newborn delivery” in WAC 182-533-0400. It updates the chapter’s terminology and payment framework in anticipation of the American Medical Association’s (AMA) shift (effective January 1, 2027) from bundled/global obstetrics codes to itemized billing, while making related “housekeeping” updates to definitions and referenced concepts.
The amendments revise core definitions: “Bundled services” is removed and the definition of “Facility fee” is clarified to cover hospital/birthing-center charges but exclude professional fees. The definition of “High-risk” pregnancy is retained but updated to focus on significant risk of a poor outcome for the pregnant person/birthing person, the fetus(es), or both. “Global fee” and “Global/total fee” concepts are removed as standalone definitions, consistent with the move away from global billing.
The amendments also update operative coverage and payment language across the maternity care delivery sections. The agency’s payment structure is adjusted by changing references from “full scope” maternity care and “total obstetrical care”/global fee phrasing to updated wording describing medical maternity care and newborn delivery services and the circumstances under which facility fees, professional fees, and additional fees are paid. The rule continues to set out: when providers must be licensed, contract with HCA, and practice within licensure; which antepartum services are included (including routine chemical urinalysis and maternity counseling); how high-risk pregnancy is defined and when delivery services are covered in hospitals; what facility fees apply (inpatient hospital vs. birthing centers); and additional fee allowances (e.g., high-risk vaginal delivery, multiple births beyond the first child, and high-risk cesarean delivery), including when HCA will not pay separately (e.g., multiple cesarean births during one surgery and postoperative cesarean care).
Key timing and procedural elements include a public hearing on August 4, 2026, and written comment submission beginning June 25, 2026, due August 4, 2026 by 11:59 p.m. Intended adoption is not sooner than August 5, 2026, and the changes are directed to be effective January 1, 2027 in connection with the AMA coding transition.
bill
Legislation • 🇺🇸 United States • Washington • Bill
The document introduces a new section to chapter 41.05 RCW, establishing reimbursement requirements for health carriers and hospitals in Washington State, primarily impacting the healthcare industry, including health carriers, hospitals, and providers of primary care and behavioral health services.
Starting January 1, 2027, reimbursement for inpatient and outpatient hospital services will be capped at the lesser of billed charges, the contractor's contracted rate, or 200% of the Medicare reimbursement rate, with specialty hospitals treating children set at 350% of the Medicare rate. Rural hospitals designated as critical access or sole community hospitals are guaranteed at least 101% of allowable costs as defined by Medicare. For primary care services, reimbursement will not fall below 150% of the Medicare rate or the contractor's contracted rate. Adjustments to these limits will take effect on January 1, 2029, raising the caps to 190% for general hospitals and 300% for specialty hospitals treating children.
The legislation aims to enhance access to affordable healthcare services while regulating reimbursement rates for various healthcare providers. Additionally, it mandates that contractors provide cost and quality data for monitoring purposes, ensuring that premiums reflect the anticipated changes in reimbursement rates. A report analyzing the impacts of these changes on network access, enrollee costs, and state expenditures is required by December 31, 2030.
bill
Legislation • 🇺🇸 United States • Washington • Bill
The legislation addresses health care workforce shortages intensified by the COVID-19 pandemic by ensuring that advanced practice registered nurses (APRNs) and physician assistants (PAs) are reimbursed at the same rate as physicians for the same services. This change is particularly important for health systems, clinics, and private practices, especially in underserved and rural areas.
Starting January 1, 2026, health carriers are required to reimburse APRNs and PAs at rates equal to those of physicians for primary care and behavioral health services. Additionally, any nonclaims-based payments made to physicians must also be available to APRNs and PAs for the same services, and reimbursement rates for physicians cannot be reduced to meet this requirement.
The legislation aims to promote equitable reimbursement practices within the health care industry, which could enhance access to care in various communities. By addressing these disparities, the law seeks to improve the overall health care landscape, particularly in areas facing workforce challenges.
bill
Legislation • 🇺🇸 United States • Washington • Bill
The document outlines legislative changes in Washington State aimed at improving compensation for health care providers who are not employed by hospitals or their affiliates. These changes primarily impact individual practitioners, small clinics, and health carriers, ensuring that they receive fair compensation.
Starting January 1, 2026, health benefit plans must include compensation provisions that adjust annually based on the consumer price index for all urban consumers. This measure is designed to address the issue of stagnant compensation rates for health care providers, which have not kept pace with rising operational costs.
Overall, the legislation seeks to promote competition within the health care market and prevent further consolidation by ensuring that providers receive adequate compensation for their services.
bill
Legislation • 🇺🇸 United States • Washington • Bill
The law sets and modifies implementation steps for Washington’s Medicaid Access Program, including deadlines for submitting required state plan amendments/waivers to CMS and conditions for assessments and use of related funding. By September 1, 2030, the Health Care Authority must submit CMS state plan amendments or waiver requests necessary to implement the program, and the program’s funding mechanisms are conditioned on: CMS final approval of those submissions (including, if needed, waiving broad-based or uniformity requirements under 42 C.F.R. and the Social Security Act), amendments to contracts with managed care organizations as necessary, and a certification from the Office of Financial Management that adopted appropriations fully support the program’s upcoming fiscal-year rates.
The law also creates/maintains the Medicaid Access Program rate framework and changes how professional services rate increases are timed and calculated. The program requires uniformly increasing professional services rates (including specified categories such as anesthesia, diagnostics, intense outpatient, opioid treatment programs, emergency room, inpatient and outpatient surgery, inpatient visits, low-level behavioral health, maternity services, and various physician/office/home and related services) for categories not already reimbursed at or above Medicare rates, using Medicare rate benchmarks from December 31 of the prior year. The uniform increase is moved to occur by January 1 of the second plan year after the CMS-submission conditions are met, and subsequent adjustments (by January 1 of the third plan year after the conditions are met and annually thereafter) must use the most recently published Medicare economic index available at the time rates are set.
To evaluate effects on access, the authority must study and report—beginning January 1 of the third plan year after conditions are met and by January 1 in each of the next two plan years—the impact of the professional services rate increases on Medicaid access using specified metrics (e.g., utilization changes from licensed providers, number of enrolled contracts by identifiable provider types, patient access measures from CAHPS surveys, and other external quality review metrics) and must disaggregate results between managed care organizations and fee-for-service.
Finally, the act changes the program’s expiration trigger: the act expires if CMS does not provide final approval of the required state plan amendment or waiver requests by January 1, 2032 (previously January 1, 2027), and requires written notice of the expiration date to affected parties and specified state recipients. The law’s effective date is June 11, 2026 (per the certification/effective-date text).
bill
Legislation • 🇺🇸 United States • Washington • Bill
Modernizing and clarifying timely payment requirements for health carriers.
1st Chamber
2nd Chamber
Executive
check_circle_outline
check_circle_outline
check_circle_outline
check_circle_outline
Introduced
December 08, 2025
Passed (Senate)
February 11, 2026
Passed (House)
March 11, 2026
Signed
March 23, 2026
Enacted • 2025-2026 Regular Session • Introduced: December 08, 2025
Sponsors: Vandana Slatter (D)
Co-sponsors: Ron Muzzall (R), Mike Chapman (D), Paul Harris (R), Marcus Riccelli (D), Annette Cleveland (D), Bob Hasegawa (D), Deborah Krishnadasan (D), T'wina Nobles (D), Javier Valdez (D)
The bill establishes new, enforceable timely-claims-payment standards for health carriers by creating a new section in chapter 48.43 RCW. For covered services, a carrier must pay or deny a claim as soon as practical but no later than 30 calendar days after receiving a clean claim. If a claim is not clean, within 21 calendar days of receiving the claim the carrier must send electronic notice (remittance advice or other notice) acknowledging the receipt date and either (i) deny payment with specific reasons and the denied portion of the claim, or (ii) request specified additional information/documentation needed to process the claim; the carrier must make a good-faith single request and may not make additional requests for 30 calendar days after the initial request.
The bill adds detailed timing rules tied to the clean-claim determination and potential extension. Once the carrier receives all requested information/documentation, the claim is treated as clean and must be paid or denied within 30 calendar days (unless the parties agree in writing on a claim-by-claim basis); the 30-day period does not begin until all requested items are received. If the provider/facility fails to submit requested information/documentation within 21 calendar days of the carrier’s request, the carrier’s pay/deny obligation is extended to 40 calendar days after receipt of the requested information/documentation. The bill also requires carriers to use a “reasonable method” to confirm receipt of claims and requested information and to respond to provider inquiries.
To enforce compliance, the bill requires carriers to pay interest on claims for which they fail to meet the bill’s subsection (1) notice and claim-timeline requirements; interest accrues monthly as simple interest and is assessed at 1% per month beginning on calendar day 1 through day 60, and at 1.5% per month after day 60 until resolution. Interest is the carrier’s responsibility and may not be applied to a covered person’s deductible, copayment, coinsurance, or similar obligations; the carrier must add the interest to the unpaid claim amount and may not require additional submissions. For any noncompliant claim unresolved for more than 90 calendar days, the commissioner may impose an administrative penalty by rule, considering whether the carrier has engaged in a pattern of violations. The new section includes exceptions for fraud or material misrepresentation by providers/facilities/covered persons (supported by review/audit patterns), and for failures caused by acts of God, bankruptcy, governmental actions responding to emergencies, cybersecurity attacks, natural disaster declarations, or strikes/lockouts/labor disputes.
The bill reenacts and amends RCW 41.05.017 (health plan coverage subjects to specified chapter 48.43 payment requirements) and amends RCW 48.43.600 to adjust and clarify carrier refund limits. Specifically, it shortens/extends timing for when a carrier may request a refund of previously paid claim amounts: in general, written requests must be made within 12 months after the original payment date (instead of 24 months), and for mental health/substance use disorder services within 6 months (and for coordination-of-benefits-related refund requests, within 18 months generally and 9 months for mental health/substance use disorder services). It also retains rules governing contested refund requests (provider has 30 days to contest; otherwise the refund request is deemed accepted), refund-payment timing limits (carrier cannot require payment sooner than 6 months after receipt of the request), and that carrier-provider contracts that conflict with the section yield to it while allowing providers to voluntarily refund. The bill applies the new timely-payment requirements to health plans filed or renewed on/after January 1, 2027; applies only to regulated health carriers (including public employees’ benefits board and school employees’ benefits board programs) and excludes Medicaid managed care plans under chapter 74.09 RCW; applies only to participating providers/facilities under contract and to Indian health providers as defined in RCW 43.71B.010 (including noncontracted/nonparticipating providers); and allows the insurance commissioner to adopt implementing rules. The new timely-payment section takes effect June 11, 2026, with the RCW 48.43.600 refund timing changes taking effect January 1, 2028 (per the bill’s effective-date provisions).
bill
Legislation • 🇺🇸 United States • Washington • Bill
The bill establishes a mechanism to redirect certain quantified “efficiency savings” from federal law changes (identified as reforms under P.L. 119-21 affecting Washington’s Medicaid program) into a dedicated state account used to fund increased Medicaid reimbursement rates to providers and hospitals. It also requires an annual calculation and reporting by the Washington Medicaid authority to the State Treasurer and legislative fiscal committees of the amount of state Medicaid expenditures that would have occurred under the federal/state rules in place prior to July 1, 2025, but were not made due to the specified reforms.
It creates two new sections in Chapter 74.09 RCW: (1) a “medicaid enhanced provider rate account” in the state treasury, with required annual transfers at the start of each fiscal year from the general fund based on the amount calculated by the authority; and (2) the authority’s reporting/calc process by June 30 each year, including a required methodology description and explicit categories of reduced expenditures/caseload/appropriations tied to P.L. 119-21 provisions (including moratoriums on certain eligibility/enrollment implementation, reduced caseload from failed additional eligibility redeterminations and from failure to meet community engagement requirements, disenrollment of deceased individuals under enhanced verification, reduced retroactive coverage periods, and modifications to cost-sharing for certain expansion enrollees).
The bill includes an emergency clause stating it is necessary for the immediate preservation of public peace, health, or safety, or support of state government and existing public institutions, and it takes effect immediately.
West Virginia
3
bill
Legislation • 🇺🇸 United States • West Virginia • Bill
The bill establishes new state requirements to collect and report immigration-related cost and patient-status data, including requirements aimed at undocumented (not lawfully present / without specified lawful documentation) persons.
It creates a new public safety/data-reporting article requiring each political subdivision to declare quarterly amounts spent on housing, sheltering, feeding, transporting, and education of noncitizen immigrants residing in the jurisdiction who do not possess specified lawful statuses (a Permanent Resident Card, work visa, or student visa) or are otherwise undocumented. It also requires county commissions and city councils to report expenditures on such persons using specified expense-account details (dates, amounts, purposes, and frequency of receipt). Noncompliance triggers a finding of violation of the state’s sanctuary-city prohibitions, expressly tying noncompliance to enforcement under the article.
It creates a new public health/immigration data section governing hospitals accepting Medicaid. Hospitals must add to patient admission/registration forms an option for the patient or representative to state or indicate whether the patient is a U.S. citizen or lawfully present, is not lawfully present, or declines to answer. The bill requires accompanying notice that the response will not affect patient care and will not result in reporting of the patient’s immigration status to immigration authorities. Hospitals must submit a quarterly report to the department within 30 days after quarter-end, identifying the number of admissions and emergency department visits during the quarter associated with each reporting category (lawfully present/citizen, not lawfully present, or declined to answer). By March 1 each year, the department must report to the Governor, President of the Senate, and Speaker of the House the total counts for the prior calendar year and must also describe information relating to costs of uncompensated care for aliens not lawfully present, the impact of uncompensated care on hospital cost or ability to provide services, hospital funding needs, and other related information. The department may adopt rules for report format and acceptable hospital form/inquiry formats, but rules may not require disclosure of patient names or other personal identifying information.
The document authorizes the Department of Health to adopt implementing rules for the reporting format and hospital form/inquiry requirements and expressly limits those rules to avoid requiring patient-name or other personal identifying information disclosures.
bill
Legislation • 🇺🇸 United States • West Virginia • Bill
The bill establishes new Medicaid provider enrollment and credentialing requirements in West Virginia by creating a new code section, §9-5-34, and consolidates credentialing expectations under an expedited, electronic, uniform process for state involvement and managed care organizations.
By July 1, 2026, the Department of Human Services (or its agent) must make Medicaid provider enrollment determinations within five business days after receipt of a completed application. The agent must allow multiple users to be logged into the system, be accredited by the National Committee for Quality Assurance, electronically notify applicants within two business days when documentation is incomplete with a detailed missing-materials explanation and a secure link to submit the missing materials, and report failures to meet the enrollment standard to the department for inclusion in quarterly performance audits. By July 1, 2026, Medicaid managed care organizations must complete provider credentialing within 60 calendar days after receipt of a clean and complete application, may request a one-time extension of up to 30 days only with written justification to the department and notice to the applicant, and are subject to contractual penalties upon missed timelines, including corrective action plans, monetary sanctions, or—at the department’s discretion—credentialing-by-default.
The Office of the Insurance Commissioner must, by July 1, 2026, prescribe an electronic credentialing application form for use by Medicaid managed care organizations based on a standard form from the Council for Affordable Quality Healthcare. Managed care organizations must use the applicable standard form for initial credentialing and recredentialing and may not require providers to submit any additional information beyond what the standard form requires, for covered basic, specialty, or supplemental health care services. The bill also permits managed care organizations to limit the scope of participating providers’ covered services.
Beginning July 1, 2026, Medicaid provider enrollment and credentialing submissions (including applications, renewals, documents, and supporting materials) must be submitted exclusively by electronic means. The bill also repeals the prior “uniform credentialing for health care practitioners” statutory framework in West Virginia Code §16-1A-1 through §16-1A-10 (as shown on page 2), removing those existing provisions entirely.
bill
Legislation • 🇺🇸 United States • West Virginia • Bill
The bill establishes and clarifies operational requirements for West Virginia’s prior authorization process under §9-5-32 of the Code, including an electronic submission and status system, specified turnaround times, rules for incomplete requests, and a framework for audit/peer-review appeal of denials.
It also narrows prior authorization mandates specifically for FDA-approved antipsychotics under fee-for-service and managed care medical assistance programs: prior authorization and utilization management controls may not be imposed on an FDA-approved antipsychotic for the purpose of removing barriers to timely treatment of serious mental illness. The provision is implemented through §9-5-32(n) and reinforced by the bill’s stated purpose to narrow prior authorization scope for these drugs.
Beyond the antipsychotic restriction, the bill details process mechanics and timing: prior authorization forms and related communications must be submitted via an electronic portal that (i) includes submission instructions for clinical documentation, (ii) provides electronic receipt notifications, (iii) includes a regularly updated, science-based list of items requiring prior authorization, (iv) conspicuously informs patients about any step-therapy requirements and documents whether step therapy was attempted and unsuccessful, and (v) is required to be prepared by July 1, 2024. The Bureau for Medical Services must provide status updates through the portal and respond within five business days, or within two business days for time-sensitive conditions where delays could seriously jeopardize life/health/safety or cause adverse consequences as judged by a health care practitioner.
The bill further defines handling of incomplete submissions (identify deficiencies within two business days; the provider has three business days to supply additional information; the Bureau must decide within two business days; otherwise the request is considered denied), permits transfer to peer review for audit/step-therapy incompleteness within two business days, carries approved prior authorizations across managed care organizations/insurers for three months for in-state services, and sets peer-to-peer appeal timing constraints (five business days for peer consultation; no longer than 10 business days for appeal decision). It also includes a discharge exemption allowing inpatient-discharge prescriptions to be immediately approved for at least three days (subject to a $5,000/day cost cap and practitioner notice/notation), authorizes a performance-based “no prior authorization” exemption for certain high-performing providers subject to internal auditing and potential revocation, and requires quarterly Inspector General data collection on prior authorization activity and appeal outcomes; it also allows the Inspector General to assess civil penalties for violations. The section applies to policies/contracts/plans/agreements beginning on or after January 1, 2024.
regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit ... (View full title on source site)
label_outlineReimbursement
label_outlinePharmacist
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
April 09, 2025
Failed (Assembly)
March 23, 2026
Failed • 2025-2026 Regular Session • Introduced: April 09, 2025
Sponsors: Todd Novak (R), Travis Tranel (R), Scott Allen (R), David Armstrong (R), Robert Brooks (R), Calvin T. Callahan (R), Joan Fitzgerald (D), Brent Jacobson (R), Alex R. Joers (D), Karen Kirsch (D), Joel Kitchens (R), Daniel Knodl (R), Rob Kreibich (R), Maureen McCarville (D), Vincent Miresse (D), Jeffrey L. Mursau (R), Jerry L. O'Connor (R), Shae A. Sortwell (R), Paul Tittl (R), Chuck Wichgers (R), Duke Tucker (R)
Co-sponsors: Mary Felzkowski (R), Howard L. Marklein (R), Rachael Cabral-Guevara (R), Kristin Dassler-Alfheim (D), Dora E. Drake (D), Jodi Habush Sinykin (D), LaTonya Johnson (D), Sarah Keyeski (D), Chris Larson (D), Steve L. Nass (R), Bradley Michael Pfaff (D), Romaine Robert Quinn (R), Melissa Ratcliff (D), Kelda Roys (D), Mark Spreitzer (D), Van H. Wanggaard (R), Eric Wimberger (R), Jesse L. James (R)
The recent legislative changes significantly impact the regulation of pharmacy benefit managers (PBMs) in Wisconsin, focusing on enhancing transparency, fairness, and accessibility in pharmaceutical pricing and reimbursement practices. Key provisions require PBMs to pay pharmacies a professional dispensing fee that matches state medical assistance rates and prohibit them from imposing fees that would require remuneration from pharmacies. Additionally, PBMs must allow any licensed pharmacy to participate in their networks under the same terms and cannot charge different copayments based on network participation.
The legislation mandates that PBMs maintain and provide access to maximum allowable cost (MAC) lists, which must be updated promptly in response to price changes. Pharmacies are granted the right to appeal MAC determinations that fall below their acquisition costs, with PBMs required to resolve these appeals within a specified timeframe. Furthermore, PBMs are prohibited from discriminating against 340B covered entities and must ensure that all pharmacies in a preferred network are reimbursed at the same rates.
Auditing practices are also addressed, with requirements for uniformity in audits across similar pharmacies and restrictions on recouping reimbursements for errors that do not result in financial harm. PBMs must deliver final audit reports within a designated period and cannot retaliate against pharmacies for reporting violations or exercising their rights under the new regulations.
Health insurance policies are required to apply amounts paid for brand-name prescription drugs towards cost-sharing requirements, ensuring that patients' out-of-pocket expenses are minimized. Additionally, advanced written notice must be provided to enrollees regarding formulary changes, ensuring stability in medication options for those currently using affected drugs.
Overall, these changes aim to create a more equitable and transparent environment for pharmacies, pharmacists, and patients, significantly impacting the pharmacy and healthcare industries in Wisconsin.
BadgerCare purchase option, basic plan, state-based insurance exchange, and granting rule-making au... (View full title on source site)
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
March 19, 2026
Failed (Senate)
March 23, 2026
Failed • 2025-2026 Regular Session • Introduced: March 19, 2026
Sponsors: Chris Larson (D), Timothy W. Carpenter (D), Dora E. Drake (D), Melissa Ratcliff (D), Kelda Roys (D)
Co-sponsors: Supreme Moore Omokunde (D), Christian Phelps (D), Debra Andraca (D), Margaret Arney (D), Mike A. Bare (D), Jill Billings (D), Brienne Brown (D), Ryan M. Clancy (D), Angelina M. Cruz (D), Karen DeSanto (D), Ben DeSmidt (D), Steve Doyle (D), Joan Fitzgerald (D), Russell Goodwin (D), Kalan Haywood (D), Francesca Hong (D), Andrew Hysell (D), Jenna Jacobson (D), Alex R. Joers (D), Karen Kirsch (D), Darrin B. Madison (D), Renuka Mayadev (D), Maureen McCarville (D), Tip McGuire (D), Vincent Miresse (D), Lori A. Palmeri (D), Priscilla A. Prado (D), Amaad Rivera Wagner (D), Ann Roe (D), Joe Sheehan (D), Christine Sinicki (D), Lee Snodgrass (D), Ryan Spaude (D), Angela Stroud (D), Shelia Stubbs (D), Lisa Subeck (D), Sequanna Taylor (D), Angelito Tenorio (D), Randy Udell (D), Robyn Vining (D), Johnson, Anderson
The bill establishes three new Wisconsin statutory provisions: a “basic health plan” requirement for the Department of Health Services (DHS) to seek federal approval to create a federally compliant ACA basic health plan covering individuals up to 200% of the federal poverty level (FPL); a “purchase options for BadgerCare” program authorizing DHS to seek federal waivers/state plan amendments to let certain individuals with income above current BadgerCare eligibility purchase BadgerCare coverage, subject to program design requirements; and a new state-based health insurance exchange framework within the Office of the Commissioner of Insurance (OCI) to ensure enrollment access for the BadgerCare purchase option.
For the BadgerCare purchase options, DHS must request necessary federal waiver(s) and/or state Medical Assistance plan amendments to create a program allowing eligible individuals with income above the applicable BadgerCare maximum income eligibility limit to purchase coverage through the new BadgerCare option rather than private individual health plan purchase. DHS must also seek federal/state approvals so qualified enrollees can use federal advanced premium tax credits and cost-sharing credits (if eligible). Program administration must be coordinated with related programs DHS administers under the same statutory chapter sections to maximize efficiency and continuity of care, and DHS must seek mechanisms aimed at long-term financial sustainability, including minimizing adverse selection, managing state financial risk and contributions, and mitigating negative premium impacts in individual and group markets.
The purchase option program must include minimum attributes: (1) an annual per-enrollee premium rate similar to the average rate paid by the state to managed care plan contractors; (2) a benefit set equal to the benefits covered under the referenced BadgerCare-related statutes; (3) annual enrollment limited to the same annual open enrollment periods used for the related programs; (4) the ability to adjust the purchase option actuarial value to no lower than 87%; and (5) reimbursement mechanisms to address potential increased costs to the programs. DHS must report by March 1, 2027 to the standing legislative committees on the status of the federal waiver request and the results of required actuarial and economic analyses for a waiver proposal. DHS must also include, in collaboration with OCI if needed, an option for small groups of 50 employees or fewer to purchase coverage for group members under the BadgerCare purchase program.
Implementation depends on federal/state approvals: if the necessary waivers or state plan amendments are approved (or if DHS determines none are necessary), DHS must implement the purchase options and allow enrollment through them. Separately, the new state-based exchange provision directs OCI to develop and operate a state-based exchange that enables access to enroll in the BadgerCare purchase option through the exchange, authorizes OCI to enter federal agreements needed for implementation, and allows OCI to promulgate rules as necessary.
regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit ... (View full title on source site)
label_outlinePharmacist
1st Chamber
2nd Chamber
Executive
check_circle_outline
stop_circle
remove_circle_outline
remove_circle_outline
Introduced
April 16, 2025
Failed (Senate)
March 23, 2026
Failed • 2025-2026 Regular Session • Introduced: April 16, 2025
Sponsors: Mary Felzkowski (R), Howard L. Marklein (R), Rachael Cabral-Guevara (R), Kristin Dassler-Alfheim (D), Dora E. Drake (D), Jodi Habush Sinykin (D), LaTonya Johnson (D), Sarah Keyeski (D), Chris Larson (D), Steve L. Nass (R), Bradley Michael Pfaff (D), Romaine Robert Quinn (R), Melissa Ratcliff (D), Kelda Roys (D), Mark Spreitzer (D), Van H. Wanggaard (R), Eric Wimberger (R), Jesse L. James (R)
Co-sponsors: Todd Novak (R), Travis Tranel (R), Scott Allen (R), David Armstrong (R), Robert Brooks (R), Calvin T. Callahan (R), Joan Fitzgerald (D), Brent Jacobson (R), Alex R. Joers (D), Karen Kirsch (D), Joel Kitchens (R), Daniel Knodl (R), Rob Kreibich (R), Maureen McCarville (D), Vincent Miresse (D), Jeffrey L. Mursau (R), Jerry L. O'Connor (R), Jessie Rodriguez (R), Shae A. Sortwell (R), Paul Tittl (R), Chuck Wichgers (R), Duke Tucker (R)
The proposed legislation introduces comprehensive reforms to the regulation of pharmacy benefit managers (PBMs) in Wisconsin, focusing on enhancing transparency, fairness, and accountability in the pharmaceutical supply chain. Key provisions require PBMs to pay pharmacies a professional dispensing fee that matches state rates and prohibit them from imposing various fees on pharmacies. Additionally, PBMs must allow any licensed pharmacy to participate in their networks under the same terms and conditions, ensuring equitable access for all pharmacies.
The legislation mandates that PBMs provide detailed maximum allowable cost lists to pharmacies, update these lists promptly, and establish an appeal process for pharmacies contesting low reimbursement rates. Furthermore, PBMs are required to notify enrollees of formulary changes well in advance and cannot remove drugs from formularies except at coverage renewal times. This aims to provide stability for patients regarding their medication options.
PBMs are also tasked with acting in the best interests of health benefit plan sponsors, including annual disclosures of profits and payments to consultants. They must remit payments for claims within 30 days and cannot discriminate against 340B covered entities in reimbursement practices. The legislation prohibits PBMs from retaliating against pharmacies for reporting violations or exercising their rights, fostering a more supportive environment for pharmacies.
Auditing practices are also addressed, requiring uniform standards for audits and prohibiting recoupments for errors that do not cause financial harm. The legislation aims to standardize reimbursement rates among pharmacies and protect pharmacies from unfair practices, ultimately benefiting consumers by improving access to pharmaceutical products.
Overall, these changes are designed to create a more transparent and equitable pharmaceutical landscape in Wisconsin, impacting the operations of PBMs, pharmacies, and health insurance providers significantly.
bill
Regulation • 🇺🇸 United States • Wisconsin • Regulatory Notice
The document establishes Wisconsin DHS’s public notice that it will change Wisconsin’s Medicaid Hospital Inpatient State Plan (Attachment 4.19-A) to eliminate the state’s Supplemental Disproportionate Share Hospital (DSH) payment program. It specifies the covered-plan sections affected and states the effective date and projected fiscal impact of the changes.
Specifically, DHS will remove §9230 “Supplemental DSH Payments for In-State Hospitals” effective June 16, 2026, aligning with the discontinuation of the Supplemental DSH program under 2025 Wisconsin Act 15. In addition, DHS will update §9300 “Rural Critical Care Supplement” to reflect changes resulting from the Supplemental DSH payment program discontinuation.
The notice states that the Medicaid and BadgerCare Plus changes are projected to reduce total annual expenditures by $182,100,000 all funds (AF), including $110,500,000 federal match (FED) and $71,600,000 state funds/general purpose revenue (GPR). It also provides procedures for obtaining copies of the proposed state plan amendment for review, and it sets out a written public comment process (comments accepted by fax, email, or mail; made available for public review between 7:45 a.m. and 4:30 p.m. daily in Madison, WI).
Wyoming
2
bill
Regulation • 🇺🇸 United States • Wyoming • Final Notice
Chapter 9 of the Wyoming Workers’ Compensation Division’s fee schedules sets statewide rules for how medical and hospital services and related items are reviewed and reimbursed. It establishes general payment principles (including payment based on the fee schedule in effect at the time of service; potential preauthorization for certain services; limits on provider billing; and required delivery of records to the Division without charge after a claim is accepted). It also defines key methodologies for code valuation, including use of gap-fill values when RBRVS lacks values and limits that prevent reimbursement exceeding billed amounts or general-public charges.
The regulation adopts fee schedules and incorporates by reference specified versions of standard coding and payment references tied to 2026 for the professional (RBRVS) and dental (RVD) components, with adoption rules that bar later amendments/editions beyond the applicable date. It requires use of accepted medical resources (e.g., RBRVS/FAIR Health/AMA CPT, MS-DRGs definitions, OPPS addenda, HCPCS, lab fee schedules, CDT) to support bill adjudication. It also authorizes the Division to change billed codes for compliance and requires that providers be informed through the payment statement, including notice of the right to appeal. Operative fee schedule additions/requirements include:
• Conversion factors for five specialty groups (anesthesia, spine procedures, evaluation & management, and specific radiology/MRI-only groupings). • Dental reimbursement set at the 85th percentile of FAIR Health Data benchmarks published July 1, 2025. • Rules for assistant surgeon billing (MD assistants at 20% with specified modifiers; non-MD assistants at 15% with an “AS” modifier). • Anesthesia payment modifier structure (AA/AD/QK/QX/QY/QZ) and additional patient status modifiers (P-1 through P-6). • Fees for Independent Medical Evaluations (IME) and impairment ratings (including code selection based on whether performed by treating vs non-treating physician and fixed hourly and per-interval rates), plus payment handling for no-call/no-show file-review scenarios. • Medical testimony/deposition charges at specified hourly and interval rates.
Beyond physician services, the chapter establishes specific fee schedules for: home health nursing (RN/LPN/CNA per-visit rates with no overtime/holiday/shift differential; a visit is 15 minutes up to a 4-hour daily maximum); private duty/attendant care (straight hourly rates; attendant care defined as activities of daily living with physician prescription and time limits; attendant provided by approved individuals); supplies, implants, DME, orthotics, and prosthetics (Rural Wyoming Medicare rate plus 30%, with limits tied to whether items are prescribed by the treating provider, documentation/invoice requirements for certain charge thresholds, gap-fill/fallback reimbursement for items not in the Rural Wyoming HCPCS schedule, special rules for certain devices including E0676 flat-rate during surgical procedure only, and prohibition on direct payment to suppliers/manufacturers for implantable items). It also sets fee rules for hearing aids and prescription lenses (invoice-based percentage for hearing aids; CMS/FAIR Health gap-fill approach for frames/lenses; repair/replacement for work-related loss), pharmacy reimbursement formulas (AWP-10% plus dispensing fee vs usual/customary charge; billing-unit/NDC requirements; $2.50 reduction for paper claims unless electronic billing is unavailable; OTC items without valid NDC treated as supplies without dispensing fee; special handling for repackaged drugs and outpatient pharmaceuticals dispensed in provider offices), compounded medications (invoice requirements and 130% of invoice for physician-billed compounded drugs; compounding service line-item reimbursement based on coverable ingredients), ambulance services (lesser-of billed or maximum allowable rate; Rural Wyoming Medicare +30% rates effective as stated), and facility fees for inpatient/outpatient/ASC settings.
Facility fee rules specify Medicare-based methodologies at set percentages of Medicare allowed amounts (notably 150% for many inpatient/outpatient/ASC classifications and an 80% fallback when no inpatient/ASC weight exists) and include required documentation categories (e.g., itemization and clinical records such as operative reports and implant logs). Skilled nursing services are governed by a Division-determined per diem room rate survey (including all-inclusive components and permitted out-of-per-diem billing categories). The chapter also sets home infusion therapy reimbursement based on CMS HIT rates plus 30% and imposes G-code billing rules (only one G-code per line item date of service within a 30-day window; per-day-rate units not to be multiplied; drugs separately payable).
The bill establishes statutory Medicaid eligibility requirements in Wyoming by adding a new subsection to W.S. 42-4-106(e) that codifies specific applicant eligibility prerequisites and enumerated qualifying circumstances. It requires the Wyoming Department of Health to promulgate implementing rules by October 1, 2026. It specifies that the act applies to Medicaid applications submitted or renewed on or after July 1, 2027, and sets an earlier effective date for specified sections upon completion of required constitutional enactment steps.
Key changes include: (1) setting eligibility prerequisites that an applicant provide a valid Social Security number and proof of identity, qualify as a U.S. citizen/national (with an exception for applicants “lawfully present” in the U.S.), and meet Wyoming residency requirements (with a rule that intending to return to the applicant’s home in another state/country does not constitute Wyoming residency); (2) requiring an applicant to fulfill at least one of several enumerated criteria, including disability under Social Security guidelines, receipt of SSI or SSI-related programs, hospice eligibility tied to voluntary hospice election and (in specified cases) length of hospice/medical institution residence, qualification for services under a Medicaid waiver or other authorized expansion, tuberculosis-related criteria, other federal Medicaid-eligibility pathways subject to federal rules, foster care/school-custody categories, enrollment in the 1115 family planning waiver with an authorization to operate through planned expiration on December 31, 2027 (and no renewal beyond then), enrollment in the employed individuals with disabilities program, and enrollment in the breast and cervical cancer treatment program; and (3) mandating that applicants also satisfy any additional department rule or federal Medicaid regulatory criteria.
The bill is effective July 1, 2027 for most provisions, while Sections 2 (rulemaking) and 4 (effective-date provision) are effective immediately upon completion of constitutional enactment prerequisites.